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ABSTRACT
The aim of the current work was to improve understanding of factors associated with
distress in women at increased risk of breast cancer because of their family history of
the disease. Levels of distress have been described in this population although few
studies have attempted to investigate causes of variation in distress. A number of
anecdotal reports and qualitative studies have highlighted that women's experiences
of breast cancer in their family is related to distress. The first study in this thesis
aimed to assess women's experiences in a quantitative manner and demonstrated
associations with general and cancer specific distress.
Applying theoretical perspectives from health psychology enables us to consider how
these experiences may influence psychological response to genetic risk. Using
Leventhal's SelfRegulatory Model (SRM) (Leventhal et al. 1980) a theoretical
model was developed for use in this thesis. This model proposed that perceptions of
breast cancer mediate the impact of experiences of the disease in the family on
psychological well-being. A large cross-sectional questionnaire study ofwomen at
increased risk of breast cancer and women in the general population was conducted
in order to systematically explore this model. As there were no measures available to
assess perceptions of breast cancer in healthy populations an existing generic
measure was adapted and evaluated in the current samples. The mediation model was
then systematically explored in a series of analyses.
The results confirmed a number ofhypotheses. Women at increased risk of breast
cancer showed higher levels of cancer specific distress and held different perceptions
ofbreast cancer than women with no experience of the disease. Analysis indicated
that experience ofbreast cancer in the family was associated with levels of distress
and perceptions of the disease and that both experience ofbreast cancer and illness
perceptions predicted distress in women at increased risk. Some support for the
mediation model was found.
This thesis has shown that the SRM can be successfully applied to women at
increased risk of breast cancer. Further work is required to explore additional aspects
xvi
of illness perceptions in healthy individuals at increased risk of disease and to test the
causality of relations revealed in this thesis. Utilising theoretical models to
understand response to risk in this clinical context is likely to provide implications




This section briefly outlines the overall organisation of the thesis. The research
reported in this thesis aims to bring a theoretical understanding to a clinical issue-
understanding variation in levels of distress in women at increased risk of breast
cancer. The research is based on a large quantitative study designed to explore the
impact of experience of breast cancer in the family and illness perceptions on levels
of general and cancer specific distress in women at increased risk of breast cancer.
Chapter 1. begins with an overview of breast cancer. The risk factors, symptoms and
prognosis of the disease are outlined as well as options for screening and treatment.
This is followed by an explanation of genetic predisposition to familial breast cancer
and the screening and preventative options available to women at increased risk. The
psychosocial aspects of familial breast cancer are then explored with a particular
focus on emotional response to breast cancer risk. Research that has examined the
psychological well-being in women at increased risk of breast cancer is reviewed.
Chapter 2. focuses on the impact of experience of cancer in the family. The impact of
women's experiences of breast cancer in the family on response to risk of familial
breast cancer is reviewed. It is concluded that whilst this is an important determinant
of response to risk research has tended to be descriptive in nature and a theoretical
perspective is required to understand the mechanism involved.
Chapter 3. provides a discussion on theoretical perspectives that can be utilised to
help understand and explain the relationship between experience of breast cancer in
the family and response to risk. This chapter discusses the potential impact of
personal experience on risk perception, decision making and illness representations.
The SelfRegulatory Model is described and a review of its application to
understanding patient response to illness is outlined. The application of this model as
a framework for understanding healthy individuals response to health threats is
discussed.
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Chapter 4. outlines the aims and design of the current research. The primary aim of
the thesis is to test a mediation model that perceptions of breast cancer mediate the
impact of experiences of the disease in the family on psychological wellbeing in
women at increased risk ofbreast cancer. This is tested with a cross-sectional study
including women at increased risk of breast cancer and a comparable sample of
women in the general population. The objectives and hypotheses to be examined
throughout the thesis are outlined and the design, participants, procedures and
measures are described. Chapter 5. gives further details of samples included in the
research and provides response rates and descriptions of samples. Chapter 6. is
dedicated to describing in more detail the main measure utilised in the research. This
chapter provides a detailed description of the development of a measure of
experience and outlines pilot work to assess the acceptability and appropriateness of
this measure for the current research. The adaptation and psychometric evaluation of
an existing quantitative measure of illness perceptions for use in the current samples
is also provided.
Chapters 7-10 comprise the results of the research. These chapters are organised to
reflect different components of the theoretical model to be tested as outlined in
Chapter 4. Chapter 7 provides the section of results referring to associations between
experience ofbreast cancer and distress. Chapter 8. covers the analysis of
associations between experience of breast cancer and illness perceptions. Chapter 9.
reports the analysis of associations between illness perceptions and distress. Each of
these chapters provides a comparison between the women at increased risk of breast
cancer and a control sample as well as exploring associations within each sample.
Chapters 7 and 9 also provide results of analysis to predict level of general and
cancer specific distress in women at increased risk of breast cancer. Chapter 10. pulls
these results together and systematically tests potential mediation models as
highlighted throughout the subsequent results chapters.
Chapter 11 provides the main discussion for the thesis that builds on the summary
discussions presented at the end of each chapter. Chapter 11. opens with a summary
of the main findings presented throughout the thesis. This is followed by a discussion
of the theoretical implications and methodological issues that have been raised in the
xix
course of this research. This is followed by a discussion of the clinical application of
this work and directions for future research and final conclusions.
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BREAST CANCER AND GENETIC PREDISPOSITION
1.1 BREAST CANCER: CLINICAL AND PSYCHOSOCIAL ASPECTS
1.1.1 What is cancer?
Growth and development of cells in the body is regulated by complex genetic
mechanisms that ensure tissues and organs develop, and remain, appropriate to the
body's needs (Wienberg 1996). If the mechanisms controlling cell growth and
division are disrupted, cells may divide in an uncontrolled manner causing the range
of diseases collectively known as cancer. Cancer originates from one cell that has
accumulated damage (or mutations) to the genetic controls over repeated cell
divisions. It can occur in almost every tissue in the body and cancer cells are able to
spread (metastasise) to other areas in the body. The series of genetic changes leading
to cancer develop over a period ofmany years and both inherited and environmental
factors are involved in this process. Accidents in cell division, failure ofDNA repair
mechanisms and environmental factors can all bring about genetic changes resulting
in a cancer cell.
1.1.2 Breast cancer
Breast cancer is a malignant tumour that develops in the cells of the breast and is the
most common form of cancer in women in the UK (excluding non-melanoma skin
cancer) comprising 18% of all female cancers (McPherson 2000). In the UK, 26,000
new cases of breast cancer are diagnosed each year (Silva and Zurida 2000). Breast
cancer is the leading cause of death in women aged 35-55 years (Baum and Schipper
1998). The average lifetime risk of breast cancer for women in the UK is 8%
meaning that approximately 1 in 12 of all women in the UK will develop breast
cancer in their lifetime. This figure represents cumulative risk for women who live to
85 years of age. About a third of all reported breast cancers occur in the older age
group 70-85. The risk for women between the ages of 30 and 50 is 1/1000 per yr
(2%) (Baum and Schipper 1998). Breast cancer can occur in men although it is very
rare (Ravandi-Kashani and Hayes 1998).
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1.1.3 Risk factors for breast cancer
There is no single cause ofbreast cancer and the disease is likely to be due to
numerous interactions between genetic and environmental factors. A number of risk
factors have been identified for breast cancer. These include family history;
sociodemographic factors; exposure to radiation; age; previous benign disease;
reproductive factors; exogenous hormones and lifestyle factors (McPherson et al.
2000). Although these risk factors are often widely publicised in the media the
majority of risks are actually very low (with the exception of age, family history and
previous atypical hyperplasia). A large proportion ofwomen who develop breast
cancer (about 66%) do not have any major risk factor (Harris et al. 1992). Baum and
Schipper (1998) indicate that the evidence for risk factors is based on observational
data which have "methodological weaknesses and leading statisticians have
questioned whether a relative risk below 2 is not within the experimental error ofthe
method". (Baum and Schipper 1998, pg 13). There is little evidence to suggest that
women can prevent breast cancer or reduce their risk by changes in lifestyle factors.
Certain risk factors (ie oral contraceptives) need to be balanced with other risks such
as unwanted pregnancy. The complexity concerning risk factors and different terms
used to portray risk (ie absolute risk, relative risk and cumulative risk) may be
difficult for the lay public to assess.
A number ofmodels have been developed to calculate an individual's risk of breast
cancer based on risk factors for the disease (McTiernan et al. 1997). The Gail model
calculates breast cancer risk from epidemiological factors including age at menarche,
age at first birth, number of affected relatives, number ofprevious breast biopsies
and evidence of atypical hyperplasia (Gail et al. 1989). This model tends to
underestimate risk due to family history because second-degree relatives and affected
paternal family members are not recognised as increasing risk. The Claus model is
based solely on family history information such as number of affected relatives and
age of diagnosis (Claus et al. 1991). Neithermodel is able to provide a perfect risk
estimate and reliability of the models over different populations has been questioned
(Emery et al. 2000).
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1.1.4 Symptoms and prognosis
Changes in breast cancer cells have been identified which allow the classification of
pre-cancerous and cancerous cells. Minor changes in cells leading to cysts are known
as hyperplasia or proliferative disease and may be due to either genetic changes in
cells or hormonal changes within the cells' environment (Kelly 2000). Changes in
the DNA ofbreast cells can result in non-malignant abnormal growth patterns known
as atypical hyperplasia. Breast cancer shows greater DNA changes and is classified
by the origins of the cancer (ie in ducts or lobules in the breast) and whether they are
confined to the original site (in situ) or have invaded surrounding areas (invasive)
(Baum and Schipper 1998). Further classification of invasive breast cancer also
exists based on pattern of growth and cell morphology (Sainsbury et al. 2000).
Controversy exists concerning the classification of ductal carcinoma and lobular
carcinoma in situ (DCIS and LCIS) (Kelly 2000). These cells are unable to
metastasise and hence may also be referred to as 'pre-cancerous' cells although they
account for a large proportion of breast cancer diagnoses (Kelly 2000). Breast cancer
cells do not necessarily follow this sequence of genetic changes and breast carcinoma
in situ may not always lead to invasive disease. Post-mortem studies have revealed
that progression from carcinoma in situ to invasive disease may be as low as 20%
(Baum and Schipper 1998).
The number and type of symptoms associated with breast cancer varies widely
depending on the stage of disease (how much it has spread) and the location of
metastases. Pre-invasive carcinomas (DCIS and LCIS) have few symptoms and are
often not detected until mammography. Invasive breast cancer can usually be felt as
a hard and irregular lump. Changes in the skin, nipple and nipple discharge are also
common, although pain in the breast is seldom a symptom of breast cancer (Baum
and Schipper 1998).
Locally advanced breast cancer patients may also suffer from lymphoedema leading
to swelling and possible pain and paralysis of the arm. Thickening and ulceration of
the skin may also occur at the site of the tumour. Metastatic breast cancer (i.e. where
cancer has spread from the affected breast) can cause a variety of symptoms
depending on where the metastases occur. Common sites of spread are bone, liver
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and brain resulting in a range of symptoms: pain, weakness, nausea, anorexia, weight
loss, jaundice, headaches and neurological symptoms. The progression of breast
cancer is extremely variable and the terminal phase of the disease may range from a
few days to several months in duration. Baum and Schipper (1998) highlight the
unpredictable nature of breast cancer:
"At one extreme, women may present with massive involvement of the
axillary nodes or even bone marrow infiltration with the primary tumour
virtually undetectable and die of breast cancer before the primary
disease is clinically apparent. At the other extreme women m ay refuse
treatment and live for 20-30 years with a slowly progressive cancer
which though it may present an unpleasant problem for the patient,
seems to lack the capacity to metastasise and kill" (Baum and Schipper
1998 pg 21-22)
1.1.5 Screening
Primary prevention of breast cancer is not possible to date because of the lack of
knowledge concerning pathogenesis of the disease. Screening aims to reduce
mortality from breast cancer by detecting and treating the disease early before it has
spread. Prognosis and survival from breast cancer depends on tumour size, stage of
disease and metastases at presentation. Small tumours (<2cm) have a 5-year survival
rate ofmore than 90%, compared to 60% for patients with tumours over 5cm (CRC
factsheet 1996). Early detection is therefore paramount in reducing mortality.
Mammography is a screening test for breast cancer that uses X rays of the breast to
detect abnormalities that may be malignant. Randomised controlled trials of
mammography have shown that attendees benefit from reduction of up to 40% in
breast cancer mortality with the highest reduction in risk shown in the 50-70 age
group (Blarney et al. 2000). Cancers detected by mammography are likely to be
smaller, non-invasive and less likely to have metastasised compared to symptomatic
cancer (Blarney et al. 2000). The National Breast Cancer Screening programme in
the UK offers mammography screening every 3 years to women in the age range 50-
64 (Scottish Intercollegiate Guideline Network 1998).
The value of screening for younger women remains controversial. Analysis of data
from randomised trials has shown no significant reduction in mortality for women
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under the age of 50 (Fletcher et al. 1993, Kerlikowske et al. 1993). This may be
because younger women's breasts are more dense making the test less sensitive.
Breast cancer is also less prevalent in younger women reducing the number of
cancers detected and cost effectiveness of screening in this group (Neugut and
Jacobsen 1995). However there are concerns that screening techniques have been
updated since these early trials. More recent studies have indicated that screening
may be effective in reducing mortality from breast cancer in women as young as 40
(Tabar et al. 2001). The benefits of screening prove difficult to evaluate due to
methodological problems. Large samples with long follow up periods are required in
order to assess the impact of screening procedures on outcomes such as mortality.
However this time span is confounded with changes in incidence and treatment over
time (Wardle and Pope 1992).
There are a number ofproblems associated with screening. Firstly, the false negative
rate is high (10-30%) as are the detection of unimportant abnormalities and false
positives (approximately 1%) (Silva and Zurida 2000). A number of factors
contribute to this including dense breast tissue, difficulties screening the entire
breast, difficulties detecting lobular carcinoma and interpretation error (Silva and
Zurida 2000). Adherence to mammography is not ideal and has been estimated at
70% (Baum and Schipper 1998). The optimal interval between mammograms has
also not been determined. There are concerns that the time interval between
screening is too long and that women reassured by screening procedures will not self
examine between tests (Baum and Schipper 1998). Seventeen percent of tumours
have been reported to occur between screening sessions (Andersson et al. 1988) and
the majority of breast cancers are first detected by women themselves (Austoker
1994). Regular breast self-examination (BSE) is encouraged in order to increase
early detection. Breast awareness in the UK, encourages women to become familiar
with their breasts and to distinguish between normal cyclic fluctuations and abnormal
changes. However there is no evidence that clinical breast examination (CBE) or
BSE increase early detection or survival (Blarney et al. 2000) and no differences in
mortality between those receiving BSE training and controls has been reported
(Baum and Schipper 1998).
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1.1.6 Diagnosis and treatment
Following identification of a breast lump subsequent investigations may include
diagnostic mammography to identify the size and character of the abnormality,
clinical examination and ultrasound. A tissue biopsy removing a sample of breast
tissue may be conducted in order to determine if the lump is benign or malignant.
Triple assessment (clinical examination, imaging investigations and pathological
evaluations) are advised in order to gain a confident diagnosis (Scottish
Intercollegiate Guidelines Network 1998, Baum and Schipper 1998). About 2/3 of
breast abnormalities detected by mammography prove to be benign on further
examination (Blarney et al. 2000).
Treatment for breast cancer may be targeted locally at the breast (surgery and
radiotherapy) and systemically to treat metastatic disease. Local surgical treatments
include mastectomy, in which the whole breast is removed with varying degrees of
chest muscle and lymph glands, or breast conservation surgery to remove the tumour
and surrounding tissue. Breast conservation surgery includes lumpectomy or
quadrantectomy (removing a quadrant of the breast). The decision regarding the
extent of surgery depends on several factors including the age of the patient, size of
tumour relative to breast size, stage of tumour, grade of tumour (how fast the cancer
cells are growing), patients preference and fitness for surgery and/or radiotherapy
(Scottish Intercollegiate Guidelines Network 1998). Mastectomy is recommended for
approximately 1/3 of localised disease (Sainsbury et al. 2000). There are a number of
possible complications following mastectomy including bruising, swelling, infection,
nerve damage, shoulder weakness or stiffness and swelling of arm due to
lymphoedema. Radiotherapy targets high energy rays to kill cancer cells and is used
after surgery to prevent local recurrence or metastases. It is normally administered in
daily sessions with breaks at weekends for up to 6 weeks. Common side effects
include skin reactions, nausea and vomiting. Pneumonitis from irradiation of the
lungs is a rare side effect occurring in less than 2% of patients (Baum and Schipper
1998).
Although breast cancer originates in the breast it may spread to other parts of the
body. Systemic treatments target cancer cells anywhere in the body and include
28
chemotherapy and hormonal treatment. These treatments may be delivered before
surgery to reduce size of lump and/or following surgery to reduce risk of spreading
(adjuvant therapy). Often patients with distant metastases are incurable and in these
cases systemic treatment is provided in order to relieve symptoms and maintain
quality of life.
Chemotherapy can be given as tablets or intravenously and a full course can take up
to 6 months to complete. Side effects of chemotherapy will vary according to the
specific drugs used but commonly include tiredness, hair loss, nausea, risk of
infection, diarrhoea, vomiting, risk of infertility, premature menopause and weight
gain. Hormone therapy uses drugs such as tamoxifen that reduce the impact of
oestrogen on cancer cells. These drugs are taken over a period of at least 5 years
following surgery (Scottish Intercollegiate Guidelines Network 1998) and side
effects include menopausal symptoms such as hot flushes and slight increased risk of
endometrial cancer. Adjuvant systemic therapy using chemotherapy and/or hormone
therapy has been shown to reduce the incidence of recurrence ofbreast cancer and
overall mortality (Early Breast Cancer Trialists' Collaborative Group 1988, 1992).
Tamoxifen has been shown to reduce the chance of recurrence by 25% and mortality
by 17% although the benefits are largely selective to patients with oestrogen receptor
positive cancers (Early Breast Cancer Trialists' Collaborative Group 1992, 1998).
Ovarian ablation is another possible treatment that has been found to reduce
recurrence and death from breast cancer in pre-menopausal women with oestrogen
receptor positive cancers (Early Breast Cancer Trialists' Collaborative Group 1996).
Side effects from this procedure include early menopause and infertility.
A number ofproblems have been identified in women subsequent to treatment for
breast cancer that may affect quality of life. These include lymphoedema due to
damage to the lymph nodes following treatment, problems with arm mobility,
menopausal symptoms and cosmetic issues. Women who have been treated for breast
cancer are also at high risk of clinical levels of anxiety and or depression, sexual
difficulties and body image problems (Maguire et al. 1978, Irvine et al. 1991).
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1.1.7 Recurrence
Following treatment patients are maintained under regular surveillance in order to
check for signs of recurrence and to ensure metastases are detected as early as
possible. The effectiveness ofmammography following breast conservative surgery
is reduced since scarring resembles the appearance of cancer (Sainsbury et al. 2000).
Recurrence has been associated with disease stage at diagnosis and extent of surgery
(more extensive surgery is associated with lower recurrence). Recurrence following
breast conservation surgery and radiotherapy is at the frequency of about 1% per
annum (Scottish Intercollegiate Guidelines Network 1998). Local recurrence of
cancer following mastectomy is most likely to occur within 2 years following
surgery (Sainsbury et al. 2000) and is often associated with distant metastases within
the subsequent decade (Scottish Intercollegiate Guidelines Network 1998).
Mortality from breast cancer has been declining since 1990 in America and Europe
(Mettlin 1999). This decline is likely to be due to earlier diagnosis with
mammography and more effective adjuvant therapy. Trials are currently being
conducted to test the best combinations of treatments, timing, doses and methods of
delivery as well as use of new drugs on survival and quality of life (Baum and
Schipper 1998). There are a number of new treatment possibilities that are currently
being tested including vaccines which trigger the bodies immune response and
treatment aimed at triggering the cancer cells suicide gene (Imperial Cancer Research
Fund- Cancer Information Service). Although no preventative measures are available
at present a number ofpotential areas are under investigation for example use of
tamoxifen as a preventative agent.
1.1.8 Summary
Breast cancer is one of the most common forms of cancer although medical
understanding of the pathogenesis of the disease is unclear. A number of risk factors
have been associated with the disease although the majority are uncontrollable and
there is little evidence to suggest that changes in lifestyle factors can prevent the
occurrence of the disease. Breast cancer has few observable symptoms although may
be detected by changes in the breast. Screening with mammography in older women
is effective in reducing mortality although remains controversial in women under the
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age of 50. The false negative rate in mammography screening is high and there are
concerns regarding the optimal timing of screening sessions. Both CBE and BSE are
of unproven efficacy across all age groups to date. Women in the general population
therefore face a fairly high risk of breast cancer with little scope for personal control
and the detection methods available are controversial and anxiety invoking. The
prognosis ofbreast cancer is extremely variable and treatment side effects may be
severe. Psychosocial problems following breast cancer are common and patients face
a risk of recurrence.
1.2 FAMILIAL BREAST CANCER: CLINICAL ASPECTS
1.2.1 Genetic predisposition to breast cancer
A family history ofbreast cancer has long been established as a risk factor for the
disease. Epidemiological studies have shown that individuals with affected relatives
have a higher risk ofbreast cancer and are more likely to develop the disease at a
younger age (Adami et al. 1980). It has been estimated that about 5-10% of breast
cancer cases are caused by hereditary factors. Studies of families with high incidence
of breast cancer suggested that the disease showed patterns indicative of dominant
inheritance (Claus et al. 1990). Molecular genetic studies have been conducted to
localise the genes linked with breast cancer and estimate their penetrance (Hall et al.
1990, Easton et al. 1993). In 1994 the BRCA1 gene associated with both early onset
familial breast and ovarian cancer was identified on chromosome 17 (Miki et al.
1994, Futreal et al. 1994) followed by discovery of a second gene (BRCA2) on
chromosome 13 (Wooster et al. 1995).
BRCA1 and BRCA2 are large genes that encode proteins involved in DNA repair
(tumour suppressor genes). Mutations can occur at any location on these genes and
are associated with a significant increased risk of developing breast cancer. Over 100
mutations on the BRCA1 gene have been identified (Collins 1996). The BRCA1 and
BRCA2 genes are autosomal dominant so the offspring of a mutation carrier has a
50% chance of inheriting the gene. Mutations can be inherited from either the
maternal or paternal side of the family. Hereditary breast cancer occurs at a younger
age because these germline genetic mutations are present in all cells at conception. It
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therefore takes less time for additional mutations to occur and subsequently for
cancer to develop compared to non-hereditary breast cancer caused by accumulated
genetic mutations in somatic cells throughout an individual's lifetime. Most breast
cancers that are due to a genetic mutation occur before the age of 65. Mutations in
either BRCA1 and BRCA2 are implicated in up to 25% of patients diagnosed with
breast cancer before age 40 (Baum and Schipper 1998).
BRCA1 and BRCA2 show high but not full penetrance. Lifetime risks associated
with a mutation in either gene were initially estimated at about 80%. These
penetrance rates are likely to be overestimated because they are based on studies of
families with extremely high incidence ofbreast cancer (Collins 1996). More recent
studies ofmutation carriers have shown lower penetrance estimates of under 60%
(Struewing et al. 1997). The risk of developing breast cancer is therefore uncertain
even for known mutation carriers. BRCA1 mutations are also associated with an
increased risk of ovarian cancer and male carriers are at an increased risk of
developing colon cancer and prostate cancer (Silva and Zurrida 2000). The risk of
ovarian cancer is not as high for BRCA2 carriers although mutations on this gene are
also associated with an increased risk of a range of other cancers including male
breast cancer, cancer of the uterus, prostate cancer, pancreatic cancer and gastric
cancer. Breast cancer patients carrying BRCA1 or BRCA2 mutations are at high risk
of contralateral breast cancer.
BRCA1 and BRCA2 are implicated in approximately 4% of breast cancers (Baum
and Schipper 1998) and are currently only thought to account for families with an
extremely strong family history (ie at least 5 cases ofbreast cancer under the age of
45 or ovarian cancer at any age) (Emery et al. 2000). However, there are also likely
to be other more common mutations with lower penetrance associated with a
moderate increased risk of breast cancer (Ford et al. 1995).
The role of environmental factors in phenotypic expression of risk is unclear.
Although studies have been carried out to determine interactions between family
history and other risk factors including reproductive factors and exogenous hormones
the results are controversial (Evans et al. 1994). In a meta-analysis of studies ofHRT
32
use and breast cancer risk Steinberg et al. (1991) found that use ofHRT significantly
increased the risk ofbreast cancer for women with a family history. Dupont and Page
(1985) also found the risk associated with proliferative breast disease was
significantly greater in women with a family history compared to those without. A
major problem with many studies of this type is the definition of family history.
Many studies define 'family history' as at least one first degree relative with breast
cancer although many such cases may not actually represent a significant family
history of the disease. This reduces the ability to detect effects within true familial
cases (Evans et al. 1994).
1.2.2 Risk assessment
Media interest in breast cancer and publicity concerning BRCA1 and BRCA2 has
lead to increased awareness of genetic causes ofbreast cancer. Cancer genetic
services have developed in order to provide information and advice about familial
cancer, to identify individuals at increased risk of cancer and to establish effective
management strategies (The Scottish Office 1998). Women are mainly referred to
familial breast cancer clinics from primary care and studies have indicated a large
increase in GP consultations regarding family history of cancer and referrals to
cancer genetic clinics (Emery et al. 2000; The Scottish Office 1998). Although
approximately 8% ofwomen over 40 have at least one first degree relative with
breast cancer only a small proportion of these women will have a significant family
history of the disease (Mettlin 1994). Familial breast cancer clinics therefore conduct
a detailed analysis of family history in order to obtain a genetic risk estimate.
Assessment of family history is prone to a number ofproblems. For example, little is
known about the accuracy of self reported family histories and errors may result from
lack of knowledge and accuracy ofprevious diagnoses and/or medical records
(Richards 1999). Families may also not include a sufficient number of females to
allow expression of the condition (Richards 1999).
Current genetic services have developed due to local pressure in a 'fragmented and
uncoordinated manner' (The Scottish Office 1998). As a result there is as yet no UK
national consensus for determining risk status and guidelines for assessing family
history vary in procedure and recommendations (Emery et al. 2000). The criteria
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provided by the National Clinical Guideline for Scotland are outlined in Figure 1.1
(Scottish Intercollegiate Guideline Network 1998). The crucial aspects of family
history include: the age at which affected relatives were diagnosed; the number of
relatives diagnosed; their relation to the counsellee and the site of their cancer
(unilateral or bilateral breast cancer and incidence of other cancers). Young age of
onset of breast cancer is considered more important than the number of affected
relatives in the family (Silva and Zurrida 2000). The empiric risk of familial breast
cancer for an individual is not static but changes with events in the family (such as
diagnoses) and age of counsellee. Women with a positive family history are at
greatest risk between the ages of 30-50 years. As their age increases beyond this
level without occurrence ofbreast cancer the chances of having inherited a mutation
and developing familial breast cancer are reduced (Evans et al. 1994). However their
risk falls to the level of the general population risk of sporadic breast cancer and this
risk increases with age.
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Figure 1.1- Criteriafor identifying women at substantial increased risk
The following categories identify women who have three or more times
the population risk of developing breast cancer.
A woman who has:
• One first degree relative with bilateral breast cancer or breast and ovarian
cancer or
• One first degree relative with breast cancer diagnosed under the age of 40
years or one first degree male relative with breast cancer diagnosed at any age or
• Two first degree or second degree relatives with breast cancer diagnosed under
the age of 60 years or ovarian cancer at any age on the same side of the family or
• Three first degree or second degree relatives with breast and/or ovarian cancer
on the same side of the family
In this context afirst degree relative is mother, sister or daughter. A second
degreefemale relative is grandmother, granddaughter, aunt or niece.
Criteria for identifying women at very high risk in whom direct gene
testing might be appropriate:
• Families with four or more relatives affected with either breast or ovarian
cancer in three generations and one alive affected individual.
1.2.3 Screening and detection
An increased understanding of genetic predisposition to breast cancer has the
potential to reduce mortality by enabling surveillance programmes and prevention
trials to be targeted to those at increased risk. In Scotland women who are deemed at
significant increased risk of breast cancer because of their family history are offered
regular clinical examination and mammography. It is recommended that screening
starts at 35 or 5 years younger than the youngest affected relative, whichever is first.
Women under 40 are offered biennial mammography and annual clinical
examination, women aged 40-50 are offered annual mammography and clinical
examination. Women aged over 50 are either discharged to the national screening
programme or continue with annual screening (Scottish Intercollegiate Guideline
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Network 1998). Although guidelines for risk management are under development
(Vasen et al. 1998, Eccles et al. 2000) there are currently no internationally agreed
protocols to determine when strategies such as screening and genetic testing should
be offered.
The effectiveness of screening among younger women in the general population
remains controversial but data are emerging to support its effectiveness among
younger women selected for their familial risk (Eccles et al. 2000, Macmillan 2000,
Lalloo et al. 1998, Kollias et al. 1998, Tilanus-Linthorst et al. 2000). The detection
rate ratio of benign and malignant biopsies has been found to be comparable to the
National screening programme. In addition a higher proportion of in situ cancers are
identified compared to a symptomatic sample matched for age and family history
(Lollias et al. 1998, Lalloo et al. 1998). Although the significance of detecting non¬
invasive tumours is unknown it is estimated that 30-50% of these lesions will
become invasive. Tilanus-Linthorst et al. (2000) compared annual surveillance of
women at increased risk with symptomatic presentation ofwomen with a family
history and found significantlymore cancers were detected at an earlier stage in the
screened sample. This may suggest the need for more frequent screening in younger
women to detect breast cancer at an early stage given the aggressive nature and rapid
development of early onset breast cancer (Neugut and Jacobsen 1995). However
shortening the screening interval holds cost implications. Although these studies are
optimistic they are of limited sample size and duration. No randomised trials to
explore the effectiveness of screening younger women with a family history have
been conducted and the impact of screening on mortality is not known in this
population. Both the clinical and cost effectiveness of these services remains
undetermined (The Scottish Office 1998). Trials are currently in progress to assess
new screening methods such as magnetic resonance imaging (MRI). Initial trials of
MRI screening for breast cancer reported higher sensitivity and specificity compared
to mammography (Kuhl et al. 2000).
1.2.4 Genetic testing
Women at high risk of breast cancer may be offered the possibility of genetic testing
for a mutation in their family. The first stage of genetic testing involves identification
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of a mutation in an affected relative ('diagnostic testing'). Both the BRCA1 and
BRCA2 genes are large and mutations can occur at any position making diagnostic
testing demanding and time-consuming. It is essential therefore that genetic testing is
offered only to women with a strong family history suggestive of autosomal
inheritance. If a mutation is identified 'predictive testing' can be carried out on a-
symptomatic individuals to determine if they have inherited the specific mutation.
The utility ofpredictive testing for genetic predisposition to breast cancer has been
criticised due to the uncertainty ofpenetrance estimates and limited options for
surveillance and prevention strategies available to mutation carriers (Evans et al.
2001). Testing may also be non informative since not every possible mutation will be
detected and there may be other moderate risk genes that remain to be discovered
1.2.5 Prevention
There are no strategies of proven effectiveness for preventing breast cancer in those
who test positive. Preventative options that may be considered include
chemoprevention or prophylactic surgery. Tamoxifen was considered for prevention
of breast cancer because it was shown to be effective in reducing risk of relapse of
breast cancer in affected patients. A number of randomised controlled studies have
assessed the impact of tamoxifen on risk reduction, although the results are
inconsistent. A large randomised placebo controlled trial of over 13,000 women in
the US reported a large reduction in risk of breast cancer (Fisher et al. 1998). The
sample consisted ofwomen at increased risk of breast cancer for a variety of reasons:
their age (60 years or older); a history of LCIS or an increased risk of breast cancer
determined by the Gail model (see 1.1.3, page 18). It was reported that tamoxifen
reduced the risk of invasive cancer by 49% and non invasive cancer by 50% across
the sample. The reduction in risk was found to be true across all subgroups although
the effect appeared to be particular to oestrogen positive tumours. Side effects
reported from tamoxifen use included increased risk of endometrial cancer, stroke,
pulmonary embolism and deep vein thrombosis.
Two further randomised placebo controlled trials of tamoxifen in the UK (Powles et
al. 1998) and Italy (Veronesi et al. 1998) found no effect of tamoxifen on breast
cancer prevention. However a number of differences in methodology and samples
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may account for differences in results. The Italian study was based on a sample of
women who had had a hysterectomy and were at lower risk of breast cancer than age
matched controls who had not had hysterectomy. The study also included a high
proportion ofwomen using HRT (Veronesi et al. 1999). The statistical power of the
study was also low due to a small sample size and low compliance rate. The UK
study was based on nearly 2500 women with a family history of breast cancer
(Powles et al. 1998). Despite a high compliance rate and sufficient statistical power
to detect differences between the groups no difference in frequency ofbreast cancer
was found between the experimental and control samples. The sample in this study
was women at familial risk of breast cancer compared to the US study whose sample
was predominately based on non-genetic risk factors. This raises the possibility that
oestrogen may be less important in the development of familial breast cancer
reducing the effect of tamoxifen in this group. Further assessment of the effects of
tamoxifen in women with a family history needs to be conducted with larger sample
size and longer follow up. A European double blind randomised trial (International
Breast Cancer Intervention Study- IBIS) is currently underway to determine the
benefits and risks associated with long term tamoxifen use in healthy premenopausal
women at increased risk.
Women at high risk who have tested positive for a genetic mutation may consider
prophylactic bilateral mastectomy in order to reduce their risk of developing breast
cancer. A retrospective study ofwomen undergoing prophylactic mastectomy found
a 90% reduction in incidence of breast cancer (Hartman et al. 1999). However no
epidemiological data or controlled prospective studies are available to prove the
effectiveness of the procedure and a residual risk of breast cancer still remains.
BRCA1 mutation carriers also have to contend with managing an increased risk of
ovarian cancer. Currently recommended screening techniques include tranvaginal
ultrasound and assessment of CA125 levels. Potential chemoprevention includes use
of oral contraceptives which has been shown to reduce the risk of ovarian cancer in
the general population by up to 60% (Berchuck et al. 1999). Prophylactic
oophorectomy may also be considered although the benefits and side effects of this
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procedure are undetermined (Berchuck et al. 1999, Fry et al. 2001). Evidence for all
these strategies is limited and clinical trials are required (Emery et al. 2000).
1.2.6 Treatment
Women with a family history of breast cancer who develop breast cancer with a good
prognosis may be advised to have a bilateral mastectomy because of the risk of
contralateral breast cancer (Scottish Intercollegiate Guidelines Network 1998).
Breast cancers associated with BRCA1 and BRCA2 mutations have shown different
cellular pathology compared to sporadic cases (Lakhani et al. 1997). This raises the
possibility that different treatment strategies may be recommended. Further clinical
research is needed to address these issues.
1.2.7 Summary
A family history of breast cancer has been recognised as a risk factor for the disease
for many years. Recent research has identified autosomal dominant genes that when
mutated predispose the carrier to developing breast cancer and are also associated
with heightened risk of other cancers. These genes do not show 100% penetrance and
the role of environmental factors is unclear. Although many women will have a
relative who has suffered from breast cancer a small proportion are likely to be at
increased risk of the disease. Familial breast cancer clinics have been established in
order to provide risk assessment and also screening for those women who are
deemed to have a significant family history. Although genetic testing is widely
publicised it is technically difficult and not available to the majority of attendees.
There are no proven preventative options for breast cancer. Chemoprevention and
prophylactic surgery are only offered within the context of a clinical trial and may
produce distressing and debilitating side effects. Women with a family history of
breast cancer therefore face much uncertainty regarding if, when and where cancer
will develop and how they should manage their risk.
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1.3 FAMILIAL BREAST CANCER: PSYCHOSOCIAL ASPECTS
1.3.1 Psychosocial issues
Although knowledge concerning cancer genetics has increased within the past
decade understanding of how to apply this information in clinical practice without
adverse consequences for the individuals concerned, is limited. As the above review
has highlighted "advances in the basic sciences may occur at a pace that outstrips
health services and genetic epidemiological research into the clinical implications
and applications ofthese discoveries" (Emery et al. 2000, pg 11). Given the
complexity of information regarding breast cancer risk, the uncertainty of risk
estimates and unproven efficacy ofmanagement options there are likely to be a
number ofpsychosocial consequences of cancer risk for the individual and their
families.
Research has begun to address the range of psychosocial issues surrounding familial
cancer risk (Hopwood 1997). These issues include the process and outcomes of
cancer risk counselling, decision-making, psychosocial effects of surveillance and
genetic testing as well as longer-term adjustment to risk. The following section of
this chapter will review the current work on psychosocial issues in breast cancer
genetic risk. Firstly, characteristics ofwomen attending for breast cancer risk
counselling will be described and the difficulties of communicating cancer risk
outlined. Secondly, the cognitive, behavioural and emotional outcomes of genetic
predisposition to breast cancer will be discussed.
1.3.2 Women attending familial breast cancer clinics
The vast majority ofwomen attending familial breast cancer clinics in the UK are
Caucasian and well educated with a mean age of around 40 (Cull et al. 1999, Watson
et al. 1999, Brain et al. 2000). Women from ethnic minorities and those with limited
education are under represented at familial breast cancer clinics, as are women with a
paternal as opposed to maternal family history (Richards 1999). The majority of
women are referred to the centre by their GP following a discussion about family
history ofbreast cancer initiated by the counsellee. The main reasons given for
attending the clinics include: to obtain information about personal risk and risk status
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of other family members, because of awareness of family history, to reduce anxiety,
to obtain genetic testing for access to breast screening and information about
prevention (Brain et al. 2000).
Earlier studies in the US attempted to describe women at increased risk in terms of
their risk perception and levels of distress. Kash et al. (1992) assessed women at high
risk of breast cancer because of their family history who were attending for screening
at a familial centre. Twenty-seven percent of these women were found to show levels
of distress that warranted clinical investigation. Seventy-six percent ofwomen
believed they were at moderate or high risk of developing breast cancer. Lerman et
al. (1994a) identified a sample of nearly 800 women at increased risk of breast
cancer either through an affected relative or women who had self referred to a
prevention-screening centre. Over two thirds of the sample perceived their breast
cancer risk as high and levels of distress in this population were higher than the
general population (although depression and mood disturbances were comparable).
Neither study provided information about the accuracy ofwomen's risk perception
relative to their actual risk status. Accuracy of risk perceptions and levels of distress
prior to genetic counselling have been explored in UK studies. Cull et al. (1999)
assessed women attending the familial breast cancer clinic in Edinburgh and found
that the majority ofwomen held fairly accurate risk perceptions. Only 14%
overestimated their risk compared to 39% ofwomen who underestimated their risk.
However, a small proportion ofwomen (n= 18, 4%) believed it was inevitable that
they would develop breast cancer. Mean trait anxiety in the sample was higher
compared to women in the general population of the same age but comparable to that
found in older women attending routine mammography screening. Watson et al.
(1999) assessed 303 first time attendees with a family history at a familial breast
cancer clinic in London. Fifty-two percent ofwomen were found to overestimate
their risk and 18% underestimated their risk prior to counselling. A third of




The aim of genetic counselling is to collect and analyse medical and family history
information in order to provide information regarding personal risk status and
education about measures available for cancer control and prevention. Women need
to comprehend a number of risk figures including the likelihood that the cancer in the
family is due to an inherited mutation, the likelihood of carrying mutation, the
probability of developing cancer and the chance of passing a mutation on to
offspring. It is important that individuals understand these risk concepts to equip
them to make an informed choice about their subsequent health management.
Perception of the probability of developing cancer has widely been used as a main
outcome measure by which to evaluate the effectiveness of genetic counselling.
However, studies assessing the impact of genetic counselling on risk perception have
been inconsistent. Some studies have shown improvements in accuracy or risk
perception subsequent to genetic risk counselling (Evans et al. 1994, Gagnon et al.
1996) whereas other studies suggest inaccuracies are maintained (Lerman et al.
1995a). A number of follow up studies of genetic counselling have shown that
although some women modify their risk perception towards the counselled risk a
significant proportion ofwomen continue to overestimate or underestimate their risk
following genetic counselling (Cull et al. 1999, Hopwood et al. 1998, Lloyd et al.
1996, Watson et al. 1999).
A large number of factors may influence interpretation and recall of risk estimates
(Kelly 1992, Hallowed and Richards 1997). The manner in which information is
expressed may influence interpretation. There are numerous ways to present risk
information in both qualitative and quantitative formats (eg high/low risk, absolute
risk, relative risk, cumulative life time risk, % increase in risk etc). In a review of
studies assessing communication of risk information Bottorff et al. (1998) concluded
that the different ways currently used to communicate cancer risks have not been
adequately evaluated. There is no clinical consensus for how to best communicate
risk information in order to maximise understanding and recall. Cognitive bias may
also affect interpretation of such probabilistic information (Tversky and Kahneman
1974, Lippman-Hand and Fraser 1979, Kessler and Levine 1987). This been
demonstrated within the genetic counselling situation (Shiloh 1994). Methodological
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differences between studies in definition and communication of risk, time delay
between counselling and risk assessment and provision ofwritten information after
counselling may account for some inconsistencies in the literature. There are no
standard measures of risk perception and measures do not capture what the risk
means for the individual.
1.3.4 Screening behaviour
In order to achieve health benefit, provision of genetic risk information must
encourage participation and adherence to the recommended screening practices.
Although women with a family history of breast cancer are more likely to report they
have had mammographic screening than those without a family history (McCaul et
al. 1996) research examining screening behaviour in women with a family history of
breast cancer has shown variable adherence to mammography and CBE (Meiser et al.
2000). Adherence to BSE has been shown to be fairly poor (Meiser et al. 2000,
Alagna et al. 1987). The vast majority of studies examining screening behaviour in
women at increased risk have been conducted in the US where lower adherence rates
may reflect the personal responsibility for cost of screening. This has been indicated
by associations between mammography use with income and employment in US
samples (Lerman et al. 1993).
Psychological distress has been associated with uptake of screening in women with a
family history ofbreast cancer although studies show conflicting results. Lerman et
al. (1993) reported a negative association between breast cancer specific distress and
adherence to mammography and Kash et al. (1992) found a negative association
between distress and adherence to BSE and CBE. Other studies have reported
positive associations between distress and screening behaviour (eg Meiser et al.
2000). Lerman and Schwartz (1993) suggest that the relations are complex and may
indicate a curvilinear relation between anxiety and screening. This is consistent with
the fear arousing communication theory which proposes that moderate levels of
anxiety motivate screening behaviour whereas high levels of distress results in
avoidance (Janis and Feshbach 1953). Reviews of fear arousing communications
however, have shown that fear is effective in producing behaviour change if
individuals have high efficacy (Witte and Allen 2000, Sutton, 1982). This suggests
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that women's beliefs about the efficacy of screening methods and self efficacy in
performing BSE need to be considered when investigating associations between
distress and screening behaviour.
Studies assessing screening use in women at increased risk of breast cancer have a
number of limitations. The majority of studies are based on retrospective self reports
of screening which have potential for bias associated with recall and social
desirability. Although self reported mammography use has been shown to be valid
when compared to objective records (Etzi et al. 1994), prospective studies are
required to confirm retrospective results. Differences between study samples, in
knowledge and awareness of risk, risk status, counselling procedure and awareness
of screening guidelines, can make comparisons between studies difficult. Samples
selected through an affected relative are not directly comparable to those with a
strong family history of breast cancer and samples recruited from familial breast
cancer clinics are often based on women who are likely to be highly motivated to
adhere to screening and are generally of a high educational level. The generalisation
of results beyond self selected samples ofwomen at increased risk may therefore be
problematic (Meiser et al. 2000).
Cross-sectional correlational studies linking anxiety and screening (eg Kash et al.
1992, Lerman et al. 1993) can also not rule out the possibility that engaging in
screening causes anxiety. Detection behaviours in which individuals face the risk of
cancer are likely to elicit greater emotional responses than prevention behaviours. A
number ofpsychological costs of screening for cancer have been outlined by Wardle
and Pope (1992) and include anxiety provoked by publicity about screening and
invitations to attend, discomfort surrounding the practical procedure of the test,
detection of abnormality and false positives, stress associated with waiting for result
and suspecting cancer and trauma associated with diagnosis of cancer. In a
qualitative study ofwomen attending the Edinburgh familial breast cancer clinic for
surveillance because of their increased risk ofbreast cancer women described how
their anxiety fluctuated and increased during the month in which the screening test
was expected, when the appointment letter was received, during the screening
procedure and on receipt of results (Appleton et al. 2000). A number of quantitative
studies using validated measures of anxiety have suggested that false positive results
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are associated with temporary increased levels of anxiety but this effect is not
maintained at long term follow up (Lerman and Rimer 1993, Fentiman 1998).
Further research is needed in this area to determine psychological costs of screening
women at increased risk of breast cancer and to identify vulnerable groups of
women.
1.3.5 Genetic testing: Interest and uptake
Interest in genetic testing for BRCA1 and BRCA2 mutations has been reported to be
as high as 90% in women with a first degree relative with breast cancer (Lerman et
al. 1994b, 1995b). Reports of actual uptake of genetic testing are lower. Lerman et al.
(1997) reported an uptake of 58% in 149 individuals from high risk families in the
US and Watson et al. (1996) reported an uptake rate of 41% among 2 high risk
families in the UK. Although the uptake rates are lower than would be predicted
from level of interest in genetic testing for BRCA1 and BRCA2 the rates exceed that
reported for other late onset genetic disorders such as Huntingtons Disease. This is
likely to reflect the difference between the disorders in terms of penetrance rates and
options for detection and prevention.
A number of studies have addressed reasons for requesting predictive testing for
breast cancer. Important factors include: to obtain certainty about risk status (Kash et
al. 1997, Lodder et al. 1999); to know the necessity for surveillance (Lerman et al.
1994b, 1995b, Kash et al. 1997, Lynch et al. 1999 Lodder et al. 1999); to consider
prophylactic surgery (Lodder et al. 1999); and to know the risk status of children
(Lerman et al. 1994b, 1995b, Lynch et al. 1999, Lodder et al. 1999). Lerman et al.
(1996, 1997) found that actual uptake of predictive testing was positively associated
with level of education, cancer specific distress, possessing health insurance and
number of affected relatives. Women were more likely to undergo genetic testing
than men and uptake was associated with more knowledge about genetic testing and
greater perception of the importance ofbenefits of testing (Lerman et al. 1996).
Jacobsen et al. (1997) looked at the decision making process of obtaining predictive
testing for breast cancer in women with first degree relatives in the US. Likelihood of
taking a test was greater for women who perceived more pros than cons of the test.
Commonly cited benefits of testing included helping other relatives to make
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decisions about testing, to motivate BSE, to decide about prophylactic surgery and to
reduce concerns if tested negative. Disadvantages of testing included increased
anxiety and concern about other relatives. Reasons for declining predictive testing
have included fear of insurance discrimination and fear of a positive test result
(Lynch et al. 1999, Lerman et al. 1995b). Uncertainty about when breast cancer
might occur and concern over the accuracy of the test have also been noted as
important factors associated with rejection ofpredictive testing (Kash et al. 1997,
Lerman et al. 1995b).
1.3.6 Genetic testing: Experience and response
Lodder et al. (1999) looked at experiences ofwomen waiting for BRCA1 and
BRCA2 test results in Holland. The majority ofwomen showed normal levels of
anxiety, although a significant proportion (25%) showed high levels of general and
cancer-specific distress. Higher levels of distress were found for: women who were
anticipating problems and were considering prophylactic surgery following a positive
test result; those with pessimistic personalities or a tendency towards emotional
suppression; women younger than 40; and those familiar with severe consequences
of breast and or ovarian cancer in their family. Lerman et al. (1994b) investigated
anticipated responses to test results. A positive result was considered likely to induce
anxiety, depression, impair quality of life but increase feelings of control. A negative
test result was anticipated to lead to guilt and continued worry and desire for
screening.
Case studies and anecdotal reports of the impact of genetic testing have shown the
process to effect the whole family and to cause a number of complex emotional
responses (Dudokdewit et al. 1997). In a study of 37 large high-risk families
undergoing testing Lynch et al. (1999) reported variable and unpredictable emotional
responses including sadness, anger, acceptance and relief from uncertainty in
response to a positive results and relief, disbelief and 'survivor guilt' in response to a
negative test result. Croyle et al. (1997) reported short-term effects during 1-2 weeks
following BRCA1 testing. General distress was found to decline at follow up for all
participants although carriers were found to show higher levels of general distress
and test-related anxiety than non carriers. Lerman et al. (1996) conducted a 1 month
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follow up ofwomen undergoing predictive testing for breast cancer. Women with a
negative result showed a reduction in depressive symptoms compared to those with a
positive result. However women receiving a positive result did not show an increase
in depression or functional impairment.
Broadstock et al. (2000) reported a lack of studies assessing the long term
psychological consequences ofpredictive testing for late onset disease. There are
concerns that genetic testing may actually reduce motivation for detection and
prevention behaviour due to increased fatalism (Marteau and Lerman 2001, Senior et
al. 1999, 2000). Lerman et al. (2000) reports an ongoing study looking at the effect
ofpredictive BRCA1 and BRCA2 testing on mammography use at one year follow
up. Few changes were observed in adherence to recommendations for women with
either a positive or negative test result although longer follow up is required.
The majority of individuals who have undergone genetic testing to date have been in
research families who have participated in genetic research for many years. Research
families are generally Caucasian, well educated and have had much time to adjust
emotionally to the new genetic knowledge before predictive testing could be offered.
The research context of genetic testing has been conducted with regard for stringent
ethical guidelines and incorporated protocols for extensive pre and post-test
counselling (Broadstock et al. 2000). There are doubts about whether findings
regarding the consequences of genetic testing can be generalised to newly identified
women at increased risk who obtain genetic counselling in clinical practice where the
processes of informed consent and genetic counselling are likely to vary from
research protocols (Broadstock et al. 2000).
1.3.7 Prophylactic surgery
Women at high risk may consider bilateral prophylactic surgery as a preventative
option. Interest in the procedure has been shown to be high in women at increased
risk of breast cancer and the decision to undergo surgery has been positively
associated with breast cancer worry, risk perception and biopsy history (Stefanek et
al. 1995). Lerman at al (1996) reported that 17% ofmutation carriers reported an
intention to undergo prophylactic mastectomy. In a prospective study of 143 women
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at increased risk who were offered prophylactic surgery Hatcher et al. (2001) found
that the women who opted for surgery (n=79) had higher subjective perception of
risk. Prior to surgery thirty-two percent of these women believed that they would
inevitably develop breast cancer. Women who decided to undergo surgery were more
likely to have had investigatory tests for previous breast symptoms or a genetic test
than those who declined.
Retrospective studies ofwomen who have undergone bilateral prophylactic
mastectomy indicated that the procedure reduces emotional concern about
developing breast cancer (Frost et al. 2000). A very small proportion ofwomen have
been shown to regret the operation and regret has been associated with lack of pre¬
operative counselling (Borgen et al. 1998). Prospective studies have indicated that
women are satisfied with the outcome of surgery (Stefanek et al. 1995). Hatcher et al.
(2001) found levels of general distress and anxiety were reduced at 6 and 18 months
follow up for women who underwent prophylactic surgery but were sustained for
women who declined surgery and were maintained on surveillance. Surgery was not
found to have a detrimental effect on body image or sexual functioning. The majority
ofwomen in this study had immediate reconstructive surgery and the effect of
different surgery on psychological response needs to be addressed in more detail.
1.4 DISTRESS IN WOMEN AT INCREASED RISK OF BREAST
CANCER
A large proportion ofwomen attending for genetic risk counselling are advised that
they are at significantly increased risk of familial breast cancer but that their family
history suggests genetic testing for BRCA1 or BRCA2 is not likely to be
informative. There are concerns that ambiguous breast cancer risk information
coupled with uncertain methods for detection and prevention may result in high
levels of psychological morbidity in women with a family history of breast cancer.
Women must face the fear of developing cancer along with its anticipated
consequences of treatment and threat to survival as well as guilt about the possibility
ofpassing a cancer predisposing gene on to their children. Distress may not only
affect quality of life but also influence the cognitive processes involved in
understanding risk information and decision-making about risk management.
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A number of studies have therefore been carried out to determine and describe levels
of distress in women at increased risk of breast cancer. Levels of distress in women
with a family history of breast cancer have been reported to be higher than general
population samples (Kash et al. 1992, Gagnon et al. 1996). The prevalence of
psychological morbidity has been reported as comparable to that of breast cancer
patients (Lerman and Schwarz 1993, Hopwood et al. 1998). However, other studies
have reported that women with at least one first degree relative who have suffered
from breast cancer show levels of distress comparable to controls without a family
history of the disease (Wellisch et al. 1991, Lerman et al. 1994a, Lloyd et al. 1996,
Zakowski et al. 1997).
Different levels of distress reported in these studies may reflect differences in
sampling (ie extent of family history) as well as the timing and situation at which
women were assessed. Levels of distress are likely to be higher for women attending
clinics for risk counselling or screening. Women attending familial breast cancer
clinics for the first time have shown levels of trait and state anxiety higher than
controls but comparable to women attending for routine breast screening (Cull et al.
1999, Watson et al. 1999). Valdimarssdottir et al. (1995) assessed levels of distress in
women attending a surveillance clinic the day before screening and one month later.
Acute distress was higher prior to screening but reduced at follow up, whereas
general distress was consistently higher than general population norms at both time
points.
The prevalence of distress might vary depending on the assessment questionnaire
used and cut offpoint chosen (Hopwood et al. 1998). It is worth remembering that
screening questionnaires overestimate actual psychological morbidity (Coyne et al.
2000). Hopwood et al. (1998) compared the prevalence ofpsychological morbidity
of 158 women assessed 3 months after genetic counselling determined by the GHQ
and psychiatric interview. Twenty-six percent ofwomen showed significant distress
on the GHQ however the psychiatric interview confirmed psychiatric disorder in just
13% ofwomen (Hopwood et al. 1998). This rate was still higher than would be
expected in age-matched controls.
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1.4.1 Types of distress
It has been suggested that global measures of distress fail to capture the specific
sources of distress for women at increased risk of breast cancer and that measures of
breast cancer related anxiety are more informative (Hopwood et al. 1998, Kent et al.
2000, Thewes et al. 2001). Models of response to stress have indicated that
assessment of appraisals and emotions related to the specific situation are likely to be
more informative than general measures (Lazarus and Folkman 1984). Different
types of distress in this sample may require alternative interventions. Standard
psychiatric interventions may be appropriate for women showing high levels of
depression or anxiety whilst those with cancer related anxiety might benefit more
from targeted psycho-education programmes (Thewes et al. 2001). Recent studies
have therefore incorporated measures designed to assess anxiety specifically
associated with breast cancer (Lerman et al. 1996, 1997, Audrain et al. 1997, Croyle
et al. 1997).
A concept prevalent in the contemporary literature is cancer worry. This represents
unwanted aversive thoughts and emotional discomfort specifically associated with
cancer risk and is apparent for many women at risk of breast cancer (Kent et al.
2000). Worries about breast cancer have been frequently assessed in women at
increased risk (Lerman et al. 1991, 1993, 1994a, Epstein et al. 1997) and women in
the general population (McCaul et al. 1996, 1998). Studies have used Likert response
items to address the frequency of breast cancer worries and the degree to which these
concerns impinge on everyday life. From this literature a cancer worry scale has been
developed (Watson et al. 1998) to assess worry directly associated with breast cancer
risk. A cancer related anxiety and helplessness scale has also been utilised (Kash et
al. 1992) although has not been published to date.
In a population study ofwomen with at least one first degree relative with breast
cancer Lerman et al. (1994a) found a third ofwomen of all ages reported worries
about breast cancer that interfered with their capacity to function in everyday life.
Watson et al. (1999) found 28% ofwomen attending a familial breast cancer clinic
for the first time worried about breast cancer frequently or constantly and 18% felt
this worry was a severe or definite problem. Hopwood et al. (2001) also reported that
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two thirds of 500 women referred to genetic counselling for breast cancer reported
high levels ofworry about developing cancer in the future although few women
reported these worries interfered with their mood or daily functioning. The authors
argued that cancer worry might actually represent a realistic response rather than
morbid anxiety (Hopwood et al. 2001).
Another measure of cancer specific distress widely used in the literature is the Impact
ofEvent scale (Horowitz et al. 1979). This measure was originally developed in
order to assess subjective levels of distress associated with a specific event in the
context of the stress response syndrome. It measures two constructs: intrusion
(thought, images dreams, waves of feeling) and avoidance (denial, blunted sensation,
behavioural inhibition, emotional numbness). The measure can be tailored to assess
distress associated with a specific event and has been adapted to assess intrusion and
avoidance associated with breast cancer risk (Kash et al. 1992, Lerman et al. 1993,
1994a, Lloyd et al. 1996, Thewes et al. 2001). Zakowski et al. (1997) and Lloyd et al.
(1996) reported that women at increased risk because of family history showed
higher levels of intrusive thoughts about breast cancer and avoidance than controls
without a family history. Lerman et al. (1994a) found over half of their sample
reported intrusive thoughts and feelings about breast cancer risk and levels of
intrusive thoughts were comparable to those observed in populations exposed to a
traumatic stressor. Valdimarsdottir et al. (1995) also reported high levels of intrusive
thoughts and avoidance of breast cancer in women on surveillance programme both
assessed prior to screening and at the follow up 1 month later.
1.4.2 Impact of genetic counselling on levels of distress
A number of prospective longitudinal studies have been designed specifically to
determine the impact of genetic risk counselling for breast cancer on levels of
general and cancer specific distress in order to determine if genetic counselling
reduces or invokes distress. Results have been inconsistent. Cull et al. (1999)
reported that levels of general distress were reduced 4 weeks following genetic
counselling for breast cancer and Julien-Deynier et al. (1999) showed a reduction in
state anxiety following genetic counselling across studies in France. However,
Hopwood et al. (1998) reported no change in prevalence of psychological morbidity
at 3 months following genetic counselling and Watson et al. (1999) reported no
change in general distress at annual follow up.
A few studies have reported a reduction in cancer specific distress subsequent to
genetic counselling. Gagnon et al. (1996) found a reduction in cancer worry at 4
months follow up and Hopwood et al. (2001) found a reduction in cancer worry
following genetic counselling for a subset ofwomen who initially overestimated
their risk as their perception became more accurate. Other studies have reported no
change in cancer specific distress including both cancer worry and intrusive thoughts
at 1, 3, 6 and 12 months following genetic counselling (Kent et al. 2000, Watson et
al. 1999). There are little data on longer term follow up ofwomen although
qualitative studies suggest that cancer specific anxiety is prominent in at least a
proportion ofwomen who have been attending a familial breast cancer clinic for over
2 years (Appleton et al. 2000).
1.4.3 Predictors of distress
It appears that there are large variations in levels of distress subsequent to genetic
counselling and that subgroups ofwomen maintain high levels of anxiety and
worries about breast cancer. There is a need to determine why some women are more
prone to high levels of anxiety. A clearer understanding of the cause of distress in
this population will help to identify women requiring additional support and plan
psychological support services.
Lerman and Schwarz (1993) suggest that possible determinants of distress might
include situational factors (eg personal risk, disease related factors), personal factors
(eg demographics), perception of the situation (eg risk perception) and coping
efforts. Subjective perception of risk shows stronger and consistent association with
levels of distress than does objective risk status (Lloyd et al. 1996, Kent et al. 2000,
Zakowski et al. 1997). Women with higher risk perceptions or who overestimate
their risk also show higher levels of cancer specific anxiety (Watson et al. 1999,
Lloyd et al. 1996, Kent et al. 2000) and general distress (Audrain et al. 1997).
Younger age has been associated with increased levels of general distress in women
with a family history ofbreast cancer both in population based studies (Lerman et al.
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1994a) and follow up assessments after genetic counselling (Cull et al. 1999).
Personality factors have also been associated with levels of distress in this
population. Audrain et al. (1997) found women who were less optimistic reported
higher levels of general distress. Lerman et al. (1996) investigated the impact of
coping style on response to genetic counselling and found that monitors who tend to
seek out information in a threatening situation showed higher levels of distress after
genetic counselling than blunters who attempt to avoid the situation. Audrain et al.
(1997) reported that together monitoring and optimism accounted for approximately
a third of variance in general distress in women who had self referred for genetic
counselling for breast or ovarian cancer.
In the follow up assessment to genetic counselling Cull et al. (1999) also found that
risk of distress was higher for women who had reported high levels of distress prior
to attending the clinic. In psychiatric interviews ofwomen referred for psychological
help following attendance at a familial breast cancer clinic Hopwood et al. (1998)
found factors contributing to levels of distress were often longstanding prior to
attending for risk counselling. Problems were not necessarily associated directly with
breast cancer risk and included work and financial problems, relationship problems
and loss and unresolved grief (Hopwood et al. 1998). A number of authors have
suggested that bereavement response and prior experiences of cancer in the family
may contribute to levels of distress (Wellisch et al. 1992, Zakowski et al. 1997, Cull
et al. 1999, Valdimarsdottir et al. 1995, Hopwood et al. 1998, 2001). To date there is
limited information on the causes of distress in women at increased risk of breast
cancer. Studies have tended to be descriptive in nature, identifying variables that are
associated with or predictive of distress rather than testing causal explanations.
Further research is needed to examine the cause of distress in a theoretical manner in
order to test causal associations and identify factors that may lend themselves to
intervention.
1.5 SUMMARY AND CONCLUSIONS
Breast cancer is a common disease in women although the aetiology is not fully
understood. A number of factors have been identified as potential causes of the
disease but few are amenable to personal control. The symptoms and progression of
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breast cancer are variable and unpredictable. The timeframe of the disease is
uncertain and may be protracted. Treatment may control localised disease but rarely
cure advanced metastatic cancer and patients face a risk of spread and recurrence.
Breast cancer is a distressing, stressful condition and the diagnosis and treatment of
the disease may have a large impact on the patient and her family. Although
detection methods and treatment strategies are improving, the efficacy of screening
remains unclear in younger women and no fully effective means ofprevention are
available.
Increased understanding of the molecular genetics involved in breast cancer has lead
to the discovery of heritable mutations that predispose carriers to developing breast
cancer at an early age. Mutations in these genes account for a proportion of familial
breast cancer cases although there are likely to be other genes yet to be discovered.
Public awareness and concern has lead to the development of cancer genetic services
aimed at providing risk assessment and health management to women with a family
history ofbreast cancer. Variable methods are used to assess risk status and
communicate risk information making the evaluation of the effectiveness of genetic
counselling difficult. National guidelines for cancer risk management are currently
under development.
Although interest in predictive testing for breast cancer is high only a small subset of
women with a strong family history of breast cancer concordant with patterns
associated with BRCA1 and BRCA2 mutations are eligible for predictive testing.
Predictive testing is problematic because of the possibility of false negatives and
uncertainty regarding the penetrance of the BRCA1 and BRCA2 genes outside
research families. For the majority ofwomen in the UK who are deemed at moderate
or high increased risk of breast cancer genetic testing would not be informative.
These women are provided with a risk estimate and offered regular screening in
order improve early detection of the disease and reduce mortality. However the
clinical efficacy and cost effectiveness of screening younger women with a family
history of breast cancer remains controversial. The uptake of recommended
screening practices is less than optimal and often associated with distress.
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Women actively seek genetic counselling services because of concerns about breast
cancer in their family. Women attending for genetic counselling must comprehend a
great deal of complex medical information. However, there is much uncertainty
concerning whether, when and where gene carriers will be affected. For women with
a significant family history of the disease but for whom a specific mutation has not
been identified the risk is even more uncertain. Based on this information women
must make decisions about their health management and adjust emotionally to their
risk status.
Concern regarding the impact of uncertain genetic risk information on mental health
has prompted research into the psychosocial consequences of discovering and living
with an increased risk of breast cancer. Levels of distress in women at increased risk
are variable. It is unclear whether genetic counselling helps reduce levels of anxiety
and cancer specific distress or has beneficial effects on mental health. A proportion
ofwomen attending familial breast cancer clinics have high levels of distress that are
not alleviated by genetic counselling. A number of factors have been postulated to be
associated with distress although few studies have examined these factors in detail.
It has been suggested that past experiences of breast cancer in the family contribute
to psychological difficulties in women at increased risk of the disease. The
subsequent two chapters will examine the literature surrounding prior experience of
breast cancer in the family and psychosocial response to risk in more detail and
outline a study to determine the effect of experience of breast cancer in the family on
levels of distress in women at increased risk ofbreast cancer.
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EXPERIENCE OF BREAST CANCER IN THE FAMILY
2.1 INTRODUCTION
2.1.1 Psychosocial impact of cancer in the family
The occurrence of cancer has a large psychosocial impact on the family. Living with
an affected relative can be even more difficult than coping with one's own illness
(Hilton 1993). Emotional responses to a relative's diagnosis of cancer have been
found to be similar to those ofpatients and include fear, anxiety, confusion and
uncertainty (Leedham and Meyerowitz 1999). Cancer in the family can disrupt
family routines and may force other family members to take on new responsibilities
and family roles. This in turn can lead to resentment, tension and anxiety (Kelly et al.
1987). Cancer in the family also creates dilemmas regarding communication about
cancer and the degree of involvement in the relative's medical care and personal
issues.
Cancer in women can have a large impact on family functioning because women are
often central figures in managing family life. Northouse (1995) reviewed the
psychosocial impact ofmaternal breast cancer on the family. The mother's illness
was found to have a significant effect on the emotional well being of the spouse and
children, to disrupt family life and alter family roles (Northouse 1995). Distress in
children has specifically been associated with the threat of loss ofmother, temporary
loss ofmother during the illness, side effects of treatment and disruption in family
roles and routines (Compas et al. 1996, Spira and Kenemore 2000).
Breast cancer is an extremely variable illness. The practical and emotional impact of
the disease on the family is likely to depend on a number of illness factors including
the type ofbreast cancer, how the disease was detected, treatment regime, disease
progression and prognosis. Compas et al. (1996) found children's perception of the
seriousness of parental cancer was associated with increased stress about the illness
experience and greater emotional distress. Children were found to hold accurate
appraisals of the seriousness of parental cancer compared with the actual stage and
prognosis of the disease. In a qualitative study of the impact ofmaternal breast
cancer on the family, Hilton (1996) found that visible and intrusive symptoms and/or
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treatment made it difficult for families to return to normal. Veach and Nicholas
(1998) suggested that the impact of cancer on the family depends on the phase of
illness (prediagnosis (testing), diagnosis, treatment, rehabilitation and remission)
although understanding of the psychosocial issues raised during these different
phases is limited. Northouse (1995) found women suffering from recurrent breast
cancer or those with high levels of symptom distress reported more problems with
family roles and a stronger detrimental impact of the disease on the family.
A number of additional individual and family factors have been found to moderate
the impact of the disease on the family. Veach and Nicholas (1998) suggested that
the developmental stage of the family is an important factor and that different family
types (ie new couples, young families, families with adolescents, ageing family) may
be disrupted in different ways. Other factors found to be important include children's
age, gender, the quality of the parent-child relationship, family coping behaviours
and flexibility in role sharing, communication styles, financial resources and
concurrent stressors (Compas et al. 1996, Hilton 1996, Lewis et al. 1993, Lichtman
et al. 1984, Vess et al. 1985). Family members directly involved in caring for
relatives with cancer may also experience increased levels of stress (Siegel et al.
1996).
Bereavement of a loved one is reported to be one of the most stressful life events a
person will face and has been associated with a decline in both physical and mental
health (Dohrenwend and Dohrenwend 1974, Kurtz et al. 1997). Bereavement from
cancer has been reported to be particularly traumatic due to the prolonged and
stressful nature of the illness (Koocher 1986). Loss of a primary family member from
cancer has been associated with increased depression (McHorney and Mor 1988).
The risk of depression following bereavement from cancer has been positively
associated with a number of factors including younger age of patient, lower
satisfaction with care giving and increased family tension (McHorney and Mor
1988).
Research to date has largely focused on the effects of cancer and bereavement on the
spouse or young children of cancer patients. A wider view of the family needs to be
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considered when investigating the impact of breast cancer when there is a familial
predisposition. Research has also tended to focus on the impact of diagnosis and
early stage breast cancer with limited work addressing the impact of other illness
phases. The long-term effect of cancer in the family needs to be addressed utilising
long-term prospective follow-ups. Retrospective studies have indicated that
experiences of cancer in the family have long-term psychosocial implications and
that unresolved issues may remain years after the illness experience (Kelly 1987,
Leedham and Meyerowtiz 1999). Relationship difficulties in the family stemming
from breast cancer have been shown to be long-lasting (Lichtman et al. 1984).
Studies of relatives involved in care-giving have identified psychological distress and
depressive symptoms following bereavement to be persistent (Siegel et al. 1996,
Kurtz et al. 1997). Finally the experience ofmultiple illness and bereavement from
cancer in the family has yet to be examined. Research on AIDS-related bereavement
in gay men found that stress responses and depression increases with the number of
bereavements experienced (Martin 1988, Gluhoski et al. 1997).
2.1.2 Psychosocial impact of familial cancer.
Women with a family history ofbreast cancer are likely to have a number of family
members who have suffered from the disease at an early age (see Figure 1.1, page
29). Relatives are likely to have witnessed and been personally involved in the
physical, emotional and social consequences of breast cancer including fear at the
time of diagnosis, observations of the disabling and disfiguring consequences of
treatment and emotional consequences of the disease in the family. These
experiences may become even more threatening when women become aware of their
own increased risk of developing the same disease. Women may therefore enter
genetic counselling about their own risk with strong emotions and fears derived from
cancer related experiences and losses within their family. McAllister (2002) reports
findings from a grounded theory that proposes the process of 'engaging' with cancer
risk (the degree of cognitive and emotional involvement with risk) is influenced by
experiences of cancer within the family. Interviews with individuals at risk of
Hereditary Non Polyposis Colorectal Cancer indicated that individuals who had
witnessed suffering or death from cancer in their family were most intensively
engaged with their risk (McAllister 2002).
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A variety of illness, individual and family factors may create very different
subjective experiences ofbreast cancer for women with the same objective family
history. The subjective experience ofbreast cancer in the family is likely to have a
large impact on how women think, feel and respond to their own risk of breast cancer
and may help to explain the wide variation in response to risk information. The
following section will review studies that have addressed the experience of breast
cancer in women at increased risk. The review aims to describe the experiences of
these women and highlight issues that may influence response to risk.
2.2 EXPERIENCE OF BREAST CANCER IN THE FAMILY:
LITERATURE REVIEW
2.2.1 Experience of breast cancer: Qualitative studies
Anecdotal accounts have reported that witnessing breast cancer in close relatives has
both negative and beneficial effects (Lynch et al. 1994). Emotional themes revealed
include fear of death and identification with mutilated maternal body image, anger
and bewilderment, unresolved grief and depression, guilt regarding lack of time spent
with the relative and lowered self-esteem (Kelly 1983, Lynch et al. 1994, Wellisch et
al. 1991, 1992, 1996). Experiences of breast cancer in relatives also inform women
about the disease and motivate them to seek information and screening (Lynch et al.
1994).
2.2.1a Maternal breast cancer
Wellisch et al. (1991, 1992, 1996) conducted a series of qualitative studies
examining psychological functioning in daughters of breast cancer patients.
Participants were found to perceive a decline in their mothers' quality of life (self
image, attractiveness and sexuality), social relationships and activities of daily living
following breast cancer. Those who had lost their mother to breast cancer reported a
greater deterioration of their mothers quality of life and daily activities. These
perceptions were associated with poor psychological adjustment (Wellisch et al.
1996). Maternal breast cancer was also found to affect daughters self concept
including self image and sexuality (Wellisch et al. 1991, 1992).
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"Why should I get attached to my body and start enjoying sex when all
that w ill betotally destroyed when I get b reast c ancer I ike my m other
did?" (Wellisch et al. 1991, pg 334)
Women reported that their experiences had altered their role in the family and long
range life plans (Wellisch et al. 1992). Changes in life plans reflected changes in
family life during the illness experience as well as changes in future plans for adult
life (eg marriage plans). Some women with a family history of breast cancer plan
their lives around the certainty that they themselves will develop the disease (Kelly et
al. 1987). For example, in psychiatric interviews with women following genetic
counselling for breast cancer Hopwood et al. (1998) reported two women who made
the decision not to have children specifically to avoid their offspring having to face
the loss of their mother as they had done.
Psychiatric interviews with women following genetic counselling have shown that
loss of a mother due to breast cancer can result in unresolved grief that continues to
affect some women for many years and may contribute to psychiatric morbidity
(Hopwood et al. 1998). Anecdotal reports have indicated that learning about ones
risk status can reactivate grief for lost relatives and may contribute to distress
following genetic counselling for breast cancer (DudokdeWit et al. 1997, Lodder et
al. 1999).
Wellisch et al. (1992) found that age at the time of the mother's diagnosis was also
associated with psychological adjustment. Women who were adolescents (11-20
years) had more adjustment problems and showed poorer psychological well-being
than women who were younger (0-10) or adults (20+). The adolescent group was
also more likely to report discomfort about involvement with mother's illness, poor
resolution of feelings about it and less subsequent satisfaction with their own sexual
relationships. Clinical interviews with adolescent daughters ofmothers with breast
cancer have indicated anxiety about family roles and their relationship with their
mother as well as fear of recurrence ofmothers breast cancer (Spira and Kenemore
2000). This clinical sample showed fears concerning personal physical and sexual
development because of their own breast cancer risk (Spira and Kenemore 2000).
These issues may reflect difficulties confronting maternal breast cancer during a
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vulnerable emotional and sexual developmental stage (Wellisch et al. 1992, Spira
and Kenemore 2000).
2.2.1b Communication about breast cancer
Chalmers et al. (1996) reported that communication patterns within the family at the
time of the relative's illness can influence adjustment and adaptation to personal risk.
Communication styles that were restricted to the physiological process involved in
breast cancer and which neglected personal and emotional aspects of the illness,
combined with unrealistic optimism and positivity about the illness were fairly
common. However, this communication style was associated with fear and anxiety
about breast cancer, family conflict over the course of the illness, poor preparation
for relative's death and bereavement problems.
2.2.1c Stages ofadaptation
Chalmers and Thompson (1996) conducted interviews with 55 women with a first
degree relative with breast cancer in order to understand how women's experiences
impact on their response to their own cancer risk. A third had lost their relative to
breast cancer, the remainder reported that their relative was alive and in remission.
The study indicated that women need to come to terms with their relatives' illness in
order to adjust fully to their own risk. Analysis revealed three stages of adaptation:
living the breast cancer experience; developing a risk perception and adjusting to the
personal risk of breast cancer. Women were described as having lived vicariously
through their relative's breast cancer and to have shared the illness experience by
developing an 'emotional connection' with the relative. The degree to which the
experience was shared depended on the woman's age, relationship with the affected
relative and concurrent stressors in the woman's life. Younger women were more
likely to report that sharing the cancer experience resulted in greater fear and anxiety.
Illness that was erratic, unpredictable and unresponsive to treatment was found to be
more emotionally demanding than illness that responded well. Greater contact with
the relative and more intense experiences (eg severe uncontrolled pain) appeared to
increase vicarious experience. Intense breast cancer experiences were more difficult
for the participant to resolve and hindered development of a personal risk perception.
Risk perception was found to increase as the participant neared the age of their
affected relative and was higher for women who felt they resembled their relative
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both physically or in personality. Individual's feelings of susceptibility to cancer
appears to increase as they near the age at which a relative was diagnosed or died
from cancer and often prompt attendance at familial breast cancer clinics (Richards et
al. 1995, Brain et al. 2000).
Chalmers and Thompson (1996) found some women able to integrate their personal
risk perception with their sense of self and adapt to risk by developing a sense of
personal control. This was achieved by self care practices such as screening,
maintaining a healthy lifestyle and rehearsing how to cope with the development of
cancer. This was not permanent state but altered with changing experiences
surrounding breast cancer in the family. Not all women achieved this final phase.
2.2. Id Risk management decisions
The experience of family members can influence women's decisions about risk
management, for example uptake of screening, considering genetic testing or
prophylactic surgery. Dudok deWit et al. (1997) carried out a case study of a family
in Holland who were involved in a genetic research study ofHereditary Breast and
Ovarian Cancer (HBOC) and were the first family for whom predictive testing
became available. The emotional response, family dynamics and individual's
decisions about genetic testing and prophylactic surgery were investigated. Decisions
to undergo predictive testing and prophylactic surgery appeared to be made
following the death of relatives supporting the stages outlined by Chalmers et al.
(1996).
"The worsened physical condition of her sister Mrs B. strengthened her
pre-test opinion in favour ofpreventative surgery" (Dudok deWit et al.
1997, pg 67).
Decisions about predictive testing or prophylactic surgery were also based upon the
degree to which individuals identified with affected relatives particularly if they were
of similar age at which a relative was diagnosed with breast or ovarian cancer.
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"Three identified female gene carriers from the older generation chose
to have a prophylactic ovariectomy, but no mastectomy. They viewed
ovarian cancer as threatening because in their previous generation the
women had died of ovarian cancer at the same age as they were now."
(Dudokdewit et al. 1997, pg 67).
2.2.2 Experience of breast cancer and response to risk: Quantitative studies
The qualitative studies outlined above highlighted certain aspects of experience that
may influence psychosocial response in women at increased risk ofbreast cancer.
Quantitative studies are required to assess the impact of these experiences on
women's response to breast cancer risk. Few studies have been designed directly to
investigate the impact of experience on response to risk although some studies have
included measures of experience that were not the main focus of the study. The
limited work on this construct most probably reflects the difficulties in quantifying
women's experience.
2.2.2a Exposure to cancer
Lodder et al. (1999) investigated psychological functioning in women waiting for
test results for predictive testing for BRCA1 or BRCA2. Women who had more
relatives affected with either breast or ovarian cancer and women whose relatives had
suffered from cancer at a younger age (<40) reported higher levels of general and
cancer specific distress. Baider et al. (1999) assessed women attending a one day
conference on familial breast cancer. Although women were of unknown risk status
and the sample was prone to selection bias the results indicated that women who
reported that both a mother and sister to have been affected with the disease showed
higher levels of intrusion than those with just one affected first degree relative.
Dudok deWit et al. (1997) assessed the effects ofpredictive testing for a range of late
onset inherited disorders (including breast/ovarian cancer, Huntingtons disease,
cerebral haemorrhage and bowel cancer). Individuals with greater experience of the
disease in close relatives who reported that the disease had had a greater impact on
their lives reported higher levels of distress prior to the test. Clear recollection of
symptoms observed in affected relatives and emotional descriptions of the impact of
the disease on their lives (including shame, fear, anger) were associated with higher
levels of intrusive thoughts about the disease.
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Lodder et al. (1999) also found that exposure to breast cancer in its later stages was
associated with levels of depression. Women who knew/had known close relatives
with metastatic cancer showed higher levels of distress compared to women who did
not know of any such relatives. The authors suggest these experiences increase
familiarity with the serious consequences of the disease and awareness ofwhat the
genetic test represents.
"I know what I am talking about, since I've seen cancer in close relatives
too often. The sickness of these relatives and the cancer hospital come
regularly to my mind and I don't want to end up there too " (Lodder et al.
1999 pg 912)
Qualitative studies had indicated that maternal experience of cancer may be
particularly distressing. Julian-Reynier et al. (1999) looked specifically at the impact
their mothers' cancer on levels of distress in women prior and post cancer genetic
risk assessment in cancer centres across France. Of 219 women assessed, 73% were
undergoing genetic risk counselling because of a family history of breast cancer and
22% because of a family history ofbowel cancer. Women whose mother had been
affected with cancer showed significantly higher levels of anxiety one week post
genetic counselling. Analysis of specific cancer types was not reported.
2.2.2b Bereavementfrom cancer
A few studies have assessed the impact ofbereavement on women's psychological
response to cancer risk. Wardle (1995) investigated the influence of the number of
friends and relatives who had developed, or died from cancer, on risk perception of
women at increased risk of ovarian cancer. Women at increased risk were compared
with women who had taken part in community screening in the previous year and a
group of controls who were not taking part in any ovarian screening programmes.
Both screening groups had experienced more cancer deaths than the controls. In all
three samples women who knew more people who had died of cancer reported a
significantly higher personal perception of risk. A significant interaction indicated
that the effect was significantly stronger in the screening groups than the controls.
Bereavement from cancer has also been associated with depression. Thewes et al.
65
(2001) found that the total number of first and second degree relatives who had died
from cancer was associated with levels of depression in women with a family history
of breast cancer.
Zakowski et al. (1997) assessed the impact ofparental bereavement on both women's
perception of breast cancer risk and levels of distress. Two groups ofwomen at
increased risk ofbreast cancer, those who had, and had not, suffered a parental
bereavement due to cancer were compared to a control group who had no history of
cancer in their first-degree relatives. Levels ofperceived risk differed between all
three groups. Women at increased risk showed significantly higher risk perceptions
than the control group. However, women who had lost a parent due to cancer had
significantly higher perceived risk than women who had not.
Parental death from cancer also appeared to account for some of the variability in
levels of distress. Women who had suffered parental bereavement due to cancer
reported higher levels of cancer specific distress than those who had not. Women
who had not lost a parent to cancer showed levels of distress comparable to the
control group. This suggests that cancer related events influence psychological
response to risk. The authors tested the hypothesis that perceived risk mediated the
impact of experience of parental death from cancer on levels of distress. Multiple
regression analysis confirmed this association. Women who had suffered a parental
bereavement because of cancer showed higher personal perception of risk that
appeared to account for the variability in levels of distress. The authors speculate that
" ...the experience of the parent's death from cancer, in addition to their
diagnosis which all women in our risk group had experienced, may
change the meaning of cancer from a potentially curable illness to a
death threat. This may heighten these women's distress about cancer in
general" (Zakowski et al. 1997, pg 367).
Although these studies provide initial evidence for the impact of experience of
cancer on response to risk information neither study assessed the nature of these
experiences in any detail. The measures used were basic and categorical assessing
general cancer experiences such as the number of people known to have cancer, or
whether the women had suffered a parental bereavement due to cancer or not
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(Wardle 1995, Zakowski et al. 1997). Wardle (1995) did not focus specifically on
experiences in the family and included experiences of cancer in friends in the
analysis. The sample size in the study by Zakowski et al. (1997) was too low to
assess the effects ofparental bereavement specifically from breast cancer. Previous
research had suggested that it is the specific experiences of breast cancer in the
family that influence women's response risk (Wellisch et al. 1991, 1992, 1996,
Chalmers and Thompson 1996).
Hopwood et al. (2001) investigated the impact ofmaternal bereavement from breast
cancer on levels of distress. In a study of 330 women assessed prior to genetic risk
counselling for breast cancer no difference was found between women who had lost
their mother to breast cancer (33%) and those who had not. In contrast to this
finding, Erblich et al. (2000) found women with a family history ofbreast cancer
who had suffered a maternal bereavement showed higher breast cancer related
distress in terms of intrusive thoughts and avoidance than those who had not.
Maternal death was associated with higher distress even though the average time
since death in the sample was 14 years. Women who had been involved in caring for
their ill mother also showed higher levels of cancer specific distress than those who
had not. This may reflect stress of caregiving in general or increased exposure to the
disease and its consequences. Alternative types of caregiving (eg physical
help/emotional support) may have different effects. Women who had experienced
both caregiving and maternal death showed the highest levels of distress and
depressive symptoms. In contrast to the findings of Zakowski et al. (1997) the effect
of these experiences on levels of distress was not found to be mediated by perceived
risk.
2.2.2c Age at maternal diagnosis/death
Zakowski et al. (1997) found no effect of age at parental death, recency of
bereavement, or parent's age at death on levels of distress although this analysis was
limited by a small sample size (n= 30). Erblich et al. (2000) found no effect of age at
maternal diagnosis or recency of diagnosis on of levels of distress in women with a
family history of breast cancer. Hopwood et al. (2001) extended the work by
Wellisch et al. (1992) on maternal bereavement during adolescence. Women who
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had lost their mother between the ages of 10-20 (n=43) showed slightly higher levels
of distress prior to genetic counselling than those who were bereaved after the age of
20 (n=l 15), or not at all, although this difference was not significant. Surprisingly
women bereaved at the youngest age (<10) (n=24) showed significantly lower levels
of cancer worry than the other age groups and were less likely to overestimate their
risk.. It is possible that children of this age may have been protected from the impact
of cancer in the family. The low number of participants in this sub-sample hinders
the reliability of the result.
2.2.2d Experience ofother unaffectedfamily members
As well as the experience of affected relatives the experiences and decisions of other
healthy family members may influence individuals' response to their own risk. For
example Dudokde Wit et al. (1997) found that the first utiliser of options such as
genetic testing and preventative surgery became the example for the rest of the
family. Smith et al. (1999) assessed the impact of siblings' test results on
psychological response to predictive testing for BRCA1. Test related distress was
assessed 1-2 weeks following test results. Women who tested positive showed higher
levels of distress at follow up than those with negative test results. However,
psychological reaction to personal test results was found to be moderated by siblings'
results. Those whose siblings all tested negative or whose sibling had not been tested
experienced the greatest level of distress, exceeding scores of cancer patients 10
weeks after diagnosis (Smith et al. 1999). Men who were the first to be tested or non-
carrier men whose siblings all tested positive also showed significant levels of test
related distress compared to other men. These results suggest that family context is
an important determinant of response to predictive testing. The authors also propose
that a number of other factors may also be important, including how siblings respond
to their test result, closeness of the relationship between siblings and the carrier
status of other relatives.
2.3 SUMMARY
Cancer has a large psychosocial impact on all family members. The illness is
distressing in nature, leads to changes in family functioning and roles and
encompasses the threat of bereavement. Women at increased risk of breast cancer are
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likely to have witnessed a number of relatives suffer from the disease at a relatively
young age. Experiences of breast cancer in the family can vary widely given the
diverse and unpredictable nature of the disease as well as individual and family
differences in response to illness. The subjective experiences of two women with the
same objective family history may therefore be very different. A family history of
breast cancer may be particularly traumatic because of the associated personal risk of
developing the disease and passing on an inherited susceptibility to one's children.
Experiences ofbreast cancer among other family members are likely to have a strong
influence on personal response and adjustment to risk status. However, studies on
psychosocial response to risk have tended to focus on the individual in isolation from
their family (Bottorff et al. 1998).
Qualitative studies have identified aspects of breast cancer experience that may
influence psychosocial adjustment in women at increased risk. These include the age
at time of relative's illness, pathogenesis of the disease, maternal bereavement,
perception of ill relatives, vicarious living of the breast cancer experience, changes in
life plans and family roles created by breast cancer in the family, identification with
the relative and communication about breast cancer within the family.
Few quantitative studies have attempted to clarify the effects of experience on
psychosocial adjustment in women with a family history of cancer. Greater exposure
to the disease, in terms more affected relatives and closer experience of late stage
illness, has been associated with increased levels of cancer specific distress and
personal perception of risk. A few studies have also shown that experience of
parental bereavement including maternal bereavement from breast cancer is
associated with heightened breast cancer specific distress. Studies examining the
effect of age at parental diagnosis or bereavement on subsequent response to risk are
inconsistent. These studies prove difficult to compare because of the range of
experiences often assessed within the same study (i.e. both maternal and paternal
cancer experiences) and the lack of statistical power to examine specific effects. The
impact of age at diagnosis and bereavement on response to risk is also likely to be
moderated by a number of additional factors including family stage, involvement in
care-giving and closeness to relative. The specific effects of these factors need to be
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examined systematically to explore inconsistencies in the literature. Comparisons
between studies are also hindered by assessment of diverse aspect of cancer specific
distress. For example, certain experiences may have different effects on intrusive
thoughts about breast cancer than on levels of cancer worry.
A number of other aspects of experience that may be associated with cancer specific
distress have been highlighted in these studies including, recollection of symptoms,
experiences of the consequences of the illness and care giving. Women may also be
influenced not only by affected relatives but also the risk status and response of other
healthy family members. These experiences may not only affect emotional response
to risk but have also been found to stimulate information seeking and to influence
decisions about management options.
The studies to date have been limited to basic categorical measures of experience (ie
the experience of bereavement or not, caregiving or not). No quantitative study to
date has investigated the subjective nature of these experiences such as women's
interpretation and perceptions of their experience. This may be crucial in
understanding the effect of experience on psychological adaptation to risk. Further
quantitative studies are required to explore subjective experiences ofwomen with a
family history ofbreast cancer. Some pilot work to refine a locally developed
questionnaire for use in this PhD project is described in Chapter 6.
The studies reviewed have been descriptive in nature aiming to identify salient
aspects of experience without theoretical reflection. There has been limited
consideration ofmechanisms by which experience may determine psychosocial
response to risk. There is a growing need to utilise a theoretical approach in order to
clarify how experiences of breast cancer might influence risk perception, behaviour
and the emotional well being of these women. This might then provide implications
for change and intervention. An overview of theoretical perspectives on these issues
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The literature reviewed in Chapter 2 indicated that subjective experience ofbreast
cancer in the family may be an important determinant ofpsychological well-being in
women with a family history of the disease and may help explain variation in
response to genetic risk information. The majority of research investigating the
impact ofwomen's experience ofbreast cancer has been exploratory and descriptive
with limited theoretically driven work aimed at predicting psychosocial response to
risk. However there are strong theoretical reasons for believing that aspects of
experience of cancer in the family may be important predictors (Rees et al. 2001).
Research driven from a theoretical perspective is able to identify and test hypotheses
regarding potential causal mechanisms. Understanding of these processes could
assist clinicians in predicting which women may exhibit high levels of distress or
hold misperceptions of risk and increase understanding of factors influencing
women's decisions regarding risk management. This holds important implications
for service development and interventions designed to improve women's adjustment
to risk. This chapter therefore aims to outline how women's experiences of breast
cancer in their family may affect psychosocial response to risk from a number of
theoretical perspectives.
The first section will outline theoretical perspectives on bias in risk perception and
discuss potential cognitive bias in the interpretation of genetic breast cancer risk
information that may be invoked by women's experience of illness in the family. The
second section will describe models of decision-making and highlight how
experiences of cancer in the family may influence decisions women make about
managing their personal risk. The third section will outline how representations of
health threats may influence psychosocial response to risk information. The impact
ofwomen's experiences on representations of breast cancer and subsequent
emotional and behavioural response to risk will be discussed.
2Material from this Chapter has been published:
Rees, G. Fry, A., and Cull, A. (2001) A family history of breast cancer: women's experiences
from a theoretical perspective. Social Science and Medicine (52), 1433-1440.
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3.2 COGNITIVE BIAS IN RISK PERCEPTION
In the general population individuals have been shown to demonstrate 'unrealistic
optimism' when estimating their vulnerability to health threats. Individuals
systematically underestimate their own risk compared to their perception of the risk
of others (Weinstein 1980, 1982, 1987). Unrealistic optimism has been shown in
women's perceptions of breast cancer risk (Absetz et al. 2000). Absetz et al. (2000)
found Finnish women who were participating in, or waiting to join a screening
programme for breast cancer perceived their own risk of breast cancer as lower than
that of their peers. Research has indicated however that greater experience of the
health threat in question (either directly or within one's social environment) and
perceived similarity to disease victims reduces optimistic bias (Weinstein 1989, Lek
and Bishop 1995). Indeed, Absetz et al. (2000) found optimistic bias was reduced in
women with a first degree relative (FDR) who had been affected with breast cancer.
This sub-sample showed no significant difference between perceptions of their own
and peers risk of breast cancer. Absetz et al. (2000) suggests that the experience of
having a FDR with breast cancer had a greater impact on risk perception than
knowledge of this as a risk factor for the disease. Tversky and Kahneman (1974)
describe three heuristics that create bias in risk perception when reasoning with
uncertain probabilistic information. These heuristics have been demonstrated in
genetic counselling situations (Shiloh 1994, Shiloh and Saxe 1989) and may explain
how experience of breast cancer heightens personal risk perception.
3.2.1a Availability:
Easily recalled events (those which are more salient, familiar, recent and imaginable)
are judged as more probable. Experiences of breast cancer in family, friends, work
colleagues and the media have been associated with increased perceptions of risk in
the general population (van der Plight 1998, Helzlsouer et al. 1994). For women at
increased risk, frequent contact with affected relatives or recent experiences ofbreast
cancer in their familywill lead women to think about the disease more often and
bring images ofbreast cancer to mind with greater frequency and clarity, heightening
perception of personal risk.
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3.2.1b Anchoring and adjustment:
Individuals are biased towards a preconceived idea about risk ('anchor') when
provided with new risk information. Women may hold preconceptions ofpersonal
risk based on their experience that act as an 'anchor' from which new risk
information given at the clinic is interpreted. For example a minority ofwomen with
a family history ofbreast cancer believe they will inevitably develop the disease
prior to genetic counselling and this belief is maintained even after the genetic
counselling session (Cull et al. 1999). The proportion of family members affected by
breast cancer may contribute to women's expectation of their level of risk:
"I think it's inevitable because there's no female members ofmy family
who haven't had it It's scary". (Appleton, 1999 quote from telephone
focus group study ofwomen at increased risk of breast cancer, personal
communication).
3.2.1c Representativeness:
Information about similarity and stereotypes are used to make judgements. Emphasis
is placed on perceived similarities when judging probabilities. Women who feel they
resemble an affected relative in their family may feel more vulnerable to the disease.
"I felt that I would get breast cancer as my body was similar to my
mother's in many ways- she had fibroids and a hysterectomy- she had
gall stones and had her gall bladder removed. I had both these
operations by my late thirties". (J.Zatz 1996, Daily life and the new
genetics: some personal stories, pg 28)
3.2.2 Genetic risk and bias
Understanding of familial disease risk is further complicated by misconceptions
about genetics. Lay concepts of inheritance are often based on resemblance and
beliefs that multiple characteristics are inherited together (Richards 1996). There is a
tendency to believe that susceptibility to illness is inherited along with other
personality and physical dimensions (Richards and Ponder 1996). These beliefs often
persist even after scientific, Mendelian accounts of inheritance have been provided
(Richards and Ponder 1996). Beliefs about the inheritance pattern in the family and
resemblance to affected relatives may have a strong impact on perception of risk.
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"When I was young my mother attributed her own breast cancer
diagnosis to birth order. She talked about being the affected first born
daughter of an affected first born daughter of an affected first born
daughter. She told me that as a first born daughter in this line, I should
expect to encounter the disease as well. With the diagnosis of one ofmy
mother's younger sisters when I was 25, my mother stopped talking
about the disease as a problem forfirst born daughters. Instead she dwelt
on the personality traits that her affected sister shared with their mother-
a certain intensity and vulnerability to stress looming large among
them". (Ellen Macke 1996. Daily life and the new genetics: some
personal stories, personal stories pg 32).
It is also widely believed that a greater proportion of inheritance is acquired from the
same sex parent (Richards and Ponder 1996). Women with a paternal family history
ofbreast cancer are under-represented at genetic clinics (McAllister et al. 1998). It
has been suggested that women with a paternal family history have lower perceptions
of risk because of limited understanding ofhow a predominately female disorder can
be passed on by males (Green et al. 1997).
3.3 DECISION MAKING AND BEHAVIOUR
Studies have indicated that experiences ofbreast cancer in the family and the
responses of other family members to their risk may influence women's decisions
about risk management (see sections 2.2.Id and 2.2.2d pages 63 & 68). Early studies
of human reasoning and decision-making attempted to discern processes that
individuals use in order to reach optimal decisions. Based on the 'utility theory'
individuals were thought to make decisions by assessing the probability and utility
(importance) of events in order to maximise positive outcome (von Neumann and
Morgenstern 1947). Evidence for this rational decision-making strategy has remained
controversial (Neumann and Polister 1992). It is now accepted that such decisions
are based upon a subjective interpretation ofboth probabilities and utilities. The
theory was therefore revised as the subjective expected utility theory (SEU) which
proposes that optimal decisions are based upon the decision maker's personal
expected utility of various outcomes.
Wroe et al. (1998) assessed subjective reasons for undergoing predictive testing in
hypothetical scenarios and in individuals who had contemplated genetic testing for a
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variety of disorders. In support of the SEU theory the decision made was predicted
by the ratio of relevant personal reasons for and against testing. Emotions were
considered as pros and cons when contemplating genetic testing. Both initial
emotional reactions to genetic testing and emotions anticipated after testing appeared
important (Wroe et al. 1998). Lerman et al. (1995b) found the main reason against
genetic testing for breast cancer was concern about emotional reactions. Women
anticipated anxiety, depression and impaired quality of life following a positive test
result. Women's experiences of breast cancer in their family and their beliefs about
the disease are likely to have a large impact on how they anticipate their response to
a positive test result.
Theories aimed at understanding health-related behaviour have been developed from
the general decision-making perspective. A number ofmodels have been developed
based on the premise that individuals make a rational analysis of the costs and
benefits of possible behaviours. The best known model of health-related behaviour is
the Health BeliefModel (HBM). This was initially designed to explain and predict
compliance with preventative behaviours such as screening and immunisation
(Rosenstock 1966, Becker 1974). According to this model readiness to engage in
health behaviour depends on four beliefs: perceived susceptibility to the health
threat; perceived seriousness of the health threat; perceived benefits of action;
perceived costs of the behaviour. An individual will be most likely to engage in
preventative behaviour if they regard themselves as susceptible to a serious illness
and consider some preventive behaviour to have more benefits than costs. Once an
individual is ready to act, behaviour is triggered by cues (Rosenstock 1966). Cues
may be internal, such as bodily states, or extraneous (eg, health messages in the
media).
Experiences of breast cancer in the family are likely to influence several components
of this model. Section 3.2 discussed the potential impact family experiences of breast
cancer on perceived susceptibility to the disease. Experience ofbreast cancer in the
family has also been found to alter perception of its severity and consequences
(Wellisch et al. 1996). Beliefs concerning the efficacy of screening (BSE, CBE and
mammography) may also be influenced by the impact of these techniques on
detection ofbreast cancer in affected relatives. Finally, exposure to cues concerning
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breast cancer risk may vary depending on cancer related events and communication
styles in the family. For example, Benedict et al. (1997) found frequency of breast
self examination was positively associated with how much daughters talked to their
mother about breast cancer.
Components of the HBM, including perceived susceptibility and barriers to action,
have predicted breast self examination among women in the general population
(Champion 1987) although HBM has been used with limited success to explain poor
adherence to screening in women at increased risk of breast cancer (eg Kash et al.
1992).
A more general theory of behavioural decisions that has been applied to health
related behaviours is the Theory ofReasoned Action (TRA) (Ajzen and Fishbein
1980). This model suggests that intentions to perform a particular behaviour arise
from both personal attitudes towards the behaviour and social influence. Attitudes
towards the behaviour may be positive or negative depending on the perceived
consequences of the behaviour. Social influence, known as 'subjective norm' refers
to the perceived expectations of important others. The theory was later extended to
the Theory of Planned Behaviour (TPB) with the addition of 'perceived behavioural
control' in order to help explain behaviour that is not entirely under volitional control
(Ajzen 1991). The model proposes that intention to perform behaviourwill be strong
if an individual holds a positive attitude towards the behaviour, perceives him/herself
to have control over the behaviour and believes that significant others expect him/her
to perform it.
Whilst this model has not been explicitly tested in women at risk of breast cancer,
studies suggest that relatives may actively encourage or dismiss utilisation of genetic
services. For example, women have been found to attend familial breast cancer
clinics following advice from another family member (Brain et al. 2000) and to
consider genetic testing following the experience of other family members (Dudokde
Wit et al. 1997). The beliefs of family members and communication styles within the
family may influence both attitudes towards the behaviour as well as providing
strong subjective norms.
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Miller et al. (1999) discuss the implications ofutilising social cognition models to
understand women's decisions regarding prophylactic oophorectomy. Miller et al.
(1999) suggest that the models could be used as a framework from which to
systematically explore the psychological consequences of all options available. They
propose that tailoring decision-making in this waywill enhance informed decision¬
making as well as satisfaction, quality of life and adherence in the longer term.
Although these models highlight the role of cognitive factors in response to risk,
application of these models has been limited by poor definition of constructs and
inadequate assessment measures (Strecher and Rosenstock 1996). Constructs are
often neglected because ofmethodological difficulties in measurement (for example
the cues to action from the HBM) and studies often focus on the comparative impact
of constructs rather than testing the integrated model as a whole (Harrison et al.
1992). Little work has addressed interactions between constructs. The models also
provide limited insight into the development of cognitions. The HBM specifically
does not explain how perceptions are formed or translate into behaviour change and
none of the models explain how perceptions are evaluated and modified. This makes
the models static in nature and unable to account for dynamic changes over time.
The models do not explicitly address emotional aspects of health threats and are
therefore unable to account for biases such as denial and avoidance. Although the
models were initially designed to inform understanding of preventative behaviours
their application to detection behaviour (e.g. BSE) is limited without incorporating
emotional factors. Although these behaviours convey benefit of early detection and
treatment they are also anxiety provoking due to fear of discovering cancer.
Reasoned perceptions regarding cancer detection can not be dissociated from
emotional response. A wider dynamic model that is able to incorporate meaning and
emotional response to risk is required to increase our understanding of psychosocial
response to genetic risk ofbreast cancer.
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3.4 ILLNESS REPRESENTATIONS
3.4.1 The Self Regulatory Model
Leventhal's (1980) Self Regulatory Model (SRM) takes into account individual's
emotional and cognitive response to a health threat and aims to describe and predict
how individuals respond to and cope with threats to health. The model was
developed from work investigating the impact of fear on attitude and behaviour
change, which indicated that cognitive and emotional aspects of health threats are
processed independently (Leventhal et al. 1997). The model proposes that
individuals actively generate cognitive and emotional representations of health
threats and these representations independently guide and regulate behaviour. Illness
representations are also known as illness perceptions and these terms will be used
interchangeably throughout. The SRM is shown in Figure 3.1. As the model indicates
stimuli from both the environment (eg risk information) and internal stimuli (eg the
experience of symptoms) trigger cognitive and emotional representations. These
representations may have been generated from past personal experience including
actual experience of illness or vicariously from the experiences of friends and family,
as well as from cultural beliefs and ideas inherent within language. Individuals derive
an action plan to cope with threat based on their representation of it. The success of a
particular coping strategy is appraised and feeds back into both the representation
and the action plan, which may be modified accordingly. To give an example, an
individual suffering from a severe headache may attribute this to stress and take
medication for the pain. However, if the pain is not reduced and the headache
worsens the individual may consider that the headache is a symptom of a more
serious condition. The individual may become anxious and make plans to see their
doctor. In this way both the representations of the health threat and coping plan have
been modified following feedback from outcomes of the initial plan.
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(Figure adaptedfrom Leventhal et al. (1997), pg 21)
The SRM expands the social cognition models by integrating cognitive, emotional
and behavioural elements and can be applied to a range of psychosocial outcomes
(Leventhal and Cameron 1987). The model provides clear mechanisms by which
experiences and conceptual knowledge may impact on beliefs and emotions in a
dynamic manner. The model also allows for the influence of individual differences in
how people represent, cope and appraise their response to health threats (eg coping
style, attributional style). The SRM therefore provides a relevant framework from
which to understand women's response to breast cancer risk. Women with different
experiences of breast cancer will construct different representations of the disease
and choose different coping strategies for dealing with risk and criteria from which to
appraise their situation.
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3.4.2 The nature of illness representations -qualitative assessment
Initial evidence for the SRM was gained from open-ended interviews with patients
with hypertension and cancer (Leventhal et al. 1980, 1986, Meyer et al. 1985). These
studies indicated that patients actively build a mental representation of their illness
and that the illness representations were based around 4 components. These were:
identity of the threat (its symptoms and label); cause (e.g. infection, genetic, stress);
time line (duration and development) and consequences (including somatic and
psychosocial). Lau and Hartman (1983) also found college students provided
information concerning the control/cure of illness when asked about their most recent
illness episode. Together these five components appear to capture the majority of
comments made when people are asked to describe illness (Bishop et al. 1987).
The dimensions outlined in the SRM are not independent but likely to be highly
interrelated. The dimensions are also not exhaustive and each attribute may be
further differentiated (Nerenz and Leventhal 1983). An individual's model of an
illness may also not necessarily be complete, well organised or medically correct. In
this flexible manner the 5 dimensions outlined in the SRM provide a useful
framework from which to investigate how individuals representations of disease are
organised, structured and impact on response to illness.
Direct experience of illness has been highlighted as a main determinant of illness
representations in affected patients (Schiaffino and Cea 1995, Paterson et al. 1999).
To date there has been little research examining factors associated with the
development of illness representations in healthy individuals. However Bishop and
Converse (1986) and Bishop et al. (1987) provide evidence that healthy individuals
hold representations of disease based around 'prototypes', i.e. 'idealised conceptions'
that help organise information about illness and assist healthy individuals to match
and evaluate symptom experiences. Bishop et al. (1987) found that 90% of healthy
individuals' comments regarding illness fell into the 5 categories previously reported
in patients. The most prominent dimensions healthy individuals spontaneously
expressed were symptoms, labels and causes of illness.
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Initial work on illness representations used open ended data collection in order to
allow patients to describe and define their own representations. In a review of studies
assessing illness perceptions between 1985-1995 Scharloo and Kaptein (1997) found
that most researchers continued to use open ended or semi-structured interviews to
elicit illness perceptions. Researchers most frequently developed codes or categories
from recorded interview material although a number of studies combined interviews
with predetermined study specific rating scales.
Qualitative methodology has the advantage of tapping representations directly
without forcing participants to respond to predefined categories. However the
disadvantages include the time consuming nature of such methods leading to low
sample sizes and difficulty generalising results. Social desirability bias may also
confound interview data. In a discussion of assessment of illness representations
Leventhal and Nerenz (1985) note that even open ended interviews may not
necessarily capture a representative illness perception but rather the most accessible
responses at that moment in time. The authors also warn how questions may be
subtly biased. For example the question 'How can you tellyour bloodpressure is
high?' is likely to elicit responses about symptom responses whereas the question
'How couldyour wife tell ifyour bloodpressure was elevated?' is more likely to
evoke beliefs about the behavioural signs ofhypertension (Leventhal and Nerenz
1985, pg 539). It is also difficult to determine the prevalence of beliefs and to
investigate the relations between dimensions with qualitative data. The variability in
qualitative methodological procedures and use of study specific rating scales also
make comparisons between studies difficult.
3.4.3 Quantitative measurement of illness representations
Quantitative measures have the advantages of allowing researchers to explore the
prevalence ofbeliefs, test the predictive value of combinations of illness dimensions,
and to clarify issues regarding the conceptual overlap of dimensions. However
Scharloo and Kaptein (1997) found studies utilising quantitative measures tended
only to assess a limited number of dimensions. The most frequent dimension
assessed was beliefs about control, measured in over 50% of the studies reviewed. A
total of 22 different instruments were used to assess control beliefs across these
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studies making comparison difficult. Study specific measures are also often used
with limited validation work. Standard measures of illness perceptions are required
in order to allow researchers to assess all dimensions in the same format, to compare
perceptions of different illnesses, to investigate interrelations between dimensions
and to assess the predictive value ofpatterns of illness representations as well as
individual dimensions.
The Implicit Models of Illness Questionnaire (IMIQ) is a 38-item questionnaire
designed to assess the dimensions of illness perceptions across a broad range of
illnesses (Turk et al. 1986). It was developed to determine if there was a generic
structure of illness representations across different illnesses (Turk et al. 1986). Turk
et al. (1986) used the IMIQ to assess perceptions of diabetes, flu and cancer held by
students, nurses and patients. The factor structure that emerged from these data
suggested that a different structure underlies cognitive representations than had been
previously proposed. The results suggested that illness representations are based on 4
dimensions: seriousness (permanent-chronic); personal responsibility; controllability
and changeability (in terms ofpain and disability). Schiaffmo and Cea (1995) also
used the IMIQ to investigate perceptions of rheumatoid arthritis, multiple sclerosis
and HIV held by patients and students but reported a different factor structure. The
results of these studies therefore suggested that the items did not to hang together in a
consistent theoretically predicted manner. The application of the questionnaire across
different illness is also questionable given the highly specific nature of some items
(eg 'similar to the common cold'). Factor analytic studies are only ever as good as
the items entered into the analysis and the structures obtained are likely to change
drastically depending on items used and the applicability of the items to the disease
in question. Turk et al. (1986) themselves caution that'the factors that we extracted
had more to do with the questions that we asked than any cognitive representation of
disease held by subjects' (pg 471).
Heijmans and de Ridder (1998) also used factor analysis to investigate the structure
of illness representations held by patients suffering from two different illnesses:
Chronic Fatigue Syndrome (CFS) and Addisons disease. A different factor solution
was found for each illness. For CFS, the factors appeared to represent manageability
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(identity and control), seriousness, personal responsibility and external cause. For
Addisons disease, the factors were interpreted as seriousness, cause, chronicity and
controllability. Although the factor structures identified in these studies do not
exactly fit the structure of illness representations described in the initial qualitative
studies the types of dimensions described are similar and "captured to some extent
the spirit ofthe common sense model" (Schiaffmo and Cea 1995).
It is entirely consistent with the SRM that the structure of illness representations and
importance placed on the dimensions differs depending on the disease in question
(Schiaffmo and Cea 1995). The factor analytic studies therefore do not dispute the 5
dimensions outlined by Leventhal, but indicate how illness perceptions may be
grouped or organised for different illnesses. Although it may be difficult to compare
alternative approaches (ie qualitative and quantitative) to investigating the structure
of illness representations, authors have noted that content analysis of qualitative
illness descriptions and factor analysis of quantitative data are complementary
methodological approaches that are likely to elicit different results in this area (Lau et
al. 1989, Bishop 1991). These approaches can be used to investigate different
questions regarding the structure of illness representations. Content analysis of
dimensions focuses on common features of illness representations whereas factor
analytic techniques assess differences in the conceptualisation of diseases (Lau et al.
1989).
3.4.4 The Illness Perception Questionnaire
A more recent quantitative instrument designed to assess illness representations is the
Illness Perception Questionnaire (IPQ) (Weinman et al. 1996). The authors aimed to
develop a theoretically based, psychometrically sound assessment of illness
perceptions that could be adapted to specific illnesses. It was hoped that such a
measure could increase understanding of illness related coping and aid the
development of interventions to improve self-management in chronic illness
(Weinman et al. 1996). Items were derived theoretically to assess each of the 5
components of illness representations (identity, timeline, consequences, cure/control,
and cause). The identity scale comprised a 12 item symptom checklist which can be
expanded for specific illnesses. The timeline, consequences and cure/control scales
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are assessed by items rated on a 5 point scale from strongly disagree to strongly
agree. Participants also rate their beliefs about specific causes of the 5-point scales.
In order to check that the questionnaire adequately covered participants'
representations, responses to the IPQ were compared with semi-structured interviews
for a sample of 52 insulin-dependent diabetic patients. Participants completed both
the IPQ and interview in a counterbalanced manner. All themes that emerged during
the interviews were also apparent in the questionnaire data. In fact the IPQ was found
to be more inclusive than the interviews since a third of respondents failed to provide
information on some of the dimensions within the interviews. This confirms the
findings of Leventhal and Nerenz (1985) who reported that checklists of symptoms
and signs elicited more responses from patients with hypertension or cancer. This
may reflect the fact that questionnaires are less likely to be influenced by situational
and personality factors (ie articulation) than interview methodology. In a systematic
review of causal attributions for heart disease French et al. (2001) compared patterns
of responses elicited from open ended interviews or questionnaire methods. No
differences were found in the frequency or rating of causal items when these items
were generated by the respondent or the experimenter.
Weinman et al. (1996) conducted a thorough test of the psychometric properties of
the IPQ on a number ofpatient populations including diabetes, rheumatoid arthritis
(RA), renal, asthma, chronic fatigue syndrome (CFS) and myocardial infarction
patients (MI). Internal consistency and test re-test reliability scores for each of the
scales (identity, timeline acute, consequences, control/cure) were high.
Intercorrelations between the subscales were also logical. Participants with a stronger
illness identity were more likely to believe that their illness was long-lasting with
greater consequences. Participants with less belief in the controllability of their
illness were more likely to believe the illness was long-lasting with greater
consequences. The IPQ showed adequate discriminant validity. The identity,
consequences and timeline subscales as well as a number of cause items significantly
differentiated between different illnesses (chronic pain, RA and CFS). Concurrent
and predictive validity was tested on the MI sample. Subscales showed logical
correlations with measures of perceived health and disability at baseline as well as
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follow up measures at 3 and 6 months including recent doctor visits, self rated health,
beliefs about likelihood of future MI and self rated beliefs about control over health
problems. Since publication the EPQ has been used in a range of studies assessing
patients response to heart disease, RA, psoriasis, chronic obstructive pulmonary
disease, CFS and Addisons disease (Moss-Morris et al. 2002). The IPQ has also been
adapted to assess the perceptions ofhealthy spouses of patients to enable
investigation of the concordance between spouses' and patients' illness perceptions
(Weinman et al. 1996, Heijmans 1999).
Original work on the IPQ showed that one of the subscales (cure/control) had lower
internal reliability and closer investigation revealed that there were two separate
components to this scale: personal control and perceived efficacy of treatment
(Weinman, personal communication). In the review of assessment of illness
perceptions Scharloo and Kaptein (1997) noted that the chronic pain literature
suggested that the timeline subscale may be further differentiated since perceived
constancy of the illness was considered an more important predictor of outcome than
the perceived duration of illness in this sample. Moss-Morris et al. (2002) discuss
potential improvements to the instrument and provide a revised version of the
questionnaire (IPQ-R). The control/cure subscale was subdivided to create separate
subscales to assess beliefs about personal control and perceived efficacy of treatment
('treatment control'). The timeline subscale was expanded and a measure ofbeliefs
about the constancy of illness was developed ('timeline cyclical' subscale) along side
the subscale to assess duration of illness (renamed 'timeline chronic/acute'). In
addition, two further components of the theoretical model were introduced. Firstly,
an 'emotional representations' subscale was designed to assess patients' emotional
response to their illness. The SRM proposes that emotional representations are
processed in parallel with cognitive representations and may evoke different coping
strategies. This component of the model is often neglected and research efforts have
mainly focused on the cognitive level. Secondly, an 'illness coherence' subscale was
developed to assess the extent to which individuals have a coherent understanding of
their illness (Moss-Morris et al. 2002). Moss-Morris et al. (2002) test the application
of the IPQ-R across 8 patient populations. Factor analysis identified and confirmed
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the 7 dimensions and the sub-scales in the final version were found to show excellent
psychometric properties (Moss-Morris et al. 2002).
3.4.5 Illness representations and outcome
A number of studies have investigated the impact of illness perceptions on patients'
response to illness.
3.4.5a Functional outcomes
Beliefs about the identity, consequences and control of chronic illness appear to be
important predictors of functional response following surgery. In a prospective study
Petrie et al. (1996) found patients initial perceptions of the consequences ofMI
predicted functional recovery including recreational activities and return to work at 3
and 6 months follow up. Orbell et al. (1998) found beliefs regarding the cause and
control of osteoarthritis prior to surgery predicted functional activity on follow-up, 9
months later. Perceptions of the identity, consequences and control of CFS and
Addisons disease have been associated with functional ability and physical
functioning (Moss-Morris et al. 1996, Heijmans and de Ridder 1998, Heijmans
1999).
Scharloo et al. (1998) found beliefs about identity predict physical functioning in
patients with psoriasis and beliefs about identity, control and cure account for
variance in physical functioning in patients with RA.
3.4.5b Illness management
Illness perceptions also appear predictive of self-management and use of health
services. Petrie et al. (1996) and Cooper et al. (1999) found initial beliefs regarding
the controllability ofMI predicted patient's subsequent attendance for rehabilitation.
Hampson et al. (1990) reported that perceptions of diabetes as a serious condition
and beliefs in the importance of treatment predicted self-management activities
including diet and exercise. Patients with osteoarthritis who believed their illness had
more symptoms and was a serious condition made greater use ofmedical services
and engaged in more self-management activities (Hampson et al. 1994). In a year
long prospective study of patients with psoriasis, beliefs at baseline (concerning
identity, consequences and control) predicted the number of visits made to an
outpatient clinic over the subsequent year (Scharloo et al. 2000).
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3.4.5c Psychological response
All of the dimensions of illness representation have been associated with the
psychological well-being of patients. Beliefs about the identity, cause, manageability,
chronicity and seriousness ofCFS have been associated with mental health and
psychological adjustment to illness (Heijmans and de Ridder 1998, Heijmans 1998
and Moss-Morris et al. 1996). Murphy et al. (1999) found depression in patients with
RA to be positively associated with beliefs regarding the identity and consequences
of the disease and negatively associated with beliefs about control or cure. Patients
who RA initially believed their disease was curable or believed they were personally
responsible for disease onset have exhibited increased depression over time
(Schiaffino et al. 1998). Orbell et al. (1998) also found beliefs regarding control,
consequences and cause of osteoarthritis were associated with levels of depression
following surgery. In a prospective longitudinal study Schiaffino et al. (1998)
reported that perceived symptom variability was associated with increased depressed
mood in patients with multiple sclerosis at 4 month follow up. Scharloo et al. (2000)
reported that a great illness identity predicted depression and poor mental health in
patients with psoriasis after controlling for the confounding effect of illness severity
and duration. Worry about psoriasis has also been associated with beliefs about the
seriousness of the condition and emotional cause of the disease, independent of the
clinical severity of the condition (Fortune et al. 2000).
These studies provide strong evidence of the role of illness representations in
response to chronic illness. A few studies have investigated the impact of both illness
representations and coping on response to illness (Fleijmans 1998, 1999, Moss-
Morris et al. 1996, Scharloo et al. 1998). These studies suggest that illness
representations are associated with coping although there is limited evidence for a
mediation effect. Illness representations appear stronger predictors of outcome than
do coping measures. This may suggest that illness representations have a direct effect
on outcome not mediated by coping strategies or that the coping measures used are
not adequate to detect an effect.
A number ofmethodological difficulties have limited the conclusions that can be
drawn from these studies. The majority of studies used cross-sectional designs and
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correlational analysis. In such studies it is impossible to determine whether
individuals view their illness more negatively because they are depressed or vice
versa. Causal relationships are difficult to establish. However, a few longitudinal
studies have suggested that cognitive representations precede illness outcomes
(Petrie et al. 1996, Orbell et al. 1998, Schiaffmo et al. 1998, Scharloo et al. 2000 ).
Intervention studies influencing cognitions or coping strategies are needed to provide
firm causal evidence. Although some studies have reported illness perceptions to be
independent of objective measures of illness severity and disability (Petrie et al.
1996, Scharloo et al. 1998, 2000, Fortune et al. 2000) a number of studies are
confounded by illness severity. In this case patients negative illness perceptions and
illness outcomes may in fact reflect reality. There is a need where possible to include
objective, clinical indices of illness for control purposes. It is however recognised
that for some diseases (eg CFS) no objective measures of illness severity exist
(Moss-Morris et al. 1996).
3.4.6 Illness perceptions of breast cancer patients
Leventhal's early work on breast cancer patients found that patients held strong
perceptions of the identity of breast cancer and described a number of symptoms
associated with the disease (Leventhal et al. 1986). Causal attributions for the disease
fell into two broad categories of personal habits (diet, stressful life) and personal
vulnerability. A number of studies have found patients hold complex multifactorial
models in which the cause ofbreast cancer is attributed to stress, genetics,
environment, specific carcinogens, hormones, diet and breast trauma (Buick et al.
1997, Taylor et al. 1984, Stewart et al. 2001). Leventhal et al. (1986) found that
patients' representations of breast cancer varied as a reflection of their experience,
including variations in type of carcinoma, natural history of the disease and treatment
type. Some patients believed the disease to be contained in time and location whereas
others perceived the disease as widespread. Some women believed breast cancer to
be a chronic, cyclical illness characterised by recurrence whereas other women
believed the disease to be acute and short lived. Buick et al. (1997) found that
recommended treatment (in their study: either adjuvant radiotherapy or
chemotherapy) had a large impact on women's perceptions of breast cancer. Prior to
treatment, chemotherapy patients perceived breast cancer as longer lasting and
89
holding more consequences than radiation patients. Buick et al. (1997) also found
that causal beliefs changed over time. In particular beliefs about chance and genetics
strengthened during and following treatment.
Buick et al. (1997) assessed the impact of illness perceptions of breast cancer on
patients' response to treatment. Illness perceptions were important predictors of
psychosocial response to treatment, independent of objective illness severity (tumour
size, metastases status, axillary node involvement and type of surgery). Negative
beliefs held by patients treated with both radiation and chemotherapy (strong illness
identity, self blame, beliefs in long duration and severe consequences and low belief
in control/cure) were associated with increased psychological distress and poor
coping post-treatment. Taylor et al. (1984) investigated the impact of causal beliefs
on adjustment to breast cancer and found no particular causal attribution to be
associated with better adjustment. However blaming another individual for the
cancer was negatively associated with adjustment. Taylor et al. (1984) also
investigated beliefs about control of the disease and found that patients who believed
they had control over breast cancer or that others (eg doctors) could control the
disease showed greater adjustment. Stewart et al. (2001) investigated breast cancer
survivors' perceptions of control over disease recurrence. Women who had remained
recurrence-free for at least two years believed recurrence had been prevented by a
number of factors including their positive attitude, diet, healthy lifestyle, exercise,
stress reduction, prayer, complementary therapies, luck and tamoxifen. This
suggested that these women felt a degree of personal control over the prevention of
recurrence.
3.4.7 Healthy women's perceptions of breast cancer
Few studies have assessed healthy women's perceptions ofbreast cancer. The
available data suggest women base their beliefs about breast cancer on information
available in the media and from family and friends. Most women perceive breast
cancer as a very serious illness (Roberts et al. 1984, Payne 1990). Roberts et al.
(1984) surveyed 810 healthy women in Scotland to determine their knowledge about
breast cancer. Knowledge about the disease was found to be poor with few women
describing any other symptom of breast cancer than a lump. Payne et al. (1990)
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found women had general knowledge about breast cancer although misconceptions
regarding cause and treatment were prevalent. Misconceptions regarding the cause of
breast cancer included not wearing a bra, taking vigorous exercise, hitting the breast
and having had many sexual partners. Other causal beliefs about the disease fell into
2 main categories: stress (personal affective states and external stressors) and
personal and environmental hazards (eg smoking). Buick et al. (1997) compared the
beliefs of healthy women with breast cancer patients and reported that healthy
women were more likely to endorse self-blame and chance as causes ofbreast cancer
than did patients.
Roberts et al. (1984) found that the majority ofhealthy women perceived little
chance of surviving breast cancer. Although 87% believed that early diagnosis
improved chances of survival over 40% ofwomen believed it was not possible to
detect the disease in its early stages. Only 31% ofwomen believed it was always or
usually possible to cure the disease. In this study 45% ofwomen knew of no other
treatment for breast cancer than surgery and only 17% of respondents referred to
chemotherapy (Roberts et al. 1984). In contrast, Buick (1997) found healthy
women's beliefs regarding the duration and impact of treatment were comparable to
those held by patients receiving chemotherapy but not those receiving radiotherapy.
In addition, healthy women also tended to overestimate the distressing nature of
cancer treatment compared to patients (Buick 1997). Payne (1990) found women to
believe in a number of treatments for breast cancer other than surgery. Women in this
study reported a variety of 'dietary treatments' (e.g. vitamins and low fat diet) as
well as 'psychological treatments' (e.g. learning to relax, and cope with stress).
These items appeared to overlap with personal control over breast cancer rather than
treatment methods.
Beliefs about breast cancer have been associated with detection behaviour. Payne
(1990) reported that women who practiced BSE were more likely to believe in the
efficacy of surgical and 'psychological treatments' for breast cancer. Savage and
Clarke (1998) conducted interviews designed to elicit older women's (> 45 years)
representations ofbreast cancer and found that women who participated in screening
were more likely to cite positive examples regarding the success ofbreast cancer
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treatment in their social circle than non-screeners who were less likely to believe in
the efficacy of cancer treatments.
3.4.8 Perceptions of genetic illness
We have little understanding of how awareness of genetic predisposition will affect
representations of disease. Information about genetic risk is most likely to influence
beliefs about cause and control or cure of illness. Michie et al. (1996) conducted
semi structured interviews with individuals at risk of inheriting a gene predisposing
them to familial adenomatous polyposis (FAP). This is an inherited form ofbowel
cancer that shows 100% penetrance. However, individuals were found to hold
multifactorial beliefs about the cause of the disease including both genetic and
lifestyle factors. Senior et al. (2000) reported an experimental study in which
participants were provided with hypothetical test results relating to either heart
disease or arthritis. Participants who were informed that the test was genetic were
more likely to attribute the illness to genes and less to lifestyle, and to rate both
conditions as less preventable, than participants who were not informed of the nature
of the test. However this study was conducted on participants with limited experience
of the illness. It remains to be seen how knowledge about genetic risk will influence
the beliefs of clinical populations with a family history of the disease in question.
Marteau and Senior (1997) argue that a thorough understanding of individuals'
representations of genetic illness needs to incorporate not only beliefs about the
disease but also beliefs about genes and inheritance. Lay understanding of genetics
and beliefs about inheritance within the family and are likely to influence illness
representations specifically of the cause and control/cure dimensions.
3.4.9 Perceptions of breast cancer in women at increased risk
Women with a family history of breast cancer have experienced the disease in their
family and are likely to have concrete images of the disease and its effects. Chalmers
and Thompson (1996) reported that the process of adapting to breast cancer risk was
achieved by rehearsing how to cope with personal development of cancer. Illness
representations derived from experiences in the family are likely to provide a
meaning about ones own risk and expectations about the potential illness experience.
However, the variable nature of breast cancer may lead women to develop different
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beliefs regarding the identity, timeline, consequences, control/cure and cause of the
disease. Women may have observed the effects of different breast cancer types and
treatments and may or may not have witnessed recurrence or terminal breast cancer.
Within the family, different levels of exposure to breast cancer and its effects,
communication about the disease and differences in the personality and coping style
of affected relatives may also influence how breast cancer is perceived. Experiences
may range from exposure to positive role models, who survived breast cancer and
coped well with the disease to more negative experiences in which relatives suffered
physical and mental hardship before death. This is demonstrated in the following
quotations:
"I'm lucky in the fact... that I have... more surviving relatives that have
had breast cancer and are fine and that's a big inspiration... You think
well its beatable its not a death sentence" (Appleton, 1999 quote from
telephone focus group study ofwomen at increased risk of breast cancer,
personal communication).
"It would be unpleasant to lose a breast, but dying the horrible death my
mother died...I'll neverforget it. The three children knew, everyone knew
there was a waitingperiod until she died. The operation was very painfid
and the scar was hideous. It was difficult to simulate normal appearance.
Then she found out she had one year to live. She was in pain all the time.
She hated putting her family through it. The end is horrible. You get thin
and your hair falls out. The cost is horrible. My father himselfpaid out
$70, 000 plus the insurance. I was going back andforth, bit it was hard
for my family to pay for my airfare. I couldn't stand to stay there and
watch mother waste away. My mother hated for me to be there and
wantedmet here at the same t ime. Ourfamily si tuation d eteriorated. "
(Kelly 1983, pg 12)
3.5 SUMMARY
Although studies have shown that women's experience ofbreast cancer in the family
influence their response to genetic risk these studies have largely been a-theoretical
and are unable to indicate the causal mechanisms involved. A number of theoretical
perspectives have been discussed in this chapter that enable us to see how
experiences of cancer in the family may influence psychosocial response to risk and
indicate factors amenable to modification. Experiences ofbreast cancer in the family
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have the potential to create bias in interpretation of risk information, contribute to
cognitive factors involved in decision-making and impact on illness representations
of breast cancer.
Experiences of cancer in the family may create bias in the interpretation of genetic
risk information in a number ofways. Firstly, by increasing the availability of images
of cancer; secondly, by providing evidence for and expectation of personal risk and
thirdly, by enhancing feelings of similarity and resemblance to affected relatives.
This bias may be particularly strong when interpreting genetic risk information since
lay understanding of genetics and inheritance is often based on resemblance and
shared inheritance.
A number of cognitive factors highlighted in the health behaviour change models
may be influenced by direct communication about breast cancer and its prevention in
the family, observation of affected relatives and by decisions and health-related
outcomes of other family member at increased risk. In this way experiences of breast
cancer in the family may ultimately influence individuals' decisions about their own
risk management (e.g. attending for screening, genetic testing, chemoprevention or
prophylactic surgery).
Focusing on the role of cognitive factors (e.g. risk perception) as determinants of
psychosocial response to risk neglects emotional aspects of risk. The SRM moves
beyond a narrow assessment of perceived probabilities to explore the wider meaning
of health threats as perceived by the individual. The model shows how a wide range
of concrete experiences, knowledge, memories and social processes are integrated to
form both a cognitive and emotional representation of the health threat. The model is
able to explain how these components are interrelated in an interactive, dynamic
manner and provides a useful framework from which to understand women's
psychosocial response to breast cancer risk. This framework may be particularly
helpful in understanding variation in levels of distress in women at increased risk of
breast cancer.
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A body of research has identified and classified dimensions that cover the scope of
individual's representations across a range of illnesses. Although the majority of
work has been conducted on patients, healthy individuals have also been shown to
hold representations of a range of diseases (Bishop and Converse 1986, Bishop et al.
1987). The IPQ has made a major contribution to research in this area by providing a
psychometrically sound quantitative measure of illness perceptions that can be
applied to most chronic illnesses. It has allowed researchers to investigate
associations among dimensions, explore patterns across the dimensions and test the
predictive value of single dimensions and combinations ofbeliefs on outcome
variables of interest. Understanding of illness representations in patient samples
(including breast cancer patients) has successfully increased understanding of
individual differences in patient's functional and emotional response to illness,
treatment and illness management. The fPQ has been adapted to assess the
perceptions of non-patient samples i.e. spouse ofpatients (Weinman et al. 1996,
Heijmans 1999). However, no work to date has investigated the influence of
representations of cancer in healthy individuals at increased genetic risk. There has
been little work addressing healthy women's perceptions ofbreast cancer and there is
limited understanding of perceptions of illness associated with genetic predisposition
although this is recognised as an important area for research. Applying the SRM to
women at increased risk of breast cancer is likely to enhance understanding of
psychosocial response to genetic risk.
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AIMS, DESIGN AND METHODS
4.1 RESEARCH QUESTIONS AND AIMS OF EMPIRICAL WORK
4.1.1 Research questions identified from the literature
The literature reviewed in Chapters 1-3 have identified a number of outstanding
research questions that have guided the aims and objectives of the current research.
The literature reviewed in Chapter 1 highlighted that the aetiology and maintenance
of distress in women at increased risk ofbreast cancer is poorly understood and
understanding of factors that account for variability in psychological adjustment to
risk is limited. There is a growing need to understand what factors contribute to
increased distress in women at increased risk of breast cancer in order to help
identify women who may suffer adjustment difficulties and inform intervention to
improve psychological wellbeing in this population.
A number of qualitative studies and anecdotal reports reviewed in Chapter 2
indicated that experience ofbreast cancer in the family is an important factor that
may be linked with poor psychological adjustment to risk. However it is still unclear
what experiences contribute to distress in women at increased risk breast cancer and
the strength of these relationships. Quantitative studied are needed to explore this in
more detail. The theoretical perspectives reviewed in Chapter 3 suggested that
experience may impact on adjustment to personal risk via cognitive as well as
emotional response mechanisms, which are amenable to change. Theoretically driven
research is required in order to investigate how women's experiences contribute to
psychosocial response to risk in order to understand the causal mechanisms involved.
The SRM was described in Chapter 3 and provides a useful theoretical background
from which to understand and predict the impact of experience of breast cancer in the
family and subsequent illness representations on psychosocial response to genetic
risk. The model suggests that awareness of risk status will stimulate the formation
and development of illness representations. Women with a family history of breast
cancer are likely to develop strong representations of the disease on the basis of their
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experiences within their family. These perceptions may provoke anxiety about breast
cancer risk and help explain variation in psychosocial response. This model and
associated measures have not been applied to at risk population before. The model
provides a framework to guide future research and generates a number of research
questions including:
• Can existing measures of illness perceptions be adapted to 'at risk'
populations?
• What perceptions of breast cancer do women at increased risk of the disease
hold?
• Do women at increased risk of breast cancer hold different illness perceptions
to women in the general population?
• What experiences are associated with illness perceptions?
• Are illness perceptions associated with psychological well-being in women at
increased risk of breast cancer?
4.1.2 Theoretical model, aims and objectives.
The subsequent work reported in this thesis applied the SRM to the problem of
understanding individual differences in women's emotional response to breast cancer
risk. The primary aim of the subsequent research was to:
• Test the mediation model (Figure 4.1) that perceptions ofbreast cancer
mediate the impact of experiences of the disease in the family on
psychological well-being in women at increased risk of breast cancer.
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Figure 4.1- Experience ofbreast cancer in the family and emotional response to
personal risk: A theoretical model.
Illness
Perceptions
Experience of breast cancer Psychological well-being
in the family
Secondary objectives of the research included:
1. To evaluate the use of the IPQ-R to assess perceptions of breast cancer in
women at increased risk and women in the general population.
2. To examine associations between experience of breast cancer and levels of
general and cancer specific distress in women at increased risk of breast
cancer and women in the general population.
3. To examine associations between experience of breast cancer and perceptions
of the disease in women at increased risk of breast cancer and women in the
general population.
4. To examine associations between perceptions of breast cancer and levels of
general and cancer specific distress in women at increased risk of breast
cancer and women in the general population.
4.1.3 Hypotheses
This theoretical model suggests a number of hypotheses that will be tested
throughout this thesis. The main hypotheses dealt with in subsequent chapters are
outlined below.
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4.1.3a Experience and distress (Chapter 7)
HI. Women with a significant family history of breast cancer will show higher
levels of cancer specific distress than women without any experience of
breast cancer.
H2. Experiences ofbreast cancer in the family will be associated with levels of
general and cancer specific distress in women at increased risk.
H3. Experiences ofbreast cancer reported by women in the general population
will be associated with levels cancer specific distress in this sample.
4.1.3b Experience and illness perceptions (Chapter 8)
H4. Women with a significant family history of breast cancer will hold more
negative perceptions of the disease (higher scores on the identity, timeline
acute, consequences and emotional representations subscales of the IPQ-R)
than women without any experience ofbreast cancer.
H5. Experiences ofbreast cancer in the family will be associated with perceptions
of the disease in women at increased risk.
H6. Experiences of breast cancer in family or friends reported by women in the
general population sample will be associated with more negative perceptions
of the disease (higher scores on the identity, timeline acute, consequences and
emotional representations subscales of the IPQ-R).
4.1.3c Illness perceptions and distress (Chapter 9)
H7. Perceptions ofbreast cancer will be significantly associated with levels of
general and cancer specific distress in women with a significant family
history of breast cancer.
4.1.3d The mediation model (Chapter 10)
H8. The impact of experience of breast cancer on levels of general and cancer
specific distress will be mediated by perceptions ofbreast cancer.
4.1.4 Analysis Plan
The hypotheses outlined above will be tested in the context of a cross-sectional
comparison ofwomen at increased risk of breast cancer and women in the general
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population. Analysis will be conducted at two levels. Firstly, differences between the
samples will be examined (HI and H4). Secondly associations between experience of
breast cancer and levels of distress (H2-H3); experience of breast cancer and illness
perceptions (H5-H6); as well as illness perceptions and levels of distress (H7) will be
further investigated in each sample. This analysis will be supplemented by additional
multivariate analysis in the increased risk sample in order to help identify the best
predictors of distress. The analysis will identify potential mediation models that will
be examined in the final results chapter (Chapter 10). An outline analysis plan in
provided in Table 4.1 Details of specific statistical techniques are provided where
appropriate.
Table 4.1- Summary ofanalysis plan.
Chapter Results Analysis
Chapter 5 Sample • Descriptive statistics
• Comparison of respondents and non
respondents
• Comparison of respondents in each
sample








Chapter 7 Experience of breast cancer
and distress
• Comparisons of samples
• Associations between experience and
distress within each sample
Chapter 8 Experience of breast cancer
and illness perceptions
• Comparisons of samples
• Associations between experience and
distress within each sample
Chapter 9 Illness perceptions and
distress
• Associations between illness
perceptions and distress in each
sample
• Predicting distress in the increased
risk sample.




A cross sectional postal questionnaire study comparing women at increased risk of
breast cancer (Sample A) and women in the general population with (Sample B) and
without experience ofbreast cancer (Sample C) was used. A sub-sample of the
increased risk sample was also followed up at 3-months with an additional
questionnaire to obtain test-retest reliability data.
4.3 PARTICIPANTS
4.3.1 Sources of participants
4.3. la Increased risk sample (Sample A)
Women on the database of the South East Scotland Familial Breast Cancer Clinic,
who had been assessed as being at least 'moderate' increased risk ofbreast cancer
and were maintained on surveillance (i.e. regular mammogram and clinical
examination). At the time of data collection only women who had received genetic
counselling and had met criteria for being at increased risk of breast cancer (see
Figure 1.1) were recorded on the database. The judgement of risk status had been
made by the clinician following genetic counselling session. At time of data
collection objective risk status was not collated on this database.
4.3.1b Generalpopulation sample (Samples B&C)
Women were identified from the Community Health Index at Fothian Health. This is
a register of all individuals registered with GPs in the Fothian region.
4.3.2 Inclusion criteria
4.3.2a Increased risk sample (Sample A)
Any woman at increased risk of breast cancer due to a family history of the disease.
4.3.2b Generalpopulation sample (Sample B&C)
Women were selected on the basis of their age and postcode sector (eg EH10 4) to be
comparable to the increased risk sample. This sample was divided into women with
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experience ofbreast cancer in their social environment (Sample B) and women
without any experience of breast cancer (Sample C).
4.3.3 Exclusion criteria
It was important that the increased risk sample was as homogeneous as possible since
variability in the sample may affect levels of distress or illness perceptions.
Therefore, women on the database of the South East Scotland Familial Breast Cancer
Clinic were excluded prior to selection if they had had preventative surgery, chemo-
prevention or genetic testing. Women with an ovarian family history were also
excluded. Women were also excluded from the database if they had taken part in any
other psychosocial research project in the last six months. Women in both samples
were excluded for the following reasons:
• Previous diagnosis of cancer in the past
• Currently undergoing investigation for cancer
• Currently suffering from another serious illness
• Currently suffering from alcoholism, schizophrenia or organic brain damage
4.4 MEASURES
4.4.1 Background demographics
Postcode sector was converted into a measure of social deprivation using the
Carstairs Index (Carstairs and Morris 1991). This is a measure of social deprivation
based on 4 criteria: overcrowding, male unemployment, low social class and
proportion of individuals within private households without a car. The scores are
collapsed into two scales a 5 point scale (Depcap 5) and a 7 point scale (Depcap 7).
High scores on both scales represent higher levels of deprivation (Carstairs and
Morris 1991).
In both samples participants were asked to report their marital status, educational
level and ethnic group. Women were also asked if they had any children, and if so
the age and gender of each child.
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Women were also asked their perception of risk with the following two questions:
How likely do you feel it is that you will develop breast cancer in your lifetime?
Very
Unlikely
Unlikely Likely Very likely Extremely likely
2 3 4 5
Do you think that your risk of ever developing breast cancer is:
a. Lower than the general population
b. The same as the general population
c. Slightly higher than the general population






4.4.2a Increased risk sample (Sample A)
The experience questionnaire is described in Chapter 6. A copy of the instrument in
given Appendix II (page A-4)
4.4.2b Generalpopulation sample (Sample B&C)
Participants in the general population sample were asked the following questions
regarding their experiences of breast cancer for control purposes.
• Have any of your relatives ever suffered from breast cancer? (yes/no)
• If yes, please list what relatives have suffered from breast cancer (eg mother, sister etc)
• Have any of your family or friends suffered from breast cancer recently? (ie in the past 12
months) (yes/no).
• Does your work bring you into contact with cancer patients on a regular basis? (yes/no, if yes
please give details)
• Do you have any other experiences of breast cancer you would like to tell us about? (open
Response to these items were used to create sub-samples. Participants who reported
any experiences of breast cancer were allocated to Sample B (general population
sample with experience of breast cancer) and those who did not report any
ended).
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experience of breast cancer were allocated to Sample C (general population sample
without any experience of breast cancer).
4.4.3 Illness perceptions
The IPQ-R (Weinman et al. 1996, Moss-Morris et al. 2002) described in Chapter 4
(section 3.4.4, page 84) was adapted to measure illness perceptions ofbreast cancer
in both samples. This measure included assessments a number of dimensions of
illness perceptions: identity, timeline acute/chronic, consequences, timeline cyclical,
personal control, treatment control, illness coherence, emotional representations,
causes. The adaptation of the questionnaire, description of subscales, scoring and
details of reliability shall be covered in detail in Chapter 6.
4.4.4 Distress
Measures ofboth general and cancer specific distress were included in this study (see
Chapter 1, section 1.4.1, page 50, for a description ofmeasures of geireral arrd carreer
specific distress in women with a family history of breast cancer).
4.4.4a General distress
The 30-item version of the General Health Questionnaire (GHQ-30) was used to
assess general distress. This is a self-administered screening test aimed at detecting
psychiatric disorder in the community and non-psychiatric clinical settings.
Participants respond to thirty statements about their general health over the past few
weeks on a 4 point scale. The GHQ-30 was scored using the 'alternative' scoring
system (0, 0, 1, 1) to determine the prevalence of psychopathology. In this method
responses are summed to achieve a total score. Using this method a score over 5 is
taken as the cut-offpoint to indicate levels of distress that warrant further clinical
assessment ('caseness') (Goldberg and Williams 1988). Responses were also scored
using the 'Likerf scoring system (0, 1, 2, 3) in order to investigate individual
differences in levels of distress. There are numerous studies on the measures internal
reliability (mean 0.87), test-retest reliability (ranging from 0.51-0.9) and validity
(correlation coefficients of 0.45-0.77 when compared to interview measures of
morbidity) (Goldberg and Williams 1988). The scale has been used previously to
assess levels of distress pre and post genetic counselling at the Edinburgh familial
breast cancer clinic (Cull et al. 1998, 1999).
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4.4.4b Cancer specific distress
Two measures of cancer specific distress were used.
4.4.4b(i) Cancer worry scale
The cancer worry scale was used to assess anxiety specific to breast cancer (Watson
et al. 1998). This is a 6 item self-administered scale assessing frequency of breast
cancer related worries and the degree to which these worries affect mood and daily
activities. Each question is scored from 1-4 and summed for a total score. The scale
has been used within populations at increased risk of cancer although there is limited
published data on its psychometric properties. Brain et al. (1999) report an alpha
reliability coefficient of .86 when administered to a sample ofwomen prior to
genetic counselling.
4.4.4b(ii) The Impact ofEvent scale
The Impact ofEvent scale was used to determine levels of intrusive and avoidant
thoughts about breast cancer. The measure was originally developed to assess
subjective levels of distress associated with a specific traumatic event (Horowitz et
al. 1979). It is a 15 item scale that measures levels of intrusive and avoidant thoughts
occurring in the past week. Seven questions refer to the frequency of intrusive
thoughts and eight to avoidance. Participants respond to each statement on a 4-point
scale ranging from 'not at all' to 'often'. When scored the responses are weighted 0,
(not at all), 1 (rarely), 3 (sometimes) and 5 (often). Original split half reliability
reported for the scale was r= .86. Cronbach's alpha values were reported as 0.78 for
the intrusion subscales and 0.82 for the avoidance subscale (Horowitz et al. 1979).
The reliability and validity of the scale have been confirmed in the general
population (Briere and Elliott 1998). The scale has recently been modified to
determine levels of cancer specific distress associated with risk of breast cancer
(Kash et al. 1992). It shows acceptable reliability (split half reliability: r= .86; test-
retest reliability: r=.87 intrusion; r= .89 avoidance; Cronbach's alpha reliability
coefficient: 0.91 (Kash et al. 1992)) and has been widely used within populations at
increased risk (e.g. Lloyd et al. 1996, Gagnon et al. 1996, Watson et al. 1999,
Lerman et al. 1994a, Valdimarsdottri et al. 1995, Zakowski et al. 1997, Thewes et al.
2001).
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Lloyd et al. (1996) included an opt out box for women who had not thought about
breast cancer in the past week (Lloyd et al. 1996). This version of the measure was
used in this study because a large proportion of the general population sample were
expected not have thought about breast cancer in the past week. A recent
psychometric assessment of the scale in women at increased risk of breast cancer
respondents criticised the measure for not including a response options for those who
had not thought about breast cancer (Thewes et al. 2001).
4.4.5 Follow up questionnaire measures
The follow up questionnaire was administered to a sub-sample of the increased risk
sample and contained the same measures of distress and illness perceptions outlined
above. The experience items were not repeated, as test-retest data were not required.
However, it was necessary to control for women's experiences between
questionnaires that may have influenced anxiety or perceptions of breast cancer.
Women were asked to report any experiences that may have influenced their
thoughts and feelings about breast cancer. Prompts were given for experiences which
have been reported to influence feelings about breast cancer risk such as attending
for screening and media reports (Appleton et al. 2000) as well as general experiences
expected to influence levels of distress or perceptions of breast cancer. The items
included in the questionnaire were:
• Since you last filled in this questionnaire about 3 months ago have you attended the
Ardmillan Familial Breast Cancer Clinic for an annual check up? (Yes/No)
• Since you last filled in this questionnaire, can you think of any experiences that may have
changed your thoughts and feelings about breast cancer? (Yes/No)
• If yes, please let us know about these experiences by ticking the box(s) and describing your
experiences:
■ Events at the clinic
■ Family experiences
■ Experiences of friends





The database from the SE Scotland Familial Breast Cancer Clinic was imported into
SPSS and a random sample of 200 women selected using the random number
selection. The following information was then obtained for this sample:
• Date ofbirth
• Address including postcode
• GP name and address.
This information was used to select a comparable sample ofwomen in the general
population. For each woman at increased risk 2 women in the general population
with the same postcode region and date ofbirth within 1 year were selected (n=400).
Following a low response rate in the general population another match for each
woman at increased risk was obtained at a later date (n=200). For 8 of the women at
increased risk only 2 appropriate matches could be identified and hence only 592
women in the general population were selected.
The women's GP's were contacted in order to ensure the exclusion criteria (see
4.3.3, page 104). GPs were provided with an information sheet about the study and
asked to contact the researcher by email, telephone or fax within the next fortnight if
they considered the patient was not suitable for the study because of the exclusion
criteria or for any other reason. The GPs were informed that if they had not contacted
the researcher within 2 weeks it would be assumed that the patient was eligible to
participate in the study.
Participants who were eligible for the study were sent an information sheet and
consent form and invited to take part in the study. Women were asked to indicate on
the consent form if they wished to participate in the research project or not and to
return the form in the freepost envelope provided. Women who consented were sent
a questionnaire pack and a freepost envelope for its return. If the questionnaire was
not returned within 3 weeks another copy of the questionnaire was sent with a
reminder letter. In the initial general population sample (n= 400) women who did not
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return their consent form were sent a reminder letter and another consent form in an
attempt to increase the sample size.
In order to obtain test-retest reliability data in the increased risk sample a second
questionnaire was sent to a subsample of the increased risk sample (participants who
had returned the first questionnaire without prompting) 3 months after they were sent
the initial questionnaire.
4.6 ETHICAL CONSIDERATIONS
Ethical approval for this study was obtained from Lothian Research Ethics
Committee. The SE Familial Breast Cancer Clinic is a research led clinic and women
who attend the clinic are aware that they may be approached for clinical trials (e.g.
IBIS, see Chapter 1, section 1.2.5, page37) or other research. A number of research
projects were being conducted at the time of this study. It was essential therefore that
the research aims be addressed as economically as possible, ideally within the
context of a single study. In order to ensure women on the database were not over-
exploited for research studies women who had participated in any other psychosocial
research project in the last six months were excluded. This also guaranteed that
women selected had not participated in the previous pilot work concerning
development of the experience questionnaire (see Chapter 6, Part 2, sections 6.3-6.8).
Women were provided with an information sheet regarding the study that clearly
stated that their decision to participate in the research or withdraw at any stage would
not affect the services they would receive now or in the future.
Initially women's GP's were contacted in order to check the exclusion criteria (see
4.3.3, page 104) and to determine any additional concerns about approaching their
patients. An 'opt out' response format was used in order to reduce the amount of
time the GP needed to spend on this task.
For the general population sample it was necessary to adhere to strict confidentiality
guidelines concerning information stored at Lothian Health Board on the Community
Health Index (CHI). Information stored on this database is confidential and direct
access is only allowed for the purposes of providing services to patients. However,
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Lothian Health Board occasionally allow information on the CHI to be used for
ethically approved medical research studies. A research officer from Lothian Health
Board selected the sample based on the criteria provided and made contact with the
GP and subsequently the patient, if the inclusion criteria were met. Lothian Health
Board included an additional information sheet to both the GP and patient to explain
the use of the CHI and to ensure that no personal information about the patient would
be available for research purposes unless the patient consented to the study. Lothian
Health Board provided a list of anonymous date of births and postcode regions of the
initial sample prior to contact with the GP as well as the number of participants who
were excluded by the GP (and reasons where provided). Contact details were only
provided by the patient, if consenting to the study.
Confidentiality was maintained during data management. Each participant was
allocated a unique study code and this code was the only identifier that appeared on
any on the participants data gathered during the study. Raw data was stored in locked
filing cabinets and data stored on computer was password protected.
Support was available ifwomen found the research distressing. Contact details of a
nurse at the Familial Breast Cancer Clinic were provided on both the information
sheet and questionnaire pack ifwomen required further information about the study
or if the study raised any issues of concern. Contact details of the principal researcher
were also provided. Resources of the Department of Clinical Psychology were also
available for psychological support in the unlikely event that the questionnaire
caused severe distress or worry. Women's GP and the Familial Breast Cancer Clinic
were notified if any participant scored above the cut-offpoint on the GHQ-30.
4.7 SAMPLE SIZE
A minimum of 100 women in each sample was required in order to achieve statistical
power for multivariate analysis of associations between measures of experience,
illness representations and distress. A sample size of 100 will be able to detect r-
squared values (percentage of variance of the dependent variable accounted for by
the model) of 10-15% in multiple regression models with 80% power (Hair et al.
1995).
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Sample size was also required in order to ensure a sufficient sample size to detect
differences in illness representations between women with different levels of distress
However, no published data were available on the differences between groups using
the IPQ-R hence power calculations using this measure could not be computed.
A response rate of 50% was expected, taking into account low response rates to
questionnaires (Altman 1997). A sample of 200 women at increased risk was
therefore selected. As no information about the experiences ofwomen in the general
population sample could be ascertained prior to the questionnaire a larger sample
was anticipated as being necessary in order to achieve a sample of 100 controls with
no experience ofbreast cancer in family or friends. Initially, 400 women were
selected from the general population. Due to a low response rate a further 192 were
approached bringing the full sample size to 592. Across both samples the overall
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5.1.1 Increased risk sample (Sample A)
From the 200 women identified from the database, sixteen were excluded by the GP
prior to the study. Reasons for exclusions are provided in Table 5.1. A sample of 184
women at increased risk was therefore invited to participate in the study.
Table 5.1- Participants excludedfrom the increased risk sample by the GP.
Exclusion reason Number ofparticipants
excluded
Not registered at GP 8
Depression 2
Anxiety and depression 1
Previous cervical cancer diagnosis 1
Serious illness 1
Previous diagnosis of endometrial cancer 1
Currently under investigation for cancer 1
No reason given 1
Total excluded 16
Sample size remaining 184
5.1.2 General population sample (Sample B&C)
Thirty women in the first general population sample (n=400) were excluded by the
GP (please see Table 5.2). In the second general population sample (n=192) an
additional 15 women were excluded by the GP and were subsequently replaced
(please see Table 5.3). A total of 562 women in the general population were
therefore invited to take part in the study.
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Table 5.2- Participants excluded by the GPfrom thefirst general population sample
selection.
Exclusion reason Number of
participants
excluded
No reason given 12
Not on GP list 5
Moved from area 4
Currently suffering from cancer 3
Participant is male 1






Sample size remaining: 370
Table 5.3- Participants excluded by the GPfrom the second generalpopulation
sample selection.
Exclusion reason Number of
participants
excluded
No reason given 10







Response rates were calculated from the number of individuals who were deemed
eligible for the study (ie not excluded by their GP) who were sent an information
sheet and consent form. The proportion ofwomen who returned their questionnaire
before and after reminders is reported.
5.2.1 Increased risk sample (Sample A)
Of the 184 women who were deemed eligible for the study, 128 (69.6%) consented
to take part. Fourteen women stated that they did not want to participate in the study
and 42 did return the consent form. It was presumed these women did not want to
participate in the study.
Ninety-nine women returned the questionnaire before reminders (53.8%). A further
18 returned the questionnaire after the reminder giving a response rate of 63.6%
(n=l 17).
5.2.1a Follow up sample
The 99 women in the increased risk sample who returned their questionnaire without
prompting were sent a follow up questionnaire. Seventy-four (74.8%) returned a
completed questionnaire.
5.2.2 General population sample (Sample B&C)
In the first general population sample (n=370) 145 (39.2%) women consented to the
study, 21 did not consent and 204 did not return to the consent form. A subsequent
form was sent to those who did not respond and 55 women returned this form stating
that they would consent to be study. In the second general population sample
(n=192), 77 women consented to the study.
Overall, 562 women were deemed eligible for the study and 277 consented to take
part. Two hundred and twenty seven questions were returned before a reminder and
31 received following a reminder. The overall response rate was 45.9% (n= 258).
Two respondents had reported on their questionnaire that they had suffered from
cancer in the past. As this was an exclusion criterion (see 4.3.3, page 104) these
116
women were excluded at this stage. The number ofwomen in the general population
sample was therefore reduced to 256 (45.5%).
5.2.2a Generalpopulation sample without experience ofbreast cancer (Sample C)
One hundred women (39.1%) in the general population did not reported any
experiences of breast cancer in family, friends or at work. This sub-sample of the
general population formed the control sample in subsequent analyses.
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5.3 DESCRIPTION AND COMPARISON OF SAMPLES
Figures 5.1 and 5.2 provides a summary of each samples and response rate
throughout the study.
Figure 5.1- Increased risk sample (A): Outline and response rate
SAMPLE A: Increased risk
sample (n=l 17, response
rate= 64%)
Follow up sub-sample (n= 74,
response rate= 75%).
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Figure 5.2- General population sample (B&C) : Outline and response rate
Identified from Community
Health Index (n= 592)
Replacement found for those
excluded by GP (n= 15)
1






response rate = 46%)
Excluded:









experience of breast cancer
(n=156)
SAMPLE C: General population
sample without any experience of
breast cancer (n=100).
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5.3.1 Comparisons of initial samples
Women selected for the increased risk (n= 200) and general population (n= 592)
samples were compared on age and Carstairs Deprivation Score. There were no
significant differences in age (t= .02, df= 790, p= 0.98), Depcap 5 (t= .26, df = 790,
p= 0.80) or Depcap 7 (t = .83, df= 790, p= 0.41) between the increased risk sample
and the full general population sample. Mean values for each sample are provided in
Table 5.4







Increased risk (A) 200 39.8 (7.39) 23-59 2.6(1.31) 3.3 (1.39)
General population
(B&C)
592 39.9 (7.33) 23-59 2.6(1.26) 3.4 (1.37)
5.3.2 Comparisons of respondents and non-respondents in each sample
5.3.2a Increased risk sample (A)
There was no significant difference in age or levels of social deprivation between
respondents and non-respondents (p<0.05) (Table 5.5). Non-respondents showed a
trend to higher levels of social deprivation than respondents on Depcap 5(p<0.1).
Table 5.5 Differences between respondents and non respondents in the increased
risk sample (Sample A)
Respondents Non respondents df t P
N 117 83
Age: Range 23-56 23-59
Mean (sd) 40.4 (7.09) 39.4 (7.60) 198 .94 0.35
Depcap 5: Mean (sd) 2.5 (1.23) 2.8 (1.40) 198 1.80 .07
Depcap 7: Mean (sd) 3.2 (1.31) 3.4(1.51) 198 1.34 0.18
5.3.2a(i) Follow-up sample
There were no differences in age or risk perception between participants who were
sent a follow up questionnaire and the rest of the increased risk sample (p<0.05).
120
There were also no differences in age or risk perception between participants who
returned a follow-up questionnaire and those who did not (p<0.05).
5.3.2b Generalpopulation sample (B&C)
There were no significant differences between respondents and non-respondents on
age or the Carstairs deprivation scores (p<0.05). A trend on Depcap 7 suggested that
the non-respondents in this sample also showed greater social deprivation than
respondents (Table 5.6).
Table 5.6- Differences between respondents and non-respondents in the general
population sample
Respondents Non respondents df t P
N 256 334
Age: Range 25-59 23-59
Mean (sd) 40.3 (6.99) 39.5 (7.57) 588 1.37 0.17
Dep 5: Mean (sd) 2.5 (1.27) 2.7(1.27) 588 1.55 0.12
Dep7: Mean (sd) 3.2 (1.34) 3.5 (1.40) 588 1.95 0.052
5.3.3 Comparisons of respondents in each sample
Respondents in the two samples showed comparable socio-demographic
characteristics. These are summarised in Table 5.7. There was no difference in age
(t= .55, df= 371, p= 0.58); education level (t=.51, df= 368, p= 0.61); marital status or
maternity between the general population sample and the increased risk sample (chi-
square= .502, df= 1, p= 0.48; chi-square= 440, df= 1, p= 0.51).
Tabic 5.7 Summary ofsocio demographic characteristicsfor respondents in each
sample.




Mean age 40.4 40.8
% Reporting education/training after age 18 45% 48%
% Married or living with a partner 88% 79%
% With at least one child 71% 73%
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As expected the samples differed significantly in their perception ofpersonal breast
cancer risk. These differences are summarised in Table 5.8 and 5.9. Participants in
the increased risk sample (A) were significantly more likely to believe they were
likely to develop breast cancer in their lifetime than women in the general population
sample (B&C) (t= 7.83, df= 366, p<0.001). Seventy-seven percent ofwomen in the
increased risk sample believed it was 'likely', 'very likely' or 'extremely likely' that
they would develop breast cancer compared to 38.3% of the general population
sample.
Table 5.8- Differences in riskperception (1) between the samples.
How likely do you feel it is that you will




sample (B&C). n, (%)
Very unlikely 1 (0.95%) 11 (4.3%)
Unlikely 25 (21.4%) 143 (55.9%)
Likely 70 (59.8%) 89 (34.8%)
Very likely 16(13.7%) 8 (3.1%)
Extremely likely 4 (3.4%) 1 (0.4%)
The vast majority ofwomen at increased risk of breast cancer (sample A) perceived
their risk as slightly or much higher than the 'general population risk of breast
cancer' (92.3%). The majority of the general population sample (B&C) perceived
their risk as 'the same as the general population' (t= 19.34, df 371, p<0.001).
Table 5.9- Differences in riskperception (2) between the samples.





sample (B&C) n (%)
Lower than the general population 0 19 (7.4%)
The same as the general population 9 (7.7%) 201 (78.5%)
Slightly higher than the general population 86 (73.5%) 35 (13.7%)
Much higher than the general population 22(18.8) 1 (0.4%)
5.3.3a Women in the general population sample without experience ofbreast cancer
(Sample C)
The control sample was the subset of the general population sample who had no
experience ofbreast cancer (see Figure 5.2). There was no significant difference
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between the control sample and increased risk sample in age (t= 1.19, df= 215, p=
0.24), education level (t= .460, df= 212, p= 0.65), marital status (chi-square= .018,
df= 1, p= 0.89) or maternity (chi-square 2.37, df= 1, p= 0.12). As expected women in
the increased risk sample scored significantly higher perceptions of breast cancer risk
on both measures than women in the control sample. Women in the increased risk
sample more likely to believe they will develop breast cancer in their lifetime (t=
7.48, df= 211, p<0.001) than the control sample. Eighty-seven (87%) ofwomen in
the control sample believed their risk of breast cancer was the same as the general
population and 67% believed they were 'very unlikely' or 'unlikely' to develop
breast cancer in their lifetime.
5.4 SUMMARY AND DISCUSSION
The response rate in the increased risk sample was good but as expected recruitment
was much lower in the general population sample. A second phase was required to
achieve the specified sample size. The difference in response rate most probably
reflects greater interest and relevance of the study for women at increased risk of
breast cancer compared to women in the general population.
The general population sample was selected on the basis of information concerning
the age and postcode region of the increased risk sample and the initial samples were
therefore of comparable age and social deprivation level. No strong bias was found
between respondents and non-respondent in each sample although there was a trend
in each sample for non-respondents to show greater social deprivation. No
differences were found between respondents in each sample on any of the
background demographic factors. The increased risk sample was comparable to both
the general population sample and the control sample in age, education, marital
status and maternity. As expected women in the increased risk sample reported
higher subjective risk perceptions than women in the general population sample.
In the general population sample two women had slipped through the exclusion
criteria. They reported on their questionnaire that they had developed cancer in the
past. These women should have been identified and excluded at the GP stage. This
raises the possibility that 2 weeks was insufficient time for GPs to fully check all
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exclusion criteria. An 'opt in' rather than 'opt out' approach at the GP stage may
have been more thorough. However, this would need to be balanced with the extra
requests on GPs for their time.
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DEVELOPMENT AND EVALUATION OF MEASURES
6.1 BACKGROUND: PSYCHOMETRIC EVALUATION OF MEASURES.
Accurate measurement is a fundamental element of scientific research and essential
for confident application of research findings. There are a number of criteria to
determine if a measure of internal psychological stimuli is psychometrically sound
and likely to provide useful information. Johnston et al. (1995) identify these criteria
as: applicability; acceptability; readability; sensitivity; specificity; reliability and
validity. Measures must be appropriate and comprehensible to the population in
question and be sensitive enough to detect differences across individuals or changes
over time. The scores obtained on the measure should be reliable and not change
unless there has been some change in the phenomenon under assessment. There are
two main types of reliability for self-report instruments. Firstly, internal consistency
indicates if one part of the measure gives similar scores to other parts of the measure.
A common statistic used to assess internal consistency is Cronbach's alpha. This
statistic represents a summary of the overall correlation between items. A value of
0.6 is regarded as acceptable for scales in the process of development whereas a
value of 0.7-0.8 is deemed as the acceptable lower limit for established tests
(Johnston et al. 1995, Kline 1998). Secondly, stability refers to the reproducibility of
the measure over time. This is often assessed by administering the measure to the
same participants at two points in time and calculating the correlation coefficient
between the scores obtained (test-retest reliability). A correlation coefficient value of
0.5 is regarded as reasonable stability (Streiner and Norman 1991). A measure must
also prove valid (measure what it is designed to measure). There are a number of
aspects of validity: face validity (degree to which items appear to resemble the
construct they are designed to assess); content validity (degree to which the measure
covers all relevant domains); concurrent validity (associations with other measures
designed to assess the same or similar construct); construct validity (degree to which
items assess the construct they are designed to sometimes assessed with factor
analysis); criterion validity (ability of the measure to discriminate between groups
hypothesised to differ on the construct in question); predictive validity (extent to
which scores are predictive of future outcomes).
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Measures of the three main constructs in this thesis (experience, distress and illness
perceptions) required psychometric evaluation to ensure they were adequate for use
in subsequent analysis (see Table 4.1, page 102). Published research has
demonstrated adequate psychometric properties of distress measures in women at
increased risk of breast cancer but these needed to be examined in the general
population sample. At the time of this study quantitative measures of experience
were not available in the literature and measures of illness perceptions had not been
evaluated in healthy populations. The purpose of this study was not to develop new
measures but to examine the utility of adapting existing measures required to test the
primary aim of the thesis (see Figure 4.1, page 100).
Prior to this research work had already begun to develop a questionnaire to assess
important aspects of experience in women with a family history of breast cancer.
Prior to the researcher joining the psychosocial research group a quantitative
questionnaire addressing experience of breast cancer in the family had been
developed based on a limited review of the literature, clinical observation and
interviews with women attending the familial breast cancer clinic in Edinburgh. This
had been administered to women attending genetic counselling sessions and
following analysis of responses a shortened version of the questionnaire had been
derived (Cull, personal communication).
A theoretically derived measure of illness perceptions (IPQ) was available in the
literature (Weinman et al. 1996) and had recently been revised (IPQ-R) (Moss-
Morris et al. 2002). However, this measure had not been evaluated for use in healthy
samples. Adapting this measure would allow comparison with research findings in
patient populations and also provide evidence regarding the potential application of
the measure in healthy samples. Three sets of analyses are reported in this chapter.
Part 1 outlines the reliability details of the cancer specific distress measures in this
study. Part 2 refers to the adaptation and assessment of experience ofbreast cancer in
the family. Part 3 reports the adaptation and evaluation of the EPQ-R to assess
healthy women's perceptions of breast cancer.
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PART 1
CANCER SPECIFIC DISTRESS MEASURES
6.2 RELIABILITY
6.2.1 Cancer worry scale
In the increased risk sample (A) the mean score on the cancer worry scale was 10.2
(sd= 2.58, n= 116). In the general population sample (B&C) the mean score was 9.1
(sd= 2.27, n= 253). Cronbach's alpha was 0.8 in the increased risk sample (A) and
0.78 in the general population sample (B&C). Test-retest reliability in the increased
risk sample was r= .75 (n=73, p< 0.001).
6.2.2 Impact of Event scale
The mean scores on the Impact ofEvent scale are provided in Table 6.1. Internal
consistency of the measure was acceptable in the increased risk sample (A)
(Cronbach's alpha = .92 (total), .87 (intrusion), .87 (avoidance)) and the general
population sample (B&C) (Cronbach's alpha = .93 (total), .89 (intrusion), .84
(avoidance)). Test-rest reliability in the increased risk sample (A) was acceptable for
the total score (r= .44, p= 0.011, n =33) and intrusion subscale (r= .61, p<0.001,
n=35) but lower for the avoidance subscale (r=.40, p= 0.082, n=35).
Table 6.1- Mean scores on the Impact ofEvent scale in the increased risk and
generalpopulation samples.
Measure Descriptive Increased risk General population
statistic sample (A) sample (B&C)
Impact ofEvent- n 58 65
Total score Mean (sd) 18.2(12.69) 14.8 (15.15)
Impact ofEvent- n 60 68
Intrusion subscale Mean (sd) 8.1 (5.94) 5.9 (5.97)
Impact ofEvent- n 58 65





6.3 THE DEVELOPMENT OF THE EXPERIENCE QUESTIONNAIRE
This questionnaire was developed prior to the researcher joining the psychosocial
research group. Previous researchers in the group had derived initial items from
issues raised in interviews with women attending the familial breast cancer clinic in
Edinburgh and a limited review of the literature. A quantitative questionnaire had
been developed and administered to women attending genetic counselling sessions.
Following analysis of responses to these items a shortened version of the
questionnaire had been devised. This questionnaire had been administered as part of
the baseline assessment in a randomised controlled trial of two models of genetic
counselling service provision. Data provided from this trial offered an opportunity
for the current author to conduct a pilot study to assess the performance of the
experience questionnaire and examine associations between experience and levels of
general and cancer specific distress. This work is outlined as follows.
PILOT WORK
6.4 AIMS AND RATIONALE
Analysis was exploratory to determine if the experience measure could be utilised in
further studies. The specific aims of this pilot work were:
• To determine if the questions were acceptable to women with a family history
of breast cancer.
• To assess the distributional properties of the data obtained and ensure items
were answered correctly.
• To explore associations between experience and levels of general and cancer
specific distress.
Previous studies (reviewed in Chapter 2) have tended to assess associations between
experience of breast cancer and either general or cancer specific distress. To clarify
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the impact of experience on psychological adjustment in this population both general
and cancer specific distress were examined and compared in this study.
Predictions were based on the literature reviewed in Chapter 2: General distress was
expected to be more strongly associated with aspects of the experience having long
term effects on the individual life and family. This included experience of
bereavement from breast cancer in the family, multiple bereavement, maternal
bereavement, age at bereavement and diagnosis and recency of these experiences
(e.g. Dohrenwend and Dohrenwend 1974, Kurtz et al. 1997, Hopwood et al. 1998,
Wellisch et al. 1992, Hopwood et al. 2001).
Cancer specific worry was predicted to be associated with experiences relating to
personal risk, this included strong identification with a relative who had suffered
breast cancer (Spira and Kenemore 2000). Positive role models of relatives who
coped well with the disease and communication about breast cancer risk in the family
was expected to be associated with reduced levels of cancer worry (Chalmers and
Thompson 1996).
A number of aspects of experience were predicted to influence both levels of general
distress and cancer worry. These included greater exposure to breast cancer, how
traumatic and upsetting the experience had been overall as well as family tensions or
changes caused by the illness experience (eg Lodder et al. 1999, Koocher 1986,
McHorney and Mor 1988, Wellisch et al. 1992).
6.5 METHOD
6.5.1 Design
Data were collected in the context of a randomised controlled trial of two models of
service provision in South East Scotland. Baseline data prior to genetic counselling
are reported. A subset of data were released from the trial for this analysis.
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6.5.2 Procedure
Participating General Practices in SE Scotland were randomised to receive the
standard or novel service for patients whom they referred for genetic risk
counselling. Referred patients were sent a postal questionnaire that they were
required to complete and return before being allocated an appointment for risk
counselling.
6.5.3 Participants
Women with a family history ofbreast cancer who had been referred for cancer risk
counselling. Baseline data from a consecutive series of 96 women were available for
use in this study.
6.5.4 Measures
6.5.4a Experience questionnaire
The questionnaire (please see Appendix II, page A-2) was organised in two parts:
Background information
The first two questions were aimed to assess the respondent's personally relevant
family history of breast cancer rather than their objective family history. Participants
were asked to report the number of close relatives they had personally known who
had suffered from breast cancer and how many, if any of these relatives had died
from breast cancer.
The participant was then asked to focus on one relative (their 'index relative') who
had suffered from breast cancer and whose illness had particularly affected them (the
participant).
The participant was asked a number of questions about their index relative:
• Their relation to them (coded categorically: 1= mother; 2= sister; 3= aunt; 4= gran; 5=
cousin).
• How close they were (3 point Likert scale: 1= 'not at all close'; 2= 'quite close'; 3= 'very
close').
• What age their relative was when first diagnosed with breast cancer (years).
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• The participants age when their relative was first diagnosed (years).
• How the relative is now (coded categorically: 1= 'alive and well'; 2= 'alive but unwell'; 3=
'died from this cancer'; 4= 'died from other causes').
• If the relative had died, how long ago this happened (years).
Subjective experience items
Participants were then asked 11 questions about their subjective experience of their
relative's illness. Participants were asked to provide answers regarding their lasting
impression of this experience. These items were coded on a Likert scale: 1= 'not at
all'; 2= 'a little'; 3= 'quite a lot'; 4= 'very much'.
• Did their illness/treatment cause them much physical suffering?
• Did their illness/treatment cause them much emotional distress?
• Overall, how upsetting was their illness for you?
• Overall, how well do you think they coped with their illness/treatment?
• Do you think you are like them in general?
• Do you feel that your relationship with this person changed when they developed cancer?
• How much do you feel your life plans have changed because of the risk of cancer in your
family?
• Did you talk about your relative's cancer with the rest of your family at the time?
• Do you talk to friends now about your possible breast cancer risk?
• Do you talk now about your own risk with your family?
6.5.4b Distress
Measures ofboth general and cancer specific distress were included in this study.
General distress
The 30-item version of the General Health Questionnaire (GHQ-30) was used to
assess general distress. This measure was described in Chapter 4 (section 4.4.4a,
page 106). Responses were scored either a 0 or 1 (0, 0, 1, 1) and summed to achieve
a total score. Using this method a score over 5 is taken as the cut-off point to indicate




The cancer worry scale (described in Chapter 4 (section 4.4.4b, page 107)) was used
to assess worry about breast cancer.
6.6 STATISTICAL METHODS
6.6.1 Descriptive statistics
Frequencies of responses for the experience items were examined to determine
whether the questions had been correctly answered and to identify missing data that
may indicate problematic items.
Descriptive statistics for scores obtained on the GHQ-30 and cancer worry scale by
this sample are reported and GHQ 'cases' were identified. The internal consistency
of the cancer worry scale was checked with Cronbach's alpha (Cronbach 1951) (see
6.1, page 128)
6.6.2 Associations between experience and levels of distress
In order to explore the data for associations between experience items and levels of
distress a number of statistical techniques were employed depending on the nature of
the items. For nominal items the chi-square test was used to determine differences in
GHQ 'caseness' and t-tests were used to determine differences in cancer worry score.
The chi-square test compares the observed frequencies in each cell of a contingency
table with the expected frequencies for each cell to test if the differences are due to
chance. The chi-square statistic reflects the size of the difference between observed
and expected frequencies, the greater the chi-square the more likely that the
differences are significant. The chi-square test assumes that the observations in the
contingency table are independent (ie each participant can have only one entry) and
that the expected frequencies in each cell should be 5 or more. The chi-square test
can only test for differences between the categories and is unable to test a one tailed
hypothesis about direction of the effect.
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The t-test aims to compare the amount of variability due to predicted differences in
scores between the two groups compared to the total variability in scores (Green and
D'Oliveria 1990). The difference in mean scores for both groups is compared to the
overall variability in scores and statistic t represents the size of the difference
between the means taking into account the total variance. The t-test is a parametric
test and assumes that scores are measured on an interval scale, are normally
distributed and variability of scores in each group is equivalent (homogeneity of
variance). The t-test is fairly robust concerning these criteria and unless data divert
substantially from the assumptions the results should remain valid (Green and
D'Oliveria 1990).
T-tests and chi-square tests were also computed to determine differences in
experience between individuals scoring above and below the median on the GHQ-30.
For ordinal/interval items including the cancer worry score and subjective experience
items Pearsons correlation coefficient was computed to determine the association
between distress and experience. Correlation coefficients vary between -1.0 and
+1.0. Both extremes represent perfect relationships between variables whereas as
coefficient of 0.0 represents no relationship. A positive coefficient means that a
higher score on one variable is associated with higher scores on the second variable.
A negative relationship means that high scores on one variable are associated with
low scores on the other variable. Intercorrelations were examined using Pearsons
product-moment correlation coefficient. This is a correlational technique suited for
use on interval scales. The variables need not be normally distributed but the
technique does assume linearity of relationship.
A probability value ofp<0.05 was taken as significant. Trends of p<0.1 are also
reported given the exploratory nature of this analysis.
6.7 RESULTS
6.7.1 Sample
The sample consisted of 96 women with a mean age of 38 years (sd= 10.41, range =
19-68 years). The majority ofwomen were married or living with a partner (68.6%)
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and 21.9% had never been married. Just fewer than twenty percent (19.8%) were
university graduates with over half of the sample (51.1%) having received further




The vast majority ofwomen reported to have personally known at least one close
relative who had suffered breast cancer (97%). Forty-six women (49 %) had known
>1 relative who had suffered from breast cancer (range= 0-6). Fifty-six women
(60%) reported that at least one of these relatives had died from breast cancer (range
0-4).
The majority of index relatives were mothers (49%), sisters (21%) or aunts (18%).
Sixty-eight percent ofwomen reported to be very close to their index relative and
23% quite close. The mean age of the index relative at diagnosis was 45.1 years
(range= 25-70, sd= 9.92), and the mean age of the participant when the index relative
was diagnosed was 23.1 years (range <1-62, sd= 12.04). Fourteen women (15%)
were under age 11 when their index relative was diagnosed, 22 (23%) were aged
between 11-20 and 45 (47%) were 21 or older. Selecting those women who chose
their mother as the index relative, the proportion ofwomen in each age category was
24% (0-10), 43% (11-20), 33% (21+). Fifty percent ofwomen reported that their
index relative had died from cancer and 4% that their index relative had died of other
causes. The mean time since death was 15.1 years (range = < 1-40 years, sd= 12.01).
Twenty-eight percent reported that their relative was alive and well and 15%
reported that their relative was alive but unwell.
Subjective experience items
Table 6.2 shows the frequencies of the subjective experience items. A number of
items appeared either negatively skewed (1, 2, 3, 4) or positively skewed (6, 7, 8).
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Table 6.2- Frequencies ofsubjective experience items
Item n Not at A little Quite a Very Missing
% all lot much
1. Did their illness/treatment cause - 11 43 32 10
them much physical suffering? 11.5 44.8 33.3 10.4
2. Did their illness/treatment cause - 10 30 46 10
them much emotional distress? 10.4 31.3 47.9 10.4
3. Overall, how upsetting was their 3 12 16 55 10
illness for you? 3.1 12.5 16.7 57.3 10.4
4. Overall, how well do you think 3 4 47 33 9
they coped with their 3.1 4.2 49 34.4 9.4
illness/treatment?
5. Do you think you are like them in 11 28 23 23 11
general? 11.5 29.2 24 24 11.5
6. Do you feel that your relationship 44 21 18 5 8
with this person changed when they 45.8 21.9 18.8 5.2 8.3
developed cancer?
7. Do you feel that your role in the 39 25 11 12 9
family changed because of their 40.6 26 11.5 12.5 9.4
cancer?
8. How much do you feel your life 41 30 10 7 8
plans have changed because of the 42.7 31.3 10.4 7.3 8.3
risk of cancer in your family?
9. Did you talk about your relative's 22 33 23 12 6
cancer with the rest of your family at 22.9 34.4 24 12.5 6.3
the time?
10. Do you talk to friends now about 35 42 9 3 7
your possible breast cancer risk? 36.5 43.8 9.4 3.1 7.3
11. Do you talk now about your own 31 46 11 5 6
risk with your family? 32.3 47.9 11.5 2.1 6.3
6.7.2b Distress
General distress
The mean score in this sample was 4.9 (sd= 7.19) and the median score was 1.
Twenty-eight women (29.2%) scored above the cut off point of 5 on the GHQ-30,
indicating possible clinical levels of distress.
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Cancer worry
Ninety-three women fully completed the cancer worry scale. The mean score on the
cancer worry scale was 11.2 (sd= 2.81, range = 6-18). The data showed a normal
distribution and no outliers were found (skew = .34, kurtosis = -.23). The Cronbach's
alpha value was .83 suggesting that the scale showed good internal reliability.
6.7.3 Distress and background demographics
General distress and cancer worry were not significantly correlated with age (p<0.05)
and were not associated with marital status or education (p<0.05).
6.7.4 Experience and distress
6.7.4a General distress
There were no significant differences between GHQ 'cases' and 'non cases' on any
experience items. Two trends were found. 'Cases' reported that their index relative
was younger at diagnosis (p= 0.07) and felt their role in the family had changed
because of their cancer (p= 0.07).
For the sub-sample ofwomen who chose their mother as the index relative (n= 42)
GHQ 'cases' were older when their mother was diagnosed (mean age= 21.5 years,
sd= 9.86) than 'non cases' (mean age= 15.0 years, sd= 8.03) (t= 2.33, df= 40, p=
0.03). When looking at levels of distress by summing scores (0, 0, 1, 1) there was a
significant correlation between GHQ score and age at mother's diagnosis (r= .38,
p=0.01, n= 42). There was no difference between the three age categories (<11, 11-
20, > 20) on GHQ 'caseness' or levels of distress for the whole sample or the sub-
sample who chose their mother as the index relative (p<0.05).
Table 6.3 indicates a number of differences in experience items between individuals
who scored above and below the median on the GHQ-30. Participants who scored >
2 were significantly more likely to report that they felt their relationship with the
index relative and role in the family changed because of the index relatives cancer
and to have found their illness more upsetting (p<0.05). Participants whose index
relative had died were more distressed if this had occurred more recently (p<0.05).
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Table 6.3- Differences in experience between women scoring above and below the
median on the GHQ-30.
Experience item t df P GHQ GHQ
score = 0 score > 2
or 1
Do you feel that your 3.04 86 0.003 n 44 44
relationship with this person Mean 1.5 2.1
changed when they developed sd 0.79 1.01
cancer?
Do you feel that your role in the 2.69 85 0.008 n 45 42
family has changed because of Mean 1.7 2.3
their cancer? sd 0.98 1.08
Recency of bereavement of 2.60 49 0.012 n 26 25
index relative (if any) (years)? Mean 19.2 10.9
sd 11.52 11.21
Overall, how upsetting was their 2.33 84 0.022 n 42 44
illness for you? Mean 3.2 3.6
sd 0.98 0.68
6.7.4b Cancer worry
There were no significant differences in cancer worry scores between participants
with different responses to the categorical experience variables. A number of the
subjective experience items were found to be associated with cancer worry. Table 6.4
shows the Pearson correlation coefficients between the cancer worry scores and
experience items. Cancer worry scores were significantly positively associated with
the extent to which participants felt their life plans had changed because of the risk of
cancer in their family and the degree ofwhich their role in the family had changed
(p<0.05). Cancer worry was also significantly positively correlated with the degree to
which the participant talks about their risk with their family (p<0.05). Trends also
suggested cancer worry was higher for participants who talk to their friends about
their risk ofbreast cancer and for women who found their relatives illness more
upsetting (p<0.1).
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Table 6.4- Correlations between cancer worry and experience items
Experience item n r P
How much do you feel your life plans have changed because
of the risk of cancer in your family
88 .48 0.000
Do you talk now about your own risk with your family? 90 .23 0.033
Do you feel that your role in the family changed because of
their cancer?
87 .23 0.034
Do you talk to friends now about your possible breast cancer
risk?
89 .20 0.067
Overall, how upsetting was their illness for you? 86 .19 0.08
6.8 SUMMARY AND DISCUSSION
6.8.1 Acceptability of the experience questionnaire
This pilot work provided useful information regarding the performance of the
experience questionnaire. Item frequencies did not reveal major problems with
missing data and suggested that the items were acceptable to the majority ofwomen
in this sample. The results did however suggest some changes to the coding and
scaling of items that may improve the questionnaire. The item assessing the
closeness of relationship between the participant and index relative was skewed with
68% ofparticipants reporting to be 'very close' to their index relative. In order to
improve the spread of responses an additional category 'extremely close' could be
used in subsequent research. The question assessing recency of bereavement of the
index relative was coded in years and ranged from less than 1 year to 40 years ago. It
may be more sensitive to code this measure in months rather than years. The 11
Likert items referring to women's subjective experience of their relatives illness were
also skewed to end points and a 5 point scale ranging from 'not at all' (1) to
'extremely' (5) may improve the distribution of the data.
6.8.2 Experience and distress
In the full sample GHQ 'caseness' was not significantly associated with any
experience items although the level of general distress was. A median split revealed
that levels of general distress were associated with some of the experience items in
the expected direction. This suggests that the Likert scoring method on the GHQ-30
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(1, 2, 3, 4) may be more sensitive in detecting associations with experience items
than scoring method used in this pilot work (0, 0, 1, 1) (See section 4.4.4a, page
106).
Higher levels of general distress were associated with greater changes in the
participant's relationship with their index relative and changes in family roles
because ofbreast cancer in the family. This confirms the findings ofWellisch et al.
(1992) whose qualitative study indicated that adjustment problems in women at
increased risk of breast cancer were associated with the changes in life plans created
by breast cancer in the family.
Wellisch et al. (1992) also observed women who were younger at the time of their
mothers diagnosis, particularly adolescents showed great problems in adjusting to
their mothers breast cancer, although other studies have reported no effect of age at
maternal diagnosis on levels of cancer specific distress (Erblich et al. 2000). In this
study no association was found between participants' age when their index relative
was diagnosed and level of general or cancer specific distress. However this study
was not examining the effect ofmaternal breast cancer alone but instead asked
participants to refer to the experience of a relative that had particularly affected them.
Approximately half of the participants chose a relative other than their mother. The
age at which other breast cancer experiences occur may not have such a dramatic
effect on women as maternal breast cancer at adolescence. Among participants who
had chosen their mother as their index relative, a positive association was found
between age at diagnosis and levels of general distress, suggesting that those who
were older when they lost their mother have higher levels of distress. This may
represent the recency of this experience. Women who were older when their mother
was diagnosed are likely to have experienced this event more recently. Alternatively
it is possible that women who were children or adolescents at the time of a breast
cancer event did not understand what was happening or were deliberately protected
from the events by other family members. No difference between adolescents and
other age groups were observed. Differences in the distribution of ages may help
explain the inconsistencies of the findings. In this study a small proportion ofwomen
were adults (21+) at the time ofmothers diagnosis (n=14) whereas Wellisch et al.
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(1992) reported 60% of their sample to be in this age category. In order to clarify
inconsistencies of the literature in this area it is important to examine the role of
factors that may moderate the impact of age including risk status and awareness or
understanding ofbreast cancer events at the time. When looking at the age of the
index relative at diagnosis a trend was found to suggest that the index relatives of
GHQ 'cases' were diagnosed at a younger age than those of 'non cases'. This effect
has also been shown in previous studies (Erblich et al. 2000, Lodder et al. 1999).
However since age at diagnosis is one of the risk criteria it is unclear if this effect
represents differences in experience of the disease or risk status.
It was surprising that general distress was not associated with other aspects of
bereavement (including experience ofbereavement, multiple bereavement and
maternal bereavement). Loss of an index relative from breast cancer was not
associated with general distress or cancer worry. Associations have been reported
between cancer bereavement and intrusive thoughts about cancer in women at
increased risk of breast cancer (Zakowski et al. 1997, Erblich et al. 2000) although
no effect has been reported on levels of cancer worry (Hopwood et al. (2001).
Bereavement may therefore influence intrusive thoughts about cancer rather than
general distress or worry over personal risk. Leedham and Meyerowitz (1999) also
suggest that past bereavement due to cancer may invoke subtle existential concerns
in adulthood rather than general distress assessed by global distress measures.
As predicted general distress was higher for women who had lost their index relative
to breast cancer more recently and those who found the illness more upsetting.
Previous qualitative studies have indicated that the more emotional and intense the
breast cancer experience the harder it can be to resolve (Chalmers and Thompson
1996) and that emotional descriptions of the impact of the disease are associated with
increased distress (DudokdeWit et al. 1997). It is unlikely that the association
between recency ofbereavement and distress represents a normal bereavement
response. The average time since bereavement of the index relative in this sample
was 15 years. Persistent grief over 1 year has been considered an abnormal response
(Koocher 1986). It is more likely that this effect may instead reflects a reactivation
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of grief shown in previous studies ofwomen attending for genetic counselling for
breast cancer (DudokdeWit et al. 1997, Lodder et al. 1999, Hopwood et al. 1998).
6.8.3 Cancer worry scale
The study revealed that the cancer worry scale was acceptable to this sample. The
scale showed good internal reliability and scores were associated with aspects of
experience of breast cancer in the family. As predicted cancer worry was positively
associated with changes in life plans and family roles because ofbreast cancer in the
family. Cancer worry was also associated with communication about cancer risk
within the family but in the opposite direction to that predicted. Communication
about risk was predicted to be associated with lower levels of cancer worry but
instead a positive association was found. Hilton (1996) found that for some families,
talking and sharing concerns about breast cancer helped them return to normal,
whereas for others communication about breast cancer was limited and did not
reduce anxiety. In this study it is possible that increased talk about cancer risk
reflected greater cancer worry or that communication about breast cancer itself
increased fear and anxiety about the disease (Chalmers et al. 1996). A cross sectional
study is unable to determine causality between these variables and further
prospective study of communication frequency and style is required to address this
issue further.
A number of items did not show predicted association with cancer worry. Cancer
worry was not associated with identification with the index relative or perceptions of
how well the relative had coped with the disease. It is possible that single items are
not able to fully tap the complex issues surrounding identification with an affected
relative or their ability to cope with breast cancer. Exposure to breast cancer
represented by the number of affected relatives personally known was not associated
with either general or cancer specific distress as has been reported in previous studies
(Wardle 1995, Baider et al. 1999). In addition, perception ofphysical suffering and
emotional distress experienced by the index relative was not associated with
measures of distress. This may be due to the skewed distribution of these items or
that they do not adequately assess exposure to the relative's illness.
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6.8.4 Methodological issues
A further methodological issue in this study was the fact that the sample had not
received genetic counselling when they completed the questionnaire. Women in this
situation may have been more concerned about attending the familial breast cancer
clinic and learning about their risk status at this time, making effects of experience of
levels of distress difficult to determine.
A number of elements of experience were omitted from the questionnaire that may
have proved important in this sample. For example the effect of caring for relatives
(Erblich et al. 2000), exposure to late stages of the disease (Lodder et al. 1999), if the
index relative was currently undergoing treatment, confidence in medical care for
breast cancer and experience of other family members (Smith et al. 1999). Positive
aspects of the experience and positive breast cancer outcomes that may act as buffers
were also not included. The experiences ofwomen with a family history of breast
cancer are likely to be diverse and a questionnaire is unable to cover all possible
experiences. Given the constraints on questionnaire length the current questionnaire
attempted to measure aspects of experience which had been indicated as important in
the literature and previous interviews with women at increased risk in Scotland.
In conclusion, the format of the experience questionnaire worked well and items
were answered correctly in this study. A number of aspects of experience were found
to show predicted associations with levels of general and cancer specific distress in
this sample. Improvements could be made to some of the response formats and
additional questions included. It was decided that following further refinement this
measure could be utilised in the main study.
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6.9 ADAPTATION OF THE EXPERIENCE QUESTIONNAIRE
A number ofmodifications to the experience questionnaire were highlighted in the
pilot work. This section discusses and justifies changes made to the experience
questionnaire and outlines how the measure performed in the main study. Descriptive
statistical results are reported and where appropriate comments are made regarding
comparison of results to those obtained in the previous pilot work. A copy of the
adapted questionnaire is included in Appendix II (page A-4)
The pilot work showed that the experience questionnaire was acceptable to women
with a family history of breast cancer and showed predicted associations with levels
of general and cancer specific distress in women with a family history of the disease.
However, the results suggested a number ofpotential improvements. These included
coding recency ofbereavement in months rather than years to improve the sensitivity
of the measure. The response scale for the subjective experience items was also
expanded from a 4 point Likert scale item to a 5 point scale. Streiner and Norman
(1991) provide data that indicates Likert scales of less than 5 points result in loss of
information and show poor reliability. Expanding the scale should therefore enhance
the reliability of the items as well as improving the distribution of data.
The primary aim of the research reported in this thesis was to test the mediation
model that perceptions of breast cancer mediate the impact of experiences of the
disease in the family on psychological well-being in women at increased risk (Fig
4.1, page 100). The experience items therefore needed to focus on aspects of
experience likely to influence women's perceptions of breast cancer.
The large number of variables included in the questionnaire was problematic because
of the potential number of statistical analyses to be conducted. Multiple testing may
lead to significant effects occurring by chance. In addition, high intercorrelations
between experience items may lead to problems ofmulticollinearity in future
multiple regression analysis (see Table 4.1, page 102). In order to counteract these
problems it was decided to reduce the number of subjective experience items using
item-scaling analysis. Factor analysis was originally considered as a technique used
for item reduction (Tabachnick and Fidell 1996). Factor analysis was performed on
146
the data but a cohesive factor structure could not be identified. A number of
limitations regarding the application of factor analysis to the data set were thought to
account for this result. Firstly, the measure was not designed as a psychometric
assessment of experience but rather a pragmatic measure of specific issues
previously identified. It was not assumed therefore that the items would fully capture
underlying latent variables. Secondly, the variables in the measure are likely to be
complexly interrelated. In factor analysis pure variables correlated with only one
factor are preferred. Tabachnick and Fidell (1996) warn that measures that include
variables of differing complexity are likely to form factors that do not reflect
underlying processes. Thirdly, the sample size was low in regards to the general rule
of thumb for factor analysis (n>300) and borderline in terms of the expected ratio of
cases to items (Ferguson and Cox 1993, Tabachnick and Fidell 1996). It was
therefore decided to group the items in terms of face validity and conduct item-
scaling analysis to ensure the items were compatible
6.9.1 Additional background items
The literature has indicated the importance of experiences ofbereavement and
diagnosis in the family (eg Kelly et al. 1987, Hilton 1993, Zakowski et al. 1997,
Erblich et al. 2000). Recent experiences are likely to have a large impact on
availability ofbreast cancer images and perceptions of the disease. A recent
diagnosis of breast cancer may have a strong effect on levels of distress and
representations of the disease. It was therefore decided to assess not only the recency
of bereavement of the index relative from breast cancer but also the recency of
bereavement of any of the relatives personally known to the respondent. Questions
concerning recency of diagnosis ofbreast cancer in the family were also included.
6.9.2 Adaptation of subjective experience items
The response frame for these items was expanded from 1 (not at all) - 4 (very much)
to 1 (not at all) - 5 (extremely). Full versions of the original questionnaire used in
pilot work and adapted questionnaire used in the main study are provided in the
Appendices. Although the first 4 items {'Did their illness/treatment cause them much
physical suffering?'Did their illness treatment cause them much emotional
distress?'Overall how upsetting was their illness for you?'Overall how well do
you think they coped with their illness/treatment?') were not strongly associated with
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distress in the previous study, the sample was assessed prior to genetic counselling
and it is possible that the items may be associated with distress after women are
informed of their risk status. These items were also considered potential determinants
ofwomen's perceptions ofbreast cancer. It was therefore decided to retain these
items in the questionnaire.
From a theoretical perspective perceived resemblance with an affected relative may
be a strong predictor of response to genetic risk (see section 4.2, page 73). However
item 5 ('Do you thinkyou are like them in general? ) was not associated with distress
in the previous study. This may be because a single general item is not adequate to
assess perceived resemblance. Additional more specific items may create a more
reliable measure of resemblance. Two questions were therefore derived from
components of resemblance highlighted as important in the literature (Davison 1989,
Richards and Ponder 1996, Richards 1996): ('Do you thinkyou are like them in body
shape and size?' and 'Do you think you are like them in personality?').
Items 6-8 showed strong associations with distress and were also predicted to be
associated with illness perceptions. These items were therefore kept in the
questionnaire/ Do you feel that your relationship with this person changed when
they developed cancer?'Do you feel that your role in thefamily had changed
because oftheir cancer?'How much do you feel your life plans have changed
because ofthe risk ofcancer in yourfamily?') However item 6 referring to 'change'
in relationship with the index relative was ambiguous and may refer to positive or
negative changes. Hilton (1996) found that some families with a patient suffering
from breast cancer talked about developing closer bonds because of the experience
whereas others described the breaking apart of relationships. The item was intended
to refer to detrimental effects of the experience on the relationship following work by
Wellisch et al. (1996). Since this item was positively associated with levels of
general distress in the previous study it appears to have been interpreted in that
manner. In order to clarify this item in subsequent research the item was reworded to
' 'Do you feel that your relationship with this person deteriorated when they
developed cancer?
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The final 3 items were omitted from the questionnaire. ('Didyou talk about your
relatives cancer with the rest ofyourfamily at the time?Do you talk to friends now
about yourpossible breast cancer risk?Do you talk now about your own risk with
yourfamily?'). These items had been predicted to show negative associations with
distress based on previous research indicating that open communication about cancer
was associated with better adjustment of family members (Leedham and Meyerwitz
1999, Chalmer and Thompson 1996, Chalmers et al. 1996). However two of these
items were found to show moderate positive associations with cancer worry. This
conflicting result highlights the diverse nature and effects of communication in these
circumstances. It is difficult to assess the impact of communication about cancer or
cancer risk on illness perceptions or levels of distress without an understanding of the
content and type of communication (ie open or restricted). Family communication
about genetic risk therefore needs to be examined in more detail than is possible in
the current study.
It was decided to include positive aspects of experience in order to determine if
positive experiences have a beneficial effect on illness perceptions and/or levels of
distress. Theoretically, it is plausible that positive experiences may promote more
positive representations of the disease in question. Studies in the literature have
shown individuals to report positive effects of cancer in the family. Petrie et al.
(1999) found breast cancer patients reported a number ofpositive aspects of their
illness experience including improved quality of close relationships, greater
appreciation of life, change in personal priorities and greater empathy for others.
Taylor and Armor (1996) discuss the use ofpositive illusions as a strategy for coping
with threatening events. They review research that suggests patients suffering from a
range of illnesses (including cancer) often react to threatening situations by
perceiving positive changes (eg gaining personal qualities, increased understanding
of others, finding meaningfulness in life etc). This provides a protective mechanism
by which to bolster ones self perception in the face of adversity. They propose that a
positive assessment of the event, perception of control and sense of optimism about
the future might promote adjustment. Similar strategies may be seen in relatives of
patients. Caregivers of terminal cancer patients have reported positive feelings
concerning the time and interaction with the affected relative (Grbich et al. 2001).
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Leedham and Meyerowitz (1999) found 93% of adults who reported retrospectively
on their experiences ofparental cancer reported at least one positive change in their
lives because of the experience. Two thirds reported improvements in their
relationship with the sick parent and a third with the healthy parent. Finally, Savage
and Clarke (1998) found older women often cited positive examples ofbreast cancer
patients observed within their social circle when asked for beliefs regarding the
treatment and cure ofbreast cancer. This suggests that observing positive experience
ofbreast cancer may also influence healthy women's perceptions of the disease. In
order to examine the impact of positive experiences ofwomen at increased risk of
breast cancer three further items reflecting positive experiences that had been
prominent in the interview data and were consistent with previous research findings
were added to the questionnaire. ('Did this person hold a positive attitude towards
their illness?'Do you feel that your experiences have brought thefamily closer
together?'To what extent have your experiences been positive?')
6.10 DESIGN AND SAMPLE
Data for this analysis were derived from the cross-sectional study outlined in
Chapters 4 and 5. Results from the increased risk sample (Sample A) are reported.
(Please see Chapter 5 (5.2.1, page 116) for a description of the sample).
6.11 STATISTICAL ANALYSIS
6.11.1 Descriptive statistics
Response distributions and descriptive statistics were examined in order to help
interpret if the items appeared to work and to check whether responses to items were
normally distributed and hence whether parametric statistics could appropriately be
used throughout the analysis presented in this thesis.
6.11.2 Item grouping
Items were grouped in terms of face validity and item-scaling analysis conducted to
ensure the items were compatible. Highly correlated items could then be summed for
use in future analysis. This technique has been recommended as a logical way to
reduce problems ofmulticollinearity in multiple regression analysis (Everitt 1996).
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From the 12 subjective items used to assess experience in the increased risk sample
five subscales were predicted: 'traumatic experience', 'coping', 'resemblance',
'change' and 'positive experience'. These subscales and constituent items are
described in Table 6.5
In order to assess the internal consistency of the item grouping, item convergent and
discriminant validity were examined. This technique is widely used in test
construction and for checking the homogeneity of items in scales (Kline 1986,
Streinder and Norman 1991). Kline (1998) describes this technique as a highly
efficient, useful procedure when data are not suitable for factor analysis. It has been
used for developing clinical measures including quality of life in cancer patients
(Cull et al. 2001). Three statistics are examined, internal consistency, item
convergence and item discriminance. Internal consistency is examined using
Cronbach's alpha. Item convergence tests the proportion of items that correlate
highly with the scale (when the item in question is omitted). Item discriminant
validity compares the strength of correlations between items with their own scale and
other scales (Nunnally and Bernstein 1994). These tests are defined below.
• Item convergent test = the number of item-scale correlations (with the item
omitted) >0.4/total no of correlations.
• Item discriminant validity test = number of times in which an item
correlates more highly with its own scale (with the item omitted) than with







Extenttowhichheexperienceasu s t ingfor theindexrelativeandespondent.
1
Didtheirillness/tr atmentcausem chphys calsuffering?
2
Didtheirillness/tr atmentcausm chemotionaldistr s ?
3
Overall,howupsettingwasth irilln sf you?
Coping
Extenttowhichheind xrelativec pedp sitively withbreastcancer.
4
Overallhowweldoy uthinkyc pedithir illness/treatment?
5








Extenttowhichheresponden sfamilylifand planshavechangedbe auseoftheirexperiences.
8
Doy ufeelthaturrelationshipwithspersdeterio ated whenth ydevelopedcanc r?
9







Doy ufeelthatourexperienceshavbroughtamilycl ser together?
12
Towhatextenhavy urxperiencesb p sitive?
6.12 RESULTS
6.12.1 Descriptive statistics
This analysis refers to the 117 participants in the increased risk sample (Sample A)
(see Chapter 5, 5.2.1, page 116).
6.12. la Background items
Few questions had missing data. Two participants omitted the question 'Have any of
these relatives been diagnosed with breast cancer recently?'' One participant omitted
the question 'How many, ifany ofthese relatives have died because ofbreast
cancer?' Three participants omitted the question 'Please couldyou let us know how
long ago these relatives died?" Two participants omitted the question ' What age
were they when breast cancer was first diagnosed?'
On average participants personally knew 2 relatives who had suffered from breast
cancer (mean =2.1, sd =1.25, range =1-7). Thirty-eight (32.5%) reported that a
relative had been diagnosed within the past 5 years. Eighty-eight (75.2%) reported
that they had at least one relative who had died from breast cancer (mean =1.1, sd =
1.02, range =0-6). The average time since the most recent bereavement was 16.3
years (sd =11.93, range =1-49 years).
The majority ofparticipants referred to their mother as the index relative on the
personal experience questions (69.2%). Other participants referred to sister (18.8%),
aunt (8.5%), cousin (2.6%) and grandmother (0.9%) as the index relative. The
average age at which the index relative had been diagnosed with breast cancer was
44.0 years (sd =10.3, range 0-47). The average age of participants when their relative
was diagnosed was 21.7 years (sd =11.74, range =0-47).
Seventy-one (60.7%) participants reported that their relative had died from breast
cancer and 6.0% had died from other causes. Thirty-six (30.8%) women reported that
their relative was alive and well and 2.6% alive but unwell. For women who had lost
their relative from breast cancer the average time since bereavement was 15.6 years
(sd =11.0, range =3months - 38 years).
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The results obtained from the background experience items in this study showed
some similarities to those reported in the pilot work. For example, the mean age of
the index relative at diagnosis (mid forties) and age of the participant (early twenties)
was comparable and the average time since bereavement of the index relative in both
samples was approximately 15 years. Slightly more women in this sample however
reported to know at least 2 relatives who had been affected by breast cancer (59%)
compared to the previous study (49%). Also, slightly more women had lost at least
one relative to breast cancer (75%) than in the previous study (60%) and a larger
proportion ofwomen in this sample reported that their index relative had died from
breast cancer (60%) than in the previous study (50%). Women in this sample were
also more likely to have chosen their mother as the index relative (69%) compared to
the previous sample (49%). These differences most probably reflect the differences
in risk status between the samples. Women in this study had received genetic
counselling and were at significant increased risk of breast cancer whereas those in
the previous study were attending a community based genetic service in order to
determine their risk status. A proportion of the previous sample may not have had a
significant family history.
6.12.1b Subjective experience items
Table 6.6 shows the descriptive statistics of the subjective experience items.
Extending the response format for these items improved the spread of the data in
comparison to the pilot work reported in Chapter 6 (Part 2, sections 6.3-6.8). In both
studies few participants responded in the categories 'not at all' or 'a little' for the
first 4 items. The results reported in Table 6.6 show that responses were more evenly
spread over the 3 remaining categories rather than being confined to 2 categories
('quite a lot' and 'very much') in the previous version of the questionnaire. The
resemblance items (6&7) also appeared to benefit from a 5 point scale. In the
previous study 24% of respondents reported themselves to be 'very much' like their
index relative in general. In the present study 10% reported they thought they were
'extremely' like their index relative physically and in personality. Item 8 concerning
relationship with the index relative showed a large change in distribution of
responses. In the previous study 45.8% reported that their relationship with their
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index relative had 'not at all' 'changed' whereas in the present study 80.3% reported
that their relationship with their index relative had 'not at all' 'deteriorated'.
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6.12.2 Item scaling analysis
A summary of the analysis is provided in Table 6.7. (Please see Appendix III, page
A-20, for full reports of item-scale correlations). Cronbach's alpha values were
reasonable for the first 3 scales ('traumatic experience', 'coping' and 'resemblance')
but very low for the last 2 scales ('change' and 'positive experience'). The item
convergent tests for the 'traumatic experience ', 'coping' and 'resemblance'
subscales were good with all items correlating r >.4 with their subscale. The 'change'
and 'positive experience' subscales failed the item convergent test with none of the
items correlating r >.4 with their subscale. The 'change' subscale did also not
perform well on the item discriminant test. (There were 3 cases in which an item on
this subscale correlated more strongly with another subscale than the 'change'
subscale). These results suggest that the 'traumatic experience', 'coping' and
'resemblance' subscales appear reliable, whereas the 'change' and 'positive
experience' subscales do not.
The change scale was assessed with each item in turn deleted. In particular the scale
was examined with item 8 omitted. This item was non-discriminatory and may have
caused problems in the scale. However even with this item omitted the alpha for the
scale was still low (.35) and correlation between the remaining items still not
adequate (r= .22, p= 0.018). It was therefore decided that the items from the 'change'
and 'positive experience' subscales should remain as single items.



















Traumatic 3 .70 .42, .62, .63 3/3 -.01 to .51 11/12
experience
Coping 2 .72 .57 2/2 -.01 to .36 8/8
Resemblance 2 .69 .51 2/2 .16 to .40 8/8
Change 3 .36 .18, .23, .30 0/3 .02 to .39 9/12
Positive 2 .35 .40 0/2 .086 to .40 8/8
experience
157
6.13 SUMMARY AND DISCUSSION
The experience questionnaire was adapted in light of the results from the pilot work
(Chapter 6, Part 2, sections 6.3-6.8) and theoretical perspectives (Chapter 3,) in order
to address the aims and hypotheses of this thesis (Chapter 4, section 4.1). A major
change was increasing the scale of the subjective experience from a 4 point to a 5
point scale in order to improve the discriminatory power of the items and distribution
of data. Examination of the distribution of comparable items in both studies revealed
that the spread of the data was improved. However, item 7 {Do you feel that your
relationship with this person deteriorated when they developed cancer?) showed a
stronger positive skew than the comparable item in the previous study referring to
relationship 'change'. Although the question was reworded in order to reflect
negative changes in the relationship the results suggested that the word 'deteriorated'
may have been too harsh to reflect more subtle changes in the relationship. The new
items assessing positive experiences in this study (items 11&12) appeared to be
answered correctly and showed good distribution across response categories.
The subjective experience items were reduced into groups for pragmatic statistical
reasons. Three of the five proposed scales were deemed acceptable following scaling
analysis and will be used in subsequent research. The remaining items will be
analysed as single items. There are a number of possible reasons why two of the
scales failed the analysis. Firstly, the proposed construct may not exist; secondly, the
items may have been inadequate and thirdly, the construct may be factorially
complex (Kline 1998). In this study the scales were developed based only on face
validity. It is possible that the predicted dimensions do not represent true dimensions
of experience. For example, items proposed to reflect the 'change' subscale included
both past changes in family roles and relationships created by breast cancer and
future changes to life plans following breast cancer risk. These aspects are likely to
represent different issues and require separate assessment. The 'positive experience'
subscale only comprised of two items. It is likely that this was insufficient to cover
all positive aspects of the experience. Although item scaling was useful in this
context the nature of the technique has been criticized due to its circularity (Kline
1998). Whilst the analysis can indicate that items assess a similar construct it
provides no information regarding the validity of that construct. This analysis
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provided acceptable sub-scales representing certain aspects of experience including
trauma, coping and issues resemblance relevant to identification. These item
groupings cannot be regarded as true 'scales'. There is no evidence that item
groupings derived represent all aspects of the dimension or are valid measures.
In order to develop psychometric measures of dimensions of experience of breast
cancer more detailed and thorough work needs to be conducted. Qualitative research
should initially be conducted to explore specific aspects of experience in depth and
derive a wide range of possible items. These items can then be used to develop a
scale of the dimension of experience in question and ensure than the scale includes
all variables that represent the dimension. Item analysis or factor analysis can then be
conducted to explore the hypothesised scale structure and determine appropriate
items that collectively assess the specific aspect of experience in question. Finally,
the reliability of the scale should be assessed and tests of its validity conducted.
PART 3
ADAPTING THE IPQ-R FOR USE IN HEALTHY SAMPLES
6.14 THE REVISED ILLNESS PERCEPTION QUESTIONNAIRE (IPQ-R):
BACKGROUND
The revised version of the EPQ (IPQ-R) was described in Chapter 4 (4.4.4). This is a
theoretically driven measure designed to assess illness perceptions across a range of
illnesses (Weinman et al. 1996, Moss-Morris et al. 2002). The measure assesses the
dimensions outlined in earlier work on illness representations (identity,
consequences, timeline, control/cure, cause) as well as a number of new components
(timeline cyclical, illness coherence, emotional representations). For a description of
dimensions please see Figure 6.1.
The identity dimension is assessed by a list of 14 symptoms. Respondents are asked
to rate whether or not they believe each of these symptoms to be specifically related
to their illness. The number of symptoms associated with the illness is summed to
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obtain an identity score. Causal items are assessed using a checklist of 18 potential
causes of illness. The respondent is asked to rate whether or not they believe each of
these factors were causes of their illness on a 5 point Likert scale. Respondents are
also asked to report what they believe to be the three most important causes of their
illness.
Seven dimensions of illness representations (timeline acute/chronic, timeline
cyclical, consequences, personal control, treatment control, illness coherence and
emotional representations) are assessed using Likert items rated on a 5 point scale
ranging from strongly agree to strongly disagree. Items for these subscales are
summed (after reverse scoring as necessary) and the mean value calculated. Where
items are omitted no subscale score is derived.
Originally these 7 dimensions of the IPQ-R were assessed using 50 items. This
questionnaire was available from the author and showed promising psychometric
properties (Weinman, personal communication, 1999). Validation studies of the IPQ-
R were conducted subsequent to the design and data collection for this thesis. The
validation work on the IPQ-R supported the factor structure but with a reduced
number of items (Weinman, personal communication, Moss-Morris et al. 2002). A
number of items were identified as not loading clearly on to one factor and hence
were excluded leaving 38 items. These versions of the IPQ-R will be referred to as
IPQ-R50 and IPQ-R38 respectively. The number of items contributing to each
subscale for both versions of the IPQ-R are provided in Table 6.8. The identity and
causal item checklists are identical in both versions of the scale. The majority of
subscales in the IPQ-R38 are shorter than those in the IPQ-R50 (timeline cyclical,
consequences, personal control, treatment control, emotional representations). The
timeline acute/chronic subscale is the only subscale to which an item is added in the
IPQ-R38. The illness coherence subscale is identical in both versions of the scale.
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Table 6.8- Number of items in subscales computedfrom the IPQ-R50 and IPQ-R38.
Subscale Number of items in Number of items in
IPQ-R 50 IPQ-R 38
Identity* 17 17
Timeline acute/chronic 5 6
Consequences 11 6
Personal control 9 6
Treatment control 6 5
Illness coherence* 5 5
Timeline cyclical 6 4
Emotional representations 8 6
Causal items* 19 19
*Identical items
The subscales of the IPQ-R38 were found to show good psychometric properties
(Moss-Morris et al. 2002). Cronbach's alpha coefficients ranged from .79 (timeline
cyclical) to .89 (timeline acute/chronic). Differing levels of stability were found
across the subscales although the majority were acceptable. Test-retest reliability
assessed in renal patients over 3 weeks ranged from r= .46, p<.01 (personal control)
to r= .80, p<.001 (identity) and from r= .35 p<0.01 (timeline cyclical) to r= .81,
p<0.001 (emotional representations) in RA patients assessed at 6 months follow-up.
6.15 AIMS AND RATIONALE
Although the IPQ and IPQ-R has shown good psychometric properties in patient
populations (Weinman et al. 1996, Moss-Morris et al. 2002) the questionnaires have
not previously been adapted to assess representations of healthy individuals at
increased risk of illness. The applicability of the measures to women at increased risk
of breast cancer is unknown. This study therefore aimed to adapt the IPQ-R to assess
perceptions ofbreast cancer held by healthy women and assess the reliability of the
measure in women at increased risk and women in the general population. This study
also aimed to describe representations ofbreast cancer in these samples. The specific
objectives for each of the aims are outlined as follows.
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To adapt the IPQ-R to assess perceptions of breast cancer held by healthy
women.
The IPQ-R will be described in more depth and examples of items provided. Details
of how the questionnaire was adapted to this population and additional items
included are provided.
To assess the reliability of using the IPQ-R to assess perceptions of breast
cancer in women at increased risk and women in the general population.
The reliability of subscales derived from both versions of the EPQ-R (IPQ-R50 and
IPQ-R38) will be evaluated in both the increased risk (Sample A) and general
population sample (Sample B&C) in order to determine which version should be
used to address the primary research question (see Chapter 4, section 4.1, pages 96-
102). It was predicted that women at increased risk of breast cancer would have
developed clear beliefs about the disease amenable to assessment by the IPQ-R and
therefore it was expected that the subscales would exhibit adequate internal
reliability in this sample. It was predicted that the IPQ-R might not perform as well
in the general population sample who may not have fully formed beliefs about the
disease. Test-retest reliability in the increased risk sample was expected to be higher
than that reported in patient samples. Healthy individuals are not directly
experiencing or responding to current symptoms or effects of illness that may cause
them to reappraise and alter their perceptions of the disease in a short space of time
and hence illness perceptions of healthy individuals at risk of disease were expected
to be more stable over a short time frame.
To describe representations of breast cancer in women at increased risk and
women in the general population.
Descriptive statistics are reported for each sample. In addition, patterns of illness
perceptions are examined in each sample. Leventhal et al. (1984) conceptualised
illness representations as schemata containing groups ofbeliefs and it is possible that
patterns of illness beliefs may be more important in determining outcome than
individual dimensions. Patterns of associations between the IPQ-R subscales were
first explored using correlational analysis. It was predicted that intercorrelations
would be comparable to that reported in patient populations (Weinman et al. 1996).
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Positive associations were predicted between identity, timeline acute/chronic,
consequences and emotional representations. The control subscales (treatment
control and personal control) were predicted to be positively associated and to show
negative correlations with timeline acute/chronic, consequences and emotional
representations. Associations between the IPQ-R subscales and causal items will also
be explored. This will examine associations between subscales and individual causal
items as well as the overall number of causal items participants report to agree with.
This was considered an important variable since previous research has shown that the
number of causal attributions for illness has been associated with distress in patients
and their spouses (Turnquist et al 1998, Weinman et al 2000).
Cluster analysis is a technique that has been used to assess and categorise the
structure of illness representations on data derived from the IPQ (Buick et al. 1997,
Moss-Morris et al. 1997, Heijmans 1999). Buick (1997) found that breast cancer
patients being treated with radiotherapy could be separated into 2 clusters based on
their scores on the IPQ. One cluster (named 'negative cluster') was represented by
high scores on identity, timeline acute/chronic, consequences and internal blame and
low scores on control/cure. Women in this cluster were more likely to report
psychological distress pre and post treatment and reported greater functional
disruption due to breast cancer. Heijmans (1999) reported a cluster analysis of IPQ
scores from Addisons disease patients. Two clusters were found one named 'high
seriousness' classified by high scores on identity, timeline acute/chronic,
consequences and low scores on controllability and the other cluster named 'low
seriousness' (high controllability and low identity, timeline acute/chronic and
consequences). Individuals in each cluster were found to differ on levels of
impairment and coping strategies.
Cluster analysis was conducted on the IPQ-R data from both samples in order to
explore the patterns of representations in women at increased risk of breast cancer
and women in the general population. A second objective of this analysis was to
provide summaries of individual's illness perceptions in order to examine
associations between patterns of illness perceptions, levels of distress and experience
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ofbreast cancer in future analysis. It was predicted that the analysis would reveal
distinct groups of individuals who differ on the IPQ-R subscales in both samples.
6.15.1 Summary of hypotheses
Table 6.9 provides an outline of the hypotheses examined in this study.
Table 6.9- Adapting the IPQ-R to assess healthy women's representations ofbreast
cancer: Summary ofhypotheses.
Aim Hypotheses
To assess the reliability of using the IPQ-R to
assess perceptions of breast cancer in women at
increased risk and women in the general
population.
• The IPQ-R will show adequate
reliability in the increased risk sample.
• The IPQ-R will show lower reliability
in the general population sample.
• The IPQ-R will show higher test-retest
reliability in the increased risk sample
than that reported in patient samples.
To describe representations of breast cancer in
women at increased risk and women in the
general population.
• Associations between illness
perceptions will reflect that found in
patient populations.
• Cluster analysis will reveal distinct
groups of individuals who hold
different representations of breast
cancer.
6.16 ADAPTING THE IPQ-R TO ASSESS HEALTHYWOMEN'S
PERCEPTIONS OF BREAST CANCER.
When work began on this study only the IPQ-R50 was in the public domain. The
IPQ-R50 was reworded to make it appropriate to assess healthy women's perceptions
of breast cancer. Participants were asked to report their personal views about breast
cancer rather than referring to their perceptions of an illness personally affecting
them. For example: 'My illness has serious financial consequences' was replaced
with 'Breast cancer has serious financial consequences'My illness will lastfor a
long time' was replaced with 'Breast cancer lasts for a long time' A brief description
of each subscale with examples of items and scoring procedures are outlined in
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Figure 6.1. If items are missing scores on that subscale are omitted. The full
questionnaire can be seen in Appendix II (page A-9). This questionnaire is colour
coded to indicate which items comprise each subscale. Details regarding reversed
scoring and subscales in the shorted version of the questionnaire (IPQ-R38) are also
provided.
Following previous research on perceptions ofbreast cancer patients (Buick 1996)
and discussions with breast cancer consultants and women at increased risk,
additional breast cancer specific items were generated. Three extra symptoms were
added to the identity subscale ('Hard or tender growths in body', 'soreness in body',
'skin changes'). The item 'hormonal' was added to the cause subscale since
oestrogen has been associated with breast cancer development (Vogel 2000). The
adapted IPQ-R50 was piloted on 11 women at increased risk of breast cancer to
ensure that all items were relevant and understood appropriately. These women were
attending the familial breast cancer clinic in Edinburgh and were invited to provide
feedback on a questionnaire designed to assess women's beliefs about breast cancer.
The women were asked to read through the questionnaire and note any items they
considered irrelevant or had difficulty understanding. They were also asked to record
any items they felt should be included in the questionnaire. No items were
consistently highlighted as problematic and there were no additional items suggested
for inclusion.
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Figure 6.1- IPQ-R scales assessing healthy women's beliefs about breast cancer.
Identity: Beliefs about the symptoms of breast cancer. Respondents tick the symptoms they
believe to be related to breast cancer from a 17 item symptom checklist. The score is the total
number of symptoms ticked.
The items for the following 7 subscales are presented in a random order. Responses are rated
on a five point scale from 'strongly disagree' to 'strongly agree'. Subscale scores are the
mean of items (after reverse scoring as necessary).
Timeline acute/chronic: Beliefs about the duration of breast cancer. 5 items. Higher scores
indicate a perception of breast cancer as more chronic. (Eg. 'Breast cancer lasts for a
lifetime'.)
Consequences: Beliefs about the impact of breast cancer on everyday life. 11 items. Higher
score represents perceptions of breast cancer as holding more serious consequences (Eg.
'Breast cancer has major consequences on patients' lives'').
Personal control: 9 items. Higher score indicates a greater perception of personal control
over breast cancer. (Eg 'Patients have the power to influence breast cancer').
Treatment control: Beliefs about the efficacy of treatment to cure and control breast cancer. 6
items. Higher score indicates greater perceived efficacy of treatment. (Eg ' Treatment is
effective in curing breast cancer').
Illness coherence: The extent to which the participant's perceptions of breast cancer are
coherent. 5 items. Higher score indicates a less coherent perception of breast cancer. (Eg
'Breast cancer doesn't make any sense to me').
Timeline cyclical: Beliefs about the prognosis of breast cancer. 6 items. Higher score
indicates a perception of breast cancer as more variable and unpredictable. (Eg 'Breast
cancer goes through cycles in which it gets better and worse').
Emotional representations: Emotional responses to breast cancer. 8 items. Higher score
represents greater emotional response to breast cancer. (Eg ' When I think about breast
cancer I get upset').
Cause: Respondents endorse 19 statements about the causes of breast cancer on a 5 point
scale ranging from 'strongly disagree' to 'strongly agree'. These items are retained
individually. Respondents are also asked to state what they believe to be the 3 most
important causes of breast cancer.
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6.17 DESIGN AND SAMPLE
The study was a cross sectional questionnaire study. The design and procedure were
described in Chapter 4. Data reported in this Chapter were derived from the
following samples: Increased risk sample (Sample A) (n= 117) and general
population sample (Sample B&C)(n= 256). Test-retest data are also examined in the
follow-up sample of at risk women (n= 74). These samples were described in
Chapter 5 (see sections 5.2 and 5.3, pages 116- 119).
6.18 STATISTICAL ANALYSIS
6.18.1 Reliability analysis
Reliability analysis was conducted on both versions of the IPQ-R (IPQ-R50 and IPQ-
R38) in order to determine which version of the IPQ-R to use in subsequent analysis.
Internal consistency of the IPQ-R subscales were assessed using Cronbach's alpha.
Test-retest reliability was obtained in the follow-up sample and examined using
Pearson's correlation coefficient.
6.18.2 Descriptive statistics
Histograms, boxplots and normal probability plots were used to examine the
distribution of subscales including the symmetry ofdistribution, spread of scores and
outliers. Descriptive statistics including mean, skew and kurtosis were also obtained
and examined for problems in the data.
6.18.3 Patterns of illness perceptions
6.18.3a Intercorrelations
In both samples correlations were examined between the IPQ-R subscales.
Exploratory analysis was also conducted to examine correlations between IPQ-R
subscales and causal items and between the causal items. Due to the number of
correlational analysis conducted significance levels ofp<0.01 are reported here.
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6.18.3b Cluster analysis
6.18.3.b(i)Background to cluster analysis
Cluster analysis was used to assess the patterns of illness representations in both
samples. This is a descriptive, exploratory technique that searches for characteristic
patterns in scores across a number of variables. It combines individuals into groups
or 'clusters' so that individuals in the same cluster are more alike (with respect to the
variables in question) than they are to individuals in another cluster. Cluster analysis
uses heuristics and plausible algorithms to create clusters and there are no statistical
assumptions for this technique. There are many different methods available based
upon a variety of algorithms that aim to maximise the differences between clusters
relative to the variance within the clusters. There are two broad categories of
methods: Hierarchical and non hierarchical.
Hierarchical methods classify individuals into clusters in a series of stages in which
progressively larger groups are formed by joining earlier clusters. Agglomerative
hierarchical methods start this process with each individual in their own cluster and
progress until all individuals are in the same cluster. There are a number of different
techniques for these methods based on different ways of defining distance between
individuals and clusters in order to determine cluster membership. The hierarchical
stages of these methods are represented graphically by dendrograms that illustrate the
fusions/divisions at each stage (please see Figure 6.2). The dendrogram is examined
in order to determine the optimum clusters that represent the data. There are no
standard selection procedures and judgements are made on a subjective interpretation
of changes in the dendrogram (Everitt 1993). It has been suggested that researchers
examine a number of cluster solutions in light of theoretical expectations (Hair et al.
1995).
Non-hierarchical (K means) cluster analysis is conducted by specifying the number
of clusters expected in the sample. The researcher selects cluster centres (cluster
seeds) and individuals are subsequently assigned to one of the clusters. The methods
utilised in this approach differ on techniques used to obtain cluster seeds and rules
for assigning individuals into clusters (Sharma 1996).
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Both hierarchical and non-hierarchical methods have advantages and disadvantages
and can produce different cluster solutions of the same data set. Hierarchical methods
are affected by outliers and are difficult to compute on large datasets. Non-
hierarchical methods are less susceptible to outliers but depend on the researcher to
select appropriate cluster seeds according to theoretical or practical considerations.
Different seeds can produce very different cluster solutions. Hair et al. (1995) reports
that non-hierarchical methods are superior to hierarchical methods when cluster
seeds can be specified. Sharma (1996) and Hair et al. (1995) have suggested that
combining the approaches maximises the advantages of both techniques and allows
the researcher to be most confident in the validity of the solution. Hair et al. (1995)
suggests combining the approaches allows non-hierarchical techniques to 'fine tune'
the results from hierarchical analysis by allowing individuals to change cluster
membership. This method will be utilised on the IPQ-R data set from both samples
and is outlined below (6.18.3b(ii)).
Once the cluster solution is obtained clusters must be interpreted and assigned a
name that reflects the nature of the cluster. It is important to determine the variables
that differentiate the clusters and the patterns of response within each cluster. Since
cluster solutions will differ depending on what method is utilised it is important to
validate the solution in order to determine that the clusters are real and not merely
imposed on the data by the method. There are a number ofways to validate a cluster
solution. For example, performing the analysis on a separate sample and comparing
the cluster solutions and cluster membership and testing the clusters for differences
expected on other variables.
Although cluster analysis does not incorporate any statistical assumptions it is
important to consider the variables entered into the analysis. The selection of
variables for analysis should be theoretically driven since cluster analysis is unable to
distinguish relevant and irrelevant variables. The distance measures are also sensitive
to differing scales in that scales with larger dispersion have more impact on the
solution. Standardized score (z scores) are used in order to eliminate this bias.
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6.18.3b (ii) Cluster analysis oflPQ-R data
Step 1.
Standardized scores (z scores) of the EPQ-R subscales were calculated for each
participant for use in analysis (Identity; timeline acute/chronic; timeline cyclical;
consequences; treatment control; personal control; illness coherence; emotional
representations). Subscales that showed adequate psychometric properties were
included in the analysis. The causal items were not included in the analysis since
there were may single items and no clear predictions as to how these items would
cluster.
Step 2.
A number of hierarchical agglomerative cluster analysis were performed on the data
from each sample (Wards method, centroid method, single linkage and complete
linkage) using squared Euclidean distance as the similarity measure. These are the
most widely used methods and distance measures in empirical studies (Everitt 1993,
Everitt 1996). Dendrograms for these analyses were examined in order to determine
the number of clusters in each sample. Means for each variable from the clusters
from the Wards method were obtained for use in the non-hierarchical analysis. The
Wards method is considered the best hierarchical method available (Hair et al. 1995,
Everitt 1996, Hack and Degner 1999).
Step 3,
A non-hierarchical Kmeans cluster analysis was performed specifying the number of
clusters identified by the hierarchical analysis and using the means for each variable
in each cluster as seed points. Clusters were interpreted and named by comparing
means scores on each of the unstandardized IPQ-R subscales.
Step 4.
To validate the cluster solution another Kmeans cluster analysis using random cluster
seed points was obtained. The results were compared in terms of cluster sizes and
cluster membership. The cluster solutions obtained for both samples were also
compared. Further validation of the cluster solutions will be explored throughout the
thesis by examination ofpredicted associations between illness perception clusters,





The alpha coefficients for both versions of the IPQ-R in each sample are provided in
Table 6.10. In the increased risk sample (A) both versions of the emotional
representations, treatment control, personal control and illness coherence subscales
performed well (Cronbach's alpha >.7). The identity, timeline acute/chronic and
consequences subscales were marginal in this sample (>0.55). The longer versions of
these subscales (derived from the IPQ-R50) showed higher levels of internal
consistency than those from the shorter version (IPQ-R38). Both versions of the
timeline cyclical subscale showed extremely low internal consistency.
In the general population sample (B&C) the identity, emotional representations and
illness coherence subscales showed acceptable internal consistency (>.7). The longer
version of the consequences subscale performed well (.76) but the shorter version
showed reduced internal consistency (.66). Both versions of the timeline
acute/chronic subscale, personal control and treatment control subscales were
marginal. The longer versions of the timeline acute/chronic subscale and personal
control subscales performed slightly better than the short versions. Both versions of
the timeline cyclical subscales showed very poor internal consistency.
Comparing the internal consistency of the subscales derived from the IPQ-R between
the increased risk (A) and general population sample (B&C) suggested that the
emotional representations and illness coherence subscales performed well across all
samples. The identity and consequences subscales showed higher internal
consistency in the general population sample than the increased risk sample. Both the
personal and treatment control subscales showed higher levels of internal consistency
in the increased risk sample than the general population sample. The timeline
acute/chronic subscales was marginal in both samples and the timeline cyclical
subscale performed poorly in all samples.
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Cronbach's alpha was systematically re-calculated for each subscale with each item
omitted in order to identify problematic items. Item deletion was found to only
marginally improve the consistency of a few subscales. The subscales that could be
improved by omitting items are highlighted with a star (*) in Table 6.10. This
analysis is reported in Appendix III (page A-21). The largest improvement was in the
general population sample in which the 38-item version of the timeline cyclical
subscale was improved from .39 to .49 with item 4 deleted. However this is still an
unacceptable level of internal consistency.
Table 6.10— Internal consistency (Cronbach's Alpha) for IPQ-R50 and IPQ-R38
subscales in the increased risk and generalpopulation samples




IPQ-R subscale IPQ-R50 IPQ-R38 IPQ-R50 IPQ-R38
Identity .66* - .77* -
Timeline acute/chronic .61 .59* .63* .61*
Consequences .69* .56* .76 .66
Personal control .82* .78* .68 .65
Treatment control .72* .73* .60* .63*
Illness coherence .81 - .84 -
Timeline cyclical .35* .43 .31* .39*
Emotional
representations
.89 .87 .87* .85
6.19.1b Test re-test reliability
Test re-test reliability was calculated for the follow up subsample of the increased
risk sample (see 5.2.1a (page 116) and Figure 5.1 (page 118) for details of sample).
The correlation coefficients for both versions of the subscales are provided in Table
6.11. The test-retest values are high for both versions of the subscales. All correlation
coefficients for the full sample are significant (p<0.001) except the longer version of
the timeline cyclical (p=0.006). Test retest reliability for individual items comprising
the timeline cyclical subscale were assessed in order to explore why stability was
lower in this scale. Five of the six items showed significant test retest reliability
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ranging from r= .34, p= 0.003, n= 73 (item 4) to r= .58, p<0.001, n= 72 (item 34).
One item (item number 7 'Patients experience breast cancer symptoms pretty much
all ofthe time') did not show a significant correlation coefficient (r= . 04, p= .74, n=
73). This suggests that this item in particular is not reliable in this population.
Test-retest correlation coefficients were also computed for participants who did (n=
37, 43%) and did not (n= 42, 57%) report experiences that may have influenced their
thoughts and feelings about breast cancer between the questionnaires. These results
are fully reported in Appendix III (page A-22). The correlation coefficients are
generally higher for participants who did not report breast cancer related experiences
between questionnaires than for participants who did. The test re-test value for the
timeline cyclical subscale was non significant for participants who reported a breast
cancer related experience between the questionnaires (r=-.2, p>.05).
Table 6.11- Test-retest correlation coefficientsfor all respondents in the follow-up
sample.
Subscale IPQ-R50 IPQ-R38
n r n r
Identity 74 ^4*** - -
3Timeline acute/chronic 67 .68*** 66 .66***
Consequences 68 77*** 70 "72***
Personal control 68 74*** 68 74***
Treatment control 68 77*** 69 74***
Illness coherence 70 .68*** - -
Timeline cyclical 70 33** 70 42***
Emotional representations 64 gg*** 64 .85***
***p<0.001
**p<0.01
Since the majority of the subscales derived from the IPQ-R50 showed greater
internal consistency than those derived from the IPQ-R38 in both samples and higher
test-retest reliability in the increased risk sample it was decided to utilise this version
3 The sample size is higher in the IPQ-R50 version the timeline acute/chronic scale because this
version is shorter than that derived from the IPQ-R38 (see section 6.14, page 159).
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of the questionnaire in subsequent analysis. Following reference to the IPQ-R refers
to this version of the measure.
6.19.2 Descriptive statistics
6.19.2a Increased risk sample (A)
One hundred and seventeen women in the increased risk sample completed the IPQ-
R. Two participants failed to complete page 9 of the questionnaire and 2 other
participants failed to complete page 10 of the questionnaire. Both of these pages
contained items from the consequences, timeline acute/chronic, personal control,
treatment control, illness coherence and emotional subscales. Since scores are not
derived for subscales with missing items the maximum sample size for these
subscales was reduced to 113. Page 9 contained items from the timeline cyclical
subscales and hence the maximum sample size for this subscale was reduced to 115.
Other missing data appeared random with no item omitted more than twice. The
sample size for the subscales ranges from 105 (emotional representation) to 117
(identity).
Table 6.12 provides the descriptive statistics of the fPQ-R subscales. Examination of
graphical distribution and descriptive statistics did not reveal any problems in the
data. The identity subscale showed a slight left (positive) skew and the
consequences, treatment control and emotional representations subscales showed a
slight right (negative) skew. No subscale had more than 4 outlying cases. The
questionnaire ID number was used to identify questionnaires that included outliers
and checks were made to ensure there were no reasons for these values (eg mistakes
in data input or written explanations on questionnaires). No evidence was found to
suggest that those participants who had outlying scores were unrepresentative and
there was not sufficient justification for removing these scores (Altman 1991).
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Table 6.12 - Descriptive statistics ofthe IPQ-R subscales in the increased risk
sample (A).4
IPQ-R subscale n Mean sd
Identity 117 4.4 2.25
Timeline acute/chronic 111 3.3 0.53
Consequences 109 3.9 0.38
Personal control 111 3.3 0.60
Treatment control 112 3.6 0.52
Illness coherence 111 2.5 0.69
Timeline cyclical 113 3.1 0.42
Emotional representations 105 3.3 0.69
Causal items
On average women in the increased risk sample agreed with 6.2 (sd 3.20) of the
cause items (rated agree/strongly agree). The rating scores for each item can be seen
in Table 6.14. The highest rated items (with mean values over 3) were: heredity,
hormonal, smoking, diet, ageing, stress, and chance. When asked to state the three
most important factors believed to cause breast cancer 113 (97%) endorsed heredity;
49 (42%) hormonal factors; 37 (32%) diet; 34 (29%) smoking; 26 (22%) ageing; 23
(20%) stress or worry; 17 (15%) a germ or virus. Only 4 other causes were noted
which were not already provided. Two of these were similar to causes already on the
list ('natural mutation' and 'random') two others were new causes not on the EPQ-R
list ('under wired bras' and 'persons body').
6.19.2b Generalpopulation sample (B&C)
Missing data in this sample also appeared random. Sample size for the subscales
ranged from 237 (personal control) to 256 (identity). Table 6.13 provides the
descriptive statistics for IPQ-R subscales. The majority of subscales in this sample
appeared normally distributed. The identity subscale showed a slight left (positive)
skew and the treatment control subscale showed a slight right (negative) skew. The
timeline cyclical subscale showed a high numbers of outliers (n= 21). Checks were
made to ensure that participants with outlying scores did not differ from the
4 Scores are computed by summing items and obtaining mean (see section 6.14, page 159-160)
175
remaining sample in terms of background demographics. No differences were found
and there were no suggestions that these participants were unrepresentative.
Table 6.13- Descriptive statistics ofthe IPQ-R subscales in the general population
sample (B&C)
IPQ-R subscale N Mean Sd
Identity 256 5.1 2.86
Timeline acute/chronic 243 3.2 0.53
Consequences 240 3.9 0.44
Personal control 237 3.2 0.47
Treatment control 244 3.6 0.42
Illness coherence 245 3.1 0.38
Timeline cyclical 238 2.9 0.70
Emotional representations 240 3.1 0.68
Causal items
On average women in the general population sample agreed with 6 (sd 3.41) of the
cause items (rated agree/strongly agree). The rating scores for each item can be seen
in Table 6.14. The highest rated items with mean values over 3 were heredity,
hormonal factors, smoking, ageing, stress, chance and diet. When asked to rank the
three most important factors believed to be causes of breast cancer 226 (88%)
endorsed heredity; 105 (41%) hormonal factors; 93 (36%) smoking; 53 (21%) stress;
53 (21%) chance or bad luck; 42 (16%) ageing; 27 (11%) diet. Altogether 36
different causes not provided by the IPQ-R50 were recorded. Twenty of these causes
overlapped with those already on the list. The 16 different causes reported were:
'over exposure to the sun', 'medication', 'problem with breasts', Tump in breast',
'contraceptive pill', 'not having children', 'fatty tissue in breast', 'exposure to
carcinogenic factors', 'menopause', 'age at first pregnancy',' too many X rays',
'never having breast fed', 'hard growths in body', 'soreness', 'abortion' and 'modem
living (food, radiation, radiowaves)'.
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Table 6.14- Descriptive statistics ofcausal items in the increased risk (A) and
generalpopulation sample (B&C)
Increased risk sample (A) General population sample
(B&C)
Causal items: n Mean sd n Mean sd
Stress or worry 116 3.2 0.99 251 3.2 0.93
Heredity - it runs in the family 117 4.6 0.50 255 4.4 0.64
A germ or virus 116 2.1 0.93 246 2.3 0.84
Diet or eating habits 117 3.3 0.99 249 3.1 0.96
Chance or bad luck 117 3.0 1.12 249 3.2 1.11
Poor medical care in the past 117 2.3 0.92 248 2.5 0.84
Pollution in the environment 116 3.0 0.91 252 3.0 0.90
Patients own behaviour 116 2.5 0.95 249 2.6 0.86
Patients mental attitude e.g. 117 2.5 0.93 249 2.6 0.87
thinking about life negatively
Family problems or worries 115 2.5 0.87 250 2.6 0.88
causes breast cancer
Overwork 117 2.4 0.75 249 2.4 0.74
Emotional state e.g. feeling 116 2.5 0.85 250 2.6 0.88
down, lonely, anxious, empty
Ageing 116 3.2 0.93 252 3.2 0.93
Alcohol 116 2.7 0.91 246 2.7 0.83
Smoking 115 3.4 0.99 252 3.5 0.88
Accident or injury 115 2.6 0.95 248 2.7 0.93
Patient's personality 117 2.2 0.78 248 2.2 0.73
Altered immunity 117 2.9 1.05 248 3.0 0.88
Hormonal 117 3.7 0.75 252 3.6 0.78
6.19.3 Patterns of beliefs5
6.19.3a Intercorrelations
6.19.3a(i) Increased risk sample (A)
Intercorrelations between IPQ-R subscales (p<0.1) are provided in Table 6.15. As
predicted, the identity, timeline acute/chronic, consequences and emotional
5 Timeline cyclical subscale is omitted from this analysis following poor internal consistency and
reliability (see section 7.13.1).
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representations subscales showed positive correlations, and the control subscales
(personal and treatment control) were significantly positively correlated. These
results suggest that women perceiving a strong identity for breast cancer were more
likely to perceive the illness as long-lasting with severe consequences (p<0.05).
Individuals who perceived more personal control over breast cancer were more likely
to perceive treatment as effective (p<0.01). Individuals with stronger emotional
representations of breast cancer perceived breast cancer as long-lasting, with severe
consequences. Individuals with less belief in the treatment control of breast cancer
were more likely to perceive the illness as more long-lasting and chronic and with
more severe consequences (p<0.05). The predicted association between emotional
representations of breast cancer and control beliefs were not observed in this sample.
The new illness coherence subscale showed intercorrelations with other subscales.
Individuals scoring higher on the illness coherence subscale (who did not have a
coherent understanding of the disease) were more likely to score higher on the
identity subscale and to have shown diminished perceptions of personal control of
breast cancer (p<0.05).
Exploratory analysis of associations with causal item revealed that the number of
causes participants agreed with was significantly correlated with consequences (r=
.32, p= <0.001, n= 109), personal control (r= .23, p= 0.015, n= 111) and illness
coherence (r= -.19, p= 0.044, n= 111). Therefore participants who believed in more
causes ofbreast cancer believed the disease to be hold greater consequences were
more likely to believe in the personal control of the disease and held a more coherent
understanding ofbreast cancer. A number of correlations were found between the
IPQ-R subscales and causal items. Due to the number of tests conducted the p value
was reduced to p<0.01. The significant results are reported in Table 6.17. The
consequences and the personal control subscales showed the greatest number of
correlations with causal items. There were also a large number of intercorrelations
within the causal items in each sample. In the increased risk sample there were 66
significant correlations (p<0.01) between causal items.
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Table 6.15-Pearson's correlation coefficients between IPQ-R subscales in the






















































6.19.3a(ii) Generalpopulation sample (B&C)
The general population sample showed a similar pattern of intercorrelations to the
increased risk sample. The correlation matrix is provided in Table 6.16. The
consequences subscale was significantly positively correlated with identity and
timeline acute/chronic as predicted, although timeline acute/chronic was not
associated with identity (p<0.05). Emotional representations subscale was
significantly associated with all other subscales in the expected direction (positively
associated with identity, timeline acute/chronic, consequences and negatively
associated with personal and treatment control). Women who had a stronger
emotional response to breast cancer were less likely to believe in the efficacy of
treatment in controlling breast cancer or personal control over the disease (p<0.05).
Both treatment control and personal control were negatively associated with timeline
acute/chronic, as predicted (p<0.05). Women who believed in the control of breast
cancer were less likely to believe the disease was long-lasting (p<0.001). However
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neither control subscale were associated with identity or consequences as was
predicted.
In this sample the illness coherence subscale was negatively correlated with
treatment control (p<0.05). Women with a stronger belief in the efficacy of
treatment to control breast cancer had a more coherent understanding of the disease.
Exploratory correlational analysis of the causal items revealed that the number of
causes participants agreed with was correlated with a number of subscales
(consequences r= .28, p< 0.001, n= 240 and personal control r= .16, p= 0.017, n=
237). In addition, participants in the general population who reported to believe in
more causes ofbreast cancer were more likely associate a greater number of
symptoms with the disease (identity r= .25, p< 0.001, n= 256) and to have a stronger
emotional response to breast cancer (r= .20, p= 0.002, n= 240). A number of
significant correlations were found between causal items and the other belief
subscales (p<0.01). These are reported in Table 6.17. Generally there were more
correlations between the causal items and belief subscales in the general population
sample compared to the increased risk sample, however the correlation coefficients
were not particularly high. In the general population sample there were 108
significant correlations between causal items (p<0.01).
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Table 6.16-Pearson's correlation coefficients between IPQ-R subscales in the




























































Table 6.17- Pearson's correlation coefficients between IPQ-R subscales and causal
items in both samples (p<0.01 reported).
Subscale Increased risk sample (A) General population sample (B&C)
Identity Accident or injury (r=.31, n= 115, p=
0.001)
Smoking (r=.28, n= 115, p= 0.003)
Heredity (r=.23, n= 255, p=0.000)
Emotional state (r=.22, n= 250, p=0.001)
Family problems (r=. 19, n= 250,
p=0.003)
Stress (r=. 18, n= 251, p=0.004)
Timeline
acute/chronic
Accident or injury (r=.19, n= 236,
p=0.004)
Consequences Altered immunity (r=.33, n= 109,
p=0.000)
Patients personality (r=.32, n= 109,
p=0.001)
Patient mental attitude (r=.31, n= 109,
p=0.001)
Emotional state (r=.29, n= 108, p= 0.002)
Chance (r=.29, n= 109, p=0.003)
Stress (r=.27, n= 108, p=0.005)
Heredity (r=.31, n= 240, p=0.000)
Hormonal (r=.30, n= 237, p=0.000)
Overwork (r=.27, n= 234, p=0.000)
Emotional state (r=.26, n=235, p=0.000)
Family problems (r=.25, n=235, p=0.000)
Smoking (r=.20, n=237, p=0.002)
Patient mental attitude (r=.20, n=234,
p=0.001)
Altered immunity (r=.18, n=232,
p=0.006)
Ageing (r=. 18, n=237, p=0.006)
Alcohol (r=.17, n=231, p=0.001)
Personal control Patients mental attitude (r=.36, n= 111,
p=0.000)
Diet (r=.34, n= 111, p=0.000)
Patients behaviour (r=.32, n= 111, 0.000)
Patients behaviour (r=.28, n=231,
p=0.000)
Patients personality (r=.24, n=230,
p=0.000)
Pollution (r=.20, n=234, p=0.002)
Patients mental attitude (r=.20, n=231,
p=0.003)
Accident or injury (r=.-18, n=230,
p=0.007)
Stress or worry (r=,17, n=233, p=0.009)
Diet or eating habits (r=.17, n=232,
p=0.009)
Illness coherence Germ or virus (r=.21, n=237, p=0.001)
Emotional
representations
Overwork (r=.22, n=234, p=0.001)
Accident or injury (r=.22, n= 233,
p=0.001)
Hormonal (r=.20, n= 237, p=0.002)
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Emotional state (r=.20, n= 235, p=0.002)
Family problems (r=.19, n=235, p=0.004)
Stress (r=.17, n= 235, p=0.001)
6.19.3b Cluster analysis6
6.19.3b(i) Increased risk sample (A)
The dendrograms from Wards hierarchical analysis clearly suggested a 2 cluster
solution (see Figure 6.2). The cluster means for these clusters on each of the
variables were obtained and entered as the cluster seed points for the non-
hierarchical analysis.
The cluster solution obtained from the non-hierarchical analysis showed a similar
number ofparticipants in each cluster. Cluster 1 contained 51 (52%) participants and
cluster 2 contained 47 (48%) participants. As Table 6.18 indicates the clusters
differed significantly on all the IPQ-R subscales (p<0.05). Participants in cluster 1
believed breast cancer: to have more symptoms; to be longer lasting and hold greater
consequences. They also held stronger emotional representations of breast cancer
than participants in cluster 2. Those in cluster 1 were less likely to believe in
treatment or personal control of breast cancer and held a less coherent understanding
of the disease those participants in cluster 2. The clusters seem to represent a
dichotomy ofbeliefs and were thus labelled 'negative representation'
(cluster 1) and 'positive representation' (cluster 2) respectively. The mean z scores
on the EPQ-R subscales for each cluster are demonstrated graphically in Figure 6.3.
In order to validate this analysis another K-means cluster analysis was conducted
using random cluster seed points and the results compared. The cluster solution was
similar. Each cluster differed significantly on all of the IPQ-R subscales and the
means on each subscale were comparable to those found in the previous solution.
The sizes of the clusters were also comparable ('negative representation' cluster n=
6 Timeline cyclical subscale is omitted from this analysis following poor internal consistency and
reliability (see section 6.19.1, page 171-174).
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55; 'positive representation' cluster n= 43). There were only 5 differences in
classification ofparticipants compared with the previous solution. One woman who
was classified in the negative cluster previously was in the positive cluster in the
analysis using random cluster seed points. Four women classified in the positive
cluster in the previous analysis were found in the negative cluster in the random seed
analysis. The comparability of cluster solutions indicates that the clusters reliably
differentiate participants on the basis of scores on the EPQ-R.










Identity 5.4 (2.42) 3.5 (1.41) 4.61 96 .000
Timeline acute/chronic 3.5 (0.51) 3.0(0.46) 4.46 96 .000
Consequences 4.0(0.31) 3.8 (0.42) 2.81 96 .006
Personal control 2.9(0.56) 3.6(0.48) -6.11 96 .000
Treatment control 3.4 (0.53) 3.9 (0.36) -5.69 96 .000
Illness coherence 2.8 (0.62) 2.1 (0.53) 6.07 96 .000
Emotional representation 3.6 (0.55) 3.0 (0.74) 4.29 96 .000
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Figure 6.2- Dendrogram from hierarchical cluster analysis oflPQ-R
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Clusters
Exploratory analysis was conducted to assess differences between the clusters on
causal items. There was no significant difference in the number of causes believed to
be associated with breast cancer between participants in the positive and negative
clusters (t=-1.53, df= 96, p= 0.129). However, participants in the positive cluster
were more likely to agree that 'family problems', 'overwork' and 'emotional state'
are causes of breast cancer than those in the negative cluster (p<0.05). There was no
significant difference between the clusters on age or risk perception (p<0.05). There
was a trend for individuals in the negative cluster to report slightly higher
perceptions of risk (mean = 3.1, sd= 0.72) than individuals in the positive cluster
(mean= 2.8, sd= 0.77) (t=1.67, df= 95, p= 0.098).
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6.19.3b(ii) General population sample (B&C)
The dendrogram from the Wards hierarchical cluster analysis also suggested a 2
cluster solution in the general population (see Appendix III page A-23). When the
means were entered into a K-means cluster analysis the cluster solution observed
reflected that found in the increased risk sample. The clusters differed significantly
on all of the fPQ-R subscales (p<0.05) (Please see Table 6.19). Cluster 1 ('negative
representation') were defined by high scores on the identity, timeline acute/chronic,
consequences and emotional representations subscales and low scores on the
personal and treatment control subscales. The mean z scores on the IPQ-R subscales
for each cluster are demonstrated graphically in Figure 6.4. The distribution of
participants between the clusters was different in the general population sample than
the increased risk sample. The 'negative representation' cluster encompassed 36% of
participants and the 'positive representation' cluster held 64% ofparticipants. When
the random K-means cluster analysis was computed exactly the same cluster solution
was obtained with the same participants in each cluster suggesting that the solution
obtained was reliable.











Identity 6.5 (3.46) 4.3 (2.20) 5.79 241 .000
Timeline acute/chronic 3.6(0.47) 3.0(0.38) 10.72 214 .000
Consequences 4.1 (0.37) 3.8 (0.41) 6.68 214 .000
Personal control 2.9 (0.46) 3.4 (0.39) 8.01 214 .000
Treatment control 3.5 (0.45) 3.8 (0.34) 5.62 214 .000
Illness coherence 3.0(0.69) 2.8 (0.69) 2.07 214 .040
Emotional representation 3.6(0.56) 2.8 (0.61) 8.38 214 .000
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Figure 6.4-Mean z scores on the IPQ-R subscalesfor each cluster in the general
population sample (B&C).











Exploratory analysis revealed that the clusters differed on a number of the causal
items. Participants in the negative cluster reported to believe in on average 6.9 causes
of breast cancer compared to 5.7 of those in the positive cluster (t= 2.39, df= 214, p=
0.018). Participants in the negative cluster were significantly more likely to agree
that 'heredity'; 'chance or bad luck'; 'overwork'; 'emotional state'; 'accident or
injury' and 'hormonal factors' were causes of breast cancer (p<0.05). There were no
significant differences in age or risk perception between the cluster groups. As in the
increased risk sample there was a trend for individuals in the negative cluster to
report slightly higher perception of risk (mean =2.5, sd= 0.72) than those in the
positive cluster (mean =2.3, sd= 0.57) (t= 1.93, df= 212, p= 0.056).
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6.20 SUMMARY AND DISCUSSION
6.20.1 Adaptation of the IPQ-R to assess perceptions of breast cancer held by
healthy women.
The IPQ-R was easily adapted to assess perceptions of breast cancer in healthy
women. A few breast cancer specific items were added to the identity and cause
checklists and pilot interviews suggested that the item were relevant and
comprehensible to women with a family history of breast cancer. Results from the
cross-sectional study revealed that the distribution ofmissing items was random and
did not suggest that women were having trouble responding to any particular item or
subscale. Missing data for any subscale in either sample did not exceed 10%. This
proportion ofmissing data is common in questionnaires following illegible, invalid
or omitted responses (Streiner and Norman 1991).
6.20.2 Reliability of the IPQ-R to assess perceptions of breast cancer held by
healthy women.
The reliability of both versions of the IPQ-R (IPQ-R50 and IPQ-R38) were examined
in both the increased risk and general population samples. The internal consistency
and test re-test reliability of the subscales derived from the IPQ-R50 were generally
higher than the subscales calculated from the IPQ-R38. This suggests that the longer
version of the questionnaire is more appropriate in these samples. It is possible
however that the Cronbach alpha value for the longer version (IPQ-R50) may have
been inflated due to the increased number of items. Cronbach alpha is a function of
both the average inter-item correlation and the number of items. The use of general
guidelines for interpreting this statistic without specifying the number of items is a
topic of statistical debate (Fayers and Machin 2000). However, analysis of internal
consistency with individual items deleted from the subscales did not consistently
reveal problematic items and did not suggest any dramatic improvements. Items that
were dropped to produce the IPQ-R38 (Moss-Morris et al. 2002) were not indicated
as problematic in the IPQ-R50 in these samples. It would have been informative to
conduct a confirmatory factor analysis on this data to test the hypothesised factor
structure of the questionnaire in this population and to indicate problematic items.
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However the aim of this analysis was not to test the psychometric structure of the
questionnaire, but merely to ensure that the measure was adequate for use in further
analysis. In addition, the sample size was not sufficient for this analysis given the
number of questionnaire items (Ferguson and Cox 1993). It may have been possible
to combine the samples in order to raise the sample size for this analysis. However
the combining heterogeneous samples is considered inappropriate since factor
structures in each sample may be obscured (Hair et al. 1995).
The timeline cyclical subscale showed particularly poor internal consistency in both
samples and a high number of outliers in the general population suggesting the
subscale was not normally distributed. There are a number ofpossible explanations
regarding the poor performance of this scale in these samples. The timeline cyclical
subscale was designed to assess perceptions of constancy in rapidly changing
illnesses such as menstrual disorders. This concept may not relevant to breast cancer
or the timeframe regarding cyclical beliefs may be longer in breast cancer than that
assessed with the current items (eg ' The symptoms ofmy illness change a great deal
from day to day'). Disease specific items developed to assess beliefs about constancy
ofbreast cancer in the longer term (eg recurrence) may capture the concept in this
context. In addition, it is possible that healthy individuals have a poor understanding
of the symptom experiences of breast cancer patients. Previous research has found
that healthy individuals who have not directly experienced symptoms of an illness
report less symptom variability than patients and that "an understanding ofthis
aspect ofchronic illness most commonly comes from hardpersonal experience"
(Schiaffino and Cea 1995, pg 544). Examining the items within the timeline cyclical
subscale also raises issues concerning its validity. Items in the scale appear to assess
cyclical beliefs (items 3, 34); perceptions of constancy (items 7, 13, 31) and
predictability (item 4) (See questionnaire in Appendix II page A-9). It is possible that
these aspects do not form a cohesive dimension but reflect a range ofdifferent illness
representations. The timeline cyclical subscale has also shown low reliability in
recent validation work (Moss-Morris et al. 2002, see also section 6.19.1a pages 171-
172). These points raise concern regarding the nature of the subscale.
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The timeline acute/chronic subscale showed marginal internal consistency in both
samples and was lower than that reported in patient populations. The internal
consistency of the emotional representations and illness coherence subscales were
high in both samples and comparable to that reported in patient populations (Moss-
Morris et al. 2002). The psychometric properties of a number of the other subscales
differed between the samples. It was predicted that the IPQ-R would shower higher
reliability in the increased risk sample than the general population sample. This was
true for the control subscales. The internal consistency of the personal control
subscale in the increased risk sample was comparable to that reported in patient
populations (Moss-Morris et al. 2002). Surprisingly, the identity and consequences
subscales performed better in the general population sample than the increased risk
sample. The identity subscale in the general population sample showed comparable
levels of internal consistency to patient populations (Moss-Morris et al. 2002).
It is possible that the order ofpresentation of items may have affected reliability
scores. Items in this study (with the exception of the identity and cause checklists)
were presented in a random order. This may have lowered internal consistency
compared to the work on patient populations when the items were grouped and
presented according to their subscale (Moss-Morris, personal communication).
Test re-test correlation coefficients for both versions of the subscales in the follow-
up sample were high. In most subscales the longer version of the scale showed higher
test-retest reliability. The personal control, treatment control, illness coherence and
emotional representation subscales all showed higher 3 month test-retest reliability in
this sample than that found for renal patients at 3 weeks and rheumatoid arthritis
patients at 6 months (Moss-Morris et al. 2002). One would expect illness perceptions
of healthy individuals to be more stable than those ofpatients who may experience
changes in their illness over time. As would be expected test-retest reliability was
higher for participants who did not report any breast cancer related experiences
between completing the questionnaires. This is consistent with the SRM that
proposes that individual's beliefs are dynamic and may change with experience. The
timeline cyclical subscale showed lower levels of test-retest reliability than other
subscales and was non-significant in the group of participants with breast cancer
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experiences between questionnaires. This indicates that either perceptions of
prognosis of breast cancer were changed drastically by experience or that this
measure is not reliable in this sample. Since women in this sample are not directly
experiencing changes in symptoms it is unlikely that the type of experiences women
reported between questionnaires would have such a strong effect on timeline cyclical
subscale. Given the problems with internal consistency of this scale it is more likely
that results reflect poor reliability.
Overall, these results suggest that the EPQ-R is applicable to assess perceptions of
breast cancer in healthy women. Some of the subscales perform better than others
and differences in internal consistency were found between the samples. The IPQ-
R50 version appeared more reliable in both samples and will be utilised in
subsequent analysis. Given the low internal consistency and test re-test reliability of
the timeline cyclical subscale as well as the poor distribution of this scale it was
omitted from further analysis. Care will be needed in the interpretation of the
timeline acute/chronic subscale in all samples and the treatment control subscale in
the general population samples due to low levels of internal consistency.
The results reported in this chapter do not provide information regarding the validity
of the IPQ-R in these samples. Further research is necessary to examine the validity
of assessment of illness perceptions in healthy populations. This will be discussed
further in the Discussion Chapter (Chapter 11).
6.20.3 Perceptions of breast cancer held by healthy women: Descriptive
statistics.
In general the mean values of the subscales suggested that healthy women believed
breast cancer holds severe consequences, is long in duration and that they held strong
emotional representations of the disease. Women believed in treatment control and to
a lesser extent personal control of breast cancer. Women also reported a coherent
understanding of the disease. Scores on these subscales ranged in both samples
suggesting that women hold differing beliefs about breast cancer. Further analysis
comparing the beliefs of the samples and investigating individual differences in
beliefs will be reported in subsequent chapters (Chapter 8).
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Women in both samples believed that there were a number of causes of breast
cancer. The most important causes identified by participants in both samples
included both controllable and uncontrollable factors (e.g. heredity, hormonal
factors, diet and smoking). This confirms previous findings that healthy individuals
hold multifactorial models of breast cancer and familial cancer (Payne 1990, Michie
et al. 1996). The majority of causes noted in the open response format were items
already on the causal list of the EPQ-R supporting the validity of these items in this
context. This is consistent with previous research which has found patterns of
attributions made for illness from fixed lists does not differ from those gleaned from
open ended methods (Weinman et al. 2000, French et al., 2001). A few sporadic
causes were mentioned that were extremely specific and not assessed by the IPQ-R.
6.20.4 Patterns of illness perceptions: Intercorrelations and Cluster analysis
Logical intercorrelations in the predicted direction were found amongst the subscales
of the IPQ-R in both samples and reflected relationships reported in patient samples
(Weinman et al. 1996). The majority of predicted associations were found in the
increased risk sample except for associations between emotional representations and
control perceptions, and associations between perceptions of personal control and
other cognitive representations.
Exploratory analysis revealed that the number of causes participants believed to be
associated with breast cancer was positively associated with perceptions of
consequences and personal control in both samples. In addition, women in the
general population sample who believed in more causes ofbreast cancer associated
more symptoms with the disease and had a stronger emotional response to breast
cancer. This is consistent with previous research that has shown a positive correlation
between number of causal attributions for illness and distress (Turnquist et al. 1988).
In addition, Weinman et al. (2000) found the number of causal attributions for
spousal MI was associated with fear of anotherMI in the following year. Beliefs
regarding the number of causes of breast cancer may therefore reflect increased
anxiety concerning the disease and susceptibility to it.
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Individual causal beliefs were associated with a number ofbelief subscales
particularly consequences and personal control. As would be expected beliefs about
personal control over breast cancer were positively associated with controllable
causes and negatively associated with uncontrollable causes. There were a large
number of intercorrelations within the causal items that suggested overlap between
items. It may be possible to reduce these items into causal dimensions. Moss-Morris
et al. (2002) outlined a principal components analysis of the causal items in the IPQ-
R. They found that 4 factors accounted for 57% of the variance. These factors were:
Psychological attributions (33%), risk factors (11%), immunity (7%), and
accident/chance (6%). However, reducing causal items in this way has received
criticism. Sutton et al. (submitted) criticised this approach for using pragmatic rather
than theoretical rationale for reducing variables. It is argued that the items lack
compatibility. The numbers of items encompassed within these subscales make the
construct difficult to interpret and target with interventions. Given these criticisms
and the limited sample size in the increased risk sample it was decided not to use a
factor analytic approach but to explore the causal items independently.
Cluster analysis was used to assess the pattern of illness perceptions in both samples
and also to provide a summary categorical variable for use in subsequent analysis.
As predicted, participants in both the increased risk and general population samples
were found to fall into discrete clusters based on their representations of the disease.
Two clusters were identified in both samples. Participants in each cluster were
differentiated by scores on all of the IPQ-R subscales. One cluster represented
negative representations and the other positive representations (high scores on the
control subscales and low scores on remaining subscales). These clusters are similar
to those found in previous research on patients with breast cancer and Addisons
disease (Buick 1997, Heijmans 1999). Causal items were not included in the analysis
due to the large number of items and lack of clear hypotheses. However, exploratory
analysis revealed that participants in each cluster responded differently to the causal
items. It is possible that causal beliefs may be important components an individuals
overall representation of disease that determine response to risk and is an area that
requires further investigation.
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Since cluster analysis is not based on statistical reasoning there are no tests to
determine which solution best describes the data. It is possible that clusters could be
further differentiated. However, given the clear 2 cluster solution represented on the
dendrogram (Figure 6.2), similarity of solutions in both samples and comparison
with previous published work the two cluster solution was deemed acceptable. The
clusters will therefore be used as dichotomous variables in order to investigate the
impact of experience of breast cancer on illness perceptions and also to address
associations between patterns of beliefs and levels of distress in both samples.
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EXPERIENCE OF BREAST CANCER AND DISTRESS
7.1 AIMS AND RATIONALE
Chapter 6 outlined an evaluation of the measures used in the current research to
assess experience ofbreast cancer in the family and illness perceptions. The
measures were deemed to show sufficient reliability to continue with the analysis
plan summarised in Chapter 4 (see Table 4.1, page 102). The main aim of the thesis
was to test the mediation model (Figure 4.1, page 100). This model was tested in its
constituent parts addressed in this and the two following chapters (Chapter 8-10).
This Chapter reports on the section ofwork concerned with objective 2. and
examines associations between experience of breast cancer in the family and level of
general and cancer specific distress. The hypotheses for this section were outlined in
Chapter 4 (4.1.3a; H1-H3) and will be described in more detail here. Associations
between experience of breast cancer and distress were addressed at two levels.
Firstly, tests were conducted to assess differences in general and cancer specific
distress between samples with different experiences of breast cancer. Secondly,
associations between specific experiences of breast cancer and levels of general and
cancer specific distress within both the increased risk and general population samples
were examined.
7.1.1 Differences in general and cancer specific distress between samples with
different experiences of breast cancer: Predictions.
Literature concerning levels of distress in women with a family history ofbreast
cancer has been inconsistent. Some studies have reported higher levels of general
distress in women with a family history of the disease compared to the general
population (Kash et al. 1992, Gagnon et al. 1996) whilst others have reported
comparable levels of distress (eg Lerman et al. 1994a, Lloyd et al. 1996). A caveat in
this research is the lack of control for possible experiences of breast cancer within
the general population. For the purpose of this study therefore, women at increased
risk of breast cancer were compared to a control sample ofwomen with no
experience of breast cancer in their social environment. It was hypothesised (HI) that
women at increased risk of breast cancer would show higher levels of cancer specific
distress because of their vulnerability to the disease and experiences in their family.
Greater experience of the disease is likely to increase accessibility of thoughts about
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the disease (see Chapter 3, section 3.2, page 73-74) and models of health anxiety
have suggested that external events may trigger intrusive thoughts about illness
(Salkovskis and Warwick 1986). In addition, Freeston et al. (1994) reported
associations between subjective probability of threat occurrence with thought
frequency and difficulty removing health related intrusive thoughts in a healthy
population. A proportion of the general population sample were expected to show
intrusive thoughts about breast cancer since health related intrusive thoughts have
been reported in general population samples (Freeston et al. 1994).
7.1.2 Experience of breast cancer and level of general and cancer specific
distress in the increased risk sample: Predictions.
The second level of investigation was to examine associations between specific
experiences ofbreast cancer in the family and levels of general and cancer specific
distress in the increased risk sample. Whilst the development ofmeasures of cancer
specific distress has proved useful for research in this area (See Chapter 1, section
1.4, page 48) there has been little work examining the how different types of distress
develop. This analysis aimed to assess what experiences ofbreast cancer in the
family were associated with both general and cancer specific distress. It was
hypothesised (H2) that experiences of breast cancer would be associated with levels
ofboth general and cancer specific distress. It was expected that the results would
replicated findings of the pilot work (see Chapter 6, part 2, sections 6.3-6.8). Level of
general distress was predicted to be associated with bereavement and diagnosis from
breast cancer in the family and the recency of these events. Cancer worry was
predicted to be positively associated with the degree of perceived resemblance
between the respondent and their index relative and negatively correlated with how
well the index relative coped with their illness and positive aspects of the experience.
Both general distress and cancer worry were expected to be associated with how
traumatic the experience had been and the impact of the experience on the
respondent's life including family roles, relationships and life plans.
Intrusive thoughts about breast cancer were also expected to be related to different
aspects of experience than cancer worry. Intrusive thoughts associated with
bereavement have been considered to contribute to increased distress in women with
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a family history of breast cancer (Zakowski et al. 1997). In addition, individuals
experiencing multiple loss have been found to report recurrent thoughts and images
regarding the experience (Nord 1996). Intrusive thoughts about breast cancer were
therefore predicted to be associated with the experience ofbereavement (including
recency of bereavement and multiple bereavement due to breast cancer) as well as
how traumatic the experience had been. Both intrusive thoughts and avoidance are
characteristic markers of stress response in cancer patients and are positively
correlated (Cordova et al. 1995). Measures of intrusion and avoidance are therefore
often summed or considered separately. Few studies have examined differences in
patterns between these constructs (Primo et al. 2000). Analysis was therefore
conducted using the total score on the Impact ofEvent scale as an overall measure of
stress response to breast cancer risk as well as separate scores on the intrusion and
avoidance subscales in order to explore the associations between experience of breast
cancer and these constructs.
From a clinical perspective it is important to determine aspects of experience that
best predict distress. This will enable clinicians to identify vulnerable women at an
early stage in the genetic counselling process and help predict potential
psychological problems. Exploratory analysis was therefore conducted to determine
what aspects of experience best predicted levels of general and cancer specific
distress in women at increased risk of breast cancer.
7.1.3 Experience of breast cancer and level of general and cancer specific
distress in the general population sample: Exploratory analysis.
A final aim of this section was to explore the impact of experiences of breast cancer
on levels of general and cancer specific distress in women in the general population.
Previous work has indicated that the experience of breast cancer in the family is
associated with increased perception of risk rather than the knowledge that a family
history of the disease is an established risk factor (Drossaert et al. 1996, Absetz et al.
2000). It is possible therefore that women in the general population with experiences
ofbreast cancer would show higher levels of cancer specific distress than women
without any experience of breast cancer. The impact of experiences of breast cancer
in family, friends and at work on levels of general and cancer specific distress is
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explored in the general population sample. It was hypothesised (H3) that experiences
ofbreast cancer reported by women in the general population would be associated
with levels of cancer specific distress.
7.2 MEASURES AND SAMPLE
Data for this analysis were derived from the cross-sectional questionnaire study. The
design and procedure were previously described in Chapter 4. The samples reported
in this study included: Increased risk sample (Sample A), general population sample
(Sample B&C) and control sample (Sample C). These samples were described in
Chapter 5.
The measures utilised in this analysis were:
• Background demographics (age, marital status, education and risk perception)
(see Chapter 4. section 4.4.1, page 104)
• Experience questionnaire (increased risk sample only) (see Chapter 6, Part 2,
section 6.3-6.8)
• Experience items for the general population sample (see Chapter 4, section
4.4.2b, page 105)
• General distress (GHQ-30) (see Chapter 4, section 4.4.4a, page 106)
• Cancer specific distress (Cancer worry scale, Impact ofEvent scale) (see
Chapter 4, section 4.4.4b, page 107)
7.3 STATISTICAL METHODS
7.3.1 Univariate analysis
Chi-square test was used to compare samples on nominal data and to examine
associations between categorical measures of distress and experience. T-tests were
used to compare samples on continuous measures and examine associations between
levels of general and cancer specific distress and experience. Pearsons correlations




Multiple regression is a set of techniques that examines the effects of several
independent (predictor) variables on one dependent (outcome) variable. The aim of
multiple regression is to derive a linear equation that relates the dependent variable
with the independent variables. Multiple regression may be used for prediction and is
also used to establish the comparative importance of independent variables in
determining outcome variables. The independent variables are assigned different
weights (regression coefficients) and the aim of analysis is to arrive at a set of
regression coefficients that bring the predicted dependent values from the equation as
close as possible to the observed dependent variable:
Y = A+B,X1+B2X2+ BkXk
Y =predicted value ofthe DV
A= intercept
X= Independent variables (ofwhich there are «).
B= coefficients assigned to each of the independent variables in the equation.
Adequate sample size is an important requirement ofmultiple regression. The sample
size must be sufficient to obtain statistical power for the analysis given the number of
independent variables, expected effect size and alpha level. The ratio of cases to
independent variables should be high. A rule of thumb to determine the minimum
sample size is a ratio of 5 observations for each independent variable, although a
ratio of up to 20 is more desirable (Hair et al. 1995).
Multiple regression also has a number of assumptions. Firstly the dependent variable
must be normally distributed. It is not however assumed that the independent
measures are normally distributed and hence dichotomous variables can be entered as
possible predictors in multiple regression models. Normality of dependent variables
can be assessed by examination of skew and kurtosis values as well the graphical
distribution of variables in box plots and normal probability plots. Residuals
(differences between the obtained and predicted scores) must be normally distributed
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about the predicted scores (normality), have a straight line relationship with
predicted scores (linearity) and show equal variance about the predicted scores
(homoscedasticity). These assumptions are assessed by examining normal probability
plots of residuals, scatterplots of the residuals and predicted dependent variables
scores and details of residual outliers (Tabachnick and Fidell 1996).
Multiple regression is also influenced by associations between independent variables
particularly multicollinearity. Multicollinearity refers to the correlation amongst 3 or
more independent variables. This reduces and confounds the predictive power of the
variables. An initial assessment ofmulticollinearity involves examining the
correlations amongst the independent variables to ensure that no high correlations
exist (r >.9). Another common measure ofmulticollinearity is tolerance. Tolerance
represents the degree to which an independent variable is explained by another
independent variable. A low tolerance value denotes high collinearity. A common cut
off value for tolerance is >0.1 (Hair et al. 1995).
7.3.2b Selecting independent variables in the model
Multiple regression is best conducted when each independent variable is correlated
with the dependent variable but uncorrelated with other independent variables
(Everitt 1996). For each independent variable the regression coefficients represent
the change in dependent variable, associated with a unit change in the independent
variable, conditional on other independent variables in the model remaining
unchanged. It is unlikely that all variables entered into the model will contribute
significantly to prediction of the dependent variable. However, all variables are
conditional on other variables in the model and if one variable is removed then the
regression coefficients of remaining variables will change.
There are a number of techniques available to determine which variables to include
in the model. These differ in the way the variables enter the equation, what happens
to variance shared by variables and how the order in which the variables are entered
into the equation is determined (Tabachnick and Fidell 1996). In standard multiple
regression all independent variables are entered into the regression equation at once
and each assessed as if all other variables have already been entered. Hierarchical
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regression requires that the researcher specify the order in which variables are
entered into the model. Variables are examined in terms ofwhat each adds to the
equation at that point of entry. Decisions about the order of variables should be based
on sound logical or theoretical arguments. Statistical regression is a set ofmethods in
which the variables are entered depending on statistical criteria. There are three
statistical regression methods available: forward regression, backward regression and
stepwise regression. These are outlined as follows.
• Forward selection: Variables are entered one at a time if they significantly
contribute to the equation.
• Backward selection: The equation starts with all variables in and deletes
variables if they do not contribute to the equation.
• Stepwise: The equation starts out empty and variables are entered according
to forward selection. At each stage all variables may also be considered for
removal using backward selection. It is possible that a variable included
earlier in the model may be removed at a later stage if its contribution to the
model is no longer significant following the entry of additional variables.
Of these approaches the Stepwise method has been considered the best approach to
obtaining the optimal prediction solution (Tabachnick and Fidell 1996). When using
multiple regression in order to test causal mechanisms and in search for explanation
the standard multiple regression technique is most appropriate.
7.3.2c Predicting level ofdistress from experience variables
Multiple regression analysis of experience variables was used to determine the best
predictors of psychological well-being in the increased risk sample. The analysis was
conducted in the following steps:
Step 1.
Experience items that were correlated with the dependent variable (p<0.1) were
selected for inclusion in the model. Both continuous and binary variables were
considered for inclusion. A number of variables (e.g. recency ofbereavement of
index relative) were only available for individuals who had particular scores on a
binary variable (eg is the index relative alive or dead). This raised problems of
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entering this variable in the analysis while also maintaining the full sample size. In
these circumstances a missing data dichotomy was used (Cohen and Cohen 1983).
Two variables are entered into the model. One binary variable represents the missing
data dichotomy (scores 1 for missing data (eg index relative is alive) and 0 for
participant with data (eg index relative has died)). The second variable is the
continuous variable (eg recency of bereavement). Individuals without scores on this
variable are provided with an arbitrary constant instead ofmissing values and hence
remain in the analysis. This analysis can be conducted using stepwise regression if
the missing values are replaced with the mean value (Cohen and Cohen 1983). Both
hierarchical analysis and stepwise regression were conducted. The results of these
analyses were comparable and the stepwise regression are reported.
Step 2.
Checks were made to ensure the sample size was sufficient for the analysis. During
study design a sample size of 100 in both the increased risk and control sample was
anticipated in order to obtain sufficient power for multiple regression. A sample size
of 100 allows a low R-squared value (.10) to be deemed as statistically significant
with a power of .80 and the significance value set at 0.05 (Hair et al. 1995). A
sufficient number of cases were available to predict GHQ and cancer worry scores.
However only 61 participants fully completed the Impact ofEvent scale and sample
size was likely to be further reduced by missing data on independent variables.
Step 3.
Normality of dependent variables was investigated by assessing skew and kurtosis.
The GHQ scale was skewed and hence multiple regression was conducted both on
the raw scores and also on a logarithmic transformation of scores. The results of the
analyses were comparable and hence results from the raw score are reported for
simplicity. The cancer worry scale showed sufficient normality for this analysis.
Step 4.
Correlations were examined amongst the independent variables to check for
multicollinearity to ensure that no variables were extremely highly correlated (r >.9).




Stepwise multiple regression analysis was conducted since the main aim of the
analyses was to determine the best predictor(s) of psychological well-being.
Step 6.
Residual scatterplots and normal probability plots were examined for multivariate
normality (Normality, linearity, homoscedasticity and independence of residuals).
Details of residual outliers were also examined. These assumptions were met for the
multiple regression equations predicting GHQ and cancer worry. Multivariate
normality for the Impact ofEvent analyses was problematic. Scatterplots suggested
that the residuals were not normally distributed around the dependent variable in this
model and the normal probability plot of the residuals from the intmsion subscale
suggested that the residuals were not normally distributed. Given these problems and
reduced sample size, it was decided that the Impact ofEvent scale did not meet the
requirements for multiple regression.
Step 7.
The statistics to be reported from this analysis were:
• Significance ofmodel (p<0.05).
• Adjusted R Square (% of variance of the dependent variable accounted for by
the model, adjusted to account for the number of predictor variables in the
model).
• Significance of variables in the model (p<0.05).
• Final equation standardized beta coefficients. (Standardized regression
coefficients representing change in the standardized dependent variable
produced by a change of 1 SD in the independent variable. Allows for direct




Background demographic data for each sample were provided in Chapter 5 (see
section 5.3, page 118). Table 7.1 shows the distribution of scores on distress
measures for each sample.
Table 7.1-Distress scores in the increased risk (A) and general population sample
(B&C).
Measure Descriptive Increased risk General population
statistic sample (A) sample (B&C)
GHQ n 116 253
Mean (sd) 27.0(11.86) 27.9(12.20)
Range 9-70 5-76
Cancer worry n 116 253
Mean (sd) 10.7(2.58) 9.1 (2.27)
Range 6-19 6-18
Impact of Event- n 58 65
Total score Mean (sd) 18.2(12.69) 14.8(15.15)
Range 0-54 0-59
Impact ofEvent- n 60 68
Intrusion subscale Mean (sd) 8.1 (5.94) 5.9 (5.97)
Range 0-25 0-23
Impact of Event- n 58 65
Avoidance Mean (sd) 10.3 (8.47) 8.8 (9.68)
subscale Range 0-34 0-23
7.4.2 Distress and background demographics
7.4.2a Increased risk sample (A)
Age was not significantly correlated with GHQ score or scores on the Impact of
Event scale. There was a trend for age to be negatively correlated with cancer worry
score in this sample (r= -.17, n= 116, p= 0.068). Marital status and education were
not associated with any distress measure. Risk perception as measured on a 5 point
Likert scale (see section 4.4.1, page 105) was significantly correlated with GHQ
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score (r= .18, n= 115, p= 0.049) and cancer worry (r= .43, n= 115, p<0.001).
Participants who reported to have thought about breast cancer in the previous week
reported higher personal perception of risk (mean= 3.1, sd= 0.74, n= 60) than those
who did not (mean= 2.8, sd= 0.69, n= 56). However there were no significant
correlations between scores on the Impact ofEvent subscales and risk perception
(p<0.05).
7.4.2b Generalpopulation sample (B&C)
Age, marital status and education were not associated with any of the distress
measures. Risk perception as measured on a 5 point Likert scale (see section 4.4.1,
page 105) was significantly correlated with cancer worry score (r= .29, n= 249,
p<0.001). Participants who reported to have thought about breast cancer in the
previous week reported higher personal perception of risk (mean= 2.6, sd= 0.74, n=
68) than those who did not (mean= 2.3, sd= 0.59, n= 181). Both the intrusion and
avoidance subscales were positively correlated with risk perception (p<0.01).
7.4.3 Comparing levels of distress in samples with different experiences of
breast cancer.
7.4.3a General distress
A GHQ 'case' is a score >5 on the GHQ-30. Thirty-six (30.8%) ofparticipants at
increased risk of breast cancer (Sample A) and 31 (31%) of the control sample
(Sample C) without any experience of breast cancer scored >5 on the GHQ. There
was no significant difference between the control sample and the increased risk
sample in the proportion of GHQ 'cases' (chi-square = .009, df= 1, p= 0.93).
There was no significant difference in mean GHQ scores between the increased risk
sample (Sample A) (n= 116, mean= 27.0, sd =11.86) and the control sample (Sample
B) (n= 98 , mean= 27.4, sd= 10.72); (t=.24, df= 212, p= 0.81).
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7.4.3b Cancer specific distress
7.4.3b(i) Cancer worry
Women in the increased risk sample scored significantly higher on the cancer worry
scale (n= 116, mean= 10.7, sd= 2.58) than women in the control sample (n= 99,
mean= 8.9, sd= 2.0); (t= 5.56, df= 213, p< 0.001).
7.4.3b(ii) Impact ofEvent scale
More women in the increased risk sample had thought about breast cancer in the past
week (52.1%) than in the control sample (23%) (chi-squared= 18.85, df= 1,
p<0.001).
The mean score for each sample on each of the subscales are provided in Table 7.2.
There was a trend that suggested that women in the increased risk sample (A) had
higher intrusion scores than women in the control sample (C) (t= 1.93, df= 81, p=
0.057). Although the increased risk sample also showed higher total scores and
avoidance scores these differences were not significant (p<0.05).





Total score n 58 21
Mean (sd) 18.2(12.69) 14.1 (12.8)
Intrusion n 60 21
subscale Mean (sd) 8.1 (5.94) 5.4 (4.74)
Avoidance n 58 23
subscale Mean (sd) 10.3 (8.47) 8.3 (8.68)
7.4.4 Experience of breast cancer and levels of distress in the increased risk
sample (A)
7.4.4a General distress
Differences between GHQ 'cases' and 'non-cases' are summarised in Table 7.3.
GHQ 'cases' were likely to have lost their index relative from breast cancer
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significantly more recently than 'non-cases' (p<0.01). They were also more likely to
have suffered bereavement in their family from breast cancer significantly more
recently than 'non-cases' (p<0.05). GHQ 'cases' reported that they personally knew
significantly more relatives who had suffered from breast cancer than non-cases
(p<0.05). There was also a trend to suggest that 'cases' felt their life plans had
changed more because of the risk of cancer in their family compared to 'non-cases'
(p=0.055).
Table 7.3- Differences in experience between GHQ 'cases' and 'non-cases' in the






Recency of bereavement of N 22 48 68 2.86 .006
index relative from breast Mean 124.5 219.02
cancer (if any) (months) SD 107.12 136.88
Number of relatives personally N 36 80 114 2.39 .019
known who had suffered from Mean 2.5 1.9
breast cancer SD 1.34 1.17
Most recent bereavement from N 25 59 83 2.44 .017






'How much do you feel your N 36 78 112 1.94 .055
life plans have changed because Mean 2.1 1.7
of the risk of cancer in your SD 1.18 0.96
family'?
The effect of recency of bereavement on general distress was confirmed in
correlational analysis. GHQ score was significantly negatively correlated with
recency ofbereavement of a relative from breast cancer (n= 85, r=-.31, p= 0.004).
For participants whose index relative had died from breast cancer GHQ score was
correlated with recency ofbereavement of index relative (n= 71, r=-.26, p= 0.032). A
few trends were identified in the data. A negative correlation between GHQ score
and experience item To what extent have your experiences been positiveV (n=l 14,
r=-.18, p= 0.059) was identified. There was also a trend for participants whose index
relative was their mother to score lower on the GHQ (n= 80, mean = 25.8, sd =
210
11.67) than participants whose index relative was not their mother (n= 36, mean=
29.9, sd= 11.96); (t= 1.74, df= 114, p= 0.084).
7.4.4b Cancer specific distress
7.4.4b(i) Cancer worry
Individuals who scored higher on the cancer worry scale were more likely to report
that their relatives illness had been traumatic (n=109, r= .22, p= 0.021) and that their
life plans (n= 114, r= .36, p< .001) and role in the family (n= 114, r= .21, p= 0.027)
had been changed because of the risk of cancer in the family. Participants who
reported higher levels of cancer worry were also likely to have been younger when
their index relative was diagnosed (n= 116, r= -.19, p= 0.044).
7.4.4b(ii) Impact ofEvent scale
Table 7.4 shows differences in experience between participants who did and did not
report to have thought about breast cancer in the previous week. Individuals who
reported to have thought about breast cancer in the previous week and completed the
Impact ofEvent scale reported significantlymore changes in their life plans because
of their experiences (p<0.05). There was also a trend for this group to have been
younger when their relative was diagnosed, to report fewer positive aspects about the
experience and also to report that their role in the family had changed (p<0.1).
211
Table 7.4- Differences in experience between participants in the increased risk
sample who did and did not complete the Impact ofEvent scale.
Experience item Thought about Did not think df t P
breast cancer in about breast
the previous cancer in the
week previous week
'How much do you feel your n 59 56 113 2.005 .047
life plans have changed Mean 2.0 1.6
because of the risk of cancer in sd 1.07 1.02
your family'?
Participants age when index n 61 56 115 1.71 .090
relative was diagnosed Mean 19.9 23.6
sd 10.96 12.35
'To what extent have your n 59 56 113 1.70 .091
experiences been positive'? Mean 2.3 2.6
sd 1.03 1.20
'Do you feel that your role in N 59 56 113 1.667 .098
the family has changed Mean 2.6 2.2
because of your experiences of SD 1.32 1.44
breast cancer'?
Correlational analysis revealed that individuals with higher scores on the Impact of
Event scale were more likely to report that their life plans had changed because of
the risk of cancer in their family (n =114, r= .36, p< 0.001). There was also a trend
for individuals with higher scores to report that they were closer to their index
relative (p<0.1) and that they found the experience more traumatic (p<0.1).
Individuals scoring higher on the intrusion subscale were more likely to report that
their life plans had changed because of the risk of cancer in their family (n= 58, r.=
40, p= 0.002) and that they resembled their index relative (n= 57, r= .26, p= 0.049).
There was also a trend for participants with higher intrusion scores to report that they
were closer to their index relative (p<0.1). There was a trend for individuals with
higher scores on the avoidance subscale to report they found the experience more
traumatic (p<0.1).
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7.4.5 Predicting distress in the increased risk sample (A) from experience
items
7.4.5a Predicting GHQ score from experience items.
A stepwise multiple regression analysis was used to predict GHQ score from the
experience variables that were associated with it (p<0.1). The items that were
considered for entry into the model were:
• Recency of bereavement of a personally known relative from breast cancer
(plus dichotomous variable categorising if participants had or had not
experienced a recent bereavement) (see 7.3.2c, step 1, page 204).
• Recency of index relative bereavement (plus dichotomous variable
categorising if participants had lost their index relative from breast cancer or
not)
• If the index relative was the participant's mother or another relative
(dichotomous variable)
• Subjective experience item 12: To what extent have your experiences been
positive?'
The recency of bereavement variables showed a strong correlation (n= 71, r= .92, p<
0.001), which would lead to problems ofmulticollinearity in a multiple regression
analysis (see 7.3.2a, page 203). It was decided to choose one of these variables for
use in the model. More participants provided data concerning the recency of
bereavement of any relative they personally knew (n=86) than the recency of
bereavement of the index relative (n=78). Models were compared using both
variables and the recency ofbereavement of any relative personally known to the
respondent accounted for more variance in GHQ score suggesting this was the better
variable to use.
The results of the regression model are provided in Table 7.5. The results indicated
that two of the experience variables were significant predictors ofGHQ score:
7 A similar model was obtained using a logarithmic transformation of GHQ score
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Recency of bereavement of a personally known relative from breast cancer and the
extent to which participants reported their experience had been positive (p<0.05).
Both of these items showed negative beta coefficients indicating that having
experienced bereavement more recently and not perceiving the experience to have
been positive predicted higher GHQ scores. Together these variables accounted for
9.9% of the variance in GHQ score (p<0.01).




F P Significant variables Std beta t P








7.4.5b Predicting cancer worry score from experience items
A stepwise multiple regression analysis was used to predict cancer worry score from
the experience variables that were associated with it (p<0.1). The items entered into
the model were:
• Participant's age when their index relative was diagnosed with breast cancer.
• Subjective experience item 10: 'How much do you feel your life plans have
changed because ofthe risk ofcancer in yourfamily?''
• Subjective experience item 9: 'Do you feel that your role in thefamily has
changed because ofyour experiences ofbreast cancer?'
• Subjective experience subscale: Traumatic experience.
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The results of the regression model are provided in Table 7.6. The results indicate
that one experience item was a significant predictor of cancer worry score:
Subjective experience item 10: 'How much do you feelyour life plans have changed
because ofthe risk ofcancer in your family?'' The positive beta coefficient suggested
that higher cancer worry scores were predicted by higher scores on the experience
item. This item accounted from 12.3% of the variance in cancer worry scores.
Table 7.6 Stepwise regression predicting cancer worry score from experience items
in the increased risk sample.
AdjR
square
F P Significant variables Std beta t P
.123 16.10 .000 Item 10: 'How much do you feel
your life plans have changed
because of the risk ofcancer in
yourfamily?''
.36 4.01 <0.001
7.4.6 Experience of breast cancer and levels of distress in the general
population sample (B&C)
7.4.6a Experience ofbreast cancer in the general population sample.
One hundred and fifty-six (60.9%) respondents in the general population sample
reported some experience ofbreast cancer (Sample B). Sixty-four (25%) reported
that a relative had suffered from breast cancer. Fourteen of these participants
reported that a first degree relative had suffered from the disease and 20 reported that
more than one relative had suffered from breast cancer. Fifty-one respondents
(19.9%) reported that a family member or close friend had suffered from breast
cancer recently. Thirty-one participants (12.1%) reported experience of breast cancer
at work and ninety (35.2%) reported 'other' experiences ofbreast cancer.
8
Age was correlated with cancer worry (p<0.1) (see 7.4.2a, page 207). When age was included as a
predictor the model was unchanged.
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7.4.6b General distress
There was no difference in the proportion ofGHQ 'cases' between participants who
reported any breast cancer experience (Sample B) (n= 156, GHQ 'cases' = 34.8%)
and the control sample (Sample C) (n= 100, GHQ 'cases' = 31.6%); (chi-square =
.28, df= 1, p= 0.60). There was no significant difference on GHQ score between
participants who reported any experience ofbreast cancer (Sample B) (n= 155,
mean= 28.3, sd= 13.1) and the control sub-sample who reported no experiences of
breast cancer at all (Sample C) (n= 98, mean= 27.4, sd = 10.7); (t= .57, df= 251, p=
0.572). Specific experiences of breast cancer in this sample were not associated with
general distress (p<0.05).
7.4.6c Cancer specific distress
7.4.6c(i) Cancer worry
There was no difference in cancer worry between participants who reported any
experience ofbreast cancer (Sample B) (n= 159, mean= 9.2, sd= 2.42) and the
control sub-sample (Sample C) (n= 99, mean= 8.9, sd= 2.01); (t= 1.22, df= 251, p=
0.221). However specific types of experience were associated with levels of cancer
worry (see Table 7.6). Participants who reported that a family member or close friend
had suffered from breast cancer recently reported higher levels of cancer worry than
those who did not report a recent experience of breast cancer (p<0.05). Participants
who reported a recent experience of breast cancer also reported higher levels of
cancer worry than the control sample without any experience ofbreast cancer (n= 99,
mean= 8.9, sd = 2.01); (t= 2.11, df= 147, p= 0.017). Participants who reported that a
first degree relative had suffered from breast cancer showed a trend to score higher
on the cancer worry scale (n= 14, mean= 10.2, sd= 2.42) than participants whose
relative who had suffered from breast cancer was not a first degree relative (n= 44,
mean= 8.6, sd= 2.11); (t= 1.94, df= 56, p= 0.057).
7.4.6.c(ii) Impact ofEvent scale
There were no differences in the proportion of individuals who reported to have
thought about breast cancer in the previous week between the sample who reported
any experience of breast cancer (Sample B) (30.5%) and the control sub-sample
(Sample C)(23.2%) (chi-square= 1.60, df= 1, p= 0.21). However, 48% of those who
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reported a family member or close friend had suffered from breast cancer recently
reported to have thought about breast cancer in the previous week, compared to
22.8% of those who reported not to have a family member or close friend who had
suffered from breast cancer recently (chi-square= 12.71, df=l, p< 0.001). Those who
reported a recent experience were also more likely to have completed the Impact of
Event scale compared to those without any experience of breast cancer at all (23%
completed the scale); (chi-square= 9.44, df= 1, p= 0.002). Just under ten percent
(9.7%) of those who reported to have contact with cancer patients at work reported to
have thought about breast cancer in the past week compared to 30.5% of those who
reported no experience of cancer at work (Chi-square= 5.83, df= 1, p= 0.016). Over
half (57.1%) ofparticipants with a first degree relative who had suffered from breast
cancer reported to have thought about breast cancer in the past week compared to
31.8% of participants who had a relative who had suffered from breast cancer who
was not a first degree relative (Chi-square= 2.89, df= 1, p= 0.09).
Participants who reported that a family member or close friend had suffered from
breast cancer recently reported higher levels of intrusive thoughts about breast cancer
(p<0.05) and also showed a trend to report more avoidance of breast cancer (p<0.1)
than the rest of the sample who did not report a recent breast cancer experience (see
Table 7.7). Although participants who reported a recent experience of breast cancer
consistently scored higher on the Impact ofEvent scales than the control sample
without any experience of breast cancer these differences were not statistically
significant (p<0.05). Participants who reported that more than one of their relatives
had suffered from breast cancer showed a trend for higher intrusion scores (n= 9,
mean= 8.8, sd =2.75) than participants who reported that one relative had suffered
from breast cancer (n=10 mean= 3.90, sd= 4.07); (t= 1.82, df= 17, p= 0.09).
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Table 7.7- Differences in psychological well-being in the general population samples
between participants with and without a recent breast cancer experience.
Psychological well- Recent No recent df t P
being measure experience of experience of
breast cancer breast cancer
Cancer worry n 50 202 250 2.45 0.015
Mean 9.8 8.9
sd 2.36 2.19
Impact ofEvent- n 24 44 66 2.19 0.032
Intrusion score Mean 8.0 4.7
sd 7.42 4.73
Impact of Event- n 23 42 63 2.05 0.044
Total score Mean 19.8 12.0
sd 18.66 12.19
Impact of Event- n 23 42 63 1.88 0.064
Avoidance score Mean 11.8 7.1
sd 11.58 8.16
7.5 SUMMARY AND DISCUSSION
The results reported in this Chapter replicated some of the findings reported in the
pilot work reported in Chapter 6 and confirmed a number of hypothesised relations
between experience of breast cancer and levels of general and cancer specific distress
at a number of levels (see section 4.1.3a, H1-H3, page 101). Firstly, the data showed
differences in levels of cancer specific distress between women at increased risk of
breast cancer (Sample A) compared to women in the general population with no
experience of the disease at all (Sample C). Secondly, a number of associations
between aspects of the experience and level of cancer specific of distress were found
in both samples.
7.5.1 Differences in general and cancer specific distress between samples with
different experiences of breast cancer.
The samples showed comparable levels of general distress and no differences were
found in the proportion ofGHQ 'cases' or scores on the GHQ between the increased
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risk (Sample A) and the control sample ofwomen with no experience of breast
cancer (Sample C). As predicted, women in the increased risk sample showed
significantly higher levels of cancer specific distress than the control sample. Women
at increased risk of breast cancer showed higher levels of cancer worry than controls.
Although a proportion ofwomen in the control sample reported they had thought
about breast cancer in the previous week, women at increased risk of the disease
were more likely to have thought about breast cancer and showed higher frequency
of intrusive thoughts about breast cancer as assessed by the Impact ofEvent scale.
This replicates previous research that has identified higher levels of cancer specific
distress in women with a family history of breast cancer (Zakowski et al. 1997,
Lloyd et al. 1996) and confirms the prediction that women with greater experience of
breast cancer are likely to experience higher levels of intrusion about the disease.
The mean cancer worry score in the increased risk sample (10.7, sd= 2.58) was
slightly lower than that reported in the pilot work which assessed women prior to
genetic counselling (mean = 11.2, sd= 2.81) (see Chapter 6, section 6.7.2b, page
139). The cancer worry scores in this study were also lower than those reported in
other studies assessing women with a family history of breast cancer prior to genetic
counselling (Watson et al. 1998, Brain et al. 1999). This may suggest that women
who have received genetic counselling show lower levels of cancer worry than
women who have yet to learn their risk status. This has methodological implications
For example, recruiting participants at cancer clinics may inflate cancer worry scores
due to anxieties about the appointment. No published information from this scale in
the general population is available for comparison to date.
The opt out box in the Impact ofEvent scale allowed respondents to omit completing
the scale if they had not thought about breast cancer in the past week (Lloyd et al.
1996). This proved useful since nearly 50% of the increased risk sample and over
70% of the general population sample reported they had not thought about breast
cancer in the past week. Although this supported suggestions that this strategy should
be utilised (Thewes et al. 2001) omitting data on these participants dramatically
reduced the sample size associated with this scale making further multivariate
analysis problematic. Comparison to published data proves difficult since mean
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scores are inflated when including only those who had thought about breast cancer in
the past week. Other studies that do not include the opt out box allow individuals
who do not report any intrusive thoughts or avoidance ofbreast cancer to score zero
on the weighted scale. Assigning a score of zero for those who reported not to have
thought about breast cancer in the past week allowed comparison with other studies
that have used this measure. These comparisons indicated that levels of intrusive
thoughts and avoidance ofbreast cancer as assessed by the Impact ofEvent scale in
the increased risk sample were comparable to those reported by women in a 3 month
follow up after breast cancer risk counselling (Lerman et al. 1996). Scores were
lower than those reported by women prior to attending for genetic counselling
(Watson et al. 1999) and also by women attending the Western General Hospital one
stop symptomatic breast clinic (Leithead 2000). Scores were higher than those
reported by the general population with no trauma history (Briere and Elliott 1998).
Although these comparative values are logical it was decided not to use data from the
whole sample in future analysis because the scores were extremely positively skewed
towards zero. Future studies using this measure with the opt out box would need to
estimate the proportion of the sample likely to complete the scale and calculate the
sample size required for statistical analysis accordingly.
7.5.2 Experience of breast cancer and levels of general and cancer specific
distress in the increased risk sample.
As expected measures of general and cancer specific distress were associated with
different experiences of breast cancer in the family. Case level distress as assessed by
the GHQ was associated with recency ofbereavement. This replicates the results
from the previous pilot work (Chapter 6, section 6.7.4a, page 139-140) in which
recency ofbereavement rather than occurrence of bereavement was associated with
levels of general distress. However no associations were found between general
distress and the experience of bereavement or diagnosis in the family, maternal
bereavement or multiple bereavement. General distress was associated with recency
of bereavement of both an affected relative and the index relative. High correlations
between these variables however, suggested that many respondents had referred to
the same event. General distress was also associated with the number ofpersonally
known relatives to have suffered from breast cancer an effect that was not identified
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in the pilot study. This may be due to differences in the samples. In this study women
knew more relatives who had suffered from breast cancer and also were aware their
family history was a significant risk factor.
General distress was found to be negatively associated with the extent to which the
participant regarded their experience as having been positive. Research on cancer
patients has shown that those patients who are able to focus on positive aspects of the
experience show reduced emotional distress and this may reflect a coping mechanism
for dealing with threatening events (Dunkelschetter et al. 1992, Taylor and Armor
1996). Women at increased risk of breast cancer who are unable to utilise this coping
mechanism may be more prone to increased levels of general anxiety. In addition
clinical work has shown that negative feelings and dissatisfaction with caregiving
may result in protracted bereavement reactions and heightened distress following
bereavement (Kurtz et al. 1997). It is not possible to determine if this association
reflects negative feelings regarding the experience or the ability to focus on positive
aspects of the experience as a coping mechanism.
The second unexpected association revealed in the analysis was that participants
whose index relative was not their mother showed higher levels of general distress.
This result was surprising since participants who chose their mother as their index
relative reported to be closer to them than did participants who chose another relative
as their index relative (p< 0.001) and is inconsistent with previous research that has
indicated the distressing nature ofmaternal breast cancer (Wellisch et al. 1991, 1992,
1996, Julian-Reynier et al. 1999, Erblich et al. 2000). The finding may have reflected
recency of bereavement of the index relative. In order to complete the questions
individuals are likely to have chosen a recent experience they can remember well.
Those who chose a relative other than their mother were significantly more likely to
have lost this relative more recently (mean months= 85.6) compared to those who
chose their mother (mean months= 220.9); (t= 4.07, df= 76, p< 0.001). Given the
strong effect of recency ofbereavement on levels of general distress it is possible
that the effect of the relation of the index relative is a function of recency of the
experience. It may also be the case that losing a relative from the same generation
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(e.g. sister) may provoke stronger issues about ones own mortality than losing ones
mother.
Multiple regression analysis revealed that general distress was best predicted by
recency ofbereavement and the extent to which the respondent believed the
experience to be positive. Together these variables only accounted for a small portion
of the variance (9.9%). However, given the vast number of factors in other areas of
life that contribute to general distress this effect is notable.
A number of predicted associations were found between cancer specific distress
measures and aspects of experience. As expected cancer worry was found to be
significantly associated with how traumatic the respondent reported their index
relative's experience to have been and the degree to which their life plans and role in
the family had been changed. Women who were younger when their index relative
was diagnosed also showed higher levels of cancer worry. This effect has been
inconsistent in the literature (Wellisch er al 1992, Erblich et al. 2000) and was not
identified in the pilot work (Chapter 6). As in the pilot work (Chapter 6, section
6.7.4b, page 140-141) no association was found between cancer worry and perceived
resemblance with the index relative although women who perceived themselves as
more similar to their index relative, did show more frequent intrusive thoughts about
breast cancer as assessed by the Impact ofEvent scale. Resemblance to relatives may
serve as a reminder ofpersonal risk status and therefore increase accessibility of
thoughts concerning the disease although it was interesting that this did not translate
into cancer worry as predicted. A greater understanding of issues related to perceived
resemblance needs to be examined in more depth in order to understand these
associations. For example a number ofmoderating factors may be critical. The
association between perceived resemblance and distress may be moderated by a
number of factors including beliefs about inheritance and genetics. The predicted
association between cancer worry and positive aspects of the experience was not
identified. Although positive interpretation of the experience may be an effective
coping strategy for reducing distress about a traumatic event it may not reduce
concern about ones own risk.
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Cancer worry was best predicted by the degree to which participants felt their life
plans had changed because of the risk of breast cancer in their family. This accounted
for 12% of the variance in cancer worry score. This item was also associated with
intrusive thoughts about breast cancer as assessed by the Impact ofEvent scale.
Although this item was designed to reflect past changes in life plans because of
breast cancer experiences following work by Wellisch et al. (1991, 1992) it is
possible that this item also captured women's concern about future changes in life
plans. Many women in this study had young families and may be concerned for the
future of their family if they were to develop breast cancer. A qualitative study
addressing how women cope with living breast cancer risk identified high levels of
concern over the future of their family if they were to develop the disease (Appleton
et al. 2000). The fairly high proportion of variance in cancer worry accounted for by
this one item may reflect concern over future life events as well as past breast cancer
related experiences.
Only a few experience items were associated with intrusive thoughts about breast
cancer assessed by the Impact ofEvent scale. This was surprising since experiences
were considered to prompt images of breast cancer and intrusive thoughts about the
disease. No associations were found between intrusive thoughts and experience of
bereavement as has been reported in other studies (Zakowski et al. 1997, Erblich et
al. 2000). The majority of questions in the experience questionnaire were concerning
experiences in the past. Although these experiences were often related to levels of
cancer worry it is possible that more recent or current experiences (e.g. BSE,
attending the clinic) would promote intrusive thoughts. No experience items were
significantly associated with the avoidance subscale of the Impact ofEvent measure.
It is therefore unclear what factors contribute to avoidance in this sample.
7.5.3 Experience of breast cancer and levels of general and cancer specific
distress in the general population sample.
As hypothesised (H3), specific experiences of breast cancer in the general population
sample were also associated with levels of cancer specific distress. A recent
experience ofbreast cancer in family or friends was found to be associated with both
cancer worry and intrusive thoughts about breast cancer. Women who had a recent
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experience in the general population were as likely to have thought about breast
cancer in the previous week as the increased risk sample (57%). This confirms
previous studies that have indicated that external stimuli can act as cues which
trigger intrusive health related thoughts (Freeston et al. 1994). However not all
experience have the same effect. Experience of breast cancer at work in this sample
was associated with reduced cancer specific distress. This may reflect habituation
with exposure to breast cancer. As in the increased risk sample no significant
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EXPERIENCE OF BREAST CANCER AND ILLNESS PERCEPTIONS
8.1 AIMS AND RATIONALE
The previous Chapter reported associations between experience ofbreast cancer in
the family and levels of distress. This provided preliminary evidence for one section
of the mediation model (Figure 4.1, page 100). The results reported in this Chapter
refer to objective 3. and examines the section of the model linking experience of
breast cancer and illness perceptions (see 4.1.2, page 99-100). The SRM proposes
that a healthy individual's perceptions of disease are derived from experience with
the illness within the social environment and that illness perceptions may influence
response to health threats (Leventhal et al. 1980). However, few studies have
investigated the origins and development of illness representations in healthy
individuals.
Leedham and Meyerowitz (1999) provided evidence that experience of cancer in the
family may influence perceptions of the disease. They conducted interviews with 45
women whose parents had suffered from cancer in their childhood. Interviewees
reported that the experience continued to affect them in adult life, particularly their
views about cancer. Nearly halfof the sample reported that they had learnt how
'horrible' cancer was and 40% reported to have gained a better understanding of
cancer. A quarter of respondents also reported that they appreciated the serious
nature of the disease. Although it is likely that women with a family history ofbreast
cancer have developed illness representations based on their experiences no research
to date has examined illness perceptions in this population.
A summary of the aims and hypotheses (H4-H6) for this set of analyses were
outlined in Chapter 4 (4.1.3b, page 101). As in Chapter 7, two levels of enquiry were
adopted. Firstly, differences in illness perceptions between the increased risk
(Sample A) and control sample (Sample C) were assessed. Secondly, detailed
analysis of associations between experiences of breast cancer and illness perceptions
in both the increased risk sample and general population sample (Sample B&C) were
examined.
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8.1.1 Differences in illness perceptions between samples with different
experiences of breast cancer: Predictions.
Comparisons were made between the increased risk sample (Sample A) and the
control sample (Sample C) who had no personal experience of breast cancer in their
social environment. Firstly, differences between the sample in patterns of illness
representations as indicated by the cluster solutions are explored followed by
comparisons of scores on the IPQ-R dimensions and causal items.
Although there has been a lack ofwork addressing illness representations in healthy
individuals it is possible to make predictions concerning associations between
experience ofbreast cancer and illness perceptions based on theory. The SRM
suggests that individuals who perceive themselves as vulnerable to a health threat are
more likely to develop representations of the disease in question. It was therefore
hypothesised (H4) that women at increased risk of breast cancer would hold stronger
and more elaborate beliefs about breast cancer (ie women at increased risk will score
higher on the identity, timeline acute/chronic, consequences and emotional
representations subscales) than women in the control sample due to their risk status
as well as greater experience of the disease. It was also predicted that women in the
increased risk sample would have a better understanding of the disease due to greater
access to information about breast cancer and their experiences (Leedham and
Meyerowitz 1999). This would be reflected by lower scores on the illness coherence
subscale compared to the control sample. Although women at increased risk were
expected to show stronger beliefs about control of breast cancer it was difficult to
determine the direction of this effect (ie would women at increased risk perceive
greater or less control than women without experience of the disease?). This would
most likely be dependant on the nature ofwomen's experience of the disease in their
family.
Previous research has shown that women in the general population perceive breast
cancer as a very serious illness and overestimate the distressing nature of the
condition (Roberts et al. 1984, Payne 1990, Buick 1997). Relative to this, women at
increased risk might show defensive response to their risk. A defensive response to a
health threat is characterised by a lowered perception of the seriousness of the health
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threat by those at risk compared to those not at risk. This effect has been
demonstrated in both hypothetical and real life health screening situations (Jemmott
et al. 1986, Croyle et al. 1997, Rimes et al. 1999). This bias is known as 'threat
minimization' and is found to occur in uncontrollable situations as a means of
reducing emotional distress association with the threat (Croyle et al. 1997). It is
unknown to date if individuals at increased risk of disease due to genetic factors who
have close experience of illness show threat minimization.
Predictions concerning differences between the samples on causal beliefs about
breast cancer were also made. Individuals who have suffered a disease themselves or
are close to patients have been shown to make causal attributions for the illness
(Turnquist et al. 1988, Taylor et al. 1984). It is likely that women in the increased
risk sample would have searched for explanations for the occurrence of breast cancer
in their family. In addition, women in the increased risk sample have attended
genetic counselling and have been provided with information concerning the
potential causes of breast cancer from qualified clinicians. In contrast, women in the
general population have previously been found to hold misconceptions about causes
of breast cancer (Payne 1990). It was predicted therefore that women in the
increased risk sample would believe in a greater number of causal factors and would
be more likely to believe in medically accepted risk factors (eg heredity, age,
hormonal factors) (see 1.1.3, page 24) than women in the control sample.
Difference in beliefs regarding controllable and uncontrollable causes of breast
cancer were also explored. Previous research has warned that genetic testing may
result in fatalism (Senior et al. 1999, 2000). Although the women in the increased
risk sample in this study had not received genetic testing they had received genetic
counselling in which they had been informed of their increased risk of breast cancer
due to a potential genetic predisposition. This may enhance deterministic beliefs
about developing breast cancer. Research has also indicated that patients often make
more attributions to uncontrollable factors than healthy individuals in order to avoid
responsibility and negative self evaluation (French et al. 2001). Turnquist et al.
(1988) found that husbands of patients with breast or cervical cancer often attribute
the disease to aspects of their wives personality (Turnquist et al. 1988). Turnquist et
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al. (1998) interpreted this as a protective bias to reduce responsibility for potential
prevention of the disease. It was possible therefore that women in the increased risk
sample may show less conviction in controllable causes of breast cancer due to
fatalism or as a means to protect self esteem.
8.1.2 Illness perceptions and experience of breast cancer in the increased risk
sample: Predictions.
The second aim of this section of analysis was to investigate associations between
experience ofbreast cancer in the family and illness perceptions in the increased risk
sample. Bishop and Converse (1986) report that healthy individuals are unlikely to
have a consensual prototype for complex illnesses such as cancer. They suggest that
' ...theprototypes are likely to be idiosyncratic capitalizing on chance aspects ofthe
persons experience' (pg 109). Work on breast cancer patients also suggests that
disparate illness perceptions are held depending on experience with the disease
(Leventhal et al. 1986, Buick et al. 1997). Representations of breast cancer held by
women at increased risk of the disease are also likely to vary depending on their
experiences in their family. It was therefore hypothesised that experiences of breast
cancer in the family will be associated with perceptions of the disease in women at
increased risk (H5).
Differences in patterns of illness perceptions (illness representation clusters) are
firstly investigated followed by tests of associations between experience items and
dimensions of illness perceptions as well as causal items. A number ofpredictions
were made concerning association between experiences in the family and illness
perceptions in the increased risk sample. These are outlined as follows.
• Women who reported their experience as more traumatic would perceive
breast cancer as more negative. (Specifically have higher scores on the
identity, consequences and emotional representations subscales).
• Women who had suffered bereavement from breast cancer or reported that
the disease had made greater changes to their life would perceive breast
cancer as more negative. (Specifically have higher scores on the timeline
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acute/chronic, consequences and emotional representations subscales and
lower scores on the personal and treatment control subscales).
• Women who reported that their relative coped well with the disease or
reported more positive aspects of the experience would perceive breast cancer
as more positive. (Specifically have higher scores on the personal control
subscale and lower scores on the consequences subscale).
• Women who had experienced a recent diagnosis ofbreast cancer in their
family were predicted to hold greater emotional representations of the disease
and believe more strongly in causal items.
8.1.3 Illness perceptions and experience of breast cancer in the general
population: Exploratory analysis.
The third aim of this chapter was to explore the impact of experience of breast cancer
on illness perceptions in women in the general population. In line with the mediation
model it was predicted that women in the general population with experience of the
disease in family or friends would hold more negative perceptions of the illness in
terms ofhigher scores on the identity, timeline acute, consequences and emotional
representations subscales (H6).
8.2 MEASURES AND SAMPLES
Data for this analysis was derived from the cross-sectional questionnaire study. The
design and procedure were previously described in Chapter 4. The samples reported
in this study included: Increased risk sample, general population sample and control
sample. These samples were described in Chapter 5.
The measures utilised in this analysis were:
• Experience questionnaire (increased risk sample only) (see Chapter 6, Part 2,
sections 6.3-6.8)
• Experience items for the general population sample (see Chapter 4, section
4.4.2b, page 105)
• IPQ-R adapted to assess healthy women's perceptions of breast cancer (see




Differences between samples on the illness representation clusters are assessed with
chi-square test and differences on the IPQ-R subscales and causal items are tested
with independent t-tests.
8.3.2 Assessing relations between experience and illness perceptions within
each sample.
Chi-square tests are used to assess differences in categorical experience measures
between the clusters and t-tests are used to determine differences in continuous
experience variables between the clusters.
Associations between IPQ-R subscales, causal items and experience measures are
assessed with either t-tests or Pearsons correlations depending on the nature of the
experience variable (categorical or continuous). Where multiple test are conducted to
explore associations with causal items the significance level is adjusted to p<0.01
accordingly.
8.4 RESULTS
8.4.1 Comparing illness perceptions between samples with different
experiences of breast cancer.
8.4.1a Illness representation clusters
A greater proportion ofwomen in the increased risk sample (Sample A) were
classified in the 'negative representation' cluster (n= 51, 52%) than women in the
control sample (Sample C) (n= 25, 30.5%); (chi-square= 8.501, df= 1, p= 0.004).
8.4.1b IPQ-R subscales
The mean scores on the IPQ-R subscales for the increased risk and general
population samples were provided in Chapter 6 (see Tables 6.12 and 6.13, pages
175&176). Table 8.1 reports the differences in illness perceptions between the
increased risk sample (Sample A) and control sample ofwomen in the general
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population without any experience of the disease (Sample C). Women at increased
risk had a more coherent understanding ofbreast cancer than the control sample
(p<0.05). Women at increased risk ofbreast cancer also had stronger emotional
representations of breast cancer and believed the disease to hold greater
consequences than controls (p<0.05).
Table 8.1- Differences in illness perceptions between the increased risk (A) and
control sample (C).
IPQ-R subscale Increased Control df t P
risk sample sample (C)
(A)
Illness coherence n 111 94 203 6.65 <0.001
Mean 2.5 3.1
sd 0.69 0.64
Emotional n 105 91 194 2.16 0.032
representations Mean 3.3 3.1
sd 0.69 0.67




On average women at increased risk of breast cancer agreed with 6.2 (sd= 3.20) of
the causal items (rated agree/strongly agree) compared to 5.5 (sd= 3.41) in the
control sample. This difference was not significant (t= 1.48, df= 215, p= 0.140).
Differences in rating scores for individual causal items are provided in Table 8.2.
Women at increased risk were more likely to agree that heredity, ageing and
hormonal factors were causes ofbreast cancer than controls (p<0.05). They were also
more likely to disagree that a germ or virus or poor medical care in the past were
causes ofbreast cancer than controls (p<0.05).
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Table 8.2- Differences in causal items between the increased risk (A) and control
sample (C).
Causal item Increased Control df t P
risk sample sample (C)
(A)
Heredity- it runs in the n 117 99 214 4.15 <0.001
family Mean 4.6 4.2
sd 0.49 0.64
Poor medical care in n 117 96 211 2.85 0.005
the past Mean 2.3 2.6
sd 0.92 0.84
Ageing n 116 98 212 2.19 0.03
Mean 3.3 3.0
sd 0.92 0.91
Hormonal n 117 98 213 2.19 0.03
Mean 3.7 3.5
sd 0.75 0.81
A germ or virus n 116 96 210 1.99 0.048
Mean 2.1 2.4
sd 0.93 0.83
8.4.2 Experience and illness perceptions in the increased risk sample
8.4.2a Differences in experience between Illness representation clusters
Table 8.3 shows differences in experience items between women in the positive and
negative representation clusters. Participants in the 'negative representation' cluster
were more likely to have had a more recent breast cancer related bereavement of an
index relative or a relative they had known personally than those in the 'postive
representation' cluster (p<0.05). Participants in the negative cluster were more likely
to report that their life plans had changed because of the risk of breast cancer in the
family and were less likely to report that their experiences had been positive
(p<0.05). Women in the 'negative representation' cluster were less likely to report
that they resembled their index relative (p<0.05).
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Table 8.3- Differences in experience between women in the 'positive representation '
and 'negative representation ' clusters.
Experience item Negative Positive df t P
cluster cluster
Recency of bereavement of index n 32 26 56 2.39 0.02
relative from breast cancer (if any) Mean 161.6 245.5
(months) sd 124.61 143.33
Experience item 10. 'How much do n 49 47 94 2.64 0.01
you feel that your life plans have Mean 2.1 1.6
changed because ofthe risk of sd 1.18 0.90
cancer in yourfamily?'
Recency of bereavement of a n 38 34 70 2.21 0.031
personally known relative from Mean 14.1 20.4
breast cancer (if any) (yrs) sd 11.10 12.9
'Resemblance' subscale n 48 47 93 2.14 0.035
Mean 5.2 6.1
sd 1.91 2.17
Experience item 12 'To what extent n 49 47 94 2.11 0.038
have your experiences been Mean 2.2 2.7
positive?' sd 0.97 1.25
'Traumatic experience' subscale n 46 46 90 1.75 0.083
Mean 12.3 11.4
sd 1.84 2.61
Experience item 11 'Do you feel that n 49 47 94 1.73 0.087
your experiences have brought the Mean 2.4 2.8
family closer together?' sd 1.20 1.30
8.4.2b Significant associations between IPQ-R subscales and experience variables
The following sections describe significant associations between each of the
dimensions of illness perceptions assessed by the IPQ-R and experience variables.
Table 8.4 provides a summary of the significant correlations (p<0.05).
Identity
Respondents who associated more symptoms with breast cancer were more likely to
have lost their index relative from breast cancer more recently (r=-.27, p= 0.023, n=
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71) and personally knew more relatives who had suffered from breast cancer (r=.18,
p= 0.05, n= 116). Individuals with a higher identity score were more likely to report
that their experiences brought the family closer together (r= .19, p= 0.041, n= 115).
Timeline acute/chronic
Individuals who perceived breast cancer as more chronic and long-lasting were likely
to have lost more relatives from breast cancer (r= .25, p= 0.009, n= 110). Women
who perceived breast cancer as long in duration were likely to have lost their index
relative from breast cancer more recently (r= -.32, p= 0.009, n= 66) and to have
experienced a breast cancer related bereavement of a personally known relative more
recently (r= -.29, p= 0.01, n= 80). They were also likely to have reported greater
changes in their life plans because of the risk of breast cancer (r= .19, p= 0.045, n=
109).
Consequences
Individuals who perceived breast cancer as holding more serious consequences were
less likely to report their experiences had been positive (r= -.36, p<.001, n= 107) and
more likely to report that their relative's illness was traumatic (r= .28, p= 0.004, n=
102). They were also likely to have lost their index relative from breast cancer more
recently (r= -.26, p= 0.037, n= 66).
Personal control
Individuals who reported less belief in personal control over breast cancer reported
greater changes in life plans because of the risk of cancer in the family (r= -.24, p=
0.014, n= 109) and were more likely to report that the illness had brought the family
closer together (r= .28, p= 0.004, n= 109).
Treatment control
Participants who had lost one or more personally known relative because of breast
cancer reported significantly less belief in treatment control of breast cancer (n= 83,
mean= 3.6, sd = 0.53) than participants who had not lost a relative to breast cancer
(n= 28, mean= 3.8, sd= 0.45); (t= -2.42, df=109, p= 0.017). Individuals who
reported less belief in treatment control of breast cancer were likely to have suffered
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bereavement more recently (r= .29, p= 0.009, n= 81) and to have lost their index
relative more recently (r= .34, p= 0.00, n= 67). Women with less belief in the
treatment control of breast cancer were also less likely to report their experiences had
been positive (r= .30, p= 0.002, n= 110) and more likely to feel that their life plans
had changed because of the risk of cancer in their family (r=-.26, p= 0.007, n= 110).
Illness coherence
Individuals with a coherent understanding of breast cancer were more likely to report
that they resembled their index relative (r= -.22, p= 0.022, n= 108).
Emotional representations
Individuals with stronger emotional representations of breast cancer were more likely
to report that their index relative's illness was traumatic (r= .39, p<.001, n= 98) and
that their role in the family (r= .20, p= 0.04, n= 103) and life plans had changed
because of breast cancer (r= .22, p= 0.027, n= 103).
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Table 8.4 - Summary ofsignificant correlations between IPQ-R subscales and
experience variables in the increased risk sample.




Identity Recency ofbereavement of index relative -.27 71 0.023
Do you feel thatyour experiences have brought the .19 115 0.05
family closer together?
Number of relatives personally known to have .18 116 0.041
suffered from breast cancer
Timeline Recency of bereavement of index relative -.32 66 0.009
acute/ Recency of bereavement of a personally known -.29 80 0.01
Chronic relative from breast cancer
Number ofpersonally known relatives who have .25 110 0.009
died from breast cancer
How much do you feelyour life plans have changed .19 109 0.04
because of the risk ofcancer in yourfamily?
Conseque To what extent have your experiences been positive? -.36 107 0.01
nces Trauma .28 102 0.004
Recency of bereavement of index relative -.26 66 0.037
Personal Do you feel thatyour experiences have brought the .28 109 0.004
control family closer together?
How much do you feel your life plans have changed -.24 109 0.014
because ofthe risk ofcancer in yourfamily?
Treatment Recency of bereavement of index relative .34 67 0.001
control To what extent have your experiences been positive? .30 110 0.002
Recency of bereavement of a personally known .29 81 0.009
relative from breast cancer
How much do you feelyour life plans have changed -.26 110 0.007
because of the risk ofcancer in yourfamily?
Illness Resemblance -.22 108 0.022
coherence
Emotional Trauma .39 98 0.001
representa How much do you feel your life plans have changed .22 103 0.027
tions because ofthe risk ofcancer in yourfamily?
Do you feel that your role in thefamily has changed .20 103 0.04
because ofyour experiences ofbreast cancer?
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8.4.2c Associations between causal beliefs and experience in the increased risk
sample.
8.4.2.c(i) Number ofcausal beliefs and experience
Participants who had a relative they personally knew diagnosed within 5 years
agreed with fewer causal items (n= 38, mean= 5.3, sd= 2.66) than those who had not
had a relative diagnosed within 5 years (n= 74, mean= 6.6, sd= 3.36); (t= 2.06, df=
110, p= 0.042).
The number of items participants agreed were causes of breast cancer was
significantly positively correlated with the following experience items:
• 'Traumatic experience' subscale (r= .25, p= 0.01, n= 110)
• 'Resemblance' subscale (r= .21, p= 0.029, n= 114)
The number of items participants agreed were causes of breast cancer was
significantly negatively correlated with:
• Experience item 12: To what extent have your experience been positive?' (r=
-.28, p= 0.003, n= 115)
• Relatives age at diagnosis (r=-.22, p= 0.017, n= 115)
• Participants age at relatives diagnosis (r= -.22, p= .016, n= 117)
8.4.2.c(ii) Individual causal items and experience variables
A number of differences in causal items were found between categorical experience
variables. Where these differences were significant (p<0.05) mean values for the
causal items are provided in Tables (Table 8.5-8.8).
Women who had lost at least one relative from breast cancer were more likely to
agree that patients mental attitude and emotional state were causes of breast cancer
compared to individuals who had not lost a relative from breast cancer (p<0.05).
These differences are demonstrated in Table 8.5.
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Table 8.5- Breast cancer related bereavement and causal beliefs in the increased risk
sample.
Causal item No relative At least one df t P
died from relative has
breast died from BC
cancer
Patients mental n 28 88 114 2.92 0.004
attitude Mean 2.1 2.7
sd 0.57 0.98
Emotional state n 28 87 113 2.65 0.009
Mean 2.1 2.6
sd 0.65 0.88
Women who reported that a relative they personally knew had been diagnosed with
breast cancer in the past 5 years were less likely to agree with a number of causal
items (Family problems, diet or eating habits, patients mental attitude, overwork,
alcohol and smoking) than women who did not have a relative diagnosed with breast
cancer in the past 5 years (p<0.05) (Please see Table 8.6).
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Table 8.6- Recent diagnosis ofbreast cancer in thefamily and causal beliefs in the
increased risk sample.
Causal item Relative diagnosed No diagnosis Df t P
within 5 yrs within 5 years
Family problems n 38 72 108 2.48 0.015
Mean 2.2 2.7
sd 0.82 0.89
Diet or eating habits n 38 74 110 2.36 0.02
Mean 3.0 3.5
sd 1.12 0.89
Patients mental attitude n 38 74 110 2.24 0.027
Mean 2.2 2.7
sd 0.91 0.93
Overwork n 38 74 110 2.11 0.037
Mean 2.2 2.5
sd 0.75 0.74
Alcohol n 38 73 109 2.06 0.041
Mean 2.4 2.8
sd 0.85 0.88
Smoking n 36 74 108 2.01 0.047
Mean 3.1 3.5
sd 1.17 0.89
Women who chose their mother as their index relative were more likely to agree that
'Alcohol' and 'Smoking' were causes ofbreast cancer (p<0.05) (Please see Table
8.7).
Table 8.7- Relation to the Index relative and causal beliefs in the increased risk
sample.
Cause item Index relative Index relative df t P
was mother was not mother
Alcohol n 80 36 114 2.60 0.01
Mean 2.8 2.4
sd 0.92 0.79




Participants who reported that their index relative had died from breast cancer were
more likely to agree that patient's mental attitude was a cause of breast cancer and
less likely to agree that heredity was a cause of the disease than women whose index
relative was still alive (p<0.05) (See Table 8.8).
Table 8.8- Index relative status and causal beliefs in the increased risk sample.
Cause item Index relative Index df t P
had died from relative is
breast cancer alive
Patients Mental n 71 39 108 2.64 0.01
attitude Mean 2.7 2.2
sd 0.93 0.84
Heredity- it runs n 71 39 108 2.61 0.01
in the family Mean 4.5 4.7
sd 0.50 0.46
There were a number of correlations between experience items and causal beliefs
although the strength of the correlations were not particularly high. Those reaching
significance ofp<0.01 are reported here.
The number of relatives personally known by the participant who had suffered from
breast cancer was positively correlated with belief that'Heredity-it runs in the
family'' is a cause ofbreast cancer (r= .24, p= 0.009, n= 117).
Participants with higher scores on the experience subscale 'Trauma' were more
likely to agree with the causal item 'Hormonal' (r= .27, p= 0.004, n= 110).
Participant with higher scores on experience item 9 'Do you feel that your role in the
family had been changed because ofyour experiences ofbreast cancer?' were more
likely to agree with the causal item 'Diet or eating habits '(r= .27, p= 0.004, n= 115).
Participant who score higher on subjective experience item 12 'To what extent have
your experiences been positive' were less likely to agree with the causal 'Altered
immunity' (r= -.30, p= 0.001, n= 115).
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8.4.3 Experience and illness perceptions in the general population sample
(Sample B&C)
8.4.3a Differences in experience between Illness representation clusters
There were no significant differences between the illness representation clusters and
experiences ofbreast cancer in the general population sample. There was a trend for
women in the 'negative representation' cluster to be more likely to have had a recent
experience of breast cancer in family or friends (26.9%) compared to participants in
the 'positive representation' cluster (16.7%); (chi square= 3.23, df= 1, p= 0.072).
8 4.3b Differences in IPQ-R subscales between women with different experiences of
breast cancer in the generalpopulation.
Women who reported different experiences of breast cancer in the general population
sample showed differences on illness perceptions as assessed by the EPQ-R. These
differences are described for each dimension as follows.
Consequences
Women with any experience of breast cancer, a recent experience of breast cancer or
'other' experiences ofbreast cancer believed the disease to hold more consequences
than the control sample ofwomen with no experience of the disease at all (Sample C)
(p<0.05) (See Table 8.9). Women with a recent experience of breast cancer in friends
of family believed the disease to hold more consequences (n= 49, mean= 4.1, sd=
0.40) than women with no recent experience (n= 190, mean= 3.9, sd= 0.43 ); (t=3.36,
df= 237, p= 0.001).
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Table 8.9- Differences in perceptions of the consequences ofbreast cancerfor
women in the generalpopulation with different experience ofthe disease.
Experience of breast cancer Experience Control df t P
of breast sample (C)
cancer
A member of the family or n 49 94 141 3.49 0.001
close friend has suffered from Mean 4.1 3.8
breast cancer recently sd 0.40 0.41
'Other' experiences of breast n 85 94 177 2.34 0.021
cancer. Mean 4.0 3.8
sd 0.46 0.41
Any experience of breast n 146 94 238 2.01 0.045
cancer Mean 3.9 3.8
sd 0.45 0.41
Timeline acute/chronic
Women who had had a recent experience of breast cancer believed the disease to be
more chronic and long-lasting (n= 50, mean= 3.4, sd= 0.59) than women without a
recent experience (n= 192, mean= 3.2, sd= 0.50); (t= 2.04, df= 240, p= 0.042).
Illness coherence
Participants who reported any experience of breast cancer (including that a relative
that had suffered from breast cancer, a recent experience of breast cancer, experience
of breast cancer at work or 'other' experiences of breast cancer) had a more coherent
understanding of breast cancer than controls (p<0.05) (See Table 8.10). In addition,
women who had experience of breast cancer at work had a more coherent
understanding ofbreast cancer than women who did not have experience of breast
cancer at work (n= 214, mean= 3.0 sd= 0.69); (t= 2.61, df= 241, p= 0.01).
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Table 8.10- Differences in illness coherencefor women in the generalpopulation
with different experience ofbreast cancer.
Experience of breast cancer Experience Control df t P
of breast sample (C)
cancer
Experience ofbreast cancer at n 29 94 121 3.36 0.001
work Mean 2.6 3.1
sd 0.75 0.64
Any experience of breast n 151 94 243 2.75 0.006
cancer Mean 2.8 3.1
sd 0.73 0.64
'Other' experiences of breast n 88 94 180 2.47 0.014
cancer Mean 2.8 3.1
sd 0.72 0.64
A relative had suffered from n 60 94 152 2.25 0.026
breast cancer Mean 2.82 3.1
sd .73 0.64
A member of the family or n 50 94 142 2.13 0.035
close friend has suffered from Mean 2.8 3.1
breast cancer recently sd 0.81 0.64
Emotional representations
Women with experience of breast cancer at work reported significantly lower
emotional representations of breast cancer than women with no experience of breast
cancer at work (n= 209 mean= 3.2, sd= 0.66); ( t= 3.84, df= 236, p<.001) and women
with no experience of the disease (p<0.05) (See Table 8.11). Women with a recent
experience ofbreast cancer had stronger emotional representations of the disease (n=
50, mean = 3.3, sd= 0.72) than women without a recent experience of breast cancer
(n= 189, mean = 3.1 sd= 0.66); (t= 2.56, df= 237, p= 0.011).
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Table 8.11- Differences in emotional representations for women in the general









Experience of breast n 29 91 118 3.17 0.002
cancer at work Mean 2.67 3.12
sd .65 .67
8.4.3c Associations between causal beliefs and experience in the general
population sample
8.4.3c(i) Any experience ofbreast cancer
Individuals with any experience ofbreast cancer were significantly more likely to
agree that heredity, chance, ageing and hormonal factors were causes of breast cancer
than the control sample (C) with no experience of breast cancer (p<0.05) (See Table
8.12).
Tabic 8.12 Experience ofbreast cancer in the general population sample and causal
beliefs.
Cause item Any Control sample df t P
experience of (C)
breast cancer
Hormonal n 154 98 250 3.04 0.003
Mean 3.8 3.5
sd 0.73 0.81
Heredity-it runs in n 156 99 253 2.62 0.009
the family Mean 4.5 4.2
sd 0.62 0.64
Chance or bad n 152 97 247 2.18 0.03
luck Mean 3.3 3.0
sd 1.13 1.04




8.4.3.c(ii) Experience ofbreast cancer in thefamily
Participants who reported that a relative had suffered from breast cancer were
significantly more likely to agree that hormonal factors were a cause of breast cancer
than controls with no experience of the disease at all (p<0.05) (See Table 8.13).
Table 8.13- Recent experience ofbreast cancer in the general population sample and
causal beliefs.






Hormonal n 64 98 160 2.25 0.026
Mean 3.7 3.5
sd 0.67 0.81
8.4.3c(iii) Recent experience ofbreast cancer in friends orfamily
Participants who reported a recent experience of breast cancer agreed with more
causes (mean= 7.4, sd= 3.3, n= 51) than those without recent experience (mean= 5.7,
sd= 3.37, n= 204); (t= 3.31, df= 253, p= 0.001) and those with no experience
(Sample C)(t= 3.20, df= 149, p= 0.002).
Participants who had had a recent experience of breast cancer in friends or family
were significantly more likely to agree that heredity, hormonal factors, patients
emotional state, ageing, family problems, patients mental attitude and stress were
causes of breast cancer than women without any experience of the disease (Sample
C) (p<0.05) (See Table 8.14).
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Table 8.14- Recent experience ofbreast cancer in the general population sample and
causal beliefs.
Cause item A family member Control df t P




Heredity - it runs n 51 99 148 3.97 0.000
in the family Mean 4.7 4.24
sd 0.48 0.64
Hormonal n 50 98 146 2.97 0.004
Mean 3.9 3.6
sd 0.70 0.81
Emotional state eg n 49 97 144 2.92 0.004
feeling down, Mean 2.9 2.5
lonely, anxious, sd 0.85 0.84
empty
Ageing n 50 98 146 2.58 0.011
Mean 3.4 3.0
sd 0.86 0.91
Family problems n 49 97 144 2.57 0.011
Mean 2.9 2.54
sd 0.89 .83
Patients mental n 49 96 143 2.45 0.016
attitude eg thinking Mean 2.9 2.5
about life sd 0.89 0.83
negatively
Stress or worry n 50 97 145 2.27 0.025
Mean 3.5 3.2
sd 0.79 0.91
8.4.3c(iv) Experience ofbreast cancer at work
Those with experience of breast cancer at work were more likely to rate ageing,
patients personality and hormonal factors as causes of breast cancer than women
with no experience of breast cancer at all (p<0.05) (See Table 8.15).
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Table 8.15- Experience ofbreast cancer at work and causal beliefs in the general
population sample.
Cause item Experience of Control df t P
breast cancer sample (C)
at work
Ageing n 30 98 126 2.59 0.011
Mean 3.5 3.0
sd 0.97 0.91
Patient's n 28 97 123 2.54 0.012
personality Mean 2.6 2.2
sd 0.99 0.66
Hormonal n 30 98 126 2.55 0.012
Mean 3.9 3.5
sd 0.57 0.81
8.4.3c(v) 'Other' experiences ofbreast cancer
Those who reported 'other' experiences of breast cancer were significantly more
likely to agree that heredity and hormonal factors were causes ofbreast cancer and
less likely to agree that pollution was a cause ofbreast cancer compared to those with
no experience at all (p<0.05) (See Table 8.16).
Table 8.16 'Other' experiences ofbreast cancer and causal beliefs in the general
population.
Cause item 'Other' Control df t P
experience of sample (C)
breast cancer
Heredity- it runs in n 90 99 187 2.59 0.01
the family Mean 4.5 4.2
sd 0.60 0.64
Pollution in the n 89 97 184 2.25 0.026
environment Mean 2.8 3.1
sd 0.89 0.83




8.5 SUMMARY AND DISCUSSION
Overall the results reported in this chapter have met a number of theoretically driven
predictions. Women at increased risk of breast cancer hold different perceptions of
the disease than women without experience of breast cancer in their social
environment. Women at increased risk have stronger emotional representations of
breast cancer and also hold different cognitive representations of the disease than
women with no experience of the disease. Perceptions ofbreast cancer in the
increased risk sample are associated with specific aspects of experiences of breast
cancer in the family. In addition, women in the general population with different
experiences of breast cancer hold different representations of the disease.
8.5.1 Differences in illness perceptions between samples with different
experiences of breast cancer.
As predicted, women in the increased risk sample were more likely to hold an overall
negative pattern of illness representations than women without experience of the
disease. Women at increased risk of breast cancer perceived breast cancer as holding
greater consequences and held stronger emotional representations of the disease than
controls. Women in the increased risk sample also reported that they had a more
coherent understanding of the disease than women without any experience of breast
cancer.
These results suggest that women at increased risk were not minimizing their threat
as shown in other screening situations (Jemmott et al. 1986, Croyle et al. 1997,
Rimes et al. 1999). Threat minimization has been proposed as most likely when the
risk is uncertain and there are limited options for control over risk (Ditto et al. 1988).
A genetic predisposition to breast cancer would therefore appear to be a likely
clinical situation for threat minimization to occur. The lack of this effect raises the
possibility that genetic based information impedes these defensive processes or that
individuals with experience of the disease in question are less likely or unable to
engage in threat minimisation. However, this study was not designed to directly
assess threat minimization process and further tests of this mechanism are required.
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The differences between the samples were not to the extent that was predicted. No
difference in perception of the duration ofbreast cancer (timeline acute/chronic
subscale) was found between the samples. This may be due to variable duration of
illness that women at increased risk of breast cancer were exposed to. It may also be
due to poor psychometric properties of this subscale demonstrated by lower
reliability (see section 6.19.1, pages 171-174). It was surprising that the samples did
also not show any differences in perceptions of control of breast cancer. It was also
surprising that women at increased risk of breast cancer believed in a similar number
of causal factors as did controls. This may be due to the large number of factors
potentially implicated in breast cancer risk and widespread information about risk
factors available to women in the general population (see Chapter 1). However
women in the increased risk sample did believe more strongly in a number of
medically correct causes as predicted (eg heredity, ageing, hormonal factors)
compared to the control sample.
There was concern that women at increased risk of breast cancer may be fatalistic
about the disease (French et al. 2001, Turnquist et al. 1988). However, women in the
increased risk sample showed stronger beliefs in some controllable items (eg diet)
and were less likely to believe in uncontrollable items (eg poor medical care in the
past) than controls. This suggests that those women facing an increased risk of breast
cancer because of their family history of the disease were still able to believe in
controllable causes and were not deterministic about their risk.
8.5.2 Illness perceptions and experience of breast cancer in the increased risk
sample.
In the increased risk sample experiences of breast cancer in the family were
associated with the overall pattern ofbeliefs represented by the clusters. As predicted
participants in the 'negative representation' cluster were more likely to report
negative experiences of breast cancer (ie a more recent bereavement of a relative
from breast cancer, greater changes in life plans because of the risk ofbreast cancer
in the family and less positive aspects of the experience). It was unexpected that
women in the 'negative representation' cluster were less likely to report that they
resembled their index relative. This may possibly reflect attempts at threat
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minimization within this sample. Women who feel they resemble their index relative
judge the risk as less threatening than women who do not feel they resemble their
index relative. Further work would be required to explore this issue in regards to
beliefs about inheritance and genetics.
All dimensions of illness perceptions were associated with aspects of experience and
the vast majority of associations were in the expected direction (see section 8.1.2,
pages 230-231). This suggests that living with a family history of breast cancer has a
wide impact on representations of the disease. As predicted women who reported
their experiences as more traumatic believed breast cancer to hold more
consequences and held stronger emotional representations of the disease. Women
who had lost their index relative more recently associated more symptoms with
breast cancer, believed the disease to be long lasting with severe consequences and
were less likely to believe in the treatment control of breast cancer. Recent or
traumatic experiences are likely to create accessible images of breast cancer in mind
(see 3.2, page 73) and therefore have a strong impact on the development of
representations of the disease.
Women who reported that breast cancer had changed their life plans believed the
illness to be long-lasting, held strong emotional representations of the disease and
were less likely to believe in the personal or treatment control of breast cancer. This
may indicate that women who have felt the consequences ofbreast cancer on their
own lives develop stronger representations of the disease. Positive experiences were
shown to have a beneficial effect on illness representations. Women who reported
that their experiences had been more positive were more likely to believe in the
treatment control of breast cancer and perceived the disease as holding less
consequences and women who reported that the experience had brought the family
closer together were more likely to believe in personal control of the disease.
A few associations occurred that had not been predicted. Women who reported that
their experiences had brought the family closer together associated more symptoms
with breast cancer. It is possible that this may reflect greater contact with the index
relative or increased awareness and discussion about symptoms of the disease.
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Women who reported that they resembled their index relative had a more coherent
understanding of breast cancer. Although the majority of predicted associations
between experiences ofbreast cancer in the family and illness perceptions were met
no associations were found between how well the participant perceived their relative
to cope with breast cancer and illness perceptions. This may suggest that a relative's
personal response and ability to cope with breast cancer may not influence a healthy
relatives perception of the disease or that a single item is inadequate to grasp this
construct.
Experience of breast cancer in the family was widely associated with causal beliefs
about the disease. In contrast to predictions women who had had a diagnosis in their
family within 5 years believed in fewer of the causal items provided on the causal
checklist of the IPQ-R and were less likely to agree with a number of the individual
causal items. However, individuals who had lost a relative from breast cancer were
more likely to agree with a number of causal items. This may reflect women
searching for causal explanations for the disease following bereavement rather than
diagnosis. Respondents in the increased risk sample who had lost a relative to breast
cancer were more likely to agree with causal factors implying patient characteristics
were important causes ofbreast cancer (e.g. patients mental attitude). In addition
women who had lost their index relative to breast cancer were less likely to believe
that heredity was a cause of breast cancer. Turnquist et al. (1988) suggested that
healthy relatives of patients often attribute the illness to the patient's personal
characteristics as a means to reduce responsibility for having caused or concerns
about possible prevention of the disease. In this sample ofwomen at increased risk of
breast cancer, attributing a relatives illness to personal characteristics rather than
hereditymay also reflect a defensive strategy to reduce feelings of vulnerability to
the disease.
8.5.3 Illness perceptions and experience of breast cancer in the general
population sample.
Exploratory analysis revealed that there was no significant difference in the overall
pattern of beliefs held by women with different experiences of breast cancer in this
sample. However a number of individual subscales and causal items were associated
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with experience in this sample. Consistent with predictions and the results from the
increased risk sample, women in the general population with more experience of
breast cancer believed the disease to hold stronger consequences. This effect was
particularly strong for women with a recent experience of breast cancer in friends or
family. Recent experience of breast cancer was also associated with the belief that
breast cancer was a long-lasting illness and stronger emotional representations of
breast cancer. The illness coherence subscale was also associated with experience of
breast cancer in the general population sample. Women who reported any experience
ofbreast cancer showed a more coherent understanding of the disease than women
without any experience ofbreast cancer. This suggests that experiences of breast
cancer in women in the general population may have beneficial as well as negative
effect on representations of the disease.
Experience of breast cancer at work appeared to have a buffering effect and was
associated with a lower emotional representation ofbreast cancer and a more
coherent understanding of the disease. This indicates that exposure to breast cancer
per se does not have uniform effects on illness perceptions but that the qualitative
nature of the exposure determines its impact on perceptions of and emotional
response to the disease in individuals not at risk.
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ILLNESS PERCEPTIONS AND DISTRESS
9.1 AIMS AND RATIONALE
Analysis reported in Chapter 7 and 8 examined two elements of the mediation model
(Figure 4.1, page 100) - associations between experience of breast cancer with levels
of distress and illness perceptions. A number of associations were identified in both
sets of analyses. The main aim of the following analysis was to address the final
section of the mediation model (Figure 4.1, objective 4) and assess the contribution
of illness perceptions to levels of general and cancer specific distress in women at
increased risk of breast cancer.
Large variations in levels of distress across individuals have been reported in women
at increased risk of breast cancer (Kash et al. 1992, Gagnon et al. 1996, Hopwood et
al. 1998, Cull et al. 1999, Watson et al. 1999) (see Chapter 1, section 1.4, page 48).
However, theoretically driven research aimed at understanding factors accounting for
variability in distress has been limited. Research based on the SRM has indicated that
illness perceptions are associated with patient's emotional response to a range of
chronic illnesses including CFS, rheumatoid arthritis, osteoarthritis, multiple
sclerosis, psoriasis and breast cancer (Heijmans 1988, Murphy et al. 1999, Orbell et
al. 1998, Schiaffino et al. 1998, Fortune et al. 2000, Buick 1997) (See Chapter 4,
section 3.4.5c, page 88). Women's emotional response to breast cancer risk may also
be associated with representations of the disease.
9.1.1 Associations between illness perceptions and levels of general and cancer
specific distress in each sample: Predictions.
It was hypothesised that perceptions of breast cancer would be significantly
associated with levels of general and cancer specific distress in women with a
significant family history of breast cancer (H7). The first aim of this analysis was to
examine associations between a) patterns ofbeliefs as represented by the illness
representation clusters; b) dimensions of perceptions as assessed by the IPQ-R
subscales and c) causal items, with levels of general and cancer specific distress. It
was predicted that women in the increased risk sample with more negative
representations of breast cancer would show higher levels of distress than women
with more positive perceptions of the disease. Higher levels of distress were expected
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in women in the 'negative representation' cluster compared to the 'positive
representation' cluster. Scores on the IPQ-R subscales (in parentheses) were
expected to be correlated with levels of distress. Specifically higher levels of distress
were predicted for women who:
• Associated more symptoms with breast cancer (Identity)
• Perceived the disease as long lasting (Timeline acute/chronic)
• Perceived the disease as holding greater consequences (Consequences)
• Did not believe in the personal or treatment control of breast cancer (Personal
control, Treatment control)
• Did not have a coherent understanding of the disease (Illness coherence)
• Had strong emotional representations ofbreast cancer (Emotional
representations)
Stronger associations were expected between illness representations and cancer
specific distress compared with measures of general distress. Exploratory analysis
was also conducted to examine associations between causal items and distress in
these samples.
The associations between illness perceptions and levels of distress in the control
sample was examined for comparison. It was predicted that fewer associations
between illness representations and distress measures would be found in this sample
and the associations would be weaker than those in the increased risk sample.
9.1.2 Predicting levels of general and cancer specific distress in the increased
risk sample: Exploratory analysis
The second aim of the analysis reported in this Chapter was to examine the
predictive value of illness perceptions in understanding variations in levels of distress
across individuals. Initially multiple regression analysis was conducted to determine
how much variability in distress was explained by illness representations alone. It
was predicted that emotional representations would account for a large proportion of
variance in cancer specific worry due to conceptual overlap between these scales.
Analysis was therefore conducted twice, once with emotional representations
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included in the model, and again with emotional representations omitted from the
model in order to derive a clinically useful result.
The results reported in Chapter 8 indicated that the experience items accounted for a
small proportion of the variance in levels of distress. Analysis was therefore
conducted including both experiences items and illness perception dimensions in the
multiple regression models in order to identify the best predictors of distress in
women at increased risk of breast cancer.
9.2 MEASURES AND SAMPLES
Data for this analysis were derived from the cross-sectional questionnaire study. The
design and procedure were previously provided in Chapter 4. The samples reported
in this study included: Increased risk sample (Sample A) and control sample (Sample
C). These samples were described in Chapter 5.
The measures utilised in this analysis were:
• General distress (GHQ-30) (see Chapter 4, section 4.4.4a, page 106)
• Cancer specific distress (Cancer worry scale, Impact ofEvent scale) (see
Chapter 4, section 4.4.4b, page 107)
• IPQ-R adapted to assess healthy women's perceptions of breast cancer (see
Chapter 6, Part 3, section 6.9-6.15)
9.3 STATISTICAL METHODS
9.3.1 Associations between illness perceptions and distress within each sample
Chi square and T-tests were used to determine any differences in levels of distress
between participants in each illness representation cluster. T-tests are also used to
determine any differences in illness perceptions and causal items between GHQ
'cases' and 'non cases' and participants who did and who did not complete the
Impact ofEvent Scale in each sample. Correlational analysis was conducted using
Pearson Correlation Coefficient to determine associations between illness
perceptions, causal items and levels of distress. Given the number of causal items
examined the p value for this analysis was adjusted to p<0.01.
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9.3.2 Predicting levels of distress in the increased risk sample
Multiple regression was used to determine best predictors of general and cancer
specific distress in the increased risk sample (Sample A). The background multiple
regression and stages of analysis were outlined in Chapter 7 (see section 73.2, page
202Due to conceptual overlap and high associations between the emotional
representations subscale of the EPQ-R and cancer specific distress measures,
regression models predicting cancer worry were conducted with and without this
subscale.
9.4 RESULTS
9.4.1 Associations between illness perceptions and distress in the increased
risk sample
9.4.1a General distress
There was a higher proportion ofGHQ 'cases' in the 'negative representation'
cluster (n=19, 38%) compared with the 'positive representation' cluster (n= 11,
23.4%) but this association was not statistically significant (chi-square= 2.42, df= 1,
p= 0.12). Individuals in the two clusters did not differ on GHQ score (t=l .31, df= 95,
p= 0.19) ('Negative representation' cluster, n= 50, mean= 28.5, sd= 12.77);
('Positive representation' cluster, n= 47, mean= 25.3, sd= 11.20).
Illness representations were associated with GHQ 'caseness'. GHQ 'cases' scored
significantly higher on the identity (p<0.01), timeline acute/chronic and emotional
representation subscales of the IPQ-R (p<0.05) (see Table 9.1). There was also a
trend for GHQ 'cases' to score higher on the consequences subscale (p<0.1) (see
Table 9.1). There were no significant differences between GHQ 'cases' and 'non
cases' on the causal items.
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Table 9.1- Differences in illness perceptions between GHQ 'cases' and 'non cases'
in the increased risk sample.
IPQ-R subscale GHQ 'case' 'Non case' df t P
Identity n 36 80 114 3.25 0.002
Mean 5.4 4.0
sd 2.41 2.1
Timeline acute/ chronic n 36 74 108 2.54 0.012
Mean 3.5 3.2
sd 0.59 0.47
Emotional n 31 73 102 2.13 0.035
representations Mean 3.6 3.2
sd 0.64 0.70
Consequences n 34 74 106 1.71 0.089
Mean 4.0 3.9
sd 0.37 0.38
The correlation matrix (Table 9.3) indicated that a number of dimensions of illness
representations were significantly correlated with GHQ score9. These were: identity
(p<0.01); emotional representations (p<0.01); timeline acute/chronic and
consequences (p<0.05). Women with higher levels of distress associated more
symptoms with breast cancer, held stronger emotional representations of the disease,
believed the disease was longer lasting with greater consequences.
No causal items were significantly correlated with GHQ score (p<0.01)
9.4.1b Cancer specific distress
9.4.1b(i) Cancer worry
Participants in the 'negative representation' cluster reported significantly higher
levels of cancer worry (mean= 11.5, sd= 2.64) than participants in the 'positive
representation' cluster (mean= 9.6, sd= 1.81, n= 47); (t= 4.15, df= 96, p<0.001).
The correlation matrix (Table 9.3) indicates that cancer worry score was strongly
correlated emotional representations (p<0.001), timeline acute/chronic (p<0.001) and
9 Similar correlation coefficients were found using the Logarithmic transformation of GHQ score
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was also significantly correlated with consequences (p<0.01) and identity (p<0.05).
Women with higher levels of cancer worry had stronger emotional representations of
the disease, perceived breast cancer to be of longer duration with severe
consequences and believed more symptoms to be associated with the disease. There
were no significant correlations between the causal items and cancer worry score
(p<0.01).
9.4.1b(ii) Impact ofEvent scale
Significantlymore women in the 'negative representation' cluster reported they had
thought about breast cancer in the previous week and completed the Impact ofEvent
scale (n= 35, 67%) than women in the 'positive representation' cluster (n= 17, 33%)
(Chi-square= 10.35, df= 1, p= 0.001). Women in the 'negative representation' cluster
scored significantly higher on the intrusion subscale of the measure (n= 34, mean =
8.7, sd= 5.76) than women in the 'positive representation' cluster (n= 17, mean = 4.9,
sd= 3.77); (t= 2.42, df= 49, p= 0.019).
Table 9.2 shows differences in illness representations between women who did and
did not report to have thought about breast cancer in the previous week. Women who
had thought about breast cancer in the previous week and completed the Impact of
Event scale showed stronger emotional representations of breast cancer and believed
more symptoms to be associated with breast cancer (higher identity score) than
women who did not complete the scale (p<0.05). There was also a trend for
individuals who had completed the scale to have a less coherent understanding of
breast cancer and to believe the disease was longer lasting than individuals who did
not complete the scale (p<0.1). There were no differences on any of the causal items
between participants who did and did not complete the Impact ofEvent scale.
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Table 9.2- Differences in illness perceptions between participants in the increased
risk sample who had and had not thought about breast cancer in the previous week.
IPQ-R subscale Had thought about Had not thought df t P
breast cancer in the about breast cancer
previous week in the previous week
Emotional n 57 48 103 2.56 0.012
representations Mean 3.5 3.2
sd 0.63 0.73
Identity n 61 56 115 2.12 0.036
Mean 4.9 4.0
sd 2.32 2.10
Illness coherence n 59 52 109 1.91 0.058
Mean 2.6 2.3
sd 0.64 0.72
Timeline n 60 51 109 1.83 0.071
acute/chronic Mean 3.4 3.2
sd 0.56 0.48
The correlation matrix (Table 9.3) shows correlations between illness representations
with total score; intrusion subscale and avoidance subscale of the Impact of Event
scale. The total score and intrusion subscale were strongly correlated with emotional
representations (p<0.001). The avoidance subscale was also significantly correlated
with emotional representations (p<0.05) although the relationship was not as strong.
The total score and intrusion subscale were significantly negatively correlated with
treatment control (p<0.05). Intrusion score was also correlated with the timeline
acute/chronic subscale (p=0.05) Women who reported greater intrusive thoughts
about breast cancer had stronger emotional representations of breast cancer, were
less likely to believe in the efficacy of treatment to control the disease and perceived
the disease as longer in duration.
The intrusion subscale was not significantly correlated any causal item (p<0.01)
The avoidance subscale was significantly correlated with the causal items:
• 'Altered immunity' (r= .37, p= 0.004, n= 58)
• A germ or virus' (r= .35, p= 0.007, n= 58)
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r= .30 p=0.001 n=116
r= .21 p=0.028 n=110
r= .20 p=0.035 n=108
r= .27 p=0.009 n=104
CancerWor y
r= .19 p=0.045 n=116
r= .25 p=0.008 n=110
r= .20 p=0.037 n=109
r= .66 p<0.001 n=104
ImpactofEvent: Totalscore
r=-.28 p=0.035 n=58
r= .48 p<0.001 n=55
ImpactofEvent: Avoidancescor
r= .29 p=0.032 n=55
ImpactofEvent: Intrusionscore
r= .26 p=0.05 n=59
r= .24 p= .066 n=59
r=-.33 p=0.007 n=60
r= .60 p<0.001 n=56
9.4.2 Associations between Illness perceptions and distress in the control
sample (Sample C)
9.4.2a General distress
There was no difference in the proportion ofGHQ 'cases' between women classified
in the 'negative representation' or 'positive representation' clusters (chi-square=
1.55, df= 1, p= 0.21). There was also no difference in GHQ score between the two
clusters (t- 1.67, df= 80, p= 0.098). Table 9.4 shows the differences in the illness
perception dimensions between GHQ 'cases' and 'non cases'. GHQ 'cases' had
significantly stronger emotional representations of breast cancer than 'non cases'
(p<0.05) and showed a trend to perceive breast cancer as holding more severe
consequences (p<0.1). GHQ 'cases' were likely to agree with more of the causal
items (n= 31, mean = 6.7, sd = 3.13) than 'noncases' (n= 67, mean = 5.0, sd= 3.46);
(t= 2.28, df= 96, p= 0.023) and were more likely to agree that 'smoking' and
'patients behaviour' were causes of breast cancer (p<0.05).
Table 9.4- Differences in illness perceptions between GHQ 'cases' and 'non cases'
in the control sample
IPQ-R subscale GHQ 'case' Non 'case' df t P
Emotional n 29 60 87 2.11 0.038
Representations Mean 3.3 3.01
sd 0.55 0.71




Smoking n 30 65 93 3.62 <0.001
Mean 3.9 3.3
sd 0.58 0.91
Patients own n 31 65 94 3.00 0.003
behaviour Mean 3.0 2.4
sd 0.91 0.81
The correlation matrix (Table 9.6) indicates that GHQ score was only significantly
correlated with emotional representations (p<0.01). Women in this sub-sample with
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higher levels of general anxiety were likely to have stronger emotional
representations of breast cancer.
9.4.2b Cancer specific distress
9.4.2b(i) Cancer worry
There was no difference in cancer worry between women classified in each illness
representation cluster (t= 1.53, df= 80, p= 0.13). The correlation matrix (Table 9.6)
indicates that cancer worry score was strongly correlated with identity and emotional
representations (p<0.001). Women with higher levels of cancer worry had stronger
emotional representations of the disease and believed more symptoms were
associated with breast cancer. There was also a trend for women with higher cancer
worry scores to have a less coherent perception of breast cancer (p<0.1).
9.4.2b(ii) Impact ofEvent scale
There was no difference in the proportion ofwomen in each illness representation
cluster who reported to have thought about breast cancer in the past week and
completed the Impact ofEvent scale (chi-square= 1.13, df= 1, p= 0.29). For those
who completed the scale no differences were found between women in each cluster
for the total score (t= .93, df= 19, p= 0.36); avoidance score (t= .86, df= 19, p= 0.40);
or intrusion score (t= .91, df= 21, p= 0.38).
Table 9.5 shows differences on IPQ-R subscales between women who reported to
have thought about breast cancer in the previous week and completed the Impact of
Event scale and those who reported not to have thought about breast cancer in the
previous week. Women who reported to have thought about breast cancer in the
previous week showed stronger emotional representations of breast cancer (p<0.05)
and showed a trend to perceive greater personal control over the disease (p<0.1).
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Table 9.5- Differences in illness perceptions between participants in the control
sample who had and had not thought about breast cancer in theprevious week.
IPQ-R subscale Thought about Did not df t P
breast cancer in think about breast
the previous week cancer in the
previous week.
Emotional n 23 67 88 2.01 0.047
representations Mean 3.4 3.03
sd 0.52 0.70
Personal control n 23 68 89 1.79 0.077
Mean 3.4 3.2
sd 0.50 0.39
The correlation matrix (Table 9.6) indicates that the total score, intrusion and
avoidance subscales on the Impact ofEvent scale were significantly correlated with
identity and emotional representations (p<0.05). Women with higher levels of
intrusive thoughts and avoidance of breast cancer were significantly more likely to
have stronger emotional representations of the disease and to associate more
symptoms with breast cancer.
Women who believed that 'Patients personality' was a cause ofbreast cancer were
significantly more likely to have a higher total score (r= .55, p= 0.001, n= 20).
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r= .28 p=0.009 n=89
CancerWor y




r= .60 p=0.004 n=21
r= .55 p=0.01 n=21
ImpactofEvent: Avoidance
r= .57 p=0.007 n=21
r= .53 p=0.014 n=21
ImpactofEvent: Intrusion
r= .51 p=0.014 n=23
r= .45 p=0.032 n=23
9.4.3 Summary of associations between illness perceptions and distress in each
sample.
Tables 9.7 and 9.8 provide a summary of the associations between general and
cancer specific distress with illness perceptions in each sample. For each measure of
distress significant associations with illness representation clusters and illness
representation dimensions are reported (p<0.05). The strength of associations are
also reported (t value or r correlation coefficient) for comparison.
Table 9.7- Summary ofassociations between general distress and illness
representations in each sample
Measure Increased risk sample (A) Control sample (C)
GHQ caseness Identity
(t= 3.25, df= 114, p= 0.002)
Timeline acute/chronic
(t= 2.54, df= 108, p= 0.012)
Emotional representations
(t= 2.13, df=102, p= 0.035)
Emotional representations
(t= 2.11, df= 87, p= 0.038)
GHQ score Identity
(r= .30, n= 116, p= 0.001)
Emotional representations
(r= .27, n= 104, p= 0.009)
Timeline acute/chronic
(r= .21, n= 110, p= 0.028)
Consequences
(r= .203, n= 108, p= 0.035)
Emotional representations
(r= .28, n= 89, p= 0.009)
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Table 9.8- Summary ofassociations between cancer specific distress and illness
representations in each sample
Measure Increased risk sample (A) Control sample (C)
Cancer worry Clusters
(t= 4.15,df= 96, p<0.001)
Emotional representations (r=
.66, n= 104, p<0.001)
Timeline acute/chronic
(r= .25, n= 110, p= 0.008)
Consequences
(r= .20, n= 109, p= 0.037)
Identity
(r=.19,n= 116, p= 0.045)
Emotional representations
(r = .50, n=90, p<0.001)
Identity
(r= .39, n= 99, p<0.001)
Completion of the
Impact of Event scale
Clusters
(chi square= 10.35, df= 1, p=
0.001)
Emotional representations (t=
2.56, df= 103, p= 0.012)
Identity
(t= 2.12, df= 115, p= 0.036)
Emotional representations
(t= -2.01, df= 88, p= 0.047)
Total score Emotional representations (r=
.48, n= 55, p< 0.001)
Treatment control
(r= -.28, n= 58, p= 0.035)
Identity
(r= .60, n= 21, p= 0.004)
Emotional representations
(r= .55, n= 21, p= 0.01)
Avoidance score Emotional representations (r=
.29, n= 55, p= 0.032)
Identity
(r= .57, n= 21, p= 0.007)
Emotional representations
(r= .53, n= 21, p = 0.014).
Intrusion score Clusters
(t= 2.42, df= 49, p= 0.019)
Emotional representations (r=
.60, n= 56, p< 0.001)
Treatment control
(r= -.33, n= 60, p= 0.007)
Timeline acute/chronic
(r= .26, n= 59, p=0.05)
Identity
(r= .51, n= 23, p= 0.014)
Emotional representations
(r= .45, n= 23, p= 0.032)
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9.4.4 Predicting distress in the increased risk sample from illness
representations
9.4.4a Predicting GHQ score10
A stepwise multiple regression analysis was used to predict GHQ score from the
illness perception dimensions that were associated with it (p<0.1) (See Table 9.3). It
was decided not to include the causal items in this model since there were no strong
hypotheses about the contribution of causal beliefs to levels of distress in this





Table 9.9 shows the results of the analysis. Two dimensions were significant
predictors ofGHQ score- identity and emotional representations. Together these
dimensions only accounted for 6.3% of the variance in GHQ score.






Std beta t P
.063 6.301 0.003 Identity .228 2.34 0.021
Emotional .211 2.16 0.033
representations
When this analysis was conducted without emotional representations included as a
predictor only identity was a significant predictor of GHQ score. This model
accounted for 10% of the variance in general distress (see Table 9.10).
10 Similar models were obtained using a logarithmic transformation of GHQ score
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Table 9.10- Stepwise multiple regression predicting GHQ scorefrom illness





Std beta t P
.101 12.83 0.001 Identity .331 3.58 0.001
9.4.4b Predicting cancer worry score
A stepwise multiple regression analysis was used to predict cancer score from the
illness perception dimensions that were associated with it (p<0.1) (see Table 9.3).





• Age (see 7.4.2a, page 207).
Table 9.11 shows the results of the analysis. Emotional representations and age were
found to be a significant predictors of cancer worry accounting for 45% of the
variance in cancer worry score. 11






Std beta t P
.454 42.53 <0.001 Emotional .658 8.89 <0.001
representations
Age -.192 -2.6 0.011
When this analysis was conducted without emotional representations included as a
predictor two other illness perception dimensions were found to predict cancer worry
score (timeline acute/chronic and identity). Age was also a significant predictor in
11 When age was removed from the model emotional representations alone accounted for 42% of the
variance in cancer worry score (std beta= .654, t=8.603, pO.OOl).
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this model. Together these dimensions accounted for 12% of the variance in cancer
worry score (see Table 9.12).12
Table 9.12- Stepwise multiple regression predicting cancer worry score from illness
perception dimensions (except emotional representations)
AdjR
square
F P Significant variables Std beta t P
.119 5.75 0.001 Timeline acute/chronic .230 2.47 0.015
Identity .209 2.25 0.026
Age -.192 -2.11 .038
9.4.5 What are the best predictors of distress among women at increased risk
of breast cancer?
Analysis was conducted to determine the best predictors of distress measures
including both the illness perception dimensions and experience variables previously
used to predict distress in the increased risk sample (see section 7.4.5, page 213 and
section 9.4.4 page 271)
9.4.5a What are the bestpredictors ofgeneral distress?13
A stepwise multiple regression analysis was used to predict GHQ score from the
experience items and IPQ-R subscale that were associated with it (p<0.1). The items
entered into the model were:
Experience items:
• Recency ofbereavement of a personally known relative from breast cancer
(plus dichotomous variable categorising if participants had or had not
experienced a recent bereavement)
• If the index relative was the participants mother or another relative
(dichotomous variable)
12 When age was removed from this model Timeline acute/chronic and Identity subscales accounted
for 9% of the variance in Cancer Worry Scores (F= 6.21, p= 0.003).
13 Similar models were obtained using a logarithmic transformation of GHQ score
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The results of the regression model are provided in Table 9.13. The results indicate
that two of the EPQ-R subscales (identity and emotional representations) were
significant predictors of distress in this sample (p<0.05). Together these variables
account for 11% of the variance in GHQ score (p<0.01). Recency ofbereavement did
not achieve significance (t=l.93, p= 0.056).
Table 9.13- Stepwise multiple regression predicting GHQ score from experience





Std beta t P




When the analysis was rerun omitting emotional representations as a predictor the
revised model accounted for a slightly larger proportion of the variance in GHQ
score (14%). The significant variables in this model were: identity (p<0.01) and
recency ofbereavement (p<0.05). The extent to which participants reported their
experience had been positive did not achieve significance (t=1.86, p= 0.066).
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Table 9.14- Stepwise multiple regression predicting GHQ score from experience
items and IPQ-R subscales (except emotional representations).
Adj R
square
F P Significant variables Std beta t P




9.4.5b What are the best predictors ofcancer worry score?
A stepwise multiple regression analysis was used to predict cancer score from the
experience variables and IPQ-R subscales that were associated with it (p<0.1) (see
section 7.4.5, page 213 and section 9.4.4 page 271). The experience items entered
into the model were:
• Participants age when their index relative was diagnosed with breast cancer.
• Subjective experience item 10: 'How much do you feel your life plans have
changed because ofthe risk ofcancer in yourfamily?'
• Subjective experience item 9: 'Do you feel that your role in thefamily has
changed because ofyour experiences ofbreast cancer?'
• Subjective experience subscale: 'Traumatic experience'.





Age was also included as a predictor (see 7.4.2a, page 207).
Table 9.15 indicates the regression model and the significant predictors. The model
produced accounted for 43% of the variance in cancer worry. The emotional
representations subscale was a very strong predictor in the model (p<0.001). The
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experience item 10: 'How much do you feelyour life plans have changed because of
the risk ofcancer in your family?'' was also a significant predictor (p<0.05).
Table 9.15- Stepwise multiple regression predicting cancer worry score from
experience items and IPQ-R subscales
AdjR
square
F P Significant variables Std beta t P
.43 36.44 .000 Emotional
representations
.601 7.54 <0.001
Change in life plans .183 2.30 0.024
When the analysis was rerun omitting emotional representations from the
independent variables the model accounted for 18.4% in the variance of cancer worry
(see Table 9.16). Two experience variables (Item 10: 'How much do you feel your
life plans have changed because of the risk ofcancer in yourfamily? '(p<0.01) and
participants age when their index relative was diagnosed with breast cancer(p<0.05))
were found to be significant predictors. The identity subscale of the IPQ-R was also a
significant predictor of cancer worry score in this model (p<0.05).
Table 9.16- Stepwise multiple regression predicting cancer worry score from
experience items and IPQ-R subscales (except emotional representations)
Adj R
square
F P Significant variables Std beta t P
.18 8.49 <0.001 Experience Item 10. .307 3.37 0.001
(Change in life plans)
Identity .233 2.57 0.012
Participants age at index
relatives diagnosis -.192 -2.12 0.037
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9.5 SUMMARY AND DISCUSSION
9.5.1 Associations between illness perceptions and general and cancer specific
distress in each sample
9.5.1a Increased risk sample (A)
Overall negative representations of breast cancer as indicated by the illness
representations clusters were associated with heightened cancer worry and intrusive
thoughts about breast cancer as assessed by the Impact ofEvent scale. A number of
predicted associations between illness perception dimensions and distress were
identified. In the increased risk sample a stronger illness identity and emotional
representations of the disease as well as perceptions of the disease as long lasting and
holding greater consequences were associated with higher levels ofboth general
distress and cancer worry. This replicates associations found between illness
perceptions and emotional response to illness in patient samples, including breast
cancer patients (reviewed in Chapter 3, see 3.4.5c and 3.4.6, pages 88-90).
The intrusion and avoidance subscales of the Impact ofEvent scale were associated
with different illness perceptions. The avoidance measure was only associated with
the emotional representations subscale of the IPQ-R and none of the cognitive
representations. The intrusion subscale was the only distress measure associated with
representations of control. Weaker belief in the ability of treatment to control breast
cancer was associated with greater intrusive thoughts about breast cancer although
perception of personal control over the disease was not associated with any of the
distress measures in the increased risk sample. This was surprising since research in
patient populations has indicated that beliefs concerning the control and cure of
disease are positively associated with adaptation (eg Heijmans and de Ridder 1998,
Scharloo et al. 1998, Hagger and Orbell 2001). In addition, negative associations
between beliefs over control of breast cancer and distress have also been shown in
breast cancer patients (Taylor et al 1984, Buick 1997) and were expected in this
sample. The control subscales of the IPQ-R, assess perceptions of control over the
prognosis and recovery of disease. Although these perceptions are of importance for
patient samples it is likely that beliefs about the control of risk and prevention are
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more important for individuals at risk of disease. In this context beliefs concerning
efficacy of detection methods (BSE, mammography) and personal control over breast
cancer risk (ie the impact of health related behaviours on risk) may be more crucial.
Indeed women at increased risk ofbreast cancer who believed more strongly in a
number of uncontrollable causal items (including altered immunity, poor medical
care in the past, accident or injury) showed higher levels of general distress and
reported greater avoidance ofbreast cancer as assessed by the Impact ofEvent scale.
An in-depth discussion on perceptions of control of risk and prevention ofbreast
cancer in relation to this work is provided in Chapter 11 (see 11.2, page 313).
The intrusion subscale of the Impact ofEvent scale was associated with different
causal items than the avoidance subscale. The intrusion subscale was associated with
internal causal items (e.g. believing breast cancer to be caused by patients behaviour
or personality). Previous research has indicated that health related intrusive thoughts
in healthy individuals might be associated with feelings ofpersonal responsibility for
prevention (Freeston et al. 1994). In this sample it is possible that perceiving
personal characteristics as causes of breast cancer may prompt intrusive thoughts
about the disease.
Stronger associations between illness representations and cancer specific distress
compared to general distress were expected in the increased risk sample. Emotional
representations showed much stronger correlations with cancer specific distress
measures than general distress. The high correlations between emotional
representations and cancer specific distress measures in all samples suggested that
there was a degree of conceptual overlap between these constructs. In the increased
risk sample the strength of association between cognitive representations and distress
measures were similar for both general and cancer specific distress. This suggests
that illness representations are equally associated with general distress and anxiety
specifically concerning breast cancer.
9.5.1b Control sample (C)
As predicted, few associations between illness representations and distress were
identified in the control sample ofwomen without any experience of breast cancer.
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General distress was only associated with emotional representations. The only
cognitive representation associated with any measure of distress in this sample was
the identity dimension. This is consistent with the SRM that proposes that feelings of
vulnerability are an important prerequisite for linking illness representations with
emotional response. Representations of breast cancer in the control sample are
unlikely to be considered personally relevant or threatening and therefore do not
provoke anxiety.
9.5.2 Predicting levels of general and cancer specific distress in the increased
risk sample
Multiple regression analyses indicated that dimensions of illness representations
were significant predictors of general distress and cancer specific distress. Women's
emotional representation ofbreast cancer and perceptions of the symptoms
associated with the disease (identity) were predictors ofboth general distress and
cancer worry. When assessing the predictive power of the cognitive representations
identity was the best predictor of general distress. Cancer worry was predicted by
identity and perception of the duration of breast cancer. Age was also found to be an
independent predictor in this model (younger age predicting higher levels of cancer
worry).
Analysis was conducted in order to determine the best predictor of distress in this
sample from the experience, illness perception and demographic variables. This was
a clinically driven research question in order to identify predictors of distress that
may be recognised by genetic counsellor and staff at the risk clinics as well to
highlight possible predictors that may be amenable to therapeutic intervention. When
the experience items and illness representations were entered into the analysis
together both were found to predict general distress and cancer worry. The measure
of emotional representations was found to be a strong predictor ofboth general and
cancer specific distress and appeared to mask a number of other predictor variables.
It was important to omit this dimension from the analysis in order to examine the
predictive value of those masked variables. Both general distress and cancer worry
were found to be best predicted by women's perception of the identity of breast
cancer and aspects of experience of the disease in the family. However, different
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types of experience were found to predict either general distress or cancer worry with
the identity dimension. Identity and recency ofbereavement were found to be the
best predictors of general distress. For cancer worry identity, changes in life plans
and age of the participant when their index relative was diagnosed were found to be
the best predictors. This supports the hypothesis previously outlined in Chapter 4 that
general distress would be associated with issues of bereavement whereas cancer
specific worry was predicted to be associated experiences directly influencing the life
and future of the individual at risk.
Although a number of variables were indicated as important predictors of distress in
this sample the proportion of variance explained by both the experience variables and
illness perception measures were disappointing. It is possible that other unmeasured
variables may be contributing to levels of distress (eg concern over passing the
genetic predisposition to ones children). It is also possible that the measures used
require additional work to improve validity (see Chapter 6). At this stage conclusions
can not be made concerning explanation of distress or causal relations between
variables in this analysis. Regression analysis is based on correlations and no firm
conclusions can be made regarding the causality of variables in this analysis (Cohen
and Cohen 1983). Alternative explanations regarding causality will be discussed in
more detail in the following chapter (see section 10.5.3, page 304) and attempts to
further explore issues of causality are discussed in Chapter 11 (see 11.3.2, page 320).
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TESTING THE MEDIATION MODEL
10.1 AIMS AND RATIONALE
The previous chapters in this thesis have demonstrated associations between:
experience of breast cancer and distress (Chapter 7); experience of breast cancer and
illness perceptions (Chapter 8); illness perceptions and levels of distress (Chapter 9).
These sets of analyses were conducted in order to explore systematically the
mediation model outlined in Chapter 4 (see Figure 4.1, page 100). This model was
developed from the Self Regulatory Model, which proposes that response to health
threats are determined by an individual's cognitive and emotional representation of
the threat derived from their experiences (Leventhal et al. 1980). The previous
chapters confirmed that the three sets of variables (experience, illness perceptions
and distress) were interrelated and that both aspects of experience and dimensions of
illness representations predicted levels of general and cancer specific distress in
women at increased risk ofbreast cancer. Flowever, this analysis does not offer any
explanation for the causal mechanisms involved. The analysis outlined in this
Chapter was conducted in order to address the primary aim of the research and test
the mediation model. It was hypothesised (H8) that the impact of experience of
breast cancer on levels of general and cancer specific distress will be mediated by
perceptions ofbreast cancer.
10.2 MEASURES AND SAMPLES
The design and procedure were previously provided in Chapter 4. The samples
reported in this study included: Increased risk sample and control sample. These
samples were described in Chapter 5.
The measures utilised in this analysis were:
• Experience questionnaire (increased risk sample only) (see Chapter 6, Part 2,
section 6.3-6.8)
• General distress (GHQ-30) (see Chapter 4, section 4.4.4a, page 106)
• Cancer specific distress (Cancer worry scale, Impact ofEvent scale) (see
Chapter 4, section 4.4.4b, page 107)
• IPQ-R adapted to assess healthy women's perceptions of breast cancer (see




Mediation refers to the process by which an independent variable is thought to
influence the dependent variable (Baron and Kenny 1986). Mediating variables are
often internal psychological variables that explain the links between stimuli and
behavioural outcome. A mediator is identified if it is able to account for the
associations between the independent and dependent variable. Baron and Kenny
(1986) illustrate the process ofmediation in the following model:





When there is a significant association between the independent variable and the
outcome variable (a) another variable may be considered to mediate this association.
Mediation is confirmed is the following conditions are met:
• Variations in the independent variable significantly account for variations of
the mediator (b)
• Variations in the mediator significantly account for variations in the outcome
variable (c)
• When the pathway via the mediator is controlled (b-c) the association
between the independent and outcome variable (a) becomes non significant.
Perfect mediation is said to occur if the association between the independent variable
and dependent variable is eliminated entirely when the mediation pathway is
controlled. However, many psychological constructs such as distress have multiple
causal factors. A reduction in the association between the independent and outcome
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variable is therefore taken to represent mediation in this field (Baron and Kenny
1986).
Baron and Kenny (1986) refer to a 'approximate significance test' for mediation.
This is known as the 'Sobel Test' (Sobel 1982). This tests that the indirect effect of
the IV on the DV via the mediator is significantly different from zero.
The formula for this test is:
a*b/SQRT (b2*sa2 + a2*sb2)
Where
a Raw (unstandardized) regression coefficient for the association between the
IV and mediator
sa Standard error of a
b Raw regression coefficient for the association between the mediator and the
DV (when the IV is also a predictor of the DV)
Sb Standard error of b
An interactive website is available to calculate this test: http://ciuantrrn2.psv.ohio-
state.edu/kris/sobel/sobel.htm (Preacher and Leonardelli 2001, accessed March
2003).
This test was calculated for all models that suggested mediation. The Sobel test
statistic and p value are reported. Full details of calculations are reported in the
Appendix III, (A-24)
10.3.2 Potential mediation models
The mediation model proposed in this thesis could be examined at different levels.
Firstly it was predicted that the difference in levels of cancer specific distress
between the samples with different experiences of breast cancer (women at increased
risk and the control sample ofwomen with no experience ofbreast cancer) would be
mediated by differences in illness perceptions (See Figure 10.2).
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Figure 10.2- Differences in levels ofcancer specific distress between samples with
different experience ofbreast cancer: Mediation via illness perceptions
Illness perceptions
Experience: >- Cancer specific
distress(Significant family histoiy/
no experience of breast cancer
at all)
Secondly, it was predicted that associations between experience of breast cancer in
the family and levels of distress in the increased risk sample would be mediated by
illness perceptions. Mediation via the overall pattern of illness perceptions as
represented by the clusters (see Figure 10.3(a)) and specific subscales (see Figure
10.3 (b)) were examined.
Figures 10.3 (a-b)- Associations between experience ofbreast cancer in the family











10.3.3 Steps of analysis
Step 1. Identify independent variables
Associations between experience ofbreast cancer and continuous distress measures
suitable formultiple regression (GHQ score and cancer worry score) were examined
in order to identify independent variables for potential mediation models. Significant
correlations between experience items and distress measures have previously been
reported (Chapter 7) and simple regression models were used to determine the
predictive value of the independent experience variable on the distress outcome
measures.
Step 2. Identify potential mediators
For each independent experience variable found to be significant in predicting a
distress outcome measure potential mediators were identified. Potential mediators
were either illness representation clusters or illness perception dimensions that had
previously been identified as being significantly associated with the independent
experience variable (Chapter 8). Logistic regression was used to determine the
predictive value of the independent variable on categorical mediator variables
(illness representation clusters) (see 10.3.4, page 287) and simple linear regression
was used to determine the predictive value of the independent variable on continuous
mediators variables (illness perception dimensions).
Step 3. Test the mediation model
The procedure outlined by Baron and Kenny (1986) was used to test the mediation
models identified. The potential mediator and independent variable were entered
consecutively into amultiple regression model. Firstly checks were made to
determine if the mediating variable was a significant predictor of the independent
variable. If so, the effect of the independent variable on the dependent variable in this
model was compared to the effect of the independent variable on the dependent
variable alone. If the effect of the independent variable was reduced in the final
model mediation was considered to have occurred and the Sobel test conducted
(Sobel 1982, Preacher and Leonardelli 2001). Simultaneous (standard) multiple
regression was used because it allows the researcher to specify the variables to
include in the model (see Chapter 8 for details ofmultiple regression techniques).
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Where alternative mediation models are found (i.e. more than 1 mediator is found to
mediate the effect of an independent variable on the same dependent variable) a third
model is tested including all potential mediators in the same model.
10.3.4 Logistic regression
Logistic regression was used to check the predictive value of experience variables on
categorical mediators (ie illness representation clusters). Logistic regression has
similar aims to multiple regression but in this case the dependent variable is
categorical rather than continuous. This makes the data unsuitable for multiple
regression because the assumptions concerning univariate and multivariate
distribution will not hold with a dichotomous dependent variable.
In logistic regression the dichotomous dependent variable is transformed using a
logistic transformation. The transformed variable can then be predicted using logistic
regression in a manner analogous to linear regression models. The aim of logistic
regression is to find the best linear combination of independent variables to
maximise the likelihood of achieving the observed category membership. The
coefficients in logistic regression are measures of the changes in odds ratio (ratio of
probabilities). As in multiple regression the analysis can be used to identify
predictors, assess the importance ofpredictors and assess strength of association.
Predictor variables may be continuous, dichotomous or a mixture and no
assumptions are made about the distribution or homogeneity of predictor variables.
However the technique is still sensitive to the problems ofmulticollinearity and
sample size. The techniques for selecting variables are similar to that outlined in
multiple regression and include standard, hierarchical and statistical regression.
The regression coefficients are interpreted the same as in multiple regression.
Standardized coefficients are tested to determine if they are significantly different
from zero. Exponentials of the coefficients can also be obtained which show the
effects of the independent variable on the odds of the dependent variable.
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The statistics examined from this analysis were:
• Model Chi-square (Tests if the log likelihood of the model is significant
compared to the constant only model).
• Wald statistic (Indicates if the predictor is reliably associated with outcome)
• Standardized regression coefficients
• Exponential regression coefficients (Change in the odds of being in one group
of the dependent variable produced by a change in one unit in the
independent variable).
• Sobel test (Tests that the indirect effect of the IV on the DV via the mediator
is significantly different from zero, see 10.3.1).
10.4 RESULTS
10.4.1 Differences in levels of cancer specificdistress between the increased risk
and control sample: Mediation via illness perceptions.
Dependent variables
Tests for differences between the sample ofwomen at increased risk of breast cancer
(Sample A) and the control sample (Sample C) were previously examined and
differences in levels of cancer worry were identified (see chapter 7). When 'sample'
was coded as a binary variable regression analysis confirmed that 'sample'
significantly predicted cancer worry score (Adjusted R square= .12, f= 30.95, p<
0.001, standardized beta= .356, t= 5.56, p< 0.001).
Mediators
'Sample' was found to be a significant predictor of three of the illness perception
dimensions: illness coherence, emotional representations and consequences (p<0.05).
The predictive value of the binary variable 'sample' on each of these potential
mediators is provided in Table 10.1.
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Illness coherence .18 44.19 <0.001 -.423 -6.65 <0.001
Emotional
representations
.018 4.65 0.032 .153 2.16 0.032
Consequences .014 3.89 0.014 .138 1.97 0.05
Potential mediation models
Three potential mediation models were tested. These are shown diagrammatically
below (Models 10.1 (i)-(iii)). Each model was tested separately and the results of the
regression analysis are provided in Table 10.2.













Table 10.2- Testing three mediation models ofillness perceptions mediating the
association between 'sample' and cancer worry
Model Adj. R F P Std. t P
Square Beta
10.1(i) .118 14.50 <0.001 Mediator .051 .70 0.49
IV .374 5.15 <0.001
10.1(H) .426 72.64 <0.001 Mediator .562 10.17 <0.001
IV .262 4.75 <0.001
lO.l(iii) .141 17.53 <0.001 Mediator .176 2.66 0.008
IV .321 4.86 <0.001
Model 10.1(i)
The results indicated that illness coherence was not a mediator, as it did not
significantly predict cancer worry in the model (p<0.05).
Model 10.1(ii)
Both 'sample' and emotional representations were significant predictors of cancer
worry in the model (p<0.05). The predictive value of 'sample' when predicting
cancer worry alone (standardized beta= .356, t= 5.56) was higher than compared to
when 'sample' was entered with emotional representations (standardized beta= .262,
t= 4.75). Including the mediator in the model improves the fit of the model and
reduced the magnitude of the coefficient of the independent variable. This suggests
that the mediator is partially replacing the independent variable as a predictor of the
dependent variable (cancer worry). The sobel test indicated that the mediator was
significant (Sobel test statistic= 2.106, p= 0.035).
Model lO.l(iii)
Both 'sample' and consequences were significant predictors of cancer worry in the
model (p<0.05). The effect of sample was lower when entered with consequences
(standardized beta= .321, t= 4.86) compared to when it is in the model alone
(standardized beta= .356, t= 5.56). This suggests that perceptions of the
consequences ofbreast cancer partially mediate the effect of sample on levels of
cancer worry. However, the sobel test indicated that the mediator was not significant
(Sobel test statistic= 1.581, p=0.114).
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Combined models
Since both emotional representations and consequences were found to mediate the
same effect (see model 10.1(ii) and 10.1 (iii)) another model was tested to include
both of these mediators. The results of this analysis are provided in Table 1.3. The
results indicated that when assessed together the emotional representation subscale is
a mediator of the effect of sample on cancer worry whereas the consequences
subscale is not.
Table 10.3- Testing the combined mediation model that emotional representations






Sample + .396 73.61 <0.001 Emotional .568 12.67 <0.001
emotional representations
representation -.015 -.349 .727
+ Consequences




10.4.2 Mediation models in the increased risk sample
10.4.2a General distress
Independent variables
Correlational analysis reported in chapter 7 revealed that GHQ score was
significantly correlated with recency ofbereavement of both a personally known
relative and the index relative from breast cancer (p<0.05). Simple regression
analysis confirmed this result:
• Recency ofbereavement of a personally known relative (Adjusted R square=
.086, f= 8.91, p= 0.004, standardized beta = -.311, t= -2.90, p= 0.004)
• Recency ofbereavement of index relative (Adjusted R square= .052, f= 4.79,
p= 0.032, standardized beta= -.257, t= -2.19, p= 0.032).
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Clusters as mediators
The results reported in Chapter 8 indicated that the individuals in each of the illness
representation clusters differed on the recency of bereavement variables. Logistic
regression confirmed that these experiences variables were significant predictors of
the binary illness representations cluster variable. (Recency of bereavement of a
personally known relative: chi-square= 8.18, df= 1, p= 0.004, Exp beta= 1.058, p=
0.007; Recency of bereavement of index relative: chi-square= 5.48, df= 1, p= 0.019,
exp beta= 1.005, p= 0.024). This suggested two possible mediation models (Models
10.2 (i) and (ii))






Recency of bereavement of:
w
(i) personally known relative
(ii) index relative
In models 10.2 (i) and 10.2 (ii) illness representation cluster variable was not found
to be a significant predictor ofGHQ score (p<0.05) and therefore the model did not
meet the criteria for mediation.
Illness perception dimension as mediators
Associations between experience items and illness perceptions were outlined in
chapter 8. Recency of bereavement was predicted by the IPQ-R subscales timeline
acute/chronic (Adjusted R square= .082, f= 6.998, p= 0.01, standardized beta= -.287,
t= -2.65, p= 0.01) and treatment control (Adjusted R square= .082, f= 7.10, p=
0.009, standardized beta= .287, t= 2.67, p= 0.009). This suggested two possible
mediation models:
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Recency of bereavement GHQ score
of a personally known Std beta= -.311
relative t= -2.90, p<0.004
In models 10.3 (i) and 10.3 (ii) the IPQ-R subscales timeline acute/chronic and
treatment control were not significant predictors ofGHQ score (p<0.05). Therefore
there was no mediation through these variables.
Recency of bereavement of the index relative from breast cancer predicted a number
of illness perception dimensions:
• Treatment control (Adjusted R square= .102, f= 8.48, p= 0.005, standardized
beta .340, t= 2.91, p= 0.005);
• Timeline acute/chronic (Adjusted R square= - .088, f= 7.25, p= 0.009,
standardized beta= -.319, t= -2.69, p= 0.009);
• Identity (Adjusted R square= .059, f= 5.43, p= 0.023, standardized beta= -
.270, t=-2.33, p= 0.023);
• Consequences (Adjusted R square = .052, f = 4.54, p= 0.037, standardized
beta= -.257, t=-2.13, p= 0.037)
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The following mediation models were therefore tested:
Models 10.4 (i-iv)- Effect ofrecency ofbereavement of index relative on GHQ score






Recency of bereavement of ^ GHQ score
Index relative Std beta= -.257
t= -2.19, p<0.032
In models 10.4 (v) and 10.4 (ii) the illness perceptions dimensions treatment control
and timeline acute/chronic were not significant predictors ofGHQ score (p<0.05).
Therefore the model did not meet the criteria for mediation.
Table 10.4 shows that in model 10.4 (iii) identity was a significant predictor ofGHQ
score. When both the independent variable and mediator are entered into the model
together the effect of the independent variable (recency of bereavement of index
relative) became non significant (p<0.05). The results suggest that the effect of
recency of bereavement of index relative was mediated by its effect on perceptions of
the identity of breast cancer. However, the sobel test indicated that the mediator was
not significant (Sobel test statistic = 1.646, p^O.0099)
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Table 10.4- Testing the mediation model that 'identity' mediates the association
between recency ofbereavement of the index relative and general distress


















Table 10.5 shows that in model 10.4 (iv) consequences was a predictor of GHQ score
(p= 0.057) and the effect of recency of bereavement of index relative became non
significant (standardized beta= -.178, t=-1.14, p=0.16). This suggests that the effect
of recency ofbereavement of index relative on levels of general distress was also
marginally mediated by its impact on beliefs about the consequences ofbreast
cancer. However, the sobel test indicated that the mediator was not significant (Sobel
test statistic= 1.940, p= 0.0524).
Table 10.5- Testing mediation model that 'consequences' mediates the association
between recency ofbereavement of the index relative and general distress.




















Since both identity and consequences were found to mediate the same effect (see
model 10.4 (iii) and 10.4 (iv)) another model was tested to include both of these
mediators. The results of this analysis are provided in Table 10.6. The results
indicated that when the mediators are assessed together the identity subscale is a
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significant mediator of the effect of recency ofbereavement on general distress
whereas the consequences subscale is not (p<0.05).
Table 10.6- Testing the combined mediation model that identity and consequences






Recency of .137 4.39 <0.001 Identity .273 2.18 .033
bereavement of
index relative Consequences .185 1.50 .138
+ identity +





Associations between experience items and cancer worry were reported in Chapter 7
(8.4.2b(i)). Cancer worry was significantly predicted by:
• Subjective experience item 10: 'How much do you feel your life plans have
changed because of the risk ofcancer in yourfamily?' (Adjusted R square=
.119. f= 16.30, p<0.001, standardized beta= .356, t= 4.04, p< 0.001)
• Subjective experience subscale: 'Traumatic experience' (Adjusted R square=
.04, f= 5.49, p= 0.021, standardized beta= .221, t= 2.34, p= 0.021)
• Subjective experience item 9: 'Do you feel that your role in the family has
changed because ofyour experiences ofbreast cancer' (Adjusted R square=
.034, f= 5.003, p= 0.027, standardized beta= .207, t= 2.24, p= 0.027)
• Participants age when index relative was diagnosed (Adjusted R square=
.027, f= 4.13, p= 0.044, standardized beta= -.187, t= -2.03, p= 0.044).
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Clusters as mediators
Of the above independent variables the only variable found to predict the illness
representation clusters in a logistic regression analysis was the Subjective experience
variable 10 (change in life plans) (Chi-square= 7.38, df= 1, p= 0.007, Exp B= .583,
p= 0.01). This suggested a mediation model illustrated by Model 10.5:
Model 10.5- Effect ofsubjective experience variable 10 (Change in life plans), on
levels ofcancer worry mediated by illness representation clusters.
Clusters
Change in life plans ► Cancer worry
Std beta= .356
t= 4.04, pO.001
The test of this mediation model is summarised in Table 10.7. The analysis revealed
that when entered into the same model both the independent variable (change in life
plans) and the mediator (illness representation clusters) were significant predictors of
cancer worry (p<0.01) The effect of the independent variable was higher on its own
(standardized beta = .356, t=4.40, p<0.001) than when entered into the model with
clusters (standardized beta= .253, t= 2.64, p=0.01). This suggests partial mediation
by illness representation clusters. However, the sobel test indicated that the mediator
was not significant (Sobel test statistic = -1.77, p=0.0763).
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Table 10.7- Testing mediation model that illness representation clusters mediates the
association between subjective experience variable 10 (Change in life plans) and
cancer worry

















Illness perception dimensions as mediators
For each independent variable potential mediators were identified.
The subjective experience variable 10 (change in life plans) was found to predict the
following IPQ-R dimensions:
• Treatment control (Adjusted R square= .057, f= 7.61, p= 0.007, standardized
beta= -.257, t= -2.76, p= 0.007);
• Personal control (Adjusted R square= .046, f= 6.24, p= 0.014, standardized
beta= -.235, t= -2.50, p= 0.014);
• Emotional representations (Adjusted R square= .038, f= 5.03, p= 0.027,
standardized beta= .218, t= 2.24, p= 0.027);
• Timeline acute/chronic (Adjusted R square= .028, f= 4.11, p= 0.045,
standardized beta= .192, t= 2.03, p= 0.045).
The following mediation models (Models 10.6 i-iv) were therefore tested:
298
Models 10.6 (i-ivj- Effect ofsubjective experience variable 10 (Change in life plans)






None of the cognitive representations in models 10.6 (i, ii, and iv) were found to be
significant predictors of cancer worry. Only emotional representations (Model 10.6
(iii)) was a significant predictor of cancer worry (p<0.05). The results of this analysis
are summarised in Table 10.8. Both the mediator (emotional representations) and
independent variable (change in life plans) were significant predictors of cancer
worry in the model. However the effect of the independent variable in this model
(standardized beta= .180, t= 2.33, p= 0.022) was lower compared to when predicting
cancer worry alone (standardized beta= .356, t= 4.04, p<0.001). This suggests partial
mediation of the independent experience variable 10 (change in life plans) on cancer
worry by emotional representations. The Sobel test confirmed that the mediator was
significant (Sobel test statistic= 2.158, p= 0.031).




Table 10.8- Testing the mediation model that emotional representations mediates the
association between subjective experience variable 10 (Change in life plans) and
cancer worry





Change in life .428 38.83 <0.001 Mediator .60 7.79 <0.001





The experience subscale 'Traumatic experience' significantly predicted two illness
perception dimensions: Emotional representations (Adjusted R square= .126, f=
15.04, p< 0.001, standardized beta= .368, t= 3.88, p< 0.001); Consequences
(Adjusted R square= .07, f= 8.59, p= 0.004, standardized beta= .281, t= 2.93, p=
0.004). This suggested two potential mediation models illustrated in Models 10.7 (i-
ii):
Models 10.7 (i-ii)- Effect ofsubjective experience subscale 'Traumatic experience'










In model 10.7(b) consequences was not found to be a significant predictor of cancer
worry in the model (p<0.05) and hence no mediation was supported.
In model 10.7(i) emotional representations was found to be a significant predictor of
cancer worry (p<0.05). The effect of the independent variable ('Traumatic
300
experience') became non significant and the beta value reduced dramatically to
(standardized beta = -.039, t=-.46, p= 0.65) in this model than when predicting the
cancer worry independently (standardized beta= .221, t= 2.34, p= 0.021) (see Table
10.9). This indicated that emotional representations of breast cancer mediate the
impact of 'Traumatic experience' of breast cancer in the family on levels of cancer
worry. The Sobel test confirmed that the mediator was significant (Sobel test
statistic^ 3.46, p= 0.00055).
Table 10.9- Testing the mediation model that emotional representations mediates the
association between subjective experience subscale 'Traumatic experience ' and
cancer worry


















The subjective experience item 9 ('Do you feel that your role in the family has
changed because ofyour experiences ofbreast cancer? ') was found to predict the
IPQ-R subscale emotional representations (Adjusted R square= .032, f= 4.34, p=
0.04, standardized beta= .203, t= 2.08, p= 0.04). The following model was therefore
tested (Model 10.8):
Model 10.8- Effect ofsubjective experience item 9 (Role change) on levels ofcancer
worry mediated by emotional representations.
Emotional
representations
Subjective experience Cancer worry




Table 10.10 provides a summary of the analysis ofmodel 10.8. The mediator
(Emotional representations) was found to be a significant predictor of cancer worry.
The effect of the independent variable (role change) became non significant
(standardized beta = .153, t= 1.97, p= 0.052) compared to when alone in the model
(standardized beta = .207, t= 2.24, p= 0.027). This indicates that emotional
representations mediates the impact of the subjective experience item 9 (Role
change) on levels of cancer worry. The Sobel test confirmed that the mediator was
significant (Sobel test statistic= -1.77, p= 0.0763).
Table 10.10- Testing the mediation model that emotional representations mediates
the association between subjective experience item 9 (Role change) and cancer
worry


















10.5 SUMMARY AND DISCUSSION
10.5.1 Differences in levels of cancer specific distress between the increased risk
and control samples: mediation by illness perceptions.
Previous analysis (Chapter 7) had indicated that although there was no difference
between the increased risk sample and control sample on levels of general distress
the increased risk sample showed significantly higher levels of cancer worry. The
samples also differed significantly on a number of dimensions of illness perceptions
including illness coherence, consequences and emotional representations (see
Chapter 8). It was possible therefore that the difference in level of cancer worry
between the samples may to some extent be explained by differences in their illness
representations. These mediation models were tested and the results suggested that
women with a significant family history of breast cancer who are at increased risk of
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developing the disease have stronger emotional representations of breast cancer and
perceive the disease to hold more consequences. These representations account for
some of the variation in levels of cancer worry between the samples although only
the emotional representations subscale was found to be a significant mediator. In
addition, sample membership was still a strong predictor of cancer worry suggesting
that there are other factors that differ between the samples (for example risk status,
risk perception etc) that may also contribute to this effect.
10.5.2 Mediation models in the increased risk sample
In the increased risk sample recency ofbereavement was the only experience
variable that significantly predicted levels of general distress. General distress was
also associated with the overall pattern of beliefs held by participants (illness
representation clusters) and a number of dimensions of illness perceptions (identity,
consequences, timeline acute/chronic and treatment control). The illness
representation clusters, perception of the duration of breast cancer (timeline
acute/chronic) and beliefs concerning the ability of treatment to control the disease
(treatment control) were not significant predictors ofGHQ score and could not act as
mediators. Recency ofbereavement of the index relative was found to be mediated
by perceptions of the identity ofbreast cancer and consequences of the disease
although these effects were not shown to be significant. Women who had lost their
index relative more recently perceived breast cancer to hold more severe
consequences and believed more symptoms to be associated with breast cancer. The
identity dimension was found to be the strongest mediator in a joint model. These
results suggested that the effect of bereavement on levels of distress in women at
increased risk of breast cancer might not only reflect issues concerning griefbut also
the impact of the experience on women's perceptions ofbreast cancer and
subsequently the meaning of their own risk. Previous research suggested that genetic
counselling provokes a reactivation of grief (DudokdeWit et al. 1997, Lodder et al.
1999, Hopwood et al. 1998). This reactivation may not only concern the sense of loss
but also invoke representations ofbreast cancer. The more recent the bereavement
the more accessible and threatening these images may be (see 3.2.1a, page 73).
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Cancer worry was associated with a number of experience variables and illness
perception subscales suggesting a number ofpossible mediation models. Illness
representation clusters were found to mediate the association between the experience
variable 'How much do you feelyour life plans have changed because ofthe risk of
cancer in yourfamily?' and cancer worry although this effect did not reach
significance. This suggested that women who reported greater changes in their life
plans because of the risk of breast cancer in their family had more negative
representations of the disease which led to increased cancer worry. When individual
dimensions of illness perceptions were examined none of the cognitive
representations were found to be mediate this effect. The emotional representations
subscale was the only dimension found to contribute to the effect. Emotional
representations appeared to be a significant mediator of experience of breast cancer
in the family on cancer worry. A number of aspects of experience assessed in this
study (including how traumatic the experience had been, changes in life plans
because ofbreast cancer risk and changes in family roles due to breast cancer) were
found to be mediated by emotional representations ofbreast cancer. This suggests
that it is the fear aroused by these experiences ofbreast cancer that promotes cancer
worry.
The number ofmediation models found in the data was disappointing. None of the
cognitive representations were found to significantly mediate experiences of breast
cancer in the family on levels of cancer specific distress. A number of
methodological problems may have led to difficulties in detecting mediation effects.
10.5.3 Methodological issues
Baron and Kenny (1986) discuss a number of assumptions ofusing this technique to
test mediation models. One of the main assumptions is that the dependent variable
does not cause the mediator. In the analysis reported in this chapter there were strong
theoretical reasons for hypothesising that the mediator (illness representations)
caused the dependent variable (level of distress). However it is also possible that
distress may influence illness representations. Measures of distress are likely to
encompass anxiety related dispositions such as negative affectivity. Negative
affectivity is a dispositional dimension that reflects individual differences in negative
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emotionality (Watson and Clark 1984). Individuals showing high negative affectivity
tend to be more distressed, upset and perceive a negative view of themselves and the
world. The construct overlaps with neuroticism and trait anxiety and reflects both
affective states and the tendency to experience negative emotions as well as styles of
perceiving, recalling and reporting events (Costa and McCrae 1985, Watson and
Clark 1984). Much work has indicated that negative affectivity is a potential
confounding factor in associations between stress and illness reports (Costa and
McCrae 1985, 1987, Watson and Pennebaker 1989, Ellington and Wiebe 1999).
These associations have been interpreted as resulting from a tendency to scan the
environment for threatening stimuli and interpret ambiguous stimuli in a negative
manner (Watson and Pennebaker 1989). Cameron et al. (1998) also found that trait
anxiety in breast cancer patients in remission was associated with increased levels of
cancer worry. It is possible therefore that negative affectivity may be associated with
measures ofboth general and cancer distress as well as representations ofbreast
cancer and act as a confounding factor in this research. In the most extreme case it is
possible that high levels of distress in women at increased risk of breast cancer
reflects a general dispositional style to perceive situations in a negative manner and
this in turn may lead to them to develop negative representations of the disease.
Additional research utilising adequate controls or longitudinal designs are required to
explore this issue in more depth. The confounding impact of negative affectivity in
this research will be discussed in more detail in Chapter 11 (see 11.3.2, page 320).
Baron and Kenny (1986) also report that using multiple regression to test mediation
models assumes no measurement error of the mediator. Although the IPQ-R showed
adequate psychometric properties in the increased risk sample the measures were not
perfect with some subscales showing low internal consistency (see chapter 6). This
will reduce the effect of the mediator and overestimate the effect of the independent
variable on the dependent variable. An additional criticism of this analysis concerns
the measurement of experience. Many of the experience variables were single items
designed pragmatically to assess specific aspects of experience. Although these
measures were useful indicators in this research it is possible that single items were




Overall the results showed that cognitive representations of breast cancer appeared to
mediate the impact of recency of bereavement from breast cancer in the family on
levels of general distress although this effect was not significant. In addition,
emotional representations ofbreast cancer partially mediated the impact of aspects of
subjective experience of breast cancer in the family on levels of cancer worry.
Although the results must be interpreted with care due to the possible effect of
negative affectivity, measurement error and conceptual overlap of constructs, the
results are encouraging. Cognitive and emotional representations ofbreast cancer
may be important mediators to target in interventions aimed at reducing levels of
general and cancer specific distress respectively. These results support further work
to apply this model to understanding variations in distress in women at increased risk
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11.1 SUMMARY OF MAIN FINDINGS
The research reported in this thesis was designed to improve understanding of the
variation in levels of distress among women with a family history ofbreast cancer. It
was proposed that personal experiences of breast cancer in the family were related to
distress and that this effect was mediated by illness perceptions. The main findings in







Step1. Experienceanddist ss (seeChapt r7.Summary andDiscussion,Se tion 7.5,page218)
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Step3. Illnessperceptionsand distress( eeChapt r9. SummaryandDiscussion, Section9.5,page277)
•Perceptionsofbreastancerw ll significantlyassociatedwithlevelsof distressinwomenithasign fica tfamily historyofbreastcancer.
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Step4. Themediationodel(s Chapter10.Summarynd Discussion,Se tion10.5, page302)
•Theimpactofexperi ncebr scancer levelsofdistr sswillbm diatedy perceptionsofbreastcancer.
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The first step in testing the mediation model was to explore the relations between
experiences of breast cancer and level of distress (Chapter 7). This work built on
pilot work that had identified associations between quantitative measures of
experience and measures of distress (Chapter 6). The results confirmed the
hypothesis that women who had different levels of exposure to breast cancer in their
social environment showed different levels of distress. Women with a significant
family history ofbreast cancer and women in the general population who reported a
recent experience of breast cancer showed higher levels of cancer specific distress
than women with no experience of the disease. Particular experiences ofbreast
cancer reported by women at increased risk were associated with levels of both
general and cancer specific distress. Case level distress was associated with recency
ofbereavement of a family member from breast cancer and the number ofpersonally
known relatives to been affected with the disease. Cancer specific distress was
associated with a number of experience items that reflected the subjective impact of
the experience (eg its effect on family roles and life plans). Experience items were
found to be significant predictors ofboth general and cancer specific distress.
However, the proportion of variance accounted for was not large suggesting that
there were likely to be other factors to consider.
These results contribute to the debate concerning level of general distress in women
at increased risk of breast cancer. Previous research has been contradictory with
some studies reporting higher distress in women at risk of breast cancer (Kash et al..
1992, Gagnon et al. 1996) and others reporting levels comparable to normative
scores (Wellisch et al. 1991, Lerman et al. 1994a, Lloyd et al. 1996, Zakowski et al.
1997, Coyne et al. 2000) (See Chapter 1, 1.4, page 48). This study found that a
significant family history ofbreast cancer is sufficient to increase anxiety and
concern specifically related to the disease but is not always associated with increased
general distress. It is possible that previous research concerning levels of distress in
women at increased risk research may have been inconsistent because the samples
differed on factors (eg bereavement) related to general distress. Experiences of breast
cancer in the general population sample were also related to cancer specific distress.
This provides additional support for the notion that women's experiences of breast
cancer are important predictors of distress regardless of risk status.
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The second step in the mediation model was to examine associations between
experience of breast cancer and illness perceptions (Chapter 8). In line with
predictions based on the SRM women with different levels of exposure to breast
cancer were found to hold different cognitive and emotional representations of the
disease. Women with a family history of breast cancer were more likely to hold an
overall negative representation of the disease compared to women without any breast
cancer experiences. In addition, specific experiences ofbreast cancer were associated
with illness perceptions in both women at increased risk ofbreast cancer and women
in the general population. This suggests that a significant family history of breast
cancer is associated with more negative perceptions of the disease but that certain
experiences ofbreast cancer are associated with specific illness representations. Both
negative and positive experiences were found to be associated with illness
perceptions. This confirms previous qualitative studies that identified links between
experiences of cancer and perceptions of the disease (Dudok deWit et al. 1997,
Lodder et al. 1999, Leedham and Meyerowitz 1999).
The third step in the mediation model was to test for associations between illness
perceptions and levels of distress (Chapter 9). Women at increased risk of breast
cancer who held overall negative representations of the disease showed higher levels
of general and cancer specific distress. A number of dimensions of illness
perceptions were associated with levels of distress in women at increased risk of
breast cancer in the predicted manner. Fewer and weaker associations between
illness perceptions and distress were identified in the control sample suggesting that
the link between illness perceptions and distress in healthy individuals is more salient
for those at risk of developing the disease. Multiple regression analysis confirmed
that illness perceptions predicted level of distress in women at increased risk of
breast cancer in combination with experience variables although the amount of
variance accounted for was still fairly small.
These analyses supported the premise ofmediation. The final stage of analysis
involved identifying and testing potential mediation models using multiple regression
analysis (Chapter 10). Although a number ofpotential mediation models linking
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experience, illness perceptions and distress were identified in the increased risk
sample few were supported by the analysis. The results suggested that higher levels
of cancer worry in women at increased risk ofbreast cancer compared to women
with no experience of the disease was found to be partially explained by women at
increased risk holding stronger emotional representations and perceiving the disease
as holding greater consequences. In the increased risk sample, recency of
bereavement was associated with stronger perceptions of the identity and
consequences of breast cancer that accounted for higher levels of general distress.
Previous research had identified links between parental death from cancer and
psychological wellbeing in women at increased risk of breast cancer and suggested
these relations may be mediated by perception of risk although tests of this model
have been inconclusive (Zakowski et al. 1997, Erblich et al. 2000). This study
suggests that perceptions of the disease may be the crucial factor.
11.2 THEORETICAL IMPLICATIONS
The work in this thesis was guided by the SelfRegulatory model. Since this model
was developed primarily to understand patients response to illness constructs
reflecting perceived risk are not explicitly incorporated in the model. Other models in
health psychology such as the Health BeliefModel (HBM) (Rosenstock 1996,
Becker 1974) have been designed in order to understand preventative health related
behaviours and include concepts ofperceived vulnerability and susceptibility (see
Chapter 3, section 3.3, page 75). These constructs are likely to be important in
understanding and explaining response of individuals to disease risk. However the
HBM was designed to explain decision making and behaviour rather than emotional
response that was the focus of the current research. Indeed the inability of the HBM
to incorporate of emotional factors is a major critique of the model. The model is
static in nature and does not identify how cognitions are formed or changed. In
addition apart from providing cues to action the model does not account for the
impact of social factors on cognitive representations.
The SRM was chose because of its focus on both cognitive and emotional
representations and the ability to understand a range ofpsychological outcomes
including psychological wellbeing. The model was felt to examine in more detail the
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meaning of risk for the individual and explicitly identified the potential link between
experience (stimuli) and development of illness perceptions. This theoretical
grounding as well as the qualitative and anecdotal evidence linking experience of
cancer and illness perceptions (Chapter 2) provided a strong justification for the
current research. Future research might usefully consider the additional constructs of
perceived susceptibility and potential interactions between this construct and illness
representations in determining psychological response to risk.
These studies were amongst the first to have applied the SRM to understanding
psychological response in individuals at increased risk of disease. The results support
the premise of the SRM - that illness perceptions are derived not only from direct
somatic or symptomatic experience but also from information available in the
external social environment (Leventhal et al. 1980, Leventhal et al. 1984). Being at
increased risk of breast cancer is sufficient stimulus to evoke representations of the
disease and different experiences of breast cancer in the family are associated with
different illness perceptions. Applying this model to women at increased risk of
breast cancer can enhance our understanding ofwhy some women report more
distress than others for the same level of genetic risk. Experiences of breast cancer
and illness representations were both found to be associated with and predictive of
levels of general and cancer specific distress. The results therefore inform us of not
only of factors that contribute to distress in women at increased risk ofbreast cancer
but also how these factor interrelate.
The associations between illness perceptions and psychological well-being in the
increased risk sample mirror to some extent findings from samples of symptomatic
patients. Studies from a range ofpatient groups have shown beliefs concerning
consequences; identity and timeline are negatively associated with psychological
adaptation to illness (eg Heijmans and de Ridder 1998, Scharloo et al. 1998, Hagger
and Orbell 2001). The same associations were demonstrated in women at increased
risk ofbreast cancer but not women in the control group suggesting that a sense of
threat is a prerequisite for this effect. Reliable associations between the identity
dimension and psychological well-being were however found in both samples. This
confirms that the identity dimension is not merely tapping the symptom experiences
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ofpatients but rather beliefs concerning nature of the illness in question (Moss-
Morris et al. 2002). These findings also support the notion that identity is an
important component of illness representations for healthy individuals (Bishop et al.
1987). Bishop et al. (1987) proposed that lay conceptions of illness are based
primarily around symptoms in order to aid detection of disease. The results from this
work suggest that additional representations are also important in healthy individuals
at risk of disease and may reflect the personal meaning of this risk.
Not all predictions derived from the SRM were met in this research. Few
associations between control beliefs and psychological well-being were identified.
This was surprising since associations between control beliefs and adaptation to
illness have been well demonstrated in patient populations including breast cancer
patients (eg Heijmans and de Ridder 1998, Scharloo et al. 1998, Hagger and Orbell
2001, Taylor et al. 1984, Buick 1997). It is likely that beliefs concerning personal
control over risk, such as ability to prevent breast cancer and confidence in screening
methods are more important in this population than control over the disease as
assessed by the IPQ-R. Access to information about breast cancer prevention has
been identified as an important information need for women at increased risk of
breast cancer and one of the main reasons why women attend familial breast cancer
clinics (Appleton et al. 2000, Brain et al. 2000). This suggests that women are
actively developing representations regarding personal control over their risk.
Chalmers and Thompson (1996) found the process of adapting to risk involved
developing a sense ofpersonal control. Lerman et al. (1996) also suggested that
genetic counselling promotes psychological adjustment by improving knowledge
about breast cancer and potential for prevention/early detection.
However, few studies have looked at beliefs regarding control of risk or prevention
of breast cancer in individuals at risk. A study by Stewart et al. (2001) indicated that
beliefs regarding personal control over breast cancer recurrence are widely held by
survivors of the disease (see section 3.4.6, page 90). Audrain et al. (1997) assessed
beliefs about control over developing breast and ovarian cancer in 256 women who
had self-selected for genetic counselling. Based on one single item used to assess
beliefs about control over developing breast cancer, 55% ofwomen reported no or
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little control and 45% perceived at least moderate amount of control. Women who
were classified as having higher perceived control over developing breast cancer
were found to show lower levels of general and cancer specific distress. An
interaction indicated that general distress was higher for women with low perception
of control and high perception ofpersonal risk. Although this suggests that beliefs
about control of risk are important, it is difficult to elucidate the meaning and
interpretation of one single generic item given the range of issues regarding control
in this population.
The SRM needs to be expanded to encompass beliefs regarding control over risk
when applied to individuals at risk of disease such as breast cancer. Control over
breast cancer in healthy individuals is a complex issue encompassing a number of
elements. There is a need to consider beliefs about prevention and risk reduction.
Perceptions ofpersonal control (eg behaviour) as well as beliefs regarding the
efficacy of screening and benefits of early detection need to be explored. As well as
beliefs regarding control of developing breast cancer it may also be important to
consider women's beliefs about control over disease progression and risk of dying
from breast cancer if they were to develop the disease. Home (1997) provided
convincing evidence that beliefs about treatment and medicine were an important
component of lay representations. No study has directly investigated these beliefs
although qualitative studies have indicated that healthy women hold perceptions of
breast cancer treatment (Payne 1990, Savage and Clarke 1998, see section 3.4.7,
page 90). Women's perceptions of specific treatments for cancer as well as beliefs
about the potential advances in treatment may be important aspects to consider.
Further exploration of these constructs and investigation into how they may fit within
the SRM would be a worthwhile contribution to research in this area.
The SRM is dynamic and suggests that illness representations and coping
mechanisms related to risk are not static elements but change depending on stimuli
and cues in the environment. Applying the SRM to women at increased risk of breast
cancer may not only help us to understand individual differences in psychological
response to risk but also variation in psychological well-being over time. Easterling
and Leventhal (1989) suggest that individuals at increased risk of a life threatening
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disease are unlikely to worry continuously but reminders of the risk will prompt
concern and anxiety. Events in the family (eg diagnosis, relapse or bereavement) are
likely to invoke distress and activate as well as alter representations. Clinic
appointments and the prospect of screening might also activate illness
representations and induce distress. Easterling and Leventhal (1989) found ex-
patients worry about breast cancer was reactivated during visits to their doctor and
qualitative studies ofwomen at increased risk of breast cancer identified heightened
distress and anxiety at the time of clinic appointment (Appleton et al. 2000).
"I don't think of having breast cancer until it becomes like the end of
May, beginning ofJune when I know that my appointment is going to pop
through the letter box that's actually when I actually start to think more
about it and it becomes into the forefront in your mind if you like".
(Appleton 1999, quote from telephone focus group study, personal
communication).
Further research in this area may hold clinical application as well as enhance
understanding of the dynamic interactions within the SRM.
The results reported in this thesis have shown how the SRM can act as a useful
framework to enhance understanding ofhow factors contribute and interact to
influence psychological response to breast cancer risk. A recent study using
alternative methodology has reported findings that are supportive of the mediation
model. McAllister (2002) presented a grounded theory based on interview data to
explain response to genetic testing for Hereditary NonPolyposis Colorectal Cancer
(HNPCC). She found that individuals' experiences of cancer in their family influence
the degree to which they 'engage' with their risk. Engagement was a concept derived
from the data that reflected 'the degree ofcognitive and emotional involvement with
one's increased risk ofdeveloping cancer as a result ofone'sfamily history of
cancer' (McAllister 2002, page 8). Level of engagement is then proposed to
influence response to testing. Individuals who were 'intensely engaged' tended to
have witnessed closer family members suffering or dying from cancer. This theory
was developed from qualitative analysis of interviews without theoretical guidance.
However there are parallels between the concept of engagement and activation of
illness representations in individuals at increased risk of cancer because of their
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family history. Greater understanding of the overlap between these concepts and
models may assist further theoretical development in this area.
11.3 METHODOLOGICAL ISSUES
11.3.1 Sample
It was important that the samples obtained for this work were representative in order
to be able to generalise the results and conclusions of this study. A random selection
ofwomen at increased risk of breast cancer was therefore selected from the database
held at the clinical genetics department. It was also important that the general
population sample was comparable to the increased risk sample on factors that may
influence knowledge and perceptions of breast cancer (eg educational level). In order
to attempt to achieve this the general population sample was selected on the basis of
information concerning age and postal region of the increased risk sample. Within
the general population sample a quarter of individuals reported that a relative had
experienced breast cancer. It is possible therefore that a small proportion of these
individuals may have an increased (genetic) risk ofbreast cancer themselves. This
justified use of a control sample who had no experience of breast cancer in their
social environment as the main comparison group.
It was only possible to recruit one sample for this study due to ethical constraints on
research in the increased risk sample (see section 54.6, page 110). Subsequent
methodological problems also arose in accessing general population samples.
Following recruitment for this study, Lothian Health Board implemented new
confidentiality guidelines that restricted researchers from accessing the Community
Health Index to obtain details on individuals within the region. Although the study
was carefully designed to test a number ofhypotheses the reliability of the results are
unknown and it is not possible to generalise findings from a single sample.
The samples were likely to have been biased to some extent. The samples were
predominately white, Caucasian and of a high educational level as seen in many
studies of screening populations (Rimer et al. 1996). Women who seek genetic
testing have been found to be ofhigher education and socio-economic status (Codori
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et al. 1994, Kash et al. 1997). The comparison of respondents and non-respondents
reported in section 5.3.2 (page 120) also revealed a trend for respondents to come
from areas of lower social deprivation. Individuals with higher levels of education
are more likely to hold beliefs about breast that are compatible with scientific and
medical approaches (Bowling 1989). It is possible that the general population sample
was also biased towards those interested in breast cancer and health issues. It is
unlikely therefore that the results of this study can generalise to women of lower
educational level or ethnic groups whose beliefs about breast cancer may be diverse
(Klonoff and Landrine 1994).
The sample may also have been biased in terms of levels of distress. Women with
high levels of distress may avoid cues about their risk, including participating in
research studies. Indeed scores on the general distress and Impact ofEvent Scales
were positively skewed in the increased risk sample. The lack of associations
between avoidance as measured by the Impact ofEvent scale and experience may
reflect that women avoiding breast cancer issues did not complete the questionnaire.
This suggests that women with the highest levels of distress whom we are most keen
to understand may not have been captured with this research. Although avoidance
may be maladaptive there are also cases when avoidance has been shown to be a
successful coping strategy for dealing with breast cancer (Cordova et al. 1995, Primo
et al. 2000). Without access to the subgroup who did not participate in the research it
is impossible to determine if this reflects higher distress or an adaptive coping
strategy.
Women in the increased risk sample had previously made the decision to seek
information about their risk and had obtained genetic risk counselling. This suggests
that these women were actively coping with their risk. It is possible that women with
a family history of breast cancer who choose not to attend for genetic counselling
may hold different representations of the disease. In addition, the experience of
attending for genetic counselling may have influenced both illness representations
and levels of distress. Different results may therefore be obtained in women prior to
genetic counselling. The experience of genetic counselling may also differ between
centres or between genetic counsellors. Further research is therefore required to
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investigate the reliability of effects described here in other familial cancer clinics and
to examine illness representations at different time points.
Comparisons were made between women at increased risk of breast cancer and
women in the general population in order to determine differences in distress and
illness representations between samples with different levels of experience ofbreast
cancer. However, the samples also differ on experience of genetic counselling for
breast cancer. It is impossible to conclude from this study that differences between
the samples are a consequence of experience of the disease in the family alone. Such
differences may also be attributed to information obtained in genetic counselling and
awareness of risk status. A controlled prospective study examining illness
perceptions before and after genetic counselling would be required to investigate this
issue.
11.3.2 Design
The study was designed using the SRM as a theoretical framework in order to
examine associations between experience, illness representations and psychological
wellbeing in an 'at risk' sample. Although the results from this work supported the
application of the SRM to this new population, the study was cross-sectional and
conclusions regarding causality can not be made. A number of alternative plausible
interpretations can be provided. One of the major limitations in this study and health
psychology research in general is the confounding influence of negative affectivity.
It is possible that negative affect influences levels of distress, reports ofpast
experience and illness perceptions and creates a conceptual overlap between the
measures used within this study. In this way negative affect may account for the
relationships reported throughout this thesis.
Negative affect is conceptualised as either a state or trait. Trait negative affect refers
to a stable underlying personality factor that is associated with negative mood and
self concept (Watson and Clark 1984). State negative affect reflects temporary
fluctuations in negative mood. Trait negative affect has been shown to influence the
interpretation of stimuli (Watson and Clark 1984, Watson and Pennebaker 1989) and
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may therefore confound the measures utilised in this research. Surprisingly little
work has addressed the impact of negative affectivity on illness representations with
the exception of Taylor et al. (1991) who provided preliminary evidence to suggest
that association between feelings of control over disease and adjustment to illness
was not confounded by negative affectivity.
Studies of depressed patients have shown negative retrospective biases in clinical
populations (Beck et al. 1979). Experimental research from cognitive psychology has
shown that transient induced mood states result in recall patterns similar to those
shown by depressed patients and increased anxiety has been associated with greater
retrieval of threat related events from autobiographical memory (Sutton et al. 1988,
Healy and Williams 1999, MacLeod 1999). These findings have led to a number of
theories regarding the impact ofmood states on cognitive processes including
memory (reviewed by Ellis and Moore 1999). Based on clinical observation, Beck
(1979) proposed the schema theory that suggests current mood states guide the
processing and organisation of information. Sad or depressed individuals are thought
to be subject to a maladaptive 'depressive schema'. This consists of sets ofbeliefs
and assumptions that produce negatively distorted thinking and assists retrieval of
mood related memories (Beck 1979). Following experimental work investigating
cognitive processes and affective states, Bower (1981) outlined the 'associative
network theory' in which mood states are proposed to be represented semantically in
memory. Affective states increase the accessibility of negative memories, concepts
and representations resulting in mood dependent thinking. Although these theories
have been extended and more comprehensive theories proposed, the link between
emotional state and cognition is clear (Teasdale 1993, Ellis and Moore 1999). It is
possible therefore that negative affective states in women at increased risk of breast
cancermight not only assist retrieval of negative events from memory but also evoke
more negative interpretations of the experience and representations of breast cancer.
In this way negative affectivitymay influence all self report data in this study and
account for the observed relationships. Future research needs to examine associations
between personality dispositions and illness representations and attempt to control
for factors such as negative affectivity.
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Causality between cognition and emotion has been debated for many years
(discussed by Lazarus 1999). A main advantage of using the SRM in this area is that
it raises awareness of both cognitive and emotional representations of breast cancer
and potential interactions between these levels of processing. However, the
multivariate and transactional nature of the SRM makes it a difficult model to test.
The researcher must conceptualise and measure multiple potentially overlapping
factors as well as specify the independent and dependent factors at a certain points in
time (Leventhal and Cameron 1987). The dynamic appraisal processes in the model
suggests that all factors are to some extent interrelated in a discursive manner.
Although this makes causality difficult to examine it is realistic to accept continuous
reciprocal causality between cognitive and emotional constructs (Lazarus 1999). The
research reported in this thesis has therefore been worthwhile to indicate the
cognitive representations involved in emotional response to breast cancer risk even if
causality has not been established. In depth qualitative studies, as well as
intervention studies and prospective longitudinal studies assessing the impact of
illness related events on illness representations and psychological well-being will
provide further insight into the dynamic processes involved. These designs may
provide further insight into the causal relations between experience, illness
perceptions and psychological response to risk. For example a longitudinal study
may be able to determine the impact of genetic counselling on illness perceptions and
distress. Such a design will be able to determine what illness perceptions are held
prior to genetic counselling and how they are associated with distress; the impact of
genetic counselling on illness perceptions and level of distress; what changes in
illness perceptions are associated with psychological wellbeing in the longer term.
11.3.3 Measures
11.3.3a Experience
The results reported in this thesis suggest that it is possible although difficult to
measure experience of breast cancer in the family in a quantitative manner. The
problems appeared to arise from attempting to encapsulate a vast range of
experiences important in this context in a short questionnaire. The concept of
experience ofbreast cancer in the family is wide and the questionnaire aimed to
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capture important aspects ofwomen's experiences that might influence their
response to their own risk. However, the face validity of the questionnaire is dubious.
In particular some items (eg resemblance items) do not refer directly to experiences
of breast cancer but rather perceptions of similarity to the affected relative.
Although focussing on the index relative appeared to be a useful and workable
format a number ofproblems arose during analysis of these items. A few respondents
reported that they were too young to remember any of the experience surrounding
their index relative and omitted the questions. Some items were also found to hold
multiple answers. For example, one participant reported that although her mother
was first diagnosed when she was 6 years old her breast cancer recurred when the
participant was age 27. Although the experience items asked for participants to report
when breast cancer was first diagnosed in the index relative it is likely (although
unclear) that respondent referred to the more recent experiences in subsequent
questions. It is likely that women in families with more than one affected relative
have witnessed a range of different outcomes and consequences of breast cancer and
did not have the opportunity to express different or conflicting experiences in the
questionnaire provided. The quote below highlights these dilemmas. In addition,
women with a family history ofbreast cancer may be more sensitive to breast cancer
experiences in individuals outside the family but this is not captured in the
questionnaire.
"My mother has had a second bout of breast cancer and this time it had
spread to her spine and this has brought i t home more, because I am
seeing her s lowly I osing her m obility a nd its inoperable and it w ill b e
terminal, and you know, although the first time she had breast cancer it
all seemed, you know treated very effectively and we thought that she was
cured. This second occurrence and the after effects of it have made me
more concerned, I think with the realism" (Appleton 1999, quote from
telephone focus group study, personal communication).
Despite a number of qualitative studies reviewed in Chapter 2 no quantitative
measure of experience was available in the literature. The measure used in this study
was under development within the research group and based on interviews and
clinical observations with women attending the familial breast cancer clinic. The
pilot analysis showed the measure to be acceptable to women at increased risk of
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breast cancer and also revealed predicted associations with levels of general and
cancer specific distress. Since the aim of this research was to test the mediation
model (Fig 4.1, page 100) there was insufficient time to develop and validate a
measure of experience. The current questionnaire was therefore deemed the most
appropriate available instrument to use during this study. However, the face validity
and reliability of the questionnaire remains a strong limitation of this research. In
particular, the use of single items to assess particular experiences may have resulted
in unreliable measures. Although items were reduced using scaling analysis this
analysis was pragmatically rather than conceptually driven. Studies assessing
experience in a different manner may therefore produce different results. Future
research in this area may proceed by focussing on specific aspects of the experience
(ie exposure to breast cancer in the family, changes to life created by breast cancer)
rather than attempting to assess a broad range of experiences. In this way measures
of specific experiences can be developed. Alternatively, a checklist of experiences
that contribute to heightened distress could be developed. This could comprise of a
list of categorical questions (eg have you experienced a bereavement from breast
cancer in your family?) that could be summed to provide a score that reflects the
degree of breast cancer experience within a woman's family.
Although the questionnaire was designed to assess aspects of experience that had
been highlighted as important in this population and were hypothesised to be
mediated by illness perceptions, a number ofpertinent aspects of experience were
neglected. These included details of the illness experience (how breast cancer was
detected, treatment regime, disease progression and recurrence) involvement with
care-giving, stage of the family and concurrent stressors (Northouse 1995, Siegel et
al. 1996, Veach and Nicholas 1998, Lewis et al. 1993).
The experience questionnaire focused on past experiences in the family. It may be
difficult to identify associations between past experience and measures of current
anxiety such as intrusive thoughts or avoidance. Future research could be directed at
understanding the effect of current breast cancer experiences. It may be useful to
compare women who currently have a relative in their family who is suffering from
breast cancer to a matched control sample ofwomen at increased risk who are not
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experiencing any breast cancer episodes in their family at the time. This would help
reduce the impact of negative retrospective bias and allow more insight into the
experience and its effects. Prospective longitudinal studies also would provide
clearer insights into how experiences impact on emotional response to risk and are
necessary to examine causality. However, great care would need to be taken when
conducting research at such a sensitive and difficult times.
11.3.3b Distress
This study and the majority of research assessing distress in women at increased risk
ofbreast cancer used self-report screening measures. These measures are designed to
be inclusive and therefore overestimate the rate of actual psychiatric morbidity
(Hopwood et al. 1998, Coyne et al. 2000). It has been noted that there is often a lack
ofdistinction between distress and clinical disorder throughout the literature in this
area (Coyne et al. 2000). This study was designed to understand factors that
contribute to general distress rather than psychiatric disorder and therefore the GHQ
was deemed adequate. In addition a control sample enabled direct comparison with
an appropriate population. Studies that wish to look specifically at rates of clinical
disorder or to assess psychological support needs would be best advised to follow up
screening measures with interviews and ensure comparisons with controls or relevant
normative data.
The results from this thesis was consistent with research in the literature indicating
the importance of cancer specific distress in this population (eg Lloyd et al. 1996).
The use of cancer specific distress measures is now widely accepted in order to
provide information about the nature of distress and inform interventions (Thewes et
al. 2001). However, there are concerns that these measures may reflect a realistic
response to the situation rather than morbid anxiety (Coyne et al. 2000, Hopwood et
al. 2001). Cancer specific distress and concern about breast cancer was also found to
be prevalent in the general population ofwomen of this age. This is the first study to
have reported levels of cancer worry in the general population. It is possible that the
sample in this study were biased to women with experience ofbreast cancer. Sixty-
one percent ofwomen reported to have some experience of breast cancer in their
social environment and 25% reported that a relative had suffered from breast cancer.
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It is possible that women with experience of breast cancer were more likely to
respond to the questionnaire and show higher level of cancer worry than women
without such experience. However there was no difference in the level of cancer
worry reported by women in the general population sample with and without
experience ofbreast cancer in their social environment. Further research is needed to
further examine the level of cancer worry in general population samples. It is not
unexpected that women in the general population would show cancer worry given
the high profile of breast cancer and promotion of self care practises (BSE) in the
media as well as the prevalence of health related intrusive thoughts in healthy
samples (Freeston et al. 1994). Although women in the increased risk sample showed
higher cancer worry than controls it is worth noting that nearly 50% of the increased
risk sample reported not to have thought about breast cancer in the previous week.
This perhaps raises concerns about the meaning and clinical utility of the cancer
worry scale. Further work is needed to examine the clinical significance of this
measure and to provide normative data.
Using the Impact ofEvent scale in samples with differing levels of distress was
problematic. Although the opt out box was useful to exclude women who had not
thought about breast cancer in the past week, it reduced the sample size below that
required for the analysis plan. It also made the results difficult to compare with other
published studies which did not include the opt out box in the questionnaire.
Although the Impact ofEvent scale was designed to allow the sub-scales to be
summed the intrusion and avoidance subscales were analysed separately in order to
understand the contribution of experience to these constructs. This was justified by
the different patterns of associations identified. Primo et al. (2000) argues that the
association between these constructs and adjustment to breast cancer may be even
more complex and that patterns of intrusion and avoidance over time may prove to
be better indicators of adjustment. This would require a longitudinal investigation.
Whilst the Impact ofEvent scale was useful to assess the magnitude of intrusive
thoughts it does not provide any information regarding the content of these
intrusions. It would be clinically important to investigate the nature of intrusive
thoughts in women at increased risk of breast cancer and whether specific thoughts
or images provoke greater anxiety.
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11.3.3c Illness perceptions
Two major aims of this thesis were to extend the SRM to individuals living with an
increased risk of breast cancer and to test the predictions of the model in this sample.
In order to achieve this it was necessary to adapt a generic quantitative measure of
illness perceptions that had been developed and used widely in patient populations -
the IPQ-R (Weinman et al. 1996, Moss-Morris et al. 2002).
Not all components of illness representations are likely to be relevant to all diseases
and it was expected that not all dimensions assessed by the IPQ-R would be
appropriate components of healthy women's beliefs about breast cancer. In addition
it is likely that other psychological constructs such as perceived susceptibility and
vulnerability from other theoretical models such as the Health BeliefModel (are
likely to be important cognitions to consider (Rosenstock 1996, Becker 1974).
One subscale in particular (timeline cyclical) was found to be inappropriate for use in
this population and omitted from subsequent analysis (see 6.19.1, pages 171-174).
Whilst some subscales (eg emotional representations and illness coherence) showed
high internal consistency in both samples other subscales were found to show
different levels of reliability in women at increased risk and women in the general
population suggesting that certain dimensions of illness representations may be more
or less relevant depending on women's risk status or experience of the disease. In the
general population sample, the identity and consequences subscales showed the
highest levels of internal consistency of the original 5 cognitive dimensions. The
timeline acute/chronic and control subscales showed lower internal reliability. This is
consistent with Bishops work on disease prototypes in healthy individuals. Bishop et
al. (1987) found that healthy individual's comments about serious diseases most
often reflected representations of the label, cause and consequence of disease and
less often cure or timeline. Although the quantitative measures derived from the IPQ-
R is able to inform us about the strength of illness perceptions in these samples it
does not give us any information regarding the relative importance of dimensions or
how elaborated the illness perceptions are in each sample. Further qualitative
analysis would be required to explore these issues.
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There were initial concerns that the identity scale would be difficult to apply to
breast cancer because of the limited symptoms associated with the disease (see
Chapter 1). Also, since women were not referring to their own illness the scale could
be interpreted as reflecting on a spectrum of symptoms ranging from early breast
lumps to symptoms related to advanced metastatic disease. It is possible that some
women may have reported symptoms ofbreast cancer prior to diagnosis whereas
others may have included treatment side effects when responding to this scale. This
may have increased the number of symptoms reported on the identity subscale and
the variability of scores obtained. In the future it may be beneficial to explicitly state
if the scale is referring to symptoms alone or symptoms resulting from both the
illness and its treatment.
A main issue that became apparent during analysis of the results was the conceptual
overlap between cancer specific distress measures and emotional representations of
breast cancer as assessed by the IPQ-R. The high correlation between these
constructs provided information regarding the concurrent validity for this new
subscale however, such strong associations may lead one to argue that the emotional
representations subscale of the IPQ-R could be construed as a measure of cancer
specific distress. Although high correlations would be expected between these
measures, cancer specific distress represents more than affective response to breast
cancer alone. It also reflects persistent thoughts about developing the disease and the
impact of these concerns on daily functioning.
Although the IPQ-R proved adequate for use in this thesis there is room for
improvement and further work needs to explore the validity of the scale in women at
increased risk ofbreast cancer. In retrospect, it would have been informative to have
examined the face validity of the questionnaire in more depth at the piloting phase.
The questionnaire was piloted on women at the clinic. It is possible that these women
were concerned about their clinic appointment and anxious about screening (Wardle
and Pope 1992, Appleton et al. 2000) and were therefore not in an ideal position to
concentrate on reading and comprehending a questionnaire. It would have been more
systematic to have piloted the questionnaire in a postal format to a random sample of
women at increased risk ofbreast cancer and to have included an evaluation sheet for
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women to complete. Alternatively, a qualitative assessment ofwomen's
understanding of the purpose, relevance, acceptability and comprehension of the
measure would have provided useful data on the face validity of the IPQ-R in this
population. This approach has been used previously when adapting questionnaires
for this population (Thewes et al. 2001).
Qualitative methodology could have been used to further investigate the concurrent
validity of the measure. It would have been informative to have conducted interviews
with a proportion of the increased risk sample and elicit illness representations in the
manner outlined by Leventhal and Nerenz (1985). Data derived from these
interviews could then be compared with responses on the IPQ-R and similarities and
differences between the methodologies examined. This triangulation could be used to
highlight items or dimensions of the IPQ-R that are less relevant to this population.
This approach could also be used to explore the validity ofpatterns of illness
representations identified by the cluster analysis and generate further information on
the importance of particular representations in this population.
11.4 STATISTICAL METHODS
The methodology used in this research was driven by the need to test a mediation
model. Quantitative measures were chosen in order to utilise the technique outlined
by Baron and Kenny (1986). Few significant meditation effects were identified. On
reflection the mediation model outlined in Chapter (Figure 4.1, page 100) may have
been too broad. In the future it may be helpful to focus the model to test specific
hypotheses concerning the mediation of specific experiences on particular
psychological outcomes. The lack ofmediation effects may reflect limitations of this
technique or problems with measures (see Chapter 10, section 10.5.3, page 304).
Poor measurement of the mediator leads to an exaggerated relationship between the
independent and dependent variables. In this study a number ofnewly
developed/adapted measures with limited psychometric testing were used. This may
underestimate the mediation effects. Further techniques such as structural equation
modelling that can be used in an attempt to explore associations between a range of
variables (Baron and Kenny 1986). In addition, structural equation modelling can be
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used to estimate feedback in the model (a causal relation from the dependent variable
to the mediator). This may provide further information regarding causal relations.
The majority of analyses reported in this thesis, including the mediation analysis
were correlational in nature and conducted on cross sectional data. Although this
analysis supported the model causality can not be inferred from this type of analysis.
The mediation analysis can not directly test the causal ordering of the model but is
able to determine if the data supports a plausible ordering. Experimental studies
involving randomised manipulation of treatment are the only test for causality.
However practical considerations render this difficult in this field. The independent
and dependent variables in this case (experience and distress) can not be ethically or
practically produced experimentally and therefore randomisation into experimental
groups is not possible. Interventions aimed at changing illness perceptions may
provide an experimental test of the model but to date these techniques have not been
adequately developed or described.
Cluster analysis was successfully utilised to explore the patterns of illness
perceptions and identified similar results to that reported in previous studies (Buick
1997, Heijmans 1999). The validity of the clusters was supported by further analysis
that identified predicted associations between the clusters and both distress and
experience measures in both samples. One of the benefits of cluster analysis is its
applied clinical relevance (Hack and Degner 1999). Cluster analysis can aid health
professionals to identify subgroups of individuals and make assumptions regarding
their adjustment and how to intervene to enhance patient's wellbeing. However,
cluster analysis is a procedure based on heuristics rather than statistical reasoning
and there are no tests of significance to determine the number of groups in the data. It
is possible therefore that the two clusters identified in these samples may be further
divided into smaller clusters. Another limitation to the cluster analysis performed on
this data was the omission of causal items from the analysis. It is possible that causal
beliefs are an important component of illness representations that may contribute to
response to risk in healthy populations. Further research is required to investigate
causal models in women at risk of breast cancer in more depth and explore
associations with psychological response to risk.
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Throughout the analysis care was taken to avoid multiple testing. Hypotheses usually
involved making comparisons between the increased risk sample and women in the
general population without any experience of breast cancer. Although it would have
been interesting to have compared the increased risk sample with the full general
population sample this would have involved repeating analysis on a proportion of the
respondents in this sample.
11.5 CLINICAL APPLICATION
11.5.1 Understanding and reducing distress
Women with a family history ofbreast cancer conveying comparable levels of risk
exhibited varying levels of distress. Even after genetic counselling a proportion of
women at increased risk of the disease had fairly high levels of distress and showed
greater cancer specific distress than controls. This suggested that some women might
benefit from psychological support in order to promote adjustment to risk status and
that interventions are likely to more effective if targeted specifically at reducing
cancer specific distress. Researchers in this field have previously suggested that
genetic counsellors should focus on sources of distress such as past cancer related
events in the family during genetic counselling (Watson et al. 1999, Hopwood et al.
1998). Watson et al. (1999) suggest that psychological support needs to be integrated
into the genetic counselling service either by broadening the training of genetic
counsellors or including mental health professionals within the clinical genetics
team. However, no guidelines currently exist for how to achieve this. Given the tight
schedule of the clinics to date the provision ofpsychological services needs to be
carefully planned and targeted at individuals who are most in need. The results
obtained in this study indicate that it may be worthwhile identifying those women
who have had certain experiences associated with distress (e.g. having lost a relative
to breast cancer recently) and to discuss adjustment difficulties or screen for
psychological problems using a validated screening tool such as the GHQ. These
women could be provided with relevant self-help material (eg how to cope with
bereavement, how to cope with worry) and information about psychological services
or referred for more detailed psychological assessment if deemed necessary.
331
Women at increased risk ofbreast cancer not only face trauma regarding past
experiences in their family but often also multiple loss, as well as ongoing
bereavement and concurrent trauma concerning their own risk. In a discussion about
responses to multiple loss from AIDS, Nord (1996) highlighted that current theories
about grief and trauma are inadequate for understanding issues ofmultiple and
ongoing bereavement since 'Existing theories and interventions concerning trauma
inevitably assume that the trauma occurred in the past creating some degree of
distance from the event' (Nord 1996, pg 404). Issues of grief and trauma therefore
need to be addressed in a different manner in this population. It is possible that
preparing women to cope with potential breast cancer related events in their family
(including diagnosis of self or other family members, communication about breast
cancer, changing family roles and bereavement) may help prevent psychological
problems. Chalmers and Thompson (1996) identified that rehearsing how to cope
with diagnosis helped women to cope with breast cancer risk. Research on terminally
ill patients and their families has indicated that preparation for death is seen as
extremely important for all involved (Steinhauser 2000, 2001). These techniques
might also help prevent persistent grief described in this population (Hopwood et al.
1998).
The results reported in this thesis have shown that women's experiences of breast
cancer in their family influence representations of breast cancer as well as having a
direct impact on levels of general and cancer specific distress. This suggests that
genetic counselling may benefit from giving attention to both the emotional aspects
of the counselees experiences in their family as well as their beliefs about what
breast cancer risk entails. It is possible that women may have developed beliefs about
the prognosis and treatment ofbreast cancer based on misinterpretations of
experiences of family members. Kelly (1987) provided an anecdotal report of a
woman whose father had received surgery for bowel cancer the day after reporting
abdominal cramps to his GP. The woman reported how she subsequently believed
bowel cancer to be an extremely rapidly developing cancer and became distressed
about her own risk. However, after learning that her father had actually suffered from
abdominal discomfort and rectal bleeding for at least one year and that detection
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techniques were available her anxiety was reduced. Beliefs based on past family
experience may not be congruent with subsequent improvements in the detection and
treatment for breast cancer. Moyer and Salovey (1996) outline changes in the
treatment and meaning ofbreast cancer over the past 4 decades. They describe how
treatment has evolved from radical mastectomy at the time ofbiopsy (prior to the
1970s) to a two stage surgical procedure today in which patients are more involved
in their treatment, have time to consider a variety of less intrusive options and are
offered the choice ofbreast reconstruction. In addition, society has become more
open about cancer and a wide range of support is available to breast cancer patients
today (support groups, self help literature etc). Given the impact ofwomen's
experiences ofbreast cancer on representations of the disease and potential for
misinterpretation of experiences and outdated information it may be beneficial not
only to provide women with information concerning cancer genetics and their risk
status but also up to date information concerning the detection and treatment of
breast cancer. In a recent telephone focus group study ofwomen attending the
familial breast cancer clinic in Edinburgh, women requested information on a variety
of topics including breast cancer treatments and current trials in order to help them
cope with their risk status (Appleton et al. 2000). This type of information may help
those holding misperceptions ofbreast cancer to update and restructure their
representations of the disease and reduce levels of anxiety. A psycho-educational
intervention is currently being carried out for women at the Edinburgh familial breast
cancer clinic and includes provision of information about the diagnosis and treatment
ofbreast cancer (Appleton, personal communication).
Health professionals involved in genetic counselling need to be aware of the
disparate beliefs ofwomen attending the clinic and to recognise illness perceptions
that may be indicative of distress. The cluster analysis reported in this thesis
suggested that an overall negative perception of breast cancer might prove to be a
useful indicator. These representations may interfere with the comprehension and
interpretation of information provided during counselling sessions. It may be useful
to train genetic counsellors to elicit and identify illness representations and to
structure the information they provide in order that counselees can integrate it with
their experiences and existing belief structure.
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There is potential for interventions aimed at improving psychological well-being in
women at increased risk of breast cancer to be based around modifiable factors in the
SRM. However results from this thesis alone are not sufficient to determine what
factors should be targeted in interventions or the most appropriate techniques to use.
Further work is required to investigate these issues. There have been a number of
intervention studies carried out with women with a family history of breast cancer
although the aims of the studies and samples recruited have been diverse. Studies
have included problem solving training to promote adherence to BSE and reduce
distress in women with a recently diagnosed first degree relative (Audrain et al.
1999, Schwarz et al. 1998) and use of introductory videos concerning cancer genetics
prior to genetic counselling on accuracy of risk perception, distress and
understanding of cancer genetics (Cull et al. 1998).
A few studies are currently under development or in progress to provide psycho-
educational material to women living with an increased risk of breast cancer in order
to improve psychological adjustment to risk. Kash et al. (1999) report an ongoing
randomised controlled trial of an intervention incorporating social support, education
and problem solving in order to enhance knowledge, coping skills, adherence to
screening and to reduce breast cancer anxiety. Preliminary reports of the 1 year
follow up reveal that the interventions appears effective in reducing breast cancer
anxiety and increasing knowledge about breast cancer (Kash et al. 1999). Wellisch et
al. (1999) also report a pilot intervention including sessions focused on education
regarding genetics, medical information concerning breast cancer and nutrition as
well as a psychological session regarding experience of being at increased risk of
breast cancer. The intervention was been found to reduce depression and anxiety but
had no effect on resolution of grief. Esplen et al. (1998, 2000) developed an
intervention also including both psychotherapeutic and psychoeducational
techniques. The intervention was aimed at increasing women's ability to cope with
their risk, screening and management decisions as well as to come to terms with their
experiences in their family and to 'detoxify the threat ofdeveloping breast cancer'.
The intervention included an exploration ofwomen's experiences of breast cancer in
their family in order to reduce fears associated with the disease, dispel myths about
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breast cancer and to clarify information concerning the disease. Women were also
given the opportunity to talk to breast cancer survivors. A pilot study of this
intervention indicated a reduction in distress, depression, anxiety and unresolved
grief in those who participated.
These initial studies are promising and suggest that interventions may effectively
promote adjustment in women at increased risk of breast cancer. However many of
the studies have only been conducted in pilot form (Esplen 1998, 2000, Wellisch et
al. 1999) and randomised control trials are necessary to fully test the effectiveness of
the intervention. In addition, most of the interventions contain a wide range of
techniques and hence the effectiveness of specific strategies is difficult to evaluate.
The interventions conducted to date are also extremely intensive, conducted on small
groups of individuals, over a long period of time at high cost. There is a growing
need to be able to target these interventions to those with greatest need who are most
likely to benefit or to identify effective strategies within the interventions to enable
the development and provision of less intensive interventions.
Taking a theoretical approach to intervention design and evaluation will assist the
identification of effective components within the intervention. The studies conducted
to date have lacked theoretical input and hence the mechanisms by which the
interventions produce effects remain elusive. The SRM is a useful framework to
assist the development and evaluation of intervention in this area. Using this model
allows the researchers to identify and target specific factors, hypothesise about the
mechanism involved and develop informative evaluation measures. The intervention
study reported by Esplen et al. (2000) may have successfully altered a number of
processes outlined in the SRM that have been examined in this thesis. The
intervention aided the participant to identify experiences ofbreast cancer in her
family that were associated with distress, challenge cognitive and emotional
representations of breast cancer, assisted appraisal of representations and coping
strategies and introduced a number of coping strategies relevant to incidences or
emotional reactions that may occur in the future. This is illustrated in quotes
describing the intervention below. The effectiveness and evaluation of this
intervention would be greatly improved by explicit hypotheses detailing effects the
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intervention was designed to achieve and the inclusion of relevant evaluative
measures.
" A goal of the supportive-expressive group therapy model is to help the
women expand and improve their repertoire ofcoping skills. Discussions
that focus on the problems encountered by group members and current
coping strategies are promoted in the group...the group also teaches
relaxation methods (such as guided imagery) to provide women with a
behavioural technique that can facilitate their ability to cope with testing
or screeningprocedures" (Esplen et al. 1998, pg 378)
"Additionally, myths about breast cancer risk that may have evolved
from a particular family experience or through the media can be
dispelled, or information can be clarified. This is the key role ofhaving a
woman with breast cancer in the groups. There can be direct exchange
between those at risk and those who have breast cancer. Women at risk
can ask questions about breast cancer and treatment to those who are
dealing with the illness. Women who had little opportunity to talk openly
to affectedfamily members are encouraged to take advantage ofseeking
out new information. Some women alter theirperception ofbreast cancer
risk, from one associated with breast cancer resulting in death to one in
which an emerging belief about the possibilities for survival occurs. "
(Esplen et al. 1998, pg 378)
Only one study has been reported that has developed an intervention based
specifically on the SRM to challenge illness representations. Petrie et al. (2000)
designed an intervention to alter representations ofmyocardial infarction (MI) in
recently admitted patients. The intervention was designed to alter negative or
'catastrophic' beliefs concerning the consequences; timeline and control/cure ofMI.
Illness perceptions were assessed at baseline, prior to discharge from hospital and at
3 and 6 month follow up. Patients in the intervention group reported a greater
understanding of their heart condition, were more ready to leave hospital and
reported greater intention to attend rehabilitation than a control group receiving
standard care. Analysis at follow up also revealed that the intervention group were
likely to have returned to work faster than controls.
Although specific details of the intervention were not provided it is likely that the
intervention involved cognitive behavioural strategies to alter illness representations.
Cognitive Behaviour Therapy (CBT) fits well with the SRM as it is based on the
premise that psychological problems are related to faultypatterns ofthinking and
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behaviour' {Enright 1997). The cognitive aspect of treatment is therefore aimed at
identifying and raising awareness ofpatterns of thought and the underlying
assumptions, examining evidence on which the thoughts are based, challenging
negative thoughts and learning coping strategies (Enright 1997). The efficacy of
cognitive behavioural therapy has been demonstrated across a range of conditions
including depression, generalised anxiety disorder, hypochondiasis and
psychological problems in cancer patients (reviewed by Enright 1997). Recent
studies have specifically applied cognitive behaviour therapy to improving mood and
self esteem in breast cancer patients (Edelman and Kidman 2000, Edelman et al.
1999). It is possible that these techniques may be applied to help women at increased
risk of breast cancer who are having psychological problems adjusting to their risk.
CBT could be used in women at increased risk of breast cancer to raise awareness of
cognitive and emotional representations of breast cancer, restructure unrealistic
negative representations of the disease (e.g. beliefs about treatment), gain a realistic
degree of control and improve coping strategies. However such interventions raise
ethical dilemmas. Breast cancer is a serious and life threatening disease and to date
there are few proven mechanisms by which to control or reduce risk. Negative
beliefs about breast cancer may therefore be more realistic and attempting to
challenge these beliefs may be maladaptive (Taylor et al. 1991, Affleck et al. 1987).
Enright (1997) warns that care must always be taken when adapting cognitive
behavioural therapy to any new area:
" Without this increased understanding of what works for whom and
why, we should remain cautious of overenthusiastic claims for efficacy
and of the clumsy application of genetic cognitive behavioural theory
being made to fit increasingly diverse disorders" (Enright 1997, pg
1815).
11.5.2 Psychological issues in detection behaviour
The SRM proposes that perceptual and conceptual representations are linked. It may
be hypothesised therefore that individuals who are provided with a label for being 'at
increased risk' of developing breast cancer may start searching for symptoms to
match this label. Previous research has found that individuals holding strong
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cognitive and emotional representations are more likely to seek medical care for
undiagnosed symptoms (Cameron et al. 1993). It is possible therefore that both the
strong illness representations derived from experiences ofbreast cancer and the label
ofbeing 'at risk' may encourage regular BSE. However these factors may also lead
to preoccupation with breast cancer, excessive BSE and health anxiety.
"I think there is a tendency to imagine at the very beginning, when you
know that you know there is a possibility ofgetting breast cancer, I think
there is a tendency to imagine that you do have lumps and that you 're
forever testing and examining yourself" (Appleton 1999, quote from
telephone focus group study, personal communication).
A number of studies have indicated that women with a family history of breast
cancer engage in excessive BSE. Approximately a third ofwomen with a family
history ofbreast cancer report that they practise BSE more than once a month
(Lerman et al. 1994a, Brain et al. 1999). Epstein et al. (1997) reported that 8% of a
sample of over 1000 women with a first degree relative with breast cancer practised
BSE excessively (at least once a day). Although increased BSE has been associated
with a number of factors such as ethnicity, perceived risk and intrusive thoughts
about breast cancer, few explanation have been provided for this behaviour (Lerman
et al. 1994a, Epstein et al. 1997). Lerman et al. (1994a) suggest that the behaviour
may reflect obsessive-compulsive disorder or a hypochondrial response to breast
cancer in the family. However in a discussion of hypochondria, Costa and McCrae
(1985) warned that taking a psychiatric view to classifying individuals into
pathological groups can often hide what is infact a continuous variable. They suggest
that examining the phenomena from a psychological standpoint might provide a
clearer explanation that applies across a range of individuals. The concept ofhealth
anxiety represents a continuum of orientation towards health concerns and could be
applied to this issue. The development and maintenance ofhealth anxiety has been
explained from a cognitive behavioural perspective (Salkovskis and Warwick 1986,
Warwick and Salkovskis 1990). Cognitive variables (i.e. beliefs about symptoms)
derived from past experience or information are activated following certain
incidences (i.e. experience of symptoms) and result in anxiety over health. Health
anxiety is associated with attentional bias and misinterpretation of stimuli and can
lead to either avoidance or excessive reassurance seeking. The theoretical
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explanation of health anxiety overlaps with the concepts and processes of the SRM.
However, the SRM also provides a clear link between cognition and coping
strategies that has been omitted from the cognitive behavioural theory of health
anxiety (Hadjistavropoulos et al. 1998). Both of these models can help explain
avoidance or excessive BSE in women at increased risk ofbreast cancer. For
example, from the SRM perspective, avoidance or excessive BSE in women at risk
ofbreast cancer may be conceptualised as a misguided coping mechanism arising
from particular cognitive and emotional representations stimulated by awareness of
risk and experiences in the family.
It is likely that breast cancer related symptoms might also activate emotional and
cognitive representations of the disease. Cameron et al. (1998) reported a trial of
tamoxifen in women with breast cancer in remission. Hormonal symptoms associated
with tamoxifen use were found to increase worries about breast cancer and BSE in
comparison to a placebo-controlled sample. Cameron et al. (1998) suggested that the
side effects of tamoxifen triggered representations of breast cancer and coping
mechanisms including BSE. This holds implications for women at increased risk of
breast cancer who maybe experiencing hormonal symptoms (eg menstrual problems,
the menopause or symptoms resulting from chemoprevention). Additional
information concerning the symptoms ofbreast cancer and the nature ofhormonal
symptoms in each case may help reduce levels of anxiety in each of these groups.
Easterling and Leventhal (1989) also suggest that even non-cancer ('neutral')
symptoms may induce distress. In a study of breast cancer survivors the experience
ofneutral symptoms (eg tiredness, pain) were associated with heightened cancer
worry. The authors suggest that neutral symptoms may act as cues to ones mortality
and vulnerability that can then activate threat cognitions. Provision of support from
the familial breast cancer clinic and availability of urgent appointments for
suspicious symptoms may be instrumental in alleviating anxiety about BSE and
detecting breast cancer. Appleton (2000) found that women attending the familial
breast cancer clinic in Edinburgh gained reassurance and security from the clinic.
They felt closely monitored and privileged to be able to receive specialist care not
available to other women.
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11.5.3 Response to diagnosis
Applying the SRM to this population may also hold implications in the scenario of a
diagnosis of breast cancer. Women holding different representations of the disease
are likely to respond to diagnosis in different ways. For example, beliefs concerning
the control of breast cancer may be associated with psychological adjustment to
diagnosis. However, there has been limited research addressing women's response to
developing breast cancer following information about their risk status. In a
retrospective study, Petrisek et al. (2000) assessed the experience ofbreast cancer
diagnosis in individuals with and without a family history of the disease. Women
with a family history of the disease were less likely to delay symptom presentation,
more likely to consult with specialists, felt comfortable about their treatment decision
and more likely to have received adjuvant therapy than those without a family history
of the disease. The authors noted that previous experiences of family members and
representations of breast cancer appeared to be influence response to diagnosis.
Petrisek et al. (2000) found that patients with a family history were more likely to be
influenced by the experience of others and to fear recurrence when making treatment
decisions.
The authors conclude that
"
Physicians...should check that patients perceptions regarding
morbidity and mortality are in proper perspective. Considering the
importance placed on the opinions offamily members and the similar
experiences of others it may be beneficial to include relatives in
treatment discussions". (Petrisek et al. 2000, pg 141).
Ifwomen are helped and supported during diagnosis, treatment and recovery it is
possible that these experiences will be less anxiety provoking for the next generation
in the family.
11.5.4 Illness perceptions of health professionals
Buick (1997) found that health professionals held different representations ofbreast
cancer when compared to healthy individuals. Although the study reported in this
thesis was not designed to assess beliefs of health professionals, women in the
general population sample who reported to have experience of breast cancer at work,
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showed different perceptions of breast cancer to those without professional
experience of the disease. A number of researchers interested in illness
representations have suggested that inconsistent views between patients and health
professionals may invoke problems in quality of care, particularly when the health
care provider does not reach beyond the medical view of the illness (Buick 1997,
Heijmans et al. 2001). Heijmans et al. (2001) systematically investigated the
incongruence between the views of GPs and their patients suffering from a chronic
illness (diabetes or osteoarthritis). Inconsistencies between illness perceptions held
by patients and their GP were demonstrated for both diseases and the level of
incongruence was associated with poorer physical and mental health. Further
analysis also revealed that incongruence predicted health status and health care use
even after patient perceptions were controlled. The different pattern of results
between the patient groups led the authors to suggest that incongruence has a larger
impact in disease with less clear treatment strategies. These results suggest that the
perceptions ofbreast cancer held by health care professionals involved with genetic
services may influence women's response to their risk status. GPs, consultants and
genetic counsellors need to be aware of their own beliefs concerning breast cancer
and breast cancer risk, potential conflict with perceptions and experiences of the
counselee and the impact of this on the provision and comprehension of cancer risk
information.
11.6 DIRECTIONS FOR FUTURE RESEARCH
This thesis reports the first studies that have directly used the SRM to address
variation in response to risk of familial breast cancer. Although the results are
promising there are a number of additional research questions that need to be
addressed before interventions based on this approach can be designed and
implemented.
As discussed in a previous section (11.3.3c) the validity ofmeasures to assess
components of the SRM require further research and additional dimensions relevant
to individuals at increased risk of disease compared to patient populations need to be
explored. These include beliefs regarding personal control over risk, efficacy of
screening and detection methods as well medical prevention of the disease in
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question. There is also a need to examine women's beliefs about genetics and
inheritance and how they interact with representations of disease (Marteau and
Senior 1997). Qualitative research is required to explore these perceptions in a
systematic manner in order to fully appreciate representations of at risk populations.
Subsequent studies are also required to test the causal nature of the model. The SRM
is dynamic and includes sets of interrelated factors making causality difficult to
unravel. In addition, the factors involved are difficult to manipulate in an
experimentally controlled manner. However a number of other designs have been
discussed that may provide insight to causal mechanisms. These includes the use of
longitudinal prospective designs to examine the impact of changing experiences and
illness perceptions on levels of distress, intervention based studies and also studies
designed in order to investigate the confounding impact of factors such as trait
negative affectivity.
The research in this thesis was designed to assess a particular section of the SRM and
did not include an assessment of coping. Although coping strategies form a major
component of the model it was not feasible to measure coping given the large
number ofmeasures already included in the questionnaire. A number of studies have
investigated a range of coping strategies in patient populations (Hagger and Orbell
2001). However, associations with illness representations or outcome are often
elusive and tests of the mediation of illness representations to outcome via coping
strategies have also proved unsuccessful (Scharloo et al. 1998, Heijmans 1998). It is
possible that the use of general coping measures may not be sensitive enough to
detect effects and it is therefore necessary to develop specific measures of coping
responses relevant to the population in question.
Research assessing coping in women at increased risk of breast cancer has tended to
focus on coping style rather than coping strategies. A monitoring coping style has
been associated with increased distress in samples ofwomen at increased risk of
breast cancer and ovarian cancer (Lerman et al. 1996, Schwartz et al. 1995).
However the implications for these results on intervention design are unclear
(Lerman et al. 1996). Although qualitative studies have investigated how women
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cope with an increased risk ofbreast cancer no measures are currently available
(Appleton et al. 2000). Further research is required to investigate and assess specific
coping strategies used within this population as well as satisfaction with these
strategies. It is likely that cognitive and emotional representations of breast cancer
will evoke different coping strategies and there is a need to examine the associations
between coping, illness representations and adaptive or maladaptive adjustment to
risk.
Another component of the SRM that has been neglected to date is the construct of
appraisal. There are no studies to date that have explicitly investigating how
individuals appraise their coping strategies and the process by which individuals alter
their representations or coping behaviour. Research into this dynamic process is
methodologically difficult and qualitative studies may be most informative in
providing an insight. An understanding of how individuals appraise and change
components of the SRM may provide information regarding potential effective
intervention techniques.
Previously in this chapter the influence of trait negative affectivity on illness
representation was discussed (see 11.3.2). A number of other personality factors may
also influence illness representations including trait optimism. This construct has
been associated with psychological adjustment to diagnosis and treatment in breast
cancer patients and may also influence representations ofwomen at increased risk of
breast cancer (Carver et al. 1994). Optimists are likely to hold more positive
representations, for example, concerning the duration and control of illness.
Preliminary evidence suggests that beliefs concerning the prevention of breast cancer
are associated with trait optimism in women at increased risk ofbreast or ovarian
cancer (Audrain et al. 1997). Research into the SRM needs to incorporate and control
for dispositional factors whilst maintaining a focus on specific components of the
model that can be targeted in interventions. As well as personality factors a number
of other beliefs may also influence illness representations for example beliefs about
genetics and inheritance. These factors also need to be considered to gain a full
understanding of the development and impact of illness representations in individuals
facing genetic predisposition to cancer.
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Leventhal et al. (1997) suggests that there may be an overlap between representations
of disease and representations of self. The impact of risk on representations of self
needs to be addressed in these populations. Nerenz and Leventhal (1983) discuss the
integration between illness and self-concept. They identified three types of relations
between illness and self-system in patient samples. Firstly, perceiving illness as
permeating all aspects of life ('total'), secondly, perceiving only a portion of life to
be effected by the illness ('encapsulated') or thirdly, perceiving oneself as healthy
but at risk of acute disease episodes ('risk'). Kemp et al. (1999) assessed illness
representations, aspects of self-schema in relation to illness, coping and adjustment
in epilepsy patients. Ability to contain the effects of the illness was associated with
avoidant coping and patients who perceived their illness as having pervasive effects
on their lives showed heightened levels of distress. Different relations between
breast cancer risk and self-concept were identified in a telephone focus group study
ofwomen attending the familial breast cancer clinic in Edinburgh (Appleton et al.
1999). Two examples highlighting different impacts of breast cancer risk on self-
concept are given in the quotes below.
"I think you never know what's going to happen in the future and I
wouldn't, I'm not going to spend my time worrying about something that
might not happen or might not happen for a long time "
"I think maybe the hardest thing I've had to do is accept that, that this
will be an ongoing fear there will never come a time in my life when I
will know, at least with current medicine as it is, there probably will
never come a time when I will think, well this is something I won't get".
(Appleton, 1999, quote from telephone focus group study, personal
communication).
Nerenz and Leventhal (1983) suggest that the experience of emotion such as
depression in response to health threats may drive the illness to penetrate ones self-
system. It is possible that awareness of a genetic predisposition to breast cancer,
representations of the disease and emotional response to risk may impact of women's
self-concept leading to further adjustment problems. The association between these
factors requires further investigation in this population.
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This thesis has demonstrated that illness representations influence women's
emotional adaptation to risk. Section 11.5.2 also discussed how the SRM could
enhance our understanding psychological issues regarding detection behaviour.
Illness representations are also likely to play an important role in women's decisions
about risk management and behavioural outcomes including participating in
screening, clinical trials or prophylactic surgery. For example, the uptake of
prophylactic surgery has been associated with heightened risk perception (Stefanek
et al. 1995, Hatcher et al. 2001). However, beliefs regarding the efficacy of
screening, consequences and treatment control ofbreast cancer may be predictive
constructs. It is important to have insight into the decision making process in order
that women can be helped to make the decision that is best for them and to ensure
that decisions are made on up to date knowledge about breast cancer and not on
unrealistic representations or misconceptions of the disease.
The work reported in this thesis may also hold implications for future work on
psychoneuroimmunological interactions involved in breast cancer risk. Negative
emotional states including anxiety and depression have been shown to have
immunosuppressive effects (Selye 1976). Research has attempted to demonstrate the
clinical implications of these findings for oncology by examining the impact of
psychosocial factors on onset, progression and mortality from cancer including the
impact ofpersonality and stress on breast cancer onset and prognosis (Giraldi et al.
1997, Butow et al. 2001, Maunsell et al. 2001). Results in this area have however
been inconsistent because ofmethodological difficulties (Edelman and Kidman
1997, Jensen 1991, Fox 1995). Research has tended to use retrospective, cross-
sectional designs, lack control for other risk factors and use small sample size with
insufficient statistical analysis (Jensen 1991). A few studies have addressed the
impact ofpsychosocial interventions on survival time in metastatic breast cancer
although conflicting results have been found (Spiegel et al. 1989, Edelman et al.
1999). Given possible associations between psychosocial factors and susceptibility to
breast cancer it is feasible that emotional response to risk, illness representations and
coping may influence phenotypic expression of risk in individual carrying a genetic
predisposition. Research in this area would need to incorporate genetic components
(including penetrance rates of different mutations etc) into the vast array of factors
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already involved in psychoneuroimmunological reactions. Although a fascinating
area for research the reactions are likely to be extremely complex and difficult to
examine. This research would require multi-professional expertise and collaboration.
11.7 CONCLUSION
A theoretical approach was utilised within this thesis in order to address clinical
research issues. This study was the first to apply the SRM to healthy women at
increased risk of breast cancer in order to understand possible mechanisms by which
experiences of breast cancer in the family influence psychological adjustment to
breast cancer risk. The research reported in this thesis has presented a number of
psychosocial factors that account for variability in distress in women at increased
risk of breast cancer and discuss how these factors might interrelate. This research
has identified a number ofmethodological issues with using the SRM in this
population including the need to develop sound measures; explore the contribution of
additional constructs pertinent to individuals with a genetic predisposition to cancer
(eg perceived preventability, susceptibility); examine conceptual overlap between
concepts and investigate issues of causality. Despite these limitations the SRM has
been a useful framework with which to explore emotional response to risk and has
potential to guide further research into psychological response to risk including the
decision making process and behavioural outcomes.
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Abstract
Individuals at increased risk of developing breast cancer due to their family history of the disease face a number of
uncertainties. Personal cancer risk estimates are imprecise and current methods for early detection or prevention are not
100% effective. It is therefore not surprising that adverse psychosocial outcomes have been desciibed within this
population. Research attempting to predict the incidence of distress and dysfunction in individuals at increased risk of
cancer has been largely a-theoretical and has overlooked a number of potentially important predictive variables. In
particular, the influence of personal experience of cancer through involvement with affected relatives has been
neglected. There are strong theoretical grounds for hypothesising that dimensions of personal experience may influence
response to cancer risk. This paper discusses the potential impact of personal experience on risk perception, illness
representations and decision-making. Systematic research in this area may improve predictions of outcome of cancer
genetic counselling and inform the clinical process. © 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Cancer; Psychosocial issues; Personal experience; Illness perception: Genetic risk.
Introduction
Breast Cancer is the most common form of cancer in
women (Cancer Research Campaign, 1999). A small
proportion of cases (about 5%) are caused by a germline
genetic mutation which predisposes an individual to
developing breast cancer, often at an early age (Evans et
al., 1994). Women with a family history of breast cancer
may be at risk of inheriting such a mutation and, relative
to the general population, are therefore at increased risk
of developing this disease.
Increased public awareness about the genetic basis of
breast cancer has led to a growing number of familial
cancer clinics which offer individuals genetic counselling
about their risk and advice about risk management.
Risk estimates are derived from family history details
including the number of relatives who have suffered
from breast cancer and the age at which they were
""Corresponding author. Tel.: +44-131-5371838; fax: + 44-
131-3436869.
E-mail address: g.rees@icrf.icnet.uk (G. Rees).
diagnosed. A minority of women may be offered genetic
testing to confirm they are at high risk. The growing
demand for these services requires that resources such as
mammography and clinical examination be targeted to
women at greatest risk.
Psychosocial studies have been concerned with the
uptake and outcome of these genetic services. A
significant minority of women attending genetic coun¬
selling show high levels of distress, intrusive worries
about breast cancer and misperceptions of risk which
are not modified by genetic counselling (Lerman et al.,
1995; Lloyd et al., 1996; Hopwood et al., 1998; Cull et
al., 1999). There are concerns that inaccurate risk
perceptions and distress may interfere with recom¬
mended health care actions for women at increased risk
and provoke inappropriate behaviour in those at low
risk (Lerman & Schwarz. 1993: Rash, Holland. Halper
& Miller, 1992; Epstein et al., 1997). Associations
between these variables are not fully understood and
we are currently unable to predict which individuals will
develop high levels of distress or hold misperceptions of
risk.
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During genetic counselling the objective details of the
family history are elicited. The personal experience of
this family history is not likely to be explored in detail.
Personal experience is shaped by exposure to and
involvement in the physical care of ill relatives, as well
as the emotional and social consequences of breast
cancer in the family. It has been frequently documented
that the experiences of relatives of cancer patients are
extremely stressful (Northouse, 1995). This may be more
so if the observing relative is aware of their own risk of
developing the disease.
The subjective experience of breast cancer in the
family may help to explain variation in women's
response to breast cancer risk. However, research on
this construct has been limited. This paper argues there
are strong theoretical reasons for believing that dimen¬
sions of that experience are important mediators of risk
perception and response to genetic risk information.
This paper discusses the potential impact of experience
from a theoretical perspective, in order to provide
hypotheses to direct future research. The paper is
divided into three main sections. The first section deals
with bias in risk perception. Examples of cognitive bias
in risk perceptions of relatives of cancer patients are
outlined and discussed with reference to experience of
cancer in the family. This is followed by a discussion on
bias particular to genetic risk. The second section looks
at how illness representations may be influenced by
illness in the family and how representations may be
altered by personal genetic risk information. The third
section examines the impact of experiences on decisions
and behaviour and ends with a discussion on how
women's emotional response to their experiences may
influence the decision-making process.
Risk perception and bias
Since the aim of genetic counselling is to provide the
individual with risk information, the recall and accuracy
of risk perception pre- and post-counselling have
received much attention. Inaccurate perceptions of risk
are commonly held and persist after genetic counselling
(Lloyd et al., 1996; Cull et al., 1999). Inaccurate
perceptions of risk, whether overestimated or under¬
estimated, could have detrimental effects on psycholo¬
gical well-being and adherence to screening.
A number of factors including the method of
presenting risk information have been shown to
influence risk perception (Hallowell & Richards, 1997).
Tversky and Kahneman (1974) described three heuristics
that cause bias in risk perceptions when people reason
using uncertain information such as probabilities. The
influence of these heuristics has been demonstrated
within the genetic counselling situation (Shiloh, 1994)
and may be linked to experiences of cancer in the family.
Availability
Easily Recalled events are judged as more probable.
Events that are more salient, familiar, recent and
imaginable are perceived as more likely. This implies
that exposure to a disease in family, friends or through
the media has the potential to influence risk perceptions.
Indeed the risk of health threats such as breast cancer
and AIDS which receive much media attention are often
overestimated (van der Pligt, 1998). Experience of breast
cancer in family, friends and work colleagues has also
been associated with heightened risk perceptions (Helzl-
souer, Ford, Hayward, Midzenski & Perry, 1994,
Drossaert. Boer & Seysel, 1996). Wardle (1995) found
that women at increased risk of ovarian cancer and
women in the general population showed positive
associations between personal risk estimates and the
number of friends and family who had died of cancer.
We would predict that women at increased risk of breast
cancer who have had closer and more frequent contact
with relatives who have suffered from breast cancer,
would be expected to show increased risk perceptions.
Women who have recently suffered a diagnosis or
bereavement in their family might also show elevated
perceptions of risk.
Representativeness
Information about similarity and stereotypes are used
to make judgements. Individuals are inclined to place
emphasis on perceived similarities, but fail to consider
the reliability of this evidence. Individuals often neglect
the impact of probabilities or the effect of sample size on
the representativeness of that observation. For instance,
parents often refer to the degree of parental resemblance
when judging their child's risk of developing an adult
onset genetic disorder, such as Huntingtons disease
(Shiloh, 1994). The degree to which a woman feels she
resembles relatives in her family who have suffered from
breast cancer may influence her perception of risk.
I felt that I would get breast cancer as my body was
similar to my mother's in many ways — she had
fibroids and a hysterectomy — she had gall stones
and had her gall bladder removed. 1 had both these
operations by my late thirties. (J. Zatz, 1996, p. 28)
We may predict that women who feel they resemble
relatives who have suffered from breast cancer, either
physically, demographically or in personality, may have
heightened perceptions of their risk. Indeed, studies have
shown that individuals' feelings of susceptibility to
familial cancer increase as they near the age at which
their relative was diagnosed (Richards, Hallowell,
Green, Murton & Statham, 1995; Brain et al., 2000).
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Anchoring and adjustment
Individuals are biased towards a preconceived idea
about their level of risk when provided with new risk
information. The initial risk estimate is said to act as an
'anchor', which is adjusted following risk information.
Shiloh and Saxe (1989) found that perception of risk
after genetic counselling for congenital disorders was
strongly influenced by expectations before counselling.
Studies have shown that individuals often make
categorical judgments of risk and reduce risk to binary
form, such as 'dangerous or safe' (Redelmeier, Rozin &
Kahneman, 1993; Shiloh, 1996). A minority of indivi¬
duals at increased risk of breast cancer believe that
development of cancer is inevitable (Cull et al., 1999).
This belief is likely to form a strong anchor that
influences the way in which subsequent risk information
is interpreted.
There is little information about what factors
influence individuals' estimates of their risk status. It is
likely that experiences in the family contribute to
preconceptions of personal risk. Shiloh and Saxe
(1989) found that experience of genetic disorder within
the social circle was associated with higher risk
expectations. It is possible that the proportion of family
members affected by breast cancer may contribute to
women's expectation of their level of risk.
I think it's inevitable because there's no female
members of my family who haven't had it.... It's
scary. (Appleton, 1999, quote from telephone focus
group study, personal communication).
Genetic risk and bias
Understanding of familial disease risk is further
complicated by misconceptions about genetics. Lay
concepts of inheritance are often based on resemblance
and the joint inheritance of multiple physical and
personality traits (Davison, 1996). There is a tendency
to believe that susceptibility to illness is associated with
similar personality and physical dimensions (Richards &
Ponder, 1996). These beliefs often persist even after
scientific, Mendelian accounts of inheritance have been
provided (Richards, 1996). Beliefs about the inheritance
pattern in the family, based on the relations and
resemblance to affected relatives, may have a strong
impact on perception of risk.
When I was young my mother attributed her own
breast cancer diagnosis to birth order. She talked
about being the affected first born daughter of an
affected first born daughter of an affected first born
daughter. She told me that as a first born daughter in
this line, I should expect to encounter the disease as
well. With the diagnosis of one of my mother's
younger sisters when I was 25, my mother stopped
talking about the disease as a problem for first born
daughters. Instead she dwelt on the personality traits
that her affected sister shared with their mother — a
certain intensity and vulnerability to stress looming
large among them. (E. Macke, 1996 p. 32).
It is also widely believed that a greater proportion of
inheritance is acquired from the same sex parent
(Richards & Ponder, 1996). Indeed women with a
paternal family history of breast cancer are under-
represented at genetic clinics (McAllister, Evans, Ormis-
ton & Daly, 1998). It has been suggested that women
with a paternal family history have lower perceptions of
risk because of limited understanding of how a
predominately female disorder can be passed on by
males (Green, Richards, Murton, Statham & Hallowed,
1997).
Illness representations
Perceptions of breast cancer and beliefs about the
disease are likely to influence how an individual reacts
(in terms of thoughts, feelings and decisions) to their
own risk status. A theoretical perspective that takes such
beliefs into account is the study of lay beliefs and
representations of illness (Leventhal Meyer & Nerenz,
1980).
Illness representations refer to peoples' perceptions of
and beliefs about an illness. Leventhal's (1980) Self
Regulatory Model states that reactions to health threats
are mediated by these representations. Illness represen¬
tations may develop from a variety of sources including
direct experience of illness and medical care, experience
of illness through family, friends and the media, as well
as ideas inherent in cultural beliefs and language.
Generally five dimensions of illness representations have
been distinguished: identity of the threat (its symptoms
and label); cause (e.g. infection, genetic, stress); time line
(duration and development); consequences (including
somatic and psychosocial); controllability in terms of
prevention and cure (Leventhal & Benyamini. 1997).
Illness representations may differ widely depending on
experience and culture and are dynamic and changing.
Variation in representations will lead to different
responses to the same health threat. Illness representa¬
tions have been associated with psychological, beha¬
vioural and medical responses to a range of chronic
illnesses (Scharloo & Kaptein, 1997). For example,
Buick (1997) found that breast cancer patients who
reported high levels of distress and functional disruption
were those who perceived the disease as long in
duration, with severe consequences, and who held strong
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beliefs of self blame and diminished belief in the
possibility of cure or control.
Genetic risk and illness representations
The experiences of women with a family history of
breast cancer are likely to have a strong impact on their
representations of the disease, particularly beliefs about
the consequences, cure and control of breast cancer.
Women with the same objective family history may have
had differing levels of exposure to the effects of breast
cancer and have witnessed different consequences of the
disease. Experiences may range from exposure to
positive role models, who survived breast cancer and
coped well with the disease, to more negative experiences
in which relatives suffered physically and mentally
before dying.
I'm lucky in the fact... that I have... more
surviving relatives that have had breast cancer and
are fine and that's a big inspiration... You think
well its beatable its not a death sentence (Appleton,
1999, quote from telephone focus group study,
personal communication).
These experiences and the subsequent representations
derived from them are likely to have a profound effect
on women's responses to genetic risk information
including their emotional adjustment and screening
behaviour. For example, Payne (1990) found that
women's beliefs about the cause and control of breast
cancer mediate the decision to practice breast self-
examination. Many of these women were found to have
experiences of breast cancer in friends and family, but
the degree to which these experiences determined illness
representations was not investigated.
We have little understanding of how awareness of
genetic predisposition to breast cancer will affect
representations of the disease. Being informed about
genetic risk is most likely to influence beliefs about the
cause of breast cancer but may also alter beliefs about its
controllability and cure. Senior, Marteau and Weinman
(2000) reported an experimental study in which partici¬
pants were provided with hypothetical test results for
either heart disease or arthritis. Participants who were
informed that the test was genetic were more likely to
attribute the illness to genes and less to lifestyle, and to
rate both conditions as less preventable, than partici¬
pants who were not informed of the nature of the test.
However, this study was conducted on participants
with limited experience of the illness. It remains to be
seen how knowledge about genetic risk will influence the
beliefs of clinical populations with a family history of the
disease in question. It is possible that the consequences
of the illness witnessed in the family may influence
beliefs about both breast cancer and genetic illness.
Decisions and behaviour
Women at increased risk of breast cancer are faced
with a number of difficult decisions about risk
management for example, whether to attend for
screening, perform breast self-examination, participate
in chemoprevention trials, have genetic testing or
prophylactic surgery. Efficacy of these measures is
not known. Given the lack of clear advice on the best
course of action, women may be strongly influenced by
their own experiences of breast cancer in their family
and also by the decisions of other family members at
increased risk. It is important to understand this
decision-making process in order to help individuals
interpret risk information and reach the decision that is
best for them.
Early studies of human reasoning and decision¬
making attempted to discern processes that individuals
use in order to make optimal decisions. Based on the
utility theory individuals were thought to make decisions
by assessing the probability and utility (importance) of
events in order to maximise positive outcome (von
Neumann & Morgenstern, 1947). Evidence for this
rational decision-making strategy has remained contro¬
versial (Neumann & Polister, 1992). It is now accepted
that such decisions are based upon a subjective
interpretation of both probabilities and utilities. The
theory was therefore generalised to the subjective
expected utility theory (SEU) which proposes that
optimal decisions are based upon the decision maker's
personal expected utility of various outcomes.
Wroe, Salkovskis and Rimes (1998) assessed sub¬
jective reasons for undergoing predictive testing in two
settings. The first used hypothetical scenarios to elicit
reasons for genetic testing in student volunteers. The
second examined reasons given by individuals who had
contemplated genetic testing for a variety of disorders.
The ratio of personal reasons for and against testing
predicted the decisions made. In support of the SEU
theory the prediction was enhanced when the reasons
were weighted according to their relevance. Beliefs about
the pros and cons of screening and preventative
measures are likely to be influenced by a number of
factors including other people's experience with the
disease or behaviour. For example, Wroe et al. (1998)
provided a scenario in which a woman refused
mammography since she believed it to be a cause of
breast cancer, based on experiences of family and
friends.
Health behaviour models
Theories aimed at understanding health-related beha¬
viour have been developed from the general decision¬
making perspective. A number of models have been
developed based on the premise that individuals make a
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rational analysis of the costs and benefits of possible
behaviours. Two of these models will be discussed
here. The best known model of health-related behaviour
is the health belief model (HBM). This was initially
designed to explain and predict compliance with
preventative behaviours such as screening and immuni¬
sations (Rosenstock, 1966; Becker, 1974). According to
this model readiness to engage in health behaviour
depends on four beliefs; perceived susceptibility to the
health threat; perceived seriousness of the health threat;
perceived benefits of action; perceived costs of the
behaviour. An individual will be most likely to engage in
preventative behaviour if they regard themselves as
susceptible to a serious illness and consider some
preventive behaviour to have more benefits than costs.
Once an individual is ready to act, behaviour is triggered
by cues (Rosenstock, 1966). Cues may be internal, such
as bodily states, or extraneous (e.g. health messages in
the media).
Components of the model, including perceived
susceptibility and barriers to action, have predicted
breast self-examination among women in the general
population (Champion, 1987). The HBM has been used
with limited success to explain poor adherence to
screening in women at increased risk of breast cancer
(Kash et al., 1992). Relative to controls, women with a
family history of breast cancer show higher levels of
perceived susceptibility and perceive breast cancer as
more severe (Wellisch, Gritz, Schain. Wang & Siau,
1991; Drossaert et al., 1996). However, the impact of a
family history of breast cancer on screening behaviour
remains unclear. Studies have reported both positive
associations between a family history of breast cancer
and screening behaviour (Lerman, Rimer, Trock,
Balshem & Engstron, 1990) and no difference in breast
self-examination and mammography attendance be¬
tween women with and without a family history (Well¬
isch et al., 1991; Alagna, Morokoff & Bevett, 1987).
It may be that the subjective experiences within the
family rather than a family history per se are important
in forming the component beliefs of the HBM. In the
studies of daughters of breast cancer patients, Wellisch,
Gritz, Schain, Wang and Siau (1992) and Wellisch,
Schains, Gritz and Wang (1996) examined daughters'
experiences and perceptions of their mothers' illness. A
number of aspects of experience appeared important
determinants of adjustment. These included the daugh¬
ter's age and degree of involvement with her mother
when suffering from breast cancer and whether the
mother had died (Wellisch et al., 1992). The daughter's
perceptions of changes in mother's quality of life, daily
living and self-image in terms of attractiveness and
sexuality also appeared important factors (Wellisch et al
1996). These experiences may not only contribute to the
perception of the severity of the disease but also act as
cues to impel the individual to seek information about
their own risk. Loss of relatives to breast cancer as well
as recent diagnosis of breast cancer in family members
has been shown to prompt women to attend breast
cancer familial clinics (Richards et al., 1995). How often
daughters of breast cancer patients talk to their mother
about breast cancer has been positively associated with
frequency of performing breast self-examination (Bene¬
dict, Coon, Hoomani & Holder, 1997).
Women with the same objective family history may
have developed different beliefs about their personal
susceptibility to breast cancer, the severity of the disease
and its consequences, depending on their experiences.
Some women may be more exposed to cues about their
risk, depending on breast-cancer-related events and
communication styles in the family.
A more general theory of behavioural decisions that
has been applied to health-related behaviours is the
theory of reasoned action (TRA) (Ajzen & Fishbein,
1980). This model suggests that intentions to perform a
particular behaviour arise from both personal attitudes
towards the behaviour and also social influence.
Attitudes towards the behaviour may be positive or
negative depending on the perceived consequences of the
behaviour. Social influence, known as 'subjective norm"
refers to the perceived expectations of important others.
The theory was later extended to the theory of planned
behaviour (TPB) with the addition of 'perceived
behavioural control' in order to help explain behaviour
that is not entirely under volitional control (Ajzen,
1991). The model proposes that intentions to perform a
behaviour will be strong if an individual holds a positive
attitude towards the behaviour, perceives him/herself to
have control over the behaviour and believes that
significant others expect him/her to perform it.
The theory of reasoned action/planned behaviour has
rarely been applied to issues raised by cancer genetics.
Devellis et al. (1990) assessed the predictive value of
both the TRA and TPB on colorectal cancer screening
for individuals at increased risk and controls. In both
groups, intention to participate in screening was
significantly associated with attitude toward the test.
The predictive power was increased when perceived
behavioural control was included in the model. Sub¬
jective norm only predicted intention to participate in
screening in the control group. The authors suggest that
subjective norm was not predictive in the high-risk
sample due to its low variability. The majority of
individuals in this sample reported that important others
wanted them to undergo screening.
Whilst this model has not been explicitly tested in
women at risk of breast cancer, studies suggest that
relatives may actively encourage or dismiss utilisation of
genetic services. For example, daughters of breast cancer
patients are often encouraged to perform breast self-
examination by their mothers (Benedict et al., 1997) and
a minority of women attend familial breast cancer clinics
1438 G. Rees et al. / Social Science & Medicine 52 (2001) 1433-1440
following advice from another family member (Brain et
al., 2000). The beliefs of family members and commu¬
nication styles within the family may influence both
attitudes towards the behaviour as well as providing
strong subjective norms.
Decision-making and emotions
Distress has been found to be an important barrier to
screening programmes in women at increased risk of
breast cancer (Lerman & Schwarz, 1993). Negative
associations have also been found between levels of
anxiety and frequency of performing breast self-exam¬
ination (Kash et al., 1992). Distress and anxiety may
also interfere with the decision-making process (Mann
1992). However, we have limited understanding of why
some women show high levels of distress whilst others
do not. It is likely that women's experiences of breast
cancer in their family contribute to levels of anxiety and
distress. For instance, women who have suffered
bereavement due to breast cancer, who are particularly
close to affected relatives or who have relatives currently
undergoing treatment may show higher levels of distress.
Zakowski et al. (1997) found that women at increased
risk of breast cancer who had a parent die from cancer
showed significantly higher levels of intrusive thoughts
about cancer than women who had not suffered such
bereavement.
Choices about risk-management strategies such as
prophylactic surgery may be made in order to reduce
anxiety. Stefanek, Helzlsouer, Wilcox and Houn (1995)
found that women who opted for prophylactic surgery
reported more worries about breast cancer than those
who had decided against or were not considering
surgery. Given that these women all had similar
objective family histories, it is possible that the
subjective experiences in the family may have contrib¬
uted to breast cancer worry.
Given the serious nature of the decisions women face
it is important to understand women's emotional
response to breast cancer events in the family and how
this may affect the decision-making process. Wroe et al
(1998) found that emotions were considered as pros and
cons when contemplating genetic testing. Both initial
emotional reactions to genetic testing and emotions
anticipated after testing appeared important.
1 am too anxious not to have the test" "I will get
upset and anxious if I get a bad result (Wroe et al.,
1998, p. 618).
Anticipated emotions are commonly cited when
considering genetic testing. Lerman et al. (1995) found
the main reason against genetic testing for breast cancer
was concern about emotional reactions. Women antici¬
pated anxiety, depression and impaired quality of life
following a positive test result. Anticipating future
emotions is extremely difficult and individuals tend only
to consider emotions immediately following the decision
rather than how they will feel in the longer term
(Redelmeier et al., 1993). Women's experiences of breast
cancer in their family and their beliefs about the disease
are likely to have a large impact on how they anticipate
their response to a positive test result.
Conclusions
Individuals at increased risk of breast cancer face
much uncertainty about if and when cancer will develop
and decisions about how to manage this risk. To date we
are unable to predict which women will have difficulties
adjusting to their genetic risk.
This review has shown that there are strong practical
and theoretical reasons for believing that women's
experiences of breast cancer in their family will influence
how they think and feel about their own risk. Two
women with the same objective risk of developing breast
cancer may have had completely different experiences of
breast cancer in their family, it is these experiences
which may invoke different responses to genetic risk
information. For example women may have had
different levels of exposure to the disease, witnessed
different medical, somatic and psychosocial conse¬
quences of the illness and identify with ill relatives to
varying degrees.
This paper has shown theoretically how these
experiences may influence women's perceptions of their
risk, representations of breast cancer and decision¬
making processes. Ultimately these experiences may
influence women's emotional and behavioural response
to risk. We are now in a position to design hypothesis-
driven studies to test the predictions suggested through¬
out this paper.
We need to understand the role of women's experi¬
ences of breast cancer in their family in how women
conceptualise cancer risk, interpret and cope with risk
information, and make subsequent decisions. Risk
counselling in future may be more effective in helping
women achieve an accurate perception of their risk and
reducing adverse psychological consequences if it begins
by taking account of the counsellees' pre-existing
framework of beliefs based on their personal experience.
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INFORMATION SHEET
Personal views about breast cancer.
What is this study about?
This study is part of a 3 year research project funded by Imperial Cancer Research Fund to investigate
women's beliefs about breast cancer. Many women feel anxious about the risk of breast cancer. This
anxiety may be associated with experiences of the disease in family and friends. It is important to
understand women's experiences and personal views about breast cancer in order to provide appropriate
support. In this study we are interested in the beliefs ofwomen in the general population and ofwomen
with a family history of breast cancer who attend the Ardmillan Familial Breast Cancer Clinic. We are
interested in comparing the beliefs of women with and without a family history of breast cancer and to
explore the associations between experiences ofbreast cancer, beliefs about breast cancer and levels of
distress.
What is the purpose of this research?
The Ardmillan Familial Breast Cancer Clinic is a research led clinic where women with a family history of
breast cancer are counselled about their risk and offered regular screening.
We have found that a small number of women who attend the clinic suffer from high levels of anxiety
about their risk of breast cancer. The ultimate aim of this research project is to understand how women's
experiences and beliefs about breast cancer are associated with this anxiety. Understanding the cause of
such anxieties will help us to provide the best possible support to these women and to target psychological
support to those who need it.
What is involved for me if I take part?
If you would like to take part in this study you will need to sign and return the enclosed consent form. We
will then send you a questionnaire pack which we will ask you to complete and return. This will contain a
number of questions about your background (marital status, number of children etc.), your experiences of
breast cancer in your family, your personal views about breast cancer, your worries and concerns about
breast cancer and your day-to-day feelings. We must stress that there are no right or wrong answers to any
of the questions asked, and we are most interested in your own personal views.
What if I do not wish to take part?
If you do not wish to take part please let us know by returning the consent form having ticked the
appropriate box. We can assure you that if you do not wish to take part in this study this will in no way
affect any of the services you receive now or in the future. You are free to withdraw from the study at any
time if you decide you do not want to complete the questionnaire.
What happens to the information I provide?
All information collected as part of this study will be treated as highly confidential. Only research staff
involved in this project shall have direct access to the information collected. Information from the study
may be passed to GPs and clinicians at the Ardmillan Familial Breast Cancer Clinic.
Can I find out more about the study?
If you would like to discuss this study further with someone who is not directly involved please contact:
Joyce Campbell, Genetic Research Nurse, Breast Unit, Western General Hospital, Crewe Road,
Edinburgh, EH4 2XU. Tel: 0131 537 1615. Joyce helped run the Ardmillan Familial Breast Cancer Clinic
for a number of years but is not directly involved with this research project.
Principal Researcher: Gwyneth Rees, Department ofClinical Psychology, Outpatients Building,
First Floor, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU.
Tel: 0131 5371838 Email G.Rees(a)icrf.icnet.uk
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Pilot experience questionnaire
You have already been asked a lot of questions for the family history form, but this
does not tell us what your own experience of breast cancer within your family has
been like. It is impossible to take into account the whole range of experiences
people have had, but these questions aim to help us to understand how different
experiences affect what people think, feel and do about their own risk.
Please complete the following 2 questions by giving the number which applies (or circle
"Don 7 know ")
How many of your relatives who have had breast cancer were personally
known to you?
How many, if any of these relatives have died because of breast cancer?
At this stage we don't want to burden you with too many questions about your
experience of breast cancer within your family and we realize that some of the
things we are asking may be upsetting for you. We would like to get an idea of
what dealing with breast cancer in your family has meant for you. For the
following few questions please think about ONE RELATIVE who has or is
suffering from breast cancer whose illness has particularly affected you. We realise
that experience varies throughout the illness but we would like you to think of your
lasting impression of their illness.
What relation was this one person to you (eg mother, sister etc)?
How close were you? Not at all Quite close Very close
close
2 3
What age were they when breast cancer was first diagnosed?
What age were you when their breast cancer was first diagnosed?
How are they now? Alive and
well
Alive Died from Die from
but unwell this cancer other causes
1 2 3 4
22b. If this person died how long ago was that?
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Did their illness/treatment cause them
much physical suffering?
Did their illness treatment cause them
much emotional distress?
Overall, how upsetting was their
illness for you?
Overall how well do you think they
coped with their illness/treatment?
Do you think you are like them in
general?
Do you feel that your relationship with
this person changed when they
developed cancer?
Do you feel that your role in the
family has changed because of your
experiences ofbreast cancer?
How much do you feel your life plans
have changed because of the risk of
cancer in your family?
Did you talk about your relative's
cancer with the rest of your family at
the time?
Do you talk now about your own risk
with your family?
Do you talk now about your own risk
with your family?
(please circle the relevant response)


























Experience questionnaire for the increased risk sample (Sample A)
Personal Experience of Breast Cancer
You have already been asked a lot ofquestions aboutyourfamily history, but this does
not tell us what your own experience ofbreast cancer within yourfamily has been like. It
is impossible to take into account the whole range ofexperiences people have had, but
these questions aim to help us understand how different experiences affect what people
think, feel and do about their own risk.
15. How many of your relatives who have had breast cancer were personally
known to you?
16a. Have any of these relatives been diagnosed with breast cancer recently
(ie within the last 5 years). Yes [ ] No [ ]
16b. If yes, please could you let us know how long ago these relatives were
diagnosed?
17a. How many, if any of these relatives have died because of breast cancer?
17b. Please could you let us know how long ago these relatives died?
We would like to get an idea ofwhat dealing with breast cancer in yourfamily has
meantfor you. For the followingfew questionsplease think about ONE RELATIVE
who has or is sufferingfrom breast cancer whose illness hasparticularly affectedyou.
We realise that experience varies throughout the illness but we would like you to think of
your lasting impression oftheir illness.
18. What relation is this person to you (eg mother, sister etc)?
19. How close were you? Not at all Quite close Very close Extremely
close close
12 3 4
20. What age were they when breast cancer was first diagnosed?
21. What age were you when their breast cancer was first diagnosed?
22a. How are they now? Alive and Alive Died from Die from
well but unwell this cancer other causes
12 3 4














Did their illness/treatment cause them
much physical suffering?
Did their illness treatment cause them
much emotional distress?
Overall, how upsetting was their
illness for you?
Overall how well do you think they
coped with their illness/treatment?
Did this person hold a positive attitude
towards their illness?
Do you think you are like them in
body shape and size?
Do you think you are like them in
personality?
Do you feel that your relationship with
this person deteriorated when they
developed cancer?
Do you feel that your role in the
family has changed because of your
experiences ofbreast cancer?
How much do you feel your life plans
have changed because of the risk of
cancer in your family?
Do you feel that your experiences have
brought the family closer together?
To what extent have your experiences
been positive?
Not at A Quite a Very Extremely
all little lot much




Experience items for the general population sample (Sample B&C)
Personal Experience of Breast Cancer
We would like to askyou about anyfamily members orfriends who have sufferedfrom
breast cancer.
15a. Have any of your relatives ever suffered from breast cancer?
Yes □ No □
Ifno, please go to question 16.
15b. Please list what relatives have suffered from breast cancer (eg mother, sister etc)
16. Have any of your family or close friends suffered from breast cancer recently?
(ie in the past 12 months)
Yes □ No □
17. Does your work bring you into contact with cancer patients on a regular basis?
Yes □ No □
Ifyes, please give details
18. Do you have any other experiences of breast cancer you would like to tell us
about?
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Experience items for the follow-up sample
Since you lastfilled in this questionnaire about 3 months ago have you attended the
Ardmillan Familial Breast Cancer Clinicfor an annual check up?
Yes
No
Since you last filled in this questionnaire, can you think of any experiences that may
have changed your thoughts and feelings about breast cancer?
Yes
No
If yes, please let us know about these experiences by ticking the box (s) and describing
your experiences. (Please continue on a separate sheet ofpaper ifnecessary)







Illness Perceptions Questionnaire- Revised (50 item) (IPO-R50). Adapted to assess
perceptions of breast caner in healthy women.
Item classification.
The subscales are colour coded for east of interpretation in this Appendix. Items that are











* Item reversed scores
- Items removed from IPQ-R38.
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Your views about breast cancer
We would now like to askyou some questions about yourpersonal views about breast
cancer. There are no right or wrong answers and we are most interested in your
personal opinion.
Listed below are a number of symptoms that you may or may not associate with breast
cancer. Please indicate by ticking in the space given, if you believe the symptom is
related to breast cancer.
This symptom is related to breast cancer.
a. Hard or tender growths in body ..















q- Loss of Strength
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We are interested in your own personal views about breast cancer.
Please indicate how much you agree or disagree with thefollowing statements about











1 There is a lot patients can do to
control symptoms of breast cancer
2 Breast cancer has a negative
impact on patients -
3 Symptoms of breast cancer come
and go in cvclcs
4 Breast cancer is very
unpredictable
5 Symptoms of breast cancer are
beyond patients' control * -
6 Breast cancer makes me feel
afraid
7 Patients experience breast cancer
symptoms pretty much all of the
time *-
8
9 Breast cancer strongly affects the
way patients see themselves as
people -
10
11 Breast cancer lasts for a long time
12 The negative effects of breast
cancer can be prevented (avoided)
by treatment
13 The symptoms of breast cancer
change a great deal from day to
day
14 Recovery from breast cancer is
largely dependent on chance or
fate * -
15 Breast cancer strongly affects the













17 Breast cancer has serious financial
consequences
18 Breast cancer causes difficulties
for those who are close to patients
19 Symptoms of breast cancer will be
around whatever patients do * -
20 Breast cancer lasts a short time *
21 Treatment can control breast
cancer
22 What patients do can determine
whether breast cancer gets better
or worse
23 I worry a lot about breast cancer -
24 Breast cancer is likely to be
permanent rather than temporary
25 I get depressed when I think about
breast cancer
26 Breast cancer is easy to five with *
27 Breast cancer makes me feel
anxious
28 Nothing patients do will affect
breast cancer *
29 Patients have the power to
influence breast cancer
30 Breast cancer does not have much
effect on patients" lives *
31 Breast cancer is present all the
time
32
33 Breast cancer does not worry me *
34 Breast cancer goes through cycles
in which it gets better and worse
35 Breast cancer improves in time a
al Item number 35 is in Treatment control subscale in IPQ-R50. In the IPQ-R38 item 35 is moved to












36 When I think about breast cancer I
get upset
37 Breast cancer lasts for a lifetime
38 Treatment is effective in curing
breast cancer
39 There is very little that can be
done to improve breast cancer *
40 Breast cancer makes me feel angry
41 Breast cancer is not a problem for
patients * -
42 Patients' actions will have no
effect on the outcome of breast
cancer *
43 Breast cancer passes quickly *
44 The course of breast cancer
depends on the patient -
45 The symptoms of breast cancer
are distressing to me -
46 Breast cancer has major
consequences on patients' lives
47 Breast cancer is a serious
condition
48 There is nothing which can help
breast cancer patients*
49 Breast cancer doesn't bother
patients much * -
50
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Causes of breast cancer
We are interested in what you consider may be the cause ofbreast cancer. As people are very
different, there is no correct answerfor this question. We are most interested in your own views
about the factors that may cause breast cancer rather than what others including doctors or
family may have suggested to you. Below is a list ofpossible causes for breast cancer. Please










Hereditary' - it runs in the
family
A germ or virus
Diet or eating habits
Chance or bad luck
Poor medical care in the past
Pollution in the environment
Patients own behaviour
Patients mental attitude e.g.
thinking about life negatively
Family problems or worries
causes breast cancer
Overwork
Emotional state e.g. feeling








In the table below, please list in rank-order the three most importantfactors that you believe to
cause breast cancer. You may use any ofthe items from the box above, or you may have
additional ideas ofyour own.















lost much sleep over worry? Not
at all
No more Rather moreMuch more
than usual than usual than usual
been having restless, disturbed nights? Not
at all
No more Rather more Much more
than usual than usual than usual
been managing to keep yourselfbusy and occupied? More so Same Rather less Much less
than usual as usual than usual than usual
been getting out of the house as much as usual? More so Same Rather less Much less
than usual as usual than usual than usual




Rather less Much less
well well








been satisfied with the way you've carried out your task? More About same Less satisfied Much
satisfied as usual than usual less satisfied










































felt constantly under strain? Not
at all
No more Rather more Much more
than usual than usual than usual
A-15
HAVE YOU RECENTLY
































been getting scared or panicky for no good reason? Not
at all
No more Rather more Much more
than usual than usual than usual








found everything getting on top of you? Not
at all
No more Rather more Much more
than usual than usual than usual
































































found at times you couldn't do anything because











The following questions ask about any concerns you may have regarding breast cancer. For each question
please tick one box to indicate your answer.
During the past month, how often have you thought about your own chances of developing
cancer? Would you say (Please tick one box to indicate your answer)
Not at all or rarely
Sometimes
Often
Almost all of the time
During the past month, have thoughts about your chances of getting cancer affected your
mood? Would you say...




Almost all of the time
During the past month, have thoughts about your chances of getting cancer affected your
ability to perform your daily activities? Would you say
Not at all or rarely
Sometimes —
Often
Almost all of the time ==

















Impact of Event scale
We are interested in knowing how people think about their risk ofbreast cancer. Please
circle the appropriate number to indicate howfrequently these comments were truefor
you durine the last 7 days.
Ifyou have not thought aboutyour risk ofbreast cancer in the last 7 days please tick
this box and go on to the next page.
I have not thought about the risk of breast cancer.
Not at Rarely Some- Often
all times
a. I thought about it when I didn't mean to 1 2 3 4
b. I avoided letting myselfget upset when112 3 4
thought about it or was reminded of it
c. I tried to remove it from memory 12 3 4
d. I had trouble falling asleep or staying asleep, 12 3 4
because of pictures or thoughts about it that
came into my mind
e. I had strong waves of feelings about it 12 3 4
f. I had dreams about it 12 3 4
g. I stayed away from reminders of it 1 2 3 4
h. I felt as if it wasn't real 12 3 4
i. I tried not to talk about it 12 3 4
j. Pictures about it popped into my mind 12 3 4
k. Other things keep making me think about it 1 2 3 4
1. I was aware that I still had a lot of feelings 12 3 4
about it, but I didn't deal with them
m. I tried not to think about it 12 3 4
n. Any reminder brought back feelings about it 1 2 3 4
o. My feelings about it were sort of numb 12 3 4




Item scale correlations of the experience questionnaire (section 6.12.2). A-20
Item deletion analysis of IPQ- (section 6.19.1a). A-21
Test re test correlation of the IPQ R50 for participants who did and did A-22
not report experiences of breast cancer between the questionnaires
(section 6.19.1b).
Dendrogram from hierarchical cluster analysis of IPQ R subscales A-23
(Wards method) in the general population sample (section 6.19.3b(ii)).




Bold represents the proposed scale for each item
Item Scale r n P
1. Did their illness/treatment Traumatic experience .63 110 .000
cause them much physical Coping -.13 111 .164
suffering? Resemblance .19 114 .046
Change .38 114 .000
Positive experience -.17 114 .075
2. Did their illness treatment Traumatic experience .62 110 .000
cause them much emotional Coping -.33 109 .001
distress? Resemblance .11 111 .27
Change .21 111 .029
Positive experience -.03 111 .75
3. Overall, how upsetting was Traumatic experience .42 110 .000
their illness for you? Coping -.005 110 .96
Resemblance .38 113 .000
Change .51 113 .000
Positive experience .05 114 .59
4. Overall how well do you Traumatic experience -.24 110 .011
think they coped with their Coping .57 111 .000
illness/treatment? Resemblance .24 113 .011
Change -.006 113 .95
Positive experience .35 113 .000
5. Did this person hold a Traumatic experience -.11 108 .25
positive attitude towards their Coping .57 111 .000
illness? Resemblance .18 111 .056
Change .04 111 .65
Positive experience .36 111 .000
6. Do you think you are like Traumatic experience .19 110 .042
them in body shape and size? Coping .27 111 .018
Resemblance .52 114 .000
Change .22 114 .005
Positive experience .26 114 .002
7. Do you think you are like Traumatic experience .29 110 .002
them in personality? Coping .16 111 .101
Resemblance .52 114 .000
Change .40 114 .000
Positive experience .35 114 .000
8. Do you feel that your Traumatic experience .34 110 .000
relationship with this person Coping -.26 111 .007
deteriorated when they Resemblance .016 114 .87
developed cancer? Change .18 114 .059
Positive experience -.15 114 .11
9. Do you feel that your role Traumatic experience .39 110 .000
in the family has changed Coping .067 111 .49
because of your experiences Resemblance .30 114 .001
of breast cancer? Change .30 114 .001
Positive experience .088 115 .35
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10. How much do you feel Traumatic experience .15 110 .12
your life plans have changed Coping .14 111 .14
because of the risk of cancer Resemblance .22 114 .02
in your family? Change .23 114 .014
Positive experience .02 115 .88
11. Do you feel that your Traumatic experience .086 110 .37
experiences have brought the Coping .29 111 .002
family closer together? Resemblance .36 114 .000
Change .13 114 .16
Positive experience .38 115 .000
12. To what extent have your Traumatic experience -.23 110 .014
experiences been positive? Coping .40 111 .000
Resemblance .19 114 .045
Change -.09 114 .32
Positive experience .38 115 .000
Item deletion analysis of the IPO-R
Cases in which the Cronbach's alpha for each of the subscales from the IPQ-R is
improved with an item omitted from the scale. For each subscale from each version of
the measure (IPQ-R50 and IPQ-R38) the item deleted and corresponding alpha
coefficient are provided.




























- - 35 .61 43 .65 35 .61




- - - -





12 .76 35 .63 12 .65
Illness coherence - - - - - - - -
Timeline cyclical 31 .38 - - 31 .33 4 .49
Emotional
representations
- - - - 40 .88 - -
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Further test-retest analysis of the IPQ-R.
The Table below shows test re-test correlation coefficients for participants who did and
did not report breast cancer related experiences between the first questionnaire and
follow-up questionnaire.
Test re-test correlation coefficients for individuals with and without breast cancer
related experiences between the questionnaires.
IPQ-R50 IPQ-R38
Subscale Participants Participants Participants Participants
with experience without with experience without
between experience between experience
questionnaires between questionnaires between
questionnaires questionnaires
N R N R N R N R
Identity 32 .55** 42 54*** - - - -
Timeline 30 .58** 37 74*** 29 .57** 37 70***
Acute/chronic
Consequences 28 40 gQ*** 30 75*** 40 7Q***
Personal 29 .54** 39 g3*** 29 51*** 39 g2***
control
Treatment 28 59*** 40 gl*** 29 .66*** 40 7g***
control
Illness 30 .68*** 40 59*** - - - -
coherence
Timeline 30 -.20 40 .56*** 30 .22 41 .56***
cyclical





Dendrogram from hierarchical cluster analysis of IPQ-R subscales (Wards method)
in the general population sample
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Sobel test calculations for mediation models suggesting mediation.
Model a b sa Sb Test
statistic
p value
ll.l(ii) .211 1.971 .098 .194 2.106 0.035
1 l.l(iii) .173 1.069 .088 .402 1.581 0.11
11.4(iii) -.0055 1.330 .002 .647 1.646 0.099
11.4(iv) -.00067 8.441 .000 4.351 1.940 0.052
11.5 .926 -1.455 .434 .457 -1.77 0.076
11.6(iii) .137 2.105 .061 .270 2.158 0.031
11.7(i) .112 2.319 .029 .300 3.46 0.0005
11.8 .100 2.132 .048 .272 2.013 0.044
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